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resumo 
 
 
A génese de um cancro está dependente da acumulação de mutações 
genéticas que dão origem a instabilidade genómica, que por sua vez resulta na 
proliferação descontrolada. Para prevenir a acumulação destas mutações, as 
células têm mecanismos de controlo (checkpoints) que suspendem o ciclo 
celular e accionam as vias de reparação do ADN. Estes eventos são muitas 
vezes regulados por dinâmicas de (des)fosforilação de proteínas. As proteínas 
fosfatases (PPs), enzimas responsáveis pela remoção do grupo fosfato de 
resíduos fosforilados, desempenham funções cruciais na regulação de muitos 
mecanismos celulares. Enquanto que no início do projecto as cinases 
envolvidas no checkpoint da replicação estavam bem estabelecidas, as PPs 
envolvidas não eram conhecidas. A Chk1, um componente da maquinaria do 
checkpoint da replicação, é exemplo dessa regulação por (des)fosforilação, 
como sejam nos resíduos Ser317 e Ser345. Assim, como primeira abordagem 
para determinar quais os grupos de PPs envolvidos na regulação do 
checkpoint da replicação, decidimos investigar o seu papel na regulação da 
fosforilação da Chk1. 
A primeira conclusão é que a desfosforilação da Chk1 ao longo do tempo, 
tanto in vivo como in vitro, ocorre com uma dinâmica bi-fásica. Em segundo, a 
abordagem in vitro sugere que as famílias PP1, PP2A e PP2C estão 
envolvidas na desfosforilação da Chk1. Uma vez que a família PP2A foi a que 
mostrou a maior acção nesta reacção, decidimos investigar outros membros da 
família in vivo, primeiro com uma abordagem geral (tratando com OA ou sobre-
expressando a PME-1), e depois com o knockdown específico da PP4 e PP6 
(através de siRNA). Os resultados mostram que a inibição das PPs afectam 
tanto a desfosforilação como o estado de activação da Chk1 em resposta a 
tratamento com Hidroxiureia (HU). Todas as PPs testadas in vivo pareceram 
ser capazes de regular, a níveis diferentes, tanto a fosforilação como a 
desfosforilação da Chk1. A função das PPs foi também investigada ao nível: da 
regulação do disparo das origens de replicação, e da recuperação da 
suspensão da replicação, induzida pela HU. No último caso, os dados indicam 
que na situação simultânea de knockdown da PP4 com tratamento de HU, há 
um atraso do ciclo celular na resolução da transição de G2/M. No ensaio de 
replicação por pulse-chase, os resultamos mostram que tanto o tratamento 
com OA, como a sobre-expressão de I-2 ou PME-1, atrasam a cronologia do 
disparo programado das origens de replicação. No entanto, nenhum dos 
tratamentos efectuados parece desregular o início do checkpoint da replicação. 
Um rastreio de 2-híbrido de levedura com uma biblioteca de cDNA de testículo 
humano foi realizado, usando a Chk1 como isco, no sentido de descobrir novos 
interactores e definir novas possíveis funções para a Chk1 no contexto da 
meiose. Com base nos resultados do rastreio, duas novas funções são 
sugeridas: a interacção com a GAGE12 sugere uma função na recombinação 
genómica/vigilância do genoma durante a meiose, e as interacções com a 
EEF1α1 e a RPS5 sugerem uma função na regulação da síntese proteíca. 
Estas experiências fornecem um visão geral para a compreensão da 
diversidade de funções das proteínas fosfatases envolvidas no checkpoint da 
replicação, bem como, abre novos caminhos para o desenvolvimento de novas 
drogas para o tratamento do cancro.  
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abstract 
 
The emergence of cancer is dependent on the accumulation of small numbers 
of genetic mutations that give rise to genomic instability, which in turn results in 
uncontrolled cell proliferation. To prevent the accumulation of such mutations 
and the evolution into a cancer state, cells operate checkpoints by arresting the 
cell cycle and triggering the DNA repair pathways. Often these events are 
regulated by protein (de)phosphorylation dynamics. Protein phosphatases 
(PPs), enzymes responsible for removing the phosphate from phosphorylated 
residues, play key roles in the regulation of many cellular mechanisms. While at 
the beginning of the project the kinases involved in the replication checkpoint 
were well established, PPs involved in the regulation of this pathway were not 
known. Chk1, a key component of the replication checkpoint machinery, is an 
example of regulation by (de)phosphorylation at several residues, such as 
Ser317 and Ser345.  Hence, as a first approach to determine which PPs could 
be involved in the regulation of the replication checkpoint, we decided to 
investigate their role in the regulation of Chk1 phosphorylation state. 
The first finding from our study was that Chk1 dephosphorylation time course, 
both in vivo and in vitro, occurred with a bi-phasic dynamics. Secondly, a 
preliminary in vitro approach suggested that PP1, PP2A and PP2C families are 
involved in Chk1 dephosphorylation. Given that PP2A was shown to be the 
major contributor for this reaction, we investigated close family members in 
vivo, first by a general approach (either with OA treatment or PME-1 
overexpression), and then by specific knockdown using siRNA for PP4 and 
PP6. Our data shows that besides affecting Chk1 dephosphorylation, the 
inhibition of PPs also affects Chk1 activation state in response to Hydroxyurea 
treatment. All the protein phosphatases tested in vivo seemed, to some extent, 
to be able to regulate either Chk1 phosphorylation or dephosphorylation. The 
PPs function was also investigated at the level of replication origin-firing 
regulation and the recovery from HU-induced replication arrest. In the latter 
study, our results indicate that PP4 knockdown triggers a HU-dependent cell 
cycle arrest in G2/M. In the pulse-chase replication assay, we show that OA 
treatment as well as I-2 or PME-1 overexpression, delay the timing of the 
normal replication origin-firing. None of the treatments performed seemed to 
abrogate the onset of the replication checkpoint. 
We have also performed a Yeast Two-hybrid screen in a human testis cDNA 
library using Chk1 as bait, in order to find novel interactors and identify new 
Chk1 putative functions in the context of meiosis. From this screen, two new 
Chk1 functions were defined due to the new putative interactions. Hence, the 
interaction with GAGE12 suggests a function in genomic recombination/ 
surveillance in meiosis and the interactions with both EEF1α1 and RPS5 
suggest a function in protein synthesis regulation. 
These experiments provide a framework for understanding the diversity of the 
protein phosphatase functions involved in the replication checkpoint, as well as, 
for opening new avenues for the development of new drugs for cancer therapy. 
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I.1 THE CELL CYCLE, AND ITS MECHANISMS 
Cells generically propagate life through their own division. While in unicellular systems 
the problems that the cell has to solve to divide are somehow different when 
comparing to multi-cellular systems, ultimately, the latter also depends on the optimal 
regulation of the former, the cell as an individual. Thus, before dividing, cells need to: 
duplicate all key molecules and structures; separate evenly all organelles into two 
daughter cells; and coordinate the machinery in order to ensure that the division does 
not occur before earlier events are terminated. The way that cells solved these key 
points is translated into what today is known as the cell cycle, where specific events 
occur in a very well defined and organized manner. The cell cycle, is composed by two 
broad phases, interphase and mitosis, which may be subdivided into four phases, 
them being G1, S, G2 and M, where the first three are part of interphase (Figure I.1).  
 
 
 
 
I.1.1 INTERPHASE 
The phases that constitute Interphase, G1, S and G2, were named after Gap (“G”) and 
Synthesis (“S”). Although somehow misleading, the G1 and G2 phases name was 
given when the cell cycle started to be elucidated and scientists thought that in those 
phases there was no relevant cellular activity and hence the name Gap. Later, it was 
demonstrated that this was not the case and in order to prepare for division, the cell 
was indeed active and executing several functions, such as for example: protein 
synthesis, DNA repair and organelle duplication. Besides these, during G1 the cell has 
FIGURE I.1 | THE DIFFERENT PHASES OF THE CELL 
CYCLE. The cell cycle is divided in 4 phases: G1, 
S, G2 and M. In broad terms G1, S, G2 may be 
grouped as Interphase. M phase is also known 
as mitosis and may also be subdivided into 4 
distinct phases: Prophase, Metaphase, 
Anaphase and Telophase. A generically fifth 
phase may be considered, the G0 phase. This 
phase refers to the cells that are not actively 
dividing. Despite G0 being depicted in early G1, 
at the moment it is unclear, where specifically 
it occurs (Weinberg 2007).!
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the opportunity to enter in G0 phase (quiescent state). This occurs when the cell is in 
a state of cell-cycle dormancy that may never finish or that may stop upon specific 
extracellular stimuli.  
For an effective segregation of the genetic information that a given cell carries, two 
key events need to occur before the cell enters into mitosis: DNA replication and 
centrosome duplication. The first occurs during S phase and the second starts in G1 
and goes until G2. For both DNA and centrosomes, the separation of either sister 
chromatids or duplicated centrosomes, takes place during M phase.  
 
I.1.1.1 DNA REPLICATION 
The determination of the DNA structure by Watson and Crick (1953) opened doors for 
the investigation of very important mechanisms, such as DNA replication. This 
molecule is constituted by only 4 different monomer units called nucleotides that are 
formed by: a pentose ("-D-2-deoxyribose), a phosphate group and a base molecule. 
This base molecule can either be a pyrimidine (thymine - T and cytosine - C) or a 
purine (adenine - A and guanine - G), depending if the molecular structure presents 
one or two rings, respectively (Figure I.2). The nucleotides are polymerized in specific 
sequences, giving rise to long strands of DNA, where the phosphate group bridges two 
adjacent pentose molecules, building up the backbone of the DNA strand. Hence, in 
turn, each pentose is bound to two phosphate groups on both 3’ and 5’ carbons. In 
order to assemble the double stranded helix, both DNA strands need to pair in an 
antiparallel way, allowing for the packing in an energetically favourable arrangement. 
This is also possible because the base-paring occurs in a complementary way, where A 
always pairs with T, and G with C, in the form of double and triple hydrogen bonds, 
respectively (Figure I.2). !!!!!!! !
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DNA replication is an extremely accurate process where only one in every 109 
replicated nucleotides is wrongly introduced. A number of different key proteins are 
involved in this very well coordinated process, as can be seen in Figure I.3.  
FIGURE I.2 | DNA COMPOSITION AND STRUCTURE. A. DNA monomers, called nucleotides, are 
constituted by a phosphate group, a sugar pentose and a base. These are organized in a 
polynucleotide chain, bound covalently in a 5’ to 3’ (sugar carbon atoms) manner, building a 
sugar-phosphate backbone. A DNA molecule is composed by two DNA strands that are held 
together by hydrogen bonds between the paired bases (B). The strands are bound in an 
anti-parallel way. On the bottom left, the DNA molecule is shown straightened out, but 
typically, it is twisted into the famous double-stranded helix, as shown on the right. B. There 
are four different bases (A, T, G and C) that bind to each other by hydrogen bonds. The 
binding is not random since the pairing is complementary. While A and T bind through two 
hydrogen bonds, G and C through three hydrogen bonds (Alberts, Johnson et al. 2002).!
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The replication process starts at specific sites called the replication origins. This site 
varies between organisms in sequence and number. While in prokaryotes there is only 
one replication origin, in eukaryotes, such as in human cells, there are several 
replication origins per chromosome, allowing for a faster replication process (Cairns 
1966; Huberman and Riggs 1968). These multiple replication origins from eukaryotes 
are usually separated by 30,000 to 300,000 base pairs and are fired at different points 
during S phase. The replication itself is usually divided in three steps: initiation, 
elongation and termination. Initiation occurs at the replication origin sites by a protein 
complex that recognizes the site and has the role of opening the DNA in order to allow 
replication to occur. Since A-T pairs have lower energy than G-C ones, usually the 
replication origin regions are rich in the first set of pair (A-T). The mentioned complex 
is composed by 6 different ORC (Origin Recognition Complex - from 1 to 6) proteins, 
being the ORC2 constitutively bound to replication origins. After the assembly of this 
complex, Cdt1 and CDC6 proteins regulate the loading of another protein complex 
onto the DNA chain, the helicase, which is an ATP-dependent molecular machine 
responsible for the unwinding of the DNA double-stranded helix during the elongation 
step. This helicase is a hexameric complex formed by MCM (minichromosome 
maintenance) proteins (from 2 to 7). Afterwards, a structure known as replication 
bubble is formed revealing the place for the start of the replication process (Arias and 
FIGURE I.3 | MAMMALIAN REPLICATION FORK. Schematic representation of a mammalian 
replication fork. For details on the whole process, see text below (Alberts, Johnson et al. 
2002).!
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Walter 2007). Hence, in each replication origin two DNA synthesis “factories” 
(replication forks) are assembled in both opposite directions of the replication bubble. 
The previous figure just focusses in one of those replication forks. The rate at which 
mammalian replication forks move is about an order of magnitude lower than the one 
from bacteria, which moves at about 1000 nucleotides per second. Since replication 
only develops from 5’ to 3’ direction, the cell faces a problem due to the antiparallel 
strand property of DNA. Thus, only one of the strands is able to replicate the DNA in a 
continuous manner, known as the leading strand. In the other, the lagging strand, the 
DNA is synthesized by the Okazaki fragments, as described below.  
In the leading strand the DNA polymerase, which in this specific case is the # type, 
cannot start the polymerization without a primer. For that, an RNA primer is first 
polymerized on the DNA strand so that the DNA polymerase may start the 
polymerization. This primer is later eliminated and substituted by DNA. In order to 
load the DNA polymerase, a couple of proteins are involved: the sliding clamp 
(Proliferating cell nuclear antigen, PCNA) and the clamp loader (Replication factor C, 
RFC). Once RFC helps the loading of PCNA (which is a circular two-subunit complex) 
onto the DNA template, is displaced by the loading of the DNA polymerase. PCNA 
function is to hold the DNA polymerase bound to the DNA template. DNA polymerase 
has two very important and distinct functions: nucleotide polymerization and 3’ to 5’ 
exonucleolytic activity. The first uses the high energy from the tri-phosphate 
nucleosides to incorporate the nucleotide into the growing chain, and the 3’ to 5’ 
exonucleolytic activity belongs to the proofreading property of the enzyme itself, 
which occurs in various ways. One is the 3’ to 5’ exonucleolytic activity per se, that 
when the enzyme is in the presence of mispairing, it removes the incorrect nucleotides 
until it can start polymerizing again. This is because the DNA polymerase needs a 3’ –
OH (hydroxyl) group from a paired-base on the growing chain in order to add the next 
nucleotide to it. Another way to ensure the proofreading, may occur when adding a 
new nucleotide to the growing chain, since before the nucleotide is covalently bound, 
the DNA polymerase needs to have a conformational change. If the new nucleotide is 
not complementary to the one in the template, there is a strong probability that the 
conformational change needed to carry on the polymerization, may not occur. Hence, 
as a result, it is more likely that the incorrect nucleotide dissociates from the enzyme.  
Since in the lagging strand the replication cannot be continuous, the process is slightly 
more complex and involves other proteins. Thus, right after the DNA helicase, single-
strand DNA-binding proteins (Replication Protein A, RPA) bind to the DNA strand in 
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order to stabilize it. Several RPA proteins bind along the DNA strand without covering 
the template bases, to facilitate the replication process. Afterwards, as in this strand 
the DNA is in the opposite direction from the one in the leading strand, DNA is 
synthesized using Okazaki fragments. In order to synthesize the latter, first the DNA 
polymerase !/primase binds to the strand near the helicase. This protein is composed 
by two domains, where one, the DNA primase, synthesizes the RNA primer that is 
going to be used by the other domain, the DNA polymerase !, which synthesizes the 
first part of the DNA of the Okazaki fragment. After this event, the 
polymerase/primase is displaced by the DNA polymerase # through a similar 
mechanism to the one in the leading strand involving RFC and PCNA. Then, DNA 
polymerase # carries the DNA synthesis until it finds the 5’ end of the RNA primer 
from the next Okazaki fragment. Subsequently, these RNA primers are substituted by 
DNA nucleotides and a DNA ligase seals the missing phosphodiester bonds through an 
ATP-dependent manner.  
The process of replication termination may occur either when two replication forks 
coming from opposite directions face each other in the middle of a chromosome, or 
when the replication forks arrive to the chromosome terminus. In this latter case, 
when it occurs with forks progressing from the lagging strand, the replication 
machinery is not able to produce an RNA primer in order to finish DNA synthesis. 
Hence, cells solved this problem through a structure called the telomere. This 
structure, which is composed by tandem repeats of six nucleotides that in mammals 
may extend for about 10,000 nucleotides in length, is generated by the activity of an 
enzyme called telomerase. In order to be able to synthesize DNA at the chromosome 
termini, telomerase contains in its structure an RNA template that allows the DNA 
polymerization based on that RNA template sequence. This RNA template varies 
between eukaryotic cells, but in humans the sequence is conserved, such that the 
hexanucleotides added to the chromosomes are GGGTTA. Telomere length is 
correlated with the proliferation potential of cells, which means that when telomeres 
get to a critical reduced size, cells become senescent and stop dividing. This reduction 
is due to the fact that in some cells the telomerase activity is lost, which leads to the 
loss of about 50-100 nucleotides in the chromosome ends per cell division cycle. 
The last problem that the replication process needs to deal with is due to the helical 
nature of the DNA molecule. Thus, as soon as the replication forks start to unwind the 
DNA double-stranded helix, high tension forces start to be generated downstream of 
the fork, which may lead to the tangling of the DNA chain. In order to resolve this 
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tension, a family of enzymes, DNA topoisomerases, act over the DNA by cutting and 
religating it. Two different DNA topoisomerases exist to solve two different sorts of 
tensions. While DNA topoisomerase I is ATP-independent and just nicks one of the 
DNA strands, DNA topoisomerase II is ATP-dependent and generates a double-
stranded break so that two double helices crossing over each other can be separated. 
DNA topoisomerase I has a tyrosine at its active site that allows the breakage of a 
phosphodiester bond through the covalent binding to one of the strands. This event 
will allow the DNA to release the tension by turning the strand. After reducing this 
tension, the phosphodiester bond is re-established, hence releasing the DNA 
topoisomerase I and allowing the reconstitution of the DNA helix. Because the 
covalent bond between the DNA topoisomerase I and the phosphate from the DNA 
strand conserves the energy from the cleaved phosphodiester bond, no additional 
energy is needed to release the enzyme and reseal the DNA helix. DNA topoisomerase 
II, in opposition to the DNA topoisomerase I, binds covalently to both interlocked 
chains and generates a transient double-strand DNA break in order to free them. This 
event induces the change in the enzyme conformation, opening then a gate that 
resolves the two interlocked double helices. After solving the problem, the double-
strand DNA break is resealed and the enzyme released.  
In the end of the DNA replication, chromosomes are duplicated and constituted by two 
sister chromatids that are visible during mitosis. Both chromatids are glued together 
by proteins called cohesins, which create an area of the chromosome called the 
centromere. This area varies in location from chromosome to chromosome and is 
characterized by specific DNA sequences that have affinity to bind cohesins. 
Centromeres are important structures that during mitosis allow the correct 
chromosome segregation.  !
I.1.2 MITOSIS 
Once the cell has replicated its DNA efficiently, as well as other organelles, it is in a 
position to divide into two daughter cells, an event that happens through mitosis. The 
cytoskeleton structures are the key players from this whole process, represented by 
both the mitotic spindle that segregates the sister chromatids, and the contractile ring 
that divides the cell in two (cytokinesis). Mitosis happens in four broad steps: 
prophase, metaphase, anaphase and telophase (Figure I.4).  
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I.1.2.1 CENTROSOME FUNCTION 
As is evident from the previous figure, centrosomes play a central role in all four 
steps. These are also known as the microtubule-organizing centres (MTOCs) and are 
critical for both the segregation of chromosomes and the fission of the cell into two 
daughter ones. The composition of centrosomes includes a pair of centrioles and an 
amorphous matrix. This complex matrix is composed of: microtubule-dependent 
motor proteins, coiled-coil proteins (thought to link the motors to the centrosome 
itself), structural proteins, components of cell-cycle control system as well as the "-
tubulin ring complex which is responsible for the microtubule nucleation (Figure I.5). 
Centrosomes function through a mechanism known as dynamic instability, evident by 
the constant polymerization and depolymerization of microtubules, where the first 
tends to be slow and the latter very rapid and sudden. This is the mechanism that 
allows different events, such as chromosome segregation, to occur. Hence, when 
mitosis events start, microtubules become about 20 times faster than during 
interphase, thus increasing the rate of the dynamic instability phenomenon. This is 
due to the phosphorylation of microtubule motor proteins and microtubule-associated 
FIGURE I.4 | MITOSIS. The 4 subphases of mitosis are shown in the picture: prophase, 
metaphase, anaphase and telophase. The cellular components involved can be identified, 
where blue is stain for the chromosomes (DNA) and green for the microtubules. (Weinberg 
2007).!
Protein Phosphatases acting on the Replication Checkpoint                                         Chapter I 
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!
Centro de Biologia Celular 
Universidade de Aveiro | Portugal 27 
Centre for Developmental and 
Biomedical Genetics 
University of Sheffield | UK !
proteins (MAPs). The main microtubule motor proteins are: kinesin-related proteins 
(that move towards the plus end of microtubules) and dyneins (that move towards the 
minus end of the microtubules). The growth of the microtubules occurs in a poleward 
flux manner, which means that the subunits of tubulin are added to the plus end and 
removed from the minus end.  
 
FIGURE I.5 | CENTROSOME STRUCTURE AND CENTRIOLES. A.1. The centrosome is the major 
MTOC, consisting of an amorphous matrix of proteins containing the "-tubulin ring 
complexes. A.2. The depicted centrosome is nucleating microtubules: the minus end of each 
microtubule is embedded in the centrosome, growing from a "-tubulin ring complex, where 
as the plus end of each microtubule is free in the cytoplasm. B.1. Electron micrograph of an 
S phase mammalian cell in culture showing a duplicated centrosome. B.2. Schematic 
representation of B.1 electron micrograph. Each centrosome contains a pair of centrioles, 
that despite being duplicated, still remain together until mitosis. The centrioles pairs are 
shown in different Section views (cross-Section and longitudinal) (Alberts, Johnson et al. 
2002).!
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I.1.2.2 CHROMOSOME SEGREGATION 
During prophase, which is when the chromosome segregation process starts, and after 
phosphorylation of a group of proteins called condensins, chromosomes start to 
condense due to the assembly of condensin complexes throughout them. In the 
meantime, a high number of cohesins that hold the sister chromatids together are lost 
from the centromeres. At this stage, the kinetochores are also assembled. These are 
large protein complexes that form around the centromeres from sister chromatids, 
and are essential for an efficient segregation of sister chromatids. Still during 
prophase the mitotic spindle starts to form, process that is occurs in parallel with the 
migration of centrosomes to opposite poles. The mitotic spindle is composed by three 
different classes of microtubules, depending where they attach to: astral microtubules 
which grow in random directions and help the movement towards the periphery of the 
cell; kinetochore microtubules that bind to kinetochores of the replicated 
chromosomes; and overlap microtubules which generate the structure that support 
the whole mitotic spindle, by the binding of microtubules from both centrosomes 
(Figure I.6).  
In the meantime, the nuclear envelope is disrupted and the microtubules from the 
growing mitotic spindle connect to the kinetochores. The disruption of the nuclear 
envelope is triggered by the phosphorylation of the lamina proteins, which are the 
proteins that lie beneath it. After microtubules from both centrosomes are bound to 
the kinetochores, the chromosomes move actively until they form the metaphasic 
plate. In order to segregate the sister chromatids, two independent movements of the 
mitotic spindle take place during anaphase, generically called anaphase A and B. While 
anaphase A results from the shortening of the kinetochore microtubules, anaphase B 
results from the combination of the elongation of the overlap microtubules and 
shortening of the astral microtubules, forcing the spindle poles to move in opposite 
directions. Besides the mitotic spindle, another protein complex, the anaphase-
promoting complex (APC), also has an import role in the chromosome segregation. In 
fact, APC helps with the initiation of the segregation process by cleaving securin (a 
segregation inhibitory protein), which results in the activation of separase (a protease) 
that in turn cleaves the cohesin complex, allowing the chromatids to separate.  
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Once the daughter chromosomes are separated in opposite poles, the last step of 
mitosis take place, the telophase. In this subphase, vesicles of nuclear membrane 
surround individual chromosomes, which subsequently fuse in order to form one 
nuclear envelope for each set of chromosomes. After, the nuclear pores re-form and 
the nuclear lamins are dephosphorylated in order to reassociate and re-form the 
nuclear lamina. The nuclear pores then start to pump in nuclear proteins increasing 
the volume of both new nuclei. Finally, chromosomes start to decondense allowing 
transcription to restart. !
I.1.4 CYTOKINESIS 
Mitosis ends with cytoplasmic division, mechanism also known as cytokinesis. This 
results from the action of a contractile ring that usually starts to assemble during 
anaphase by the binding of actin and myosin II, among other proteins, to the intra-
FIGURE I.6 | THE MITOTIC SPINDLE. On top is the schematic representation of a mitotic spindle 
from a mammalian cell during metaphase, with reference to the various categories of 
microtubules. Below is a phase-contrast micrograph correspondent to the scheme, where it 
is possible to see the aligned chromosomes on the equator of the mitotic spindle (Alberts, 
Johnson et al. 2002). For detail see text.!
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cellular plasma membrane proteins. The contraction of this ring occurs by the same 
mechanism as in muscle cells contraction, where actin filaments slide against myosin 
II filaments. This phenomemon always takes place perpendicular to the mitotic spindle 
axis. In this way it is ensured that the two daughter cells receive an identical and 
complete set of chromosomes. As the contraction progresses the ring gets smaller and 
is compensated with the addition of vesicles to the membrane in order to increase the 
membrane surface area. The contractile ring disappears completely as soon as both 
daughter cells are separated. !
I.2 CELL CYCLE REGULATION 
Above all events, DNA instability is a central player in the transformation of a normal 
cell into a cancer one, either as a cause or consequence of it. For that reason, 
throughout the whole cell cycle it is very important that all processes related with DNA 
metabolism are well coordinated and controlled. To achieve this, the cell has molecular 
regulators that are responsible for the maintenance of the timing and sequence of the 
events that take place during the different cell cycle phases.  
 
I.2.1 REGULATION THROUGH SIGNAL TRANSDUCTION 
All pathways that work within a given cell result from an intricate and integrated 
combination of proteins that constitute what is known as signalling cascades. The idea 
of a signalling cascade is the same as a relay race, where a specific message needs to 
be passed hand-in-hand, or protein-to-protein in this specific case, in order to get to 
its final destination and do its job. Although the concept is simple, in cells it usually 
becomes complex due to the multiple steps, players and stimuli. Nonetheless, it is 
possible to classify the proteins that constitute a specific signalling cascade in three 
distinct groups: sensors, transducers (or mediators) and effectors. Through this 
classification it is easy to understand which is the function of each protein, being 
sensors the proteins that detect the specific signal and passes it to the transducers, 
which in turn pass it to other transducers until it arrives to the effector, which 
ultimately translates the signal in a given chemical or physical action. The triggering 
signals may have either extra- or intra-cellular origins, where stimulation by growth 
factors is an example from the first and DNA damage from the latter. Typically this 
transmition of signals is made by post-translational modifications in specific proteins. 
Many different types of protein modifications can be found, such as: phosphorylation, 
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acetylation, ubiquitination among others. For all these modifications there are specific 
enzymes responsible either for the addition or the removal of the chemical groups. As 
an example of that are both HATs (Histone acetyltransferases) and HDACs (Histone 
deacetylases), which respectively add and remove acetyl groups to/from the lysines of 
the N-terminal end of histones, inducing conformational changes. In summary, post-
translational modifications may result in several responses: induce the 
activation/inactivation of a given protein; induce a change in its intracellular location; 
or even induce for an interaction to occur. It is by these mechanisms that the different 
cellular responses are regulated, where differentiation, growth and death are the main 
events.  
 
I.2.2 MOLECULAR REGULATION OF THE CELL CYCLE 
Just recently, from the 1970s onwards, the molecular mechanisms behind the 
regulation of the cell cycle, started to be unveiled. In order to understand and to 
approach it, there were two different schools of thought: the Kornbergian that 
defended that there was no point in trying to understand the control of the cell cycle 
until the biochemical mechanisms of processes like DNA replication had been 
understood; and the Geneticists and Embryologists that claimed it was possible to 
understand the regulation of the cell cycle if one could treat mechanisms such as DNA 
replication as black boxes that received unknown signals from a cell cycle controller 
and sent back other signals as well (Hartwell, Culotti et al. 1974). Time gave the 
reason to the latter school, but up until now not every mechanism of the cell cycle is 
yet fully understood. 
As mentioned, the cell cycle is composed by 4 different phases: G1, S, G2 and M. The 
progression through the different phases started to be understood with the work from 
Rao and Johnson (Johnson and Rao 1970; Rao and Johnson 1970) where they fused 
cells in different cell cycle phases and observed what would be induced in 
consequence of that procedure. From there, scientists started to believe in the 
existence of factors that could promote and help in the transition between phases. 
These factors where later found to be composed by cyclins and cyclin-dependent 
kinases (CDKs) (Lee and Nurse 1988).  Among these proteins that are involved in the 
regulation of the cell cycle progression there are cyclins A, B and D and CDKs 1 (or 
CDC2), 2, 4 and 6. While the protein levels of the CDKs are nearly constant 
throughout the whole cell cycle, cyclin protein levels, as the name suggests, varies 
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along the cell cycle, in a specific order, as they are needed through the cycle (Figure 
I.7.A). 
 
Concerning decision making on the progression of the cell cycle, the G1 is the most 
important phase. This is due to the fact that in this phase the cell is able to respond to 
the extracellular stimuli such as growth factors (mitogens) by integrating that 
information with the current homeostasis status of the cell. This is carried out through 
the activity of cyclin D – CDK4/6 complexes. Three different cyclin D proteins that 
form complexes with both CDK4 and CDK6 can be found, complexes which present a 
certain degree of tissue specificity (Matsushime, Ewen et al. 1992; Won, Xiong et al. 
FIGURE I.7 | CYCLINS AND THE CELL CYCLE. A. Cyclin levels fluctuate dramatically throughout 
the cell cycle.  B. This fluctuation is coupled with the activity of the different CDKs that work 
specifically at given cell cycle phase. As a consequence of CDK activity, cell cycle progresses 
as well as the phosphorylation status of pRb, shown in the outer red circle (Weinberg 2007). 
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1992; Xiong, Zhang et al. 1992; Khatib, Matsushime et al. 1993; Hunter and Pines 
1994; Meyerson and Harlow 1994; Schmidt, Ichimura et al. 1994; Tam, Theodoras et 
al. 1994). Their function is so important during G1 phase, that they regulate the 
Restriction (R) point. This is the point where the cell decides whether it should 
proceed to cell division or reverts to G0 state (quiescent state). If the decision is to go 
through the remaining phases of the cell cycle, the cell is not responsive anymore to 
growth factors, and flows almost autonomously through S, G2 and M phases. As seen 
in Figure I.7, the progression of the cell cycle is accompanied with subsequent 
complexes of cyclin-CDKs where E-CDK2 appears at the end of the G1 phase, after the 
R point, enters into the S phase, at which point cyclin E is substituted by cyclin A 
generating the complex A-CDK2. By the end of the S phase CDK2 is in turn 
substituted by CDK1 (also known as CDC2, as shown in the Figure I.7, but for 
consistency with the other CDKs we use the CDK1 nomenclature), which later on, 
when entering M-phase, gets the cyclin substitution from A to B. All of these cyclins, 
E, A and B, have two different forms whose specific functions are still under 
investigation. The expression of subsequent cyclins is regulated by the previous cyclin-
CDK complex. This complex will be active until the synthesized cyclin takes its active 
role. Once this occurs, the newly formed complex has the responsibility of shutting 
down the expression of the previous cyclin. 
As mentioned, just during G1 the cell is responsive to external growth factors, such as 
TGF-" (Transforming Growth Factor-"). As such, type D cyclin expression can be 
regulated by the external environment. In fact, TGF-" induces the expression of 
CDK4/6 inhibitors such as the p15 protein. Since this protein inhibits the D-CDK4/6 
complex, it also inhibits the expression of D cyclin as well as E cyclin, hence, 
preventing the progression of the cell cycle. Of course, this has only an inhibitory 
function if it occurs before the R point. The p16, p18 and p19 proteins also belong to 
the same family of CDK4/6 inhibitors and were originally named INK4 after Inhibitors 
of CDK4. The other two CDKs, CDK2 and CDK1, also have specific inhibitors: p21, p27 
and p57. Despite of TGF-" also inducing the expression of p21, in a weaker manner, 
p21 expression is highly induced by intracellular events such as DNA damage. These 
events can then allow the cell to inhibit the cell cycle progression and repair the 
damage in a mechanism known as checkpoint, which will be further explored in 
Section III.1. Interestingly, p21 as well as p27 have a stimulatory effect over CDK4/6 
activity. Hence, if during early/mid G1 their levels are high enough to inhibit the E-
CDK2 complexes, as the cell progresses more and more, D-CDK4/6 recruit p21 and 
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p27 to stimulate its activity, which in last instance release E-CDK2 to be active. This 
activation occurs through the phosphorylation of specific CDK residues. In CDK2 and 
CDK1, phosphorylation occurs at Thr-160 and Thr-161 respectively, by CAK (CDK-
activating kinase) formed by CDK7, Cyclin H and a RING-finger protein MAT1 (Nigg 
1996; Draetta 1997). Also, on CDK1, both Thr-14 and Tyr-15 are phosphorylated, by 
kinases such Wee1, Mik1 and Myt1, as soon as the B-CDK1 complex is formed during 
late S/G2 phases (Lundgren, Walworth et al. 1991; Parker, Atherton-Fessler et al. 
1991; Booher, Holman et al. 1997). However, these are inhibitory phosphorylations 
that occur to prevent premature entry into M phase. When this time comes, CDK1 is 
dephosphorylated by the dual-specific protein phosphatase CDC25C (Gautier, Solomon 
et al. 1991; Kumagai and Dunphy 1991; Strausfeld, Labbe et al. 1991), which is 
regulated by a positive feedback loop, since the more B-CDK1 is dephosphorylated, 
the more it phosphorylates CDC25C increasing its activity (Hoffmann, Clarke et al. 
1993). 
To better understand how cells integrate external signalling into cell cycle decision-
making processes, it is important to know about Retinoblastoma protein (pRb), also 
known as the gatekeeper of the cell cycle. This protein, a target of the cyclin-CDK 
complexes, while in its unphosphorylated/hypophosphorylated form, prevents the cell 
cycle to proceed. Because of this, pRb is correlated with the R point, where it gets 
hyperphosphorylated, thus preventing its inhibitory role (Figure I.7.A). This is 
achieved in part by D-CDK4/6 activity, during early G1 and later by E-CDK2 
(Matsushime, Ewen et al. 1992; Meyerson and Harlow 1994). In fact, E-CDK2 can only 
phosphorylate pRb if this protein is first phosphorylated by the D-CDK4/6 complex. 
The pRb inhibitory role is because in early G1 pRb sequesters E2F/DP transcription 
factors, which prevents them activating the transcription of key genes for the 
progression of the cell cycle. pRb also recruits HDACs that deacetylate the surrounding 
area where these transcription factors are bound to, thus preventing that essential 
genes for the progression of the cell cycle are expressed out of time. With cell cycle 
progression, pRb becomes more phosphorylated allowing the release of the 
transcription factors and subsequently the expression of specific genes. Among those 
it is possible to find: dihydrofolate reductase, thymidine kinase, histone H2A, DNA 
polymerase !, PCNA, cyclin E, cyclin A, CDK1 and E2F itself (Dou, Fridovich-Keil et al. 
1991; Pearson, Nasheuer et al. 1991; Dou, Zhao et al. 1994; Furukawa, Terui et al. 
1994; Johnson, Ohtani et al. 1994; Lukas, Muller et al. 1994; Lee, Chiang et al. 1995; 
Ohtani, DeGregori et al. 1995; Schulze, Zerfass et al. 1995; Tommasi and Pfeifer 
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1995; Botz, Zerfass-Thome et al. 1996; Geng, Eaton et al. 1996; Oswald, Dobner et 
al. 1996; Slansky and Farnham 1996; Dyson 1998). Once the cell exits mitosis, pRb is 
dephosphorylated by the activity of PP1 (Protein Phosphatase 1), resetting pRb for the 
next cell cycle. 
Although we focussed mainly on G1 progression and D-CDK4/6 function, this complex 
is not the only one to have key roles in the regulation of the cell cycle. Also A-CDK2 
and B-CDK1 perform very important roles, such as regulation of DNA synthesis and 
breakdown of the nuclear envelope by phosphorylation of the lamins, respectively. To 
shut down the B-CDK1 activity, APC targets cyclin B for degradation.   
 
I.3 PHOSPHORYLATION IN SIGNAL TRANSDUCTION CASCADES 
As it has been noticed with the description in the previous Section, phosphorylation is 
an important signalling reaction that occurs within a cell. Thus, given that 
phosphorylation is mediated by kinases, one of the major contributors for the 
triggering of a response, it is obvious that dephosphorylation, performed by protein 
phosphatases, is as important a process to counteract the phosphorylation signal and 
to regulate the activity of many proteins in different cellular functions and contexts. 
Phosphorylation is a reaction where in general a phosphate group is added through a 
phosphoester bond (O-phosphate) to the hydroxyl side chain of different amino acid 
residues such as: Serine (Ser, S), Threonine (Thr, T) and Tyrosine (Tyr, Y) (Figure 
I.8), with each accounting for approximately 86.4, 11.8 and 1.8% of the human 
phosphoproteome (Olsen, Blagoev et al. 2006). 
 
FIGURE I.8 | PROCESS OF PROTEIN 
PHOSPHORYLATION/DEPHOSPHORYLATION. 
Kinases transfer a phosphate group from an 
ATP molecule to the hydroxyl side chain of 
the target amino acid (i.e. ser, thr or tyr), 
while phosphatases remove the phosphate 
group from the protein. The addition of the 
negatively charged phosphate group to the 
protein may cause the conformational 
change of the protein itself (Arena, Benvenuti 
et al. 2005).!
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Despite these residues being the most common targets for phosphorylation in 
mammalian cells, the phosphate group may also be added to other residues such as 
aspartate (A-phosphate), histidine and arginine (N-phosphate), or even to specific 
lipids such as PIP2 (Toker 1998) (Table I.1).  
 
In addition to being a reversible type of post-translational modification, several other 
reasons have favoured phosphorylation a very important signalling reaction to be 
selected through evolution. First because phosphorylation does not require new 
protein synthesis or degradation, and second because it involves the addition of a 
phosphate group to the target molecule, reaction that only takes a few seconds. 
Altogether, these characteristics make phosphorylation a very potent signalling 
mechanism within a cell, thus through this mechanism cells may regulate proliferation, 
differentiation, adhesion, metabolism and apoptosis. These facts support the idea that 
aberrant regulation of phosphorylation correlates strongly with several types of 
diseases, including cancer. As mentioned, in order for this type of reaction to occur, 
two superfamilies of enzymes are involved: Protein Kinases (PKs) and Protein 
Phosphatases (PPs). Hence, these are good candidates to target for disease therapy 
development. Indeed, Protein Kinases are the second largest drug target in 
Pharmaceutical Industry (Cohen 2002). In contrast, due to the non-existence of good 
tools to study Protein Phosphatases, these are much less studied as targets for 
TABLE I.1 | LIST OF KINASE SUBSTRATES AND RELATIVE PRODUCTS AFTER PHOSPHORYLATION. In 
grey are the most typical substrates for the respective kinases (Arena, Benvenuti et al. 
2005).!
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therapies. However, this tendency has been changing in the past decade. This is 
because more information has been acquired for these enzymes, revealing that PPs 
can be regulated by interaction with specific proteins or subunits, which target them 
for specific places and functions. As such, drugs may be designed to disrupt specific 
interactions, avoiding the inhibition of a broad range of holoenzyme phosphatase 
complexes. This feature, gives to PPs the potential to be good targets for disease 
therapies.  
 
I.3.1 CLASSIFICATION OF PROTEIN PHOSPHATASES 
With the Human Genome Project it was described that while there are 518 genes 
encoding for Protein Kinases, accounting for 1.5-2.5% of all eukaryotic genes, for 
Protein Phosphatases there are only about 147 genes. Both these enzyme groups have 
target specificity, hence, not taking into account the enzymes with dual specificity, PKs 
and PPs can be divided into two distinct groups: the Ser/Thr group and the Tyr group. 
As it would be expected, due to the percentages of the phospho-residues, most of the 
known and predicted kinase genes are Ser/Thr specific, around 428 genes, while 90 
are part of the tyrosine kinase family (Manning, Whyte et al. 2002; Alonso, Sasin et 
al. 2004). However, in what concerns Protein Phosphatases, the scenario is the 
opposite, meaning that from the 147 predicted and known Protein Phosphatase genes 
only 40 belong to the Ser/Thr family of Protein Phosphatases, and the remaining 107 
to the Tyr family. The way nature evolved in order to respond to all the different 
dephosphorylatable targets with such a low number of protein phosphatases, was 
either by adding discrete modular domains onto a core catalytic subunit, as it is the 
case for example of Tyr Phosphatases, or by interaction of the catalytic subunit with 
other regulatory or targeting subunits, such as in most Ser/Thr phosphatases (with 
the exception of the PP2C group, as well as PP5) (Moorhead, Trinkle-Mulcahy et al. 
2007).  
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In the early days of phosphorylation, PPs were classified based on their property of 
targeting specific residues. Hence, they were divided into three groups as mentioned: 
the Ser/Thr specific, the Tyr specific and the dual specificity. This division was 
supported later by the analysis of the whole genome. However, with further 
investigation of each individual enzyme, it was found that many of the PPs initially 
classified as Ser/Thr or Tyr specific, have in fact dual specificity, being able to function 
in Tyr, Ser, Thr, RNA and phosphoinositides (Alonso, Sasin et al. 2004; Begley and 
Dixon 2005). Moreover, another group of PPs with the active site signature DXDXT/V, 
that makes use of an Asp nucleophile for catalysis, was also found to have 
TABLE I.2 | CLASSIFICATION OF HUMAN PROTEIN PHOSPHATASES. Classification based on: 
sequence, specifcity and mechanism of action. Makes reference to: family, class, number of 
genes, regulatory subunits and examples of functions and/or substrates (Moorhead, Trinkle-
Mulcahy et al. 2007).!
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phosphatase activity on either Ser/Thr or Ser/Tyr residues, depending on the family of 
enzymes. Hence, while the former is typical for the FCP1/SCP1 family, the latter is 
characteristic of the Haloacid Dehalogenase (HAD) family of Protein Phosphatases (Li, 
Oghi et al. 2003; Tootle, Silver et al. 2003). These two families make up the Asp-
based catalysis group of PPs. Hence, according to the current available information on 
sequence, structure and catalytic properties of the different enzymes, Protein 
Phosphatases are divided into three distinct groups: the Ser/Thr group, comprising the 
phosphoprotein phosphatase (PPP) family (which includes PP1, PP2A, PP2B, PP4, PP5, 
PP6 and PP7) and the protein phosphatase MG2+ and Mn2+ dependent (PPM) family 
(that includes the PP2C group); the protein Tyr phosphatase group (PTP); and the just 
mentioned Asp-based protein phosphatases group (Table I.2). 
From these three groups, the first to be more intensively described was the classical 
Ser/Thr one. While the Ser/Thr Phosphatases had their boom in the mid 1970s, early 
1980s, just a decade later, the Protein Tyr Phosphatases (PTP) started to be studied, 
with the purification (Charbonneau, Tonks et al. 1989) and the cloning (Guan, Haun et 
al. 1990) of the first PTP. Concerning the Asp-based catalysis PPs, only in the early 
XXI century were they started to be described as such (Li, Oghi et al. 2003; Tootle, 
Silver et al. 2003). The impact of all these PPs in a cell is extremely high, since they 
help in the regulation of many different signalling cascades, as shown in the Table I.2 
above.  
 
I.3.1.1 SER/THR PROTEIN PHOSPHATASE CATALYTIC SUBUNITS1 
The classical Ser/Thr phosphatase group, which was the first group to be defined pre-
sequencing era, is nowadays divided into two distinct families based on the catalytic 
subunits amino acid sequence homology, the PPP and the PPM, as mentioned above. 
As a consequence, while the PPM family activity is dependent on either MG2+ or Mn2+ 
cations, the PPP family is more diverse concerning this matter, where for instance the 
PP2B activity is dependent on Ca2+ ions and PP1 active centre presents two metal 
ions, both Fe2+ and Zn2+. The latter, PP1, is probably the paradigm of the classical 
Ser/Thr phosphatases in the sense of acquiring specificity of targeting depending on 
the regulatory protein they are bound to. In fact, there are at the moment more than 
90 regulatory subunits already described, number which is expected to grow based on 
bioinformatics studies (Meiselbach, Sticht et al. 2006). There are 4 different PP1 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
1 Since this group is the main focus of the present work, further description will only be carried 
out for it. 
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isoforms (!, #/$, "1 and "2) presenting 90% of sequence homology. Despite this 
property, they can have different subcellular locations, such as for example all being 
present in the nucleus but with the PP1! and the PP1" being more enriched in the 
nucleoli (Andreassen, Lacroix et al. 1998; Trinkle-Mulcahy, Sleeman et al. 2001). 
Indeed, the same PP1 isoform, depending on the regulatory subunit that it is 
interacting with, may be in different subcellular compartments, fulfilling different 
functions with different targeting proteins. Overall, the regulatory subunits interact 
with PP1 through the small motif RVXF, which is thought to be the primary docking 
site. However, after docking, the resulting conformational changes, will induce 
secondary interactions to other sites of the proteins in order to stabilize the whole 
interaction (Moorhead, Trinkle-Mulcahy et al. 2007). This motif was refined using the 
acquired knowledge on previous known regulatory subunits and coupled with studies 
aimed at understand this process. Hence, it was possible to define the motif as R/K1-2 
V/I [P] F/W where the amino acid in between brackets can be any one except proline 
(Meiselbach, Sticht et al. 2006). A study performed on the different PP1 isoforms 
supported the idea that each PP has its own specificity and function. In this study, 
Okada and co-workers (2004) depleted cells from the different specific isoforms and 
observed in fact different phenotypes. Hence, by depleting PP1!, cells rounded up and 
showed increased cell death, indicating an essential role in cell proliferation. In the 
case of PP1"1 depletion, cells also rounded up and presented a decreased G1 phase 
and increased S phase cell populations. And lastly, in the event of PP1! depletion, cells 
were enlarged and appeared flat and rich in lamellipodia.  
PP2A also from PPP family, that is correlated with the much more recently described 
PP4 and PP6, is expressed in the cell as a heterotrimeric structure, where the catalytic 
(C) subunit may be one of two different isoforms, ! and !. The other components of 
the full structure belong to the A and B subunit groups, where there are 2 different A 
subunit genes and a number of different B subunit genes spread over 4 different 
classes of genes. Functionally, while the A subunit serves as a scaffold for the catalytic 
subunit, allowing the binding of the B subunit, this one is important for both targeting 
and regulating the enzyme (McCluskey, Sim et al. 2002; Gallego and Virshup 2005). 
The other two PP2A related phosphatases, PP4 and PP6 were classified as such due to 
their sequence homology (Brewis, Street et al. 1993; Bastians and Ponstingl 1996; 
Cohen 1997), which to PP4 is about 65% (Cohen, Philp et al. 2005) and to PP6 is 
about 57% (Honkanen and Golden 2002). PP4 and PP6 are also regulated by 
conserved subunits throughout metazoans. An important characteristic from these 
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three protein phosphatase catalytic subunits (PP2A, PP4 and PP6), is that they may be 
regulated by methyl esterification at their C-terminus, a covalent modification that can 
modulate their interactions with the specific regulatory subunits (Johnson, Noble et al. 
1996; Cheung, Campbell et al. 2003).  
PP2B and PP7 are nowadays grouped together due to their dependency on Ca2+. PP2B, 
also known as PP3 or calcineurin due to its function at the neuronal level, is composed 
by two different subunits the catalytic subunit A and the regulatory subunit B with four 
Ca2+ binding sites. From PP7 not a lot is known concerning the animal kingdom. More 
information on this specific phosphatase is known from the study in Arabidopsis 
thaliana where it was described to be in the nucleus and thought to be regulating the 
blue-light signalling (Moller, Kim et al. 2003).  
The remaining member of the PPP family is PP5, which despite sharing 35-45% 
sequence identity to the PPP family members, does not need either regulatory or 
targetting subunits since in its N-terminal there are three tandem Tetratricopeptide 
Repeats (TPR) domains. These TPR domains are repeats of about 34 amino acids that 
function as an interaction scaffold (Moorhead, Trinkle-Mulcahy et al. 2007). 
Comparatively to the other PPP genes, this enzyme was described much later, not only 
because it is less abundant than the remaining PPP partners, but also due to its 
extremely low activity under normal PP assay conditions (Chinkers 2001). In addition, 
at the C-terminus of PP5, where the catalytic domain is located, besides having a NLS 
(Nuclear Localization Signal) (Borthwick, Zeke et al. 2001), an autoinhibitory signal 
may also be present (Sinclair, Borchers et al. 1999; Kang, Sayner et al. 2001).  
Regarding the PPM family members (PP2C), and as mentioned for PP5, also do not 
have regulatory subunits since their amino acid sequence comprises domains which 
fulfil that task. Despite the sequence difference to the PPP family, the PPM member 
PP2C! crystal structure has revealed that the active sites of the two families are very 
similar (Das, Helps et al. 1996). In addition, due to its dependency on MG2+ ions, it 
was reported that at the physiological levels of MG2+ the activity of PP2C is half of its 
maximal point, hence it is considered a constitutively active enzyme in vivo. Since 
most of the PPM enzymes are mainly exclusive to the nucleus or with significant 
nuclear enrichment, it is now known that it has to do with important functions at the 
DNA level, such as response to stress (Wenk and Mieskes 1995; Takekawa, Maeda et 
al. 1998; Komaki, Katsura et al. 2003; Dai, Zhang et al. 2006). 
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I.3.1.2 SER/THR PROTEIN PHOSPHATASE INHIBITORS 
Protein phosphatases may be inhibited by several different molecules: either 
endogenous proteins (e.g. I-2 and PME-1) or naturally occurring exogenous small 
molecules (e.g. Okadaic Acid, Microcystin and Fostriecin). These are great tools to 
investigate the general function of the different PPs and may ultimately be used as 
therapeutic drugs. Some of these inhibitors are described below in order to better 
understand the basis of the experimental data generated with this work.    
 
OKADAIC ACID 
Okadaic acid (OA) that is a naturally occurring small molecule toxin, with a polyether 
composition (Figure I.9), was the first of the protein phosphatase inhibitors to be 
discovered.  
 
It was firstly isolated from Halichondria okadai and Halichondria melanodocia being 
later verified that they were not the producers, but instead the accumulators of such a 
compound. In fact, OA is secreted by dinoflagellates, and is the main cause of 
diarrhetic shellfish poisoning (Messner, Ao et al. 2001). This compound is a very 
potent PP1 and PP2A inhibitor, with determined IC50 values of 20 nM and 0.2 nM, 
respectively (Sheppeck, Gauss et al. 1997). As PP4 and PP6 are related to PP2A the 
same concentration is enough to inhibit them (Cohen 1997). As a note for the 
interpretation of the referred values, the precision of the determined IC50 values differ 
greatly among publications, depending always on the cell type used and the assay 
itself, nonetheless the trend is always maintained between the different PP classes. 
Because of this, Okadaic acid has been reported to induce very different outcomes 
such as apoptosis or premature entry into mitosis in mammalian cell lines (Boe, 
Gjertsen et al. 1991; Ghosh, Paweletz et al. 1992). Also, OA was reported to act as a 
FIGURE I.9 | STRUCTURE OF OKADAIC ACID.!
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tumour promoter (Katoh, Fitzgerald et al. 1990), an anti-cancer drug (Mordan, Dean 
et al. 1990) or even a transformation revertant. Of course, this may be a consequence 
of different phosphorylation profiles of cell cycle/DNA-damage proteins. To support 
this idea it has already been shown that OA may stimulate or inhibit pRb 
phosphorylation as well as CDK/Cyclin activity levels (Messner, Ao et al. 2001). 
Structurally, OA is thought to bind PP1 through the YRCG residues (amino acids 267-
270) or in its vicinity (Zhang, Zhao et al. 1994). Indeed, a couple of years later, a 
mutational analysis suggested that OA inhibits PP1 via interaction with the tyrosine-
272 amino acid (Zhang, Zhang et al. 1996). 
 
MICROCYSTIN 
The cyclic heptapeptides, where microcystins are included, are produced by the blue-
green algae (cyanobacteria) (Carmichael, Beasley et al. 1988; Codd 1988). From this 
group of molecules, the most frequent is the microcystin-LR (Figure I.10) which is 
produced by Microcystis aeruginosa (Carmichael 1992; Codd, Metcalf et al. 1999).  
 
The LR termination corresponds to the variable amino acids that are present in the 
molecule structure, Leucine and Arginine in this case, which might be different in other 
versions of the microcystin, such as –LA, -LY and -RR (Sheppeck, Gauss et al. 1997). 
This is a long known toxic molecule, with hepatotoxic effects (Carmichael, Beasley et 
al. 1988; Codd 1988). In 1878 issue of Nature there was a reference to the toxic 
consequences of the use of water after a blue-green algae bloom. After all these 
years, it is now widely known that microcystins are potent tumour promoters and 
some data even suggests that microcystins are tumour initiators (Nishiwaki-
Matsushima, Ohta et al. 1992; Ueno, Nagata et al. 1996; Ito, Kondo et al. 1997; 
FIGURE I. 10 | STRUCTURE OF MICROCYSTIN-LR. #!
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Falconer and Humpage 2001). In addition, there is some debate on whether 
microcystin-LR can directly induce or not mutations over DNA. Despite contradictory 
data, some experiments showed that the use of this molecule induced: point 
mutations in different strains of Salmomella typhimurium, genotoxic stress on E. coli 
(strain PQ37) and LOH at the TK locus in human lymphoblastoid TK6 cells, among 
other DNA defects in other cell lines (Ding, Shen et al. 1999; Mankiewicz, Walter et al. 
2002; Zhan, Sakamoto et al. 2004). Recently, work from Lankoff and colleagues 
(2004), has shown that the DNA damage observed in other experiments was related 
to early stages of apoptosis and not to the genotoxicity of the molecule. Also, in the 
same work they showed that the use of Microcystin-LR suppressed the repair of 
radiation induced DNA damage. 
These are all consequences of PP1 and PP2A inhibition, since Microcystin-LR inhibits 
both enzymes at the same level, the IC50 being about 0.1 nM (McCluskey, Sim et al. 
2002). After determining the crystal structure of Microcystin-LR bound to PP1 it was 
revealed that the mutation of the critical cystein-273 in PP1 to alanine prevented the 
covalent binding of Microcystin-LR to PP1 (Goldberg, Huang et al. 1995; Bagu, Sykes 
et al. 1997). Even though the mutation prevents the binding it does not reduce the 
potency of the toxin, suggesting that binding and inhibition are two different processes 
that may regulate PP1 (Runnegar, Maddatu et al. 1995).  
 
FOSTRIECIN 
Fostriecin is a natural occurring antibiotic that was found in a fermentation broth of 
Streptomyces pulveraceus subspecies fostreus (McCluskey, Sim et al. 2002) (Figure 
I.11).  
 
From all the small molecule inhibitors described to act on PPPs, Fostriecin is the most 
selective one, since it displays a 40,000 fold difference for PP2A over PP1, meaning 
that the IC50 values are 3.4 nM and 131 $M, respectively (McCluskey, Sim et al. 
FIGURE I.11 | FOSTRIECIN STRUCTURE.!
Protein Phosphatases acting on the Replication Checkpoint                                         Chapter I 
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!
Centro de Biologia Celular 
Universidade de Aveiro | Portugal 45 
Centre for Developmental and 
Biomedical Genetics 
University of Sheffield | UK !
2002). This molecule has already been described as an antitumour drug that acts 
through the DNA topoisomerase type II, which is the same active principle as 
doxorubicin (Boritzki, Wolfard et al. 1988). In this context then, Fostriecin has been 
suggested to at least contribute to the efficacy of PP inhibition in the treatment 
against solid tumours in humans. !
INHIBITOR-2 
Inhibitor-2 (I-2) was first described as a heat-stable protein that specifically inhibited 
protein phosphatase activity (Huang and Glinsmann 1976). The protein was then 
isolated in a heterodimer complex with the PP1 protein, which was later termed 
MgATP-dependent phosphatase. In fact, this inhibition is PP1 specific with an IC50 of 
0.8 nM (McCluskey, Sim et al. 2002). The MgATP-dependent phosphatase complex is 
activated after GSK3 phosphorylates I-2 in the Thr-72 residue. This phosphorylation 
occurs mainly during mitosis and mostly at the centrosomes (25 fold increase) 
suggesting a role for I-2 in controlling centrosome-associated PP1 activity, as well as 
in cell division (Leach, Shenolikar et al. 2003). Besides Thr-72 phosphorylation carried 
out by GSK3, I-2 may also be phosphorylated at several other sites by GSK3, but also 
CDK1, MAPK, CKII and CKI, some of which also phosphorylate Thr-72 (Yang, 
Vandenheede et al. 1981; Hemmings, Resink et al. 1982; DePaoli-Roach 1984; 
Puntoni and Villa-Moruzzi 1995). 
Supporting the fact that I-2 may be involved in cell cycle regulation are some 
observations of fluctuation in the levels of expression throughout the cell cycle which 
peaks at mitosis (Brautigan, Sunwoo et al. 1990). In addition, I-2 migrates to the 
nucleus when entering S phase. This migration is phosphorylation dependent, since 
mutation of Thr-72, Ser-86 and Ser-120/121 to Alanine, all prevent that migration, 
which means that all these sites need to be phosphorylated for the migration to occur. 
Additionally, mutating the NLS also prevents this migration (Kakinoki, Somers et al. 
1997). Functionally, this translocation might be important for the inhibition of PP1 
which, as mentioned, is described to regulate pRb phosphorylation state and as a 
consequence the entry into S phase (Kakinoki, Somers et al. 1997). 
 
PROTEIN PHOSPHATASE METHYLESTERASE-1 
The Protein Phosphatase Methylesterase 1 (PME-1) is an enzyme capable of 
demethylating the C-terminal from the PP2A phosphatase. In fact, PP2A is methylated 
on Leu-309 by the Leucine Carboxylmethyltransferase (LCMT) (De Baere, Derua et al. 
1999). This methylation has no drastic effect on PP2A activity but there is the 
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indication that it is important for the recruitment of some B subunits to the PP2A A/C 
dimer in mammals (Ogris, Gibson et al. 1997; Lee, Chang et al. 2000; Tolstykh, Lee 
et al. 2000; Yu, Du et al. 2001; Ortega-Gutierrez, Leung et al. 2008). Due to this, one 
expects demethylation to have a functional activity on PP2A, and hence PME-1 may 
potencially be a PP2A inhibitor. Concerning this hypothesis, experiments have 
revealed that PME-1 besides presenting a functional nuclear localization signal, was 
associated with an inactive population of PP2A, regardless of its esterase status or 
localization (Longin, Jordens et al. 2004). In addition, Login and colleagues (2008) 
have also reported that PME-1 stabilized PP2A in the nucleus in a demethylated 
format. Given this, later on, it was also shown that this interaction removed the 
manganese ions that are needed for PP2A activity, it was proven that PME-1 indeed, 
inhibited PP2A (Xing, Li et al. 2008). One last observation, was that PP2A methylation 
levels varied along the cell cycle, suggesting that PME-1 activity also varied with the 
cell cycle progression (Turowski, Fernandez et al. 1995). 
PME-1 has homolog sequences in many different species such as S. cerevisiae, C. 
elegans and zebrafish, observation that indicates the enzyme is conserved across 
eukaryotes. In addition, structurally, PME-1 has a motif found in the lipases that utilize 
a catalytic triad-activated serine as their active nucleophile site, and in addition has 
other scattered homologies to other lipases where this motif is found (Ogris, Du et al. 
1999). 
 
I.4 SIGNAL TRANSDUCTION CASCADES AND CANCER 
I.4.1 CANCER HALLMARKS 
Cancer is one of the major health impact diseases of our time. In 2004, just in the 
European Union, there were an estimated 2.9 million new cases and 1.7 million deaths 
(Boyle and Ferlay 2005). As a disease with higher incidence in older people, these 
numbers are expected to increase as the European population continues to age. These 
facts enhance the effort that has been put in understanding the complexity of this 
disease. In fact, it is arguable to mention cancer as a disease or group of them, 
whether we look at it from an aetiology point of view or triggering mechanisms. 
However, although different cancers have different starting events, the outcome is 
broadly the same. Hence, after about a quarter of a century of cancer research, 
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Hanahan and Weinberg (2000) proposed what they have called “The Hallmarks of 
Cancer” mentioning six characteristics shared by most if not all cancers (Figure I.12).  
 
 
 
 
I.4.1.1 SELF-SUFFICIENCY IN GROWTH SIGNALS!
Under normal circumstances, cells need growth factors from the surrounding 
environment to trigger division. However, the impairment of either a growth factor 
receptor or a molecule downstream in the pathway, may induce constitutive activity 
and hence stimulate growth and subsequent cell division. This impairment usually 
occurs at the DNA level, by different kinds of mutations, such as deletions, insertions, 
translocations, etc. Among the different molecules and pathways known to be prone to 
these mutations there are receptors such as the EGFR (Epidermal Growth Factor 
Receptor) (Slamon, Clark et al. 1987); (Yarden and Ullrich 1988), or signalling 
proteins like Ras or SOS (Medema and Bos 1993); (Kinzler and Vogelstein 1996); 
Aplin et al., 1998; (Giancotti and Ruoslahti 1999).  
 
I.4.1.2 INSENSITIVITY TO ANTI-GROWTH SIGNALS!
A high percentage of the cells in our body are not in active division. This is due to the 
activity of growth inhibitory signalling cascades that have their action through two 
different mechanisms: either by inducing cells to enter in a quiescent state (G0) or to 
differentiate. While the latter is in principle irreversible, the first case under normal 
FIGURE I.12 | CANCER SHARED FEATURES. 
Mentioned features are proposed to be 
shared by most, if not all cancers (Hanahan 
and Weinberg 2000). !
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conditions does not prevent cells from restarting proliferation, as soon as the 
extracellular signals allow it. In the event of a cancer, tumour cells tend not to 
respond to these inhibitory growth signals. A known example on this disruption is the 
abrogation of pRb whose function, as already described, is to regulate the progression 
through interphase, in particular from G1 to S phases (Hatakeyama and Weinberg 
1995).  
 
I.4.1.3 EVASION FROM APOPTOSIS 
Apoptosis also know as “programmed cell death”, is a mechanism of cell number 
control and prevention of transformation where the cell: disrupts its membranes, 
breaks down both nuclear and cytoplasmic skeletons, extrudes its cytoplasm, 
degrades the chromosomes and fragments the nucleus. The effectors of this 
mechanism are specific intracellular proteases, which Thornberry and Lazebnik (1998), 
have named caspases after cysteine-rich aspartate proteases. Apoptosis may 
influence the onset of cancer when either proapoptotic signals are down-regulated or 
antiapoptotic signals are up-regulated constitutively by the hypo or hyper activity of 
specific effectors. p53, also known as the Guardian of the Genome, plays many 
important roles in the maintenance of the DNA integrity and consequently of the 
homeostatic balance of the cellular environment. Under normal circumstances, p53 
indirectly regulates the release of cytochrome C, an extremely important catalyst of 
apoptosis, from mitochondria (Green and Reed 1998). Hence, the down-regulation of 
p53 activity by specific mutations can confer cells the ability to escape from apoptosis, 
which is in fact, the case in many tumours. 
 
I.4.1.4 SUSTAINED ANGIOGENESIS 
Along with the invasion and metastasis this is one of the features with higher impact 
in human death due to cancers. The capability that tumours have to generate their 
own capillary system is very important for their development and maintenance. 
However, this fact indicates that the neoplasm will compete with and most probably 
start to deplete the nutrients that are normally for the use of the tissue where it is 
located. In consequence, this competition for nutrients will start to generate a 
malfunction on the originally healthy organ, allowing neoplasias to develop indefinitely 
and increase in size (Bouck, Stellmach et al. 1996); (Hanahan and Folkman 1996); 
(Folkman 1997).  
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Angiogenesis also responds to a defined signalling cascade with specific activators, 
such as VEGF (Vascular endothelial growth factor), and inhibitors, like 
thrombospondin-1. Being thrombospondin-1 regulated by p53, and the latter mutated 
in many tumours, ultimately the function of the former is impaired in those cases, 
allowing for an uncontrolled blood vessel formation (Dameron et al. 1994).  
 
I.4.1.5 UNLIMITED REPLICATIVE POTENTIAL 
In general, cells have a limited number of doublings. Hence, as mentioned earlier a 
given cell stops proliferating when it enters in a senescence state, as a consequence of 
the critical shortening of the telomeres size. However, this shorting of telomeres can 
be corrected by the action of telomerase (Bryan and Cech 1999). From the analysis of 
different tumour cells it was noticed that the telomeres size was maintained over 
doublings and also, 85-90% of those cells were capable of this due to the increase of 
the telomerase activity (Shay and Bacchetti 1997). Hence, this seemed to be the 
reason why cancer cells have this special feature of unlimited replicative potential, 
crucial for the successful growth of the tumour. To support this hypothesis, it has been 
shown in a number of different experiments that when telomerase expressing systems 
are added to cells in culture, either in early (Bodnar, Ouellette et al. 1998); (Vaziri 
and Benchimol 1998) or late passage (Counter, Hahn et al. 1998); (Halvorsen, 
Leibowitz et al. 1999); (Zhu, Wang et al. 1999), they confer the mentioned unlimited 
replicative potential to them.  
 
I.4.1.6 TISSUE INVASION AND METASTASIS 
Metastasis is the process by which the tumour cell migrates from the primary site to 
other parts of the body. This is a process with high impact in deaths due to cancer, 
being responsible for up to 90% of those deaths (Sporn 1996). In addition, metastasis 
is the baseline to distinguish benign from malignant cells, where the former do not 
leave the primary site. Different types of cancers tend to present specific patterns of 
invasion and metastasis, mainly due to the direction of the blood flow.  
Although cancer cells can migrate, that is usually not the case for normal cells as they 
are restricted to the tissue or organ where they first originated, due to the presence of 
basement membranes that surround organs. In this context, the loss in function of 
cell-cell adhesion has been related to a high percentage of epithelial cancers. In fact, 
E-cadherin, a protein with cell-cell adhesion function, has been shown to be implicated 
in this transformation process when it is affected by mutations or proteolysis of the 
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extracellular cadherin domain (Christofori and Semb 1999). Moreover, the same 
authors have also demonstrated by using mouse models, that when E-cadherin is 
overexpressed there is an impairment of the invasive and metastatic phenotypes, but 
when the protein function is abrogated, the invasion and metastasis is highly 
increased. Therefore, cell-cell adhesion function maintenance is a key event in 
preventing cell migration and the generation of metastasis.  
 
I.4.2 DDR, A SIGNAL TRANSDUCTION CASCADE TO PREVENT CANCER 
Throughout the years, investigations have shown that in a broad sense, the 
accumulation of mutations in key genes is the event that ultimately degenerates 
normal cells into tumour cells, due to impairment of crucial signalling cascades. It 
seems clear, if these mutations are not repaired, DNA replication will propagate them 
to the subsequent cell generations.  
About 20 years ago, Hartwell and Weinert (1989), described the existence of key cell 
cycle mechanisms that had the ability to prevent late cell cycle events from being 
initiated before earlier ones were finished. To these control mechanisms they have 
called checkpoints. Conceptually, when a given checkpoint is triggered it arrests the 
cell cycle, giving time for the cell to solve the problem. Taking these facts into 
account, in addition to the increasing information about both the DNA-damage 
response (DDR) and the DNA-repair pathway, Zhou and Elledge (2000), a number of 
years later, compiled the information available and stated that checkpoints were part 
of a larger set of mechanisms that constituted the DDR pathway. Indeed, the DDR is a 
signal transduction pathway that coordinates cell-cycle transitions, DNA replication, 
DNA repair and apoptosis (Cimprich and Cortez 2008). Hence, this pathway ultimately 
prevents the propagation of mutations and the transformation of a given cell (to be 
detailed in Section III.1). However, as it has been exemplified throughout different 
signalling cascades mentioned in the text, problems such as cancer might also arise 
when players from these key pathways are somehow non-functional.  
 
I.4.3 THERAPEUTIC POTENCIAL OF PROTEIN PHOSPHATASES IN CANCER 
In many cases phosphorylation is the main signalling transduction reaction of key 
pathways such as the DDR. Hence, the deregulation of the protein phosphatase 
activity on such pathways may help the impairment of key cell cycle regulators and 
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DDR players (for example Chk1, ATM, ATR, p53 or DNA-PK), which may ultimately 
lead to cancer development. Supporting this idea, are observations where protein 
phosphatases appear to be deregulated in some cancers and tightly interacting with 
DDR proteins. Concerning the former, there are examples where it was found that the 
basal levels of nuclear PP1 activity were significantly higher in hepatoma cells, when 
compared with hepatocytes, translated by the dramatically increased amounts of PP1! 
and PP1! in the nuclear fraction of the hepatoma cells. In addition, this nuclear PP1 
activity was significantly higher at the G1/S transition in hepatoma cells, when 
compared with hepatocytes, which is probably correlated to the fact that PP1, as well 
as PP2A, are implicated in pRb regulation (Imai, Kakinoki et al. 1999). Relative to the 
interaction of PPs with DDR players, it has been shown that PP1 is activated following 
IR in Jurkat cells, in an ATM-dependent manner (Guo, Brautigan et al. 2002), as well 
as regulating p53 Ser15 after DNA-damaging induced stress (Haneda, Kojima et al. 
2004). Moreover, not only PP1, but also PP2A have been correlated with many 
different DNA-damage mechanisms. In fact, PP2A has already been shown to regulate 
the activity of some proteins such as DNA-PK and ATM, by enhancing the kinase 
activity of the former and maintaining the latter in an inactive form (Douglas, 
Moorhead et al. 2001; Dozier, Bonyadi et al. 2004; Goodarzi, Jonnalagadda et al. 
2004).  
If initially PPs were thought to be unspecific and promiscuous in what concerns their 
targets within a given cell, after the confrontation with these and other descriptions 
throughout the previous Sections, it is easy to understand that along side Protein 
Kinases, PPs also have important and specific functions. Since, in the last instance, the 
result of cancer research, is to develop a new drug or contribute to new discoveries 
that could be translated into new putative targets that may help treatment, PPs arise 
as a new group for therapy targeting. 
Historically, the first cancer therapeutic drugs were developed without knowing the 
molecular basis of cancer origin. Hence, most of the therapies were developed in a 
non-specific manner, since they do not target any particular type of cancer cell, but 
rather every cell in the organism. These therapies take advantage of the fact that 
most cancer cells have a high proliferation rate, and hope that the fast accumulation 
of DNA damage due to the treatment may be aggressive enough for those cells and 
consequently induce apoptosis. Just from the late 70s onwards, cancers started to be 
studied from the molecular angle, opening a door to a new and more specific route for 
cancer therapeutics, contrasting with the common general approach. This in 
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association to new therapeutic approaches, where the genetic background of the 
patient is taken into account, allows for more efficient and tailor-made therapies. 
Therefore, as explored here, cell cycle regulators, and in this particular case protein 
phosphatases and their regulatory subunits, are becoming attractive targets for new 
anti-cancer agents, due to their specificity and deep association with cell crucial 
pathways.  
 
I.5 THESIS AIMS 
Checkpoints, in particular in the DDR pathway, have been the target of intensive 
studies for a number of years. The main purpose of this effort is to uncover the 
mechanisms underlying many of the cellular events that prevent a cell from getting 
transformed. DNA is subjected everyday to various types of stress, which may 
ultimately put at risk the integrity of the genome. Nonetheless, cells have developed 
efficient mechanisms to repair several types of DNA damage. These pathways have 
evolved in a way that, through the activity of checkpoints during different cell cycle 
phases, they prevent the progression of the cell cycle until the DNA has been repaired. 
Both DNA replication and DNA repair machineries ensure a high degree of fidelity in 
their specific DNA mechanisms, so that the subsequent cell generations inherit good 
quality DNA without the possibility of carrying any genetically determined disease 
induced by an acquired mutation. Among the different reactions carried out in these 
pathways, phosphorylation, as described above, is probably the most used as a 
transduction signal. Indeed, most of the key players are either kinases or 
phosphatases, enzymes that respectively add and remove the phosphate group from 
the target protein. The latter, the Protein Phosphatases group, is sub-divided into 
families according to: target, structure and catalytic mechanism. Due to the higher 
abundance of phosphorylated serine and threonine residues in the cell proteome, an 
important contribution of specific protein phosphatases in the regulation of the DDR 
pathway is predicted. 
Hence, we propose to evaluate the role of Ser/Thr phosphatases on the recovery from 
the replication checkpoint arrest, through their ability in dephosphorylating Chk1, a 
key enzyme in this and other mechanisms. In fact, when Chk1 is knocked-out in mice 
it turns that these are not viable, thus proving to be an essential gene. Although a lot 
was known about how Chk1 was activated, no information was found on its shut down 
by dephosphotylation. Therefore, with this approach, besides defining a role for 
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Ser/Thr PPs in the recovery from the replication checkpoint arrest, we expect to 
contribute to the identification of the protein phosphatase responsible for Chk1 
dephosphorylation.  
Moreover, as mentioned above, the deregulation of phosphatase activity has been 
correlated with disease. Thus, in the replication checkpoint, it would be important to 
know if protein phosphatases are critical players in the establishment of an efficient 
checkpoint response. This goal will be specifically assessed by the application of a 
technique that takes advantage of the fact that replication in eukaryotes is carried out 
in a timely defined and organized manner, by triggering different replication origins at 
distinct times. This technique is confocal microscopy based for the observation of the 
replication progression in the presence or absence of replication stress. 
Finally, although Chk1 has been implicated in other important mechanisms, few 
protein interactions are currently known to occur. Because we have potent tools 
available in order to screen for new putative interactions, we decided that this would 
be a great contribution for the knowledge of the Chk1 interactome. Thus, a Yeast Two-
Hybrid will be performed using Chk1 as bait, in order to retrieve possible interactions 
and describe new putative roles for this key kinase. 
 
 !!!!!!!!!!!!!!!!!!!!!
Protein Phosphatases acting on the Replication Checkpoint                                         Chapter I 
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!
Centro de Biologia Celular 
Universidade de Aveiro | Portugal 54 
Centre for Developmental and 
Biomedical Genetics 
University of Sheffield | UK !
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Protein Phosphatases acting on the Replication Checkpoint                                       Chapter II 
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!
Centro de Biologia Celular 
Universidade de Aveiro | Portugal 55 
Centre for Developmental and 
Biomedical Genetics 
University of Sheffield | UK !
CHAPTER II 
M E T H O D S  
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II.1 DNA TECHNIQUES 
II.1.1 DNA GEL ELECTROPHORESIS 
The agarose gel was prepared by mixing the agarose with the 1x TAE Buffer in a 
conical flask. The agarose weight and the 1x TAE volume varied depending on the 
percentage needed for the DNA band separation. After mixing, the slurry was heated 
until all the agarose melted. Before adding the ethidium bromide to a final 
concentration of 0.5 mg/ml, the gel was allowed to cool down to 60ºC. At this point 
the mixture was poured into the gel tray with the respective comb and left it to set. 
Meanwhile, the horizontal electrophoresis tank was filled with enough 1x TAE Buffer to 
cover completely the agarose gel. Once the gel was set, the comb was removed and 
the gel was transferred into the tank with the buffer.  The DNA samples were prepared 
by mixing with the 6x loading buffer (LB) (0.25% bromophenol blue/30% glycerol in 
water) and loaded into the wells of the gel using a micropipette. DNA Marker (1kb 
Ladder from Bioline) was also loaded into the gel. The lid of the gel tank was closed in 
a way that the DNA could migrate towards the anode. The electric wires were plugged 
to the power supply and the gel was left to run until the front of the gel migrated the 
appropriate distance. The agarose gel was then analyzed and photographed under UV 
light using UVIpro equipment (UVItec). 
II.1.2 RESTRICTION DIGESTIONS 
For regular DNA digestion with restriction enzymes, the manufacturer’s instructions 
were followed. In a given reaction microtube, the different components were mixed as 
described below: 
100 $g/ml DNA 
1x reaction buffer (specific for each restriction enzyme and company) 
1U/$g DNA of restriction enzyme 
The final mixture was incubated at the specific temperature for the restriction enzyme 
for the appropriate time, ranging from 1h to overnight when convenient. In the case 
of sequential digestions with different enzymes, the DNA was purified in between 
reactions. In all cases the restriction enzyme should contribute to less than 10% of 
the final volume.  
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II.1.3 PCR (POLYMERASE CHAIN REACTION) 
To amplify DNA, polymerase chain reactions (PCR) were performed using PfuUltraTM 
(Strategene) DNA polymerase. Each reaction was performed in a DNase free 200 $l 
microtube according to manufacturer’s directions. In each reaction tube the different 
components were added by the order as in the following table: 
 
 
Depending on the type of Thermocycler, either single or multiple blocks, the reaction 
timings for denature, annealing and polymerization changed according to 
manufacturer’s instructions (Table II.2). 
 
* Annealing temperatures may need optimization. Usually they vary from 55º to 72ºC  
** This specific equipment is the Stratagene’s RoboCycler% Temperature Cycler 
 
TABLE II.1 | PCR AMPLIFICATION MIXTURE COMPONENTS !
TABLE II.2 | PCR CYCLING PARAMETERS FOR STRATAGENE’S PFUULTRATM HIGH-FIDELITY DNA 
POLYMERASE USED FOR VECTOR DNA SMALLER THAN 10KB !
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In order to test the amplification of DNA, an aliquot of the PCR product was analysed 
by agarose gel electrophoresis. Specific changes to this protocol will be detailed when 
appropriate.  
 
II.1.4 DNA EXTRACTION FROM LOW MELTING POINT AGAROSE 
DNA bands from restriction enzyme digestion or PCR can be extracted from an 
agarose gel after electrophoresis. For best results usually the samples were ran in a 
low melting point agarose gel. The procedure is similar to what is described in Section 
II.1.1 but the agarose used has hydroxyethyl groups in the polysaccharide chain. This 
fact allows the agarose to set at around 30ºC and melt at about 65ºC, which is lower 
than the dsDNA melting point. To avoid the melting of the gel while is running, the gel 
must be ran in a cold room (4ºC) at 40V for 3-4h. To increase the quality and 
percentage of DNA recovery from the gel, usually this gel is not run with Ethidium 
Bromide. For this reason, two identical samples were run in parallel and after that, the 
gel was cutted in half in order to separate the two samples. At this point one of the gel 
portions was stained with a 0.5 mg/ml Ethidium Bromide solution for 20 min and then 
washed several times with distilled water. To extract the desired band, the two 
portions of gel were aligned and analyzed under a long-wavelength UV lamp. With a 
scalpel, the band from the non-stained portion of the gel was extracted and 
transferred into a clean and pre-weighted microtube, where the slice mass was 
determined. In order to purify the DNA from the agarose gel two methods were used: 
through QIAquick gel extraction column (QIAGEN) or agarose digestion by "-Agarose I 
(NEB).  
 
II.1.4.1 QIAQUICK GEL EXTRACTION KIT (QIAGEN) 
To each volume of gel, 3 volumes of Buffer QG were added to the tube (100 mg ~ 100 
$l). This mixture was incubated at 50ºC for 10 minutes, vortexing briefly the tube 
every 2-3 min to help dissolving. When the mix was clear, one gel volume of 
isopropanol was added to it and all of it was transferred to a new QIAquick spin 
column. In order to bind the DNA to the column, the sample was centrifuged for 1 min 
at maximum speed. The flow-through was discarded and 750 $l of Buffer PE was then 
added to the column to wash it. The column was centrifuged twice for 1 min to 
remove completely the washing buffer. Afterwards, the column was transferred into a 
sterile microtube and 30-50 $l of Buffer EB or sterile distilled water were added to the 
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centre of it and let to stand for 1 min. At this point the column was centrifuged for 1 
min and the DNA collected in the microtube to stored at -20ºC. 
 
II.1.4.2 AGAROSE DIGESTION BY !-AGARASE I 
After determining the gel mass in the tube, 1/10 of its volume was calculated (100 mg 
~ 100 $l) and the equivalent of 10x "-Agarase I Buffer was added to the tube. This 
mixture was incubated for 10 min at 65ºC in order to melt the agarose. Then, it was 
left to cool down to about 40ºC and 1 $l of "-Agarase I for each 200 $l of gel was 
added to the tube. At this point, the mixture was incubated for 30 min at 40ºC. 
Afterwards, 1 $l more of "-Agarase I was added to the tube and incubated for another 
30 min. The DNA was then purified by isopropanol precipitation as it will be described 
in Section II.1.5.2. 
 
II.1.5 DNA PURIFICATION 
II.1.5.1 QIAQUICK PCR PURIFICATION KIT (QIAGEN) 
QIAquick spin columns were used to purify DNA fragments from different enzymatic 
reactions and remove primers, nucleotides, enzymes and salts from solution. In all the 
cases, 5 volumes of Buffer PB were added to 1 volume of sample and then mixed. The 
mixture was transferred into a QIAquick spin column and spinned down by 
centrifugation for 1 min at 14,000 rpm. The flow-through was discarded and 750 $l of 
Buffer PE were added to column to wash it. The column was centrifuged twice for 1 
min at 14,000 rpm. Once the column was clean, it was transferred into a sterile 
microtube. There, 30-50 $l of EB Buffer or sterile water were added to the centre of 
the column and left to stand for 1 min. After this time, the column was centrifuged for 
1 min to elute the DNA into the microtube and then stored at -20ºC. 
 
II.1.5.2 ETHANOL DNA PRECIPITATION 
This specific protocol is used to either concentrate DNA samples or to purify them. 
Isopropanol may be used instead of ethanol with no problem added to the process. To 
1 volume of sample, 0.1 volumes of 3 M Sodium Acetate (pH 5.2) and 2.5 volumes of 
ice cold 100% Ethanol were added, mixed and incubated for at least 30 min at -20ºC. 
Afterwards, the mixture was centrifuged for 15 min at 14,000 rpm in a 0ºC centrifuge. 
Then, the supernatant was carefully discarded, without disturbing the pellet and 750 
$l of 70% Ethanol were added to the tube. The mixture was vortexed and stored for 5 
Protein Phosphatases acting on the Replication Checkpoint                                       Chapter II 
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!
Centro de Biologia Celular 
Universidade de Aveiro | Portugal 61 
Centre for Developmental and 
Biomedical Genetics 
University of Sheffield | UK !
min at -20ºC. To clean the DNA, the sample was centrifuged once again for 5 min at 
14,000 rpm in a 0ºC cooled centrifuge. In the end the supernatant was discarded and 
the pellet left to air dry (or incubated for a short period at 37ºC) before ressuspended 
in sterile water.   
 
II.1.5.3 PHENOL/CHLOROFORM EXTRACTION 
When the objective was to clean the DNA from proteins, the phenol/chloroform 
extraction is done. In this case, an equal volume of phenol/chloroform solution was 
added to the DNA sample and then mixed until an emulsion was observed. This 
mixture, was centrifuged for 1 min at 14,000 rpm in order to separate both aqueous 
and organic phases. At this point, the aqueous phase was transferred into a new 
microtube and again an equal volume of chloroform was added and mixed to form an 
emulsion. To recover the aqueous phase, the mixture was centrifuged again as 
described earlier and then the DNA was purified by ethanol precipitation as described 
in II.1.5.2. 
 
II.1.6 DNA LIGATION 
In order to ligate DNA fragments (derived from restriction digestion or PCR) to 
vectors, these had to be previously purified from an agarose gel as described in 
Section II.1.4. The ligation reaction followed manufacturer’s directions, mixing in a 
sterile tube 120 fmol of insert DNA and the equivalent to a molar ratio (insert:vector) 
of vector, being the ratios used usually 3 and 9. To a final volume of 20 $l, were 
added to the tube with the DNA: 2 $l of 10x T4 ligase reaction buffer, 1 $l of T4 DNA 
ligase (NEB) and sterile water. The mixture was incubated overnight at RT and then 
used to transform bacteria. Ligation controls were performed each time the 
experiment was executed. The controls consisted in transforming digested vector that 
was previously incubated in the presence or absence of T4 DNA ligase. This protocol 
was used for either cohesive or blunt ends. In the later case or when only one 
restriction enzyme was used, before the ligation reaction, vector samples were treated 
with SAP (Roche) in order to prevent re-ligation. The reaction occurred mixing the 
vector DNA with 1/10 of the volume of 10x SAP dephosphorylation buffer and 1 $l of 
SAP. The tube was incubated at 37ºC for 1h and then the enzyme was inactivated by 
heating the tube at 65ºC for 15 min. Finally, the vector was purified as described in 
Section II.1.5.1.  
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II.1.7 PREPARATION OF COMPETENT CELLS 
II.1.7.1 E.COLI XL1-BLUE COMPETENT CELLS 
To prepare aliquots of E. coli XL1-Blue competent cells, one colony of the strain was 
incubated in 10 ml of SOB (supplemented with 100 $l of MgCl2 and MgSO4, 1 M stock 
solutions) overnight at 37ºC with shaking. Then, 1 ml of the overnight culture was 
transferred into another 50 ml of SOB (supplemented with 500 $l of MgCl2 and MgSO4, 
1 M stock solutions) and incubated until OD550 ~ 0.3 (about 2-3h incubation). At this 
point, the culture was incubated on ice for 15 min and centrifuged at 3000 rpm for 6 
min (at 4ºC). The supernatant was discarded and the pellet was ressuspended in 15 
ml of Solution I (Section VIII.10.3). The suspension was then incubated for further 15 
min on ice and centrifuged as above. The pellet was carefully ressuspended in 3 ml of 
Solution II (Section VIII.10.3) and immediately aliquoted in 100 $l fractions, frozen in 
dry ice or liquid nitrogen and finally stored at -80ºC. 
 
II.1.7.2 YEAST COMPETENT CELLS 
The colonies used to prepare yeast competent cells need to be relatively fresh (not 
more than 4 weeks) and should have 2-3 mm in diameter. In the case where no fresh 
culture is available, competent cells may be prepared from -80ºC glycerol stock. One 
colony of the relevant yeast strain was transferred into 1.5 ml of YPD and vortexed to 
break up the cell clumps. Afterwards, the cell suspension was transferred into 50 ml of 
YPD and incubated overnight at 30ºC and 200 rpm. By the end of this incubation the 
OD600 should be higher than 1. Subsequently, sufficient culture (usually between 20 
and 40 ml) was transferred into 30 ml of fresh YPD, in order to get an OD600 between 
0.2-0.3, and then, incubated for 3h at 250 rpm. The culture was next centrifuged at 
1000g for 5 min at RT and the supernatant discarded. At this point, the pellet was 
washed by ressuspending it in 50 ml of sterile water followed by centrifugation as 
above. Finally, the supernatant was discarded and pellet was ressuspended in 1.5 ml 
of sterile and freshly prepared 1x TE/LiAc. These cells may be used in the following 
hour for transformation and never frozen.   
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II.1.8 TRANSFORMATION 
II.1.8.1 SUBCLONING EFFICIENCY DH5! COMPETENT CELLS 
This strain was mostly used for regular plasmid growth, not for subcloning and always 
following manufacturer’s directions. An aliquot was thawed on ice and 50 $l of cells 
were transferred into a sterile microtube with 1-10 ng of DNA and gently mixed. Then, 
the tube was incubated for 30 min on ice and heat shocked for 20 sec in a 37ºC water 
bath. Afterwards, it was cooled down for 2 min on ice. Pre-warmed LB (950 $l) was 
added to the tube and incubated at 37ºC for 1 h at 225 rpm. Usually, 200 $l of culture 
was spread on an appropriate selective plate. In parallel to these, negative and 
positive control transformations were performed, in the absence or presence of control 
plasmid, respectively.  
 
II.1.8.2 E.COLI XL-1 BLUE COMPETENT CELLS 
XL1-Blue strain was normally used in subcloning experiments, due to its high 
transformation efficiency. Cells were thawed on ice and 50 $l were transferred to a 
sterile microtube containing the desired DNA and gently mixed. This mixture was 
incubated on ice for 20 min. At this point, the tube was heat shocked incubating on a 
water bath at 42ºC for 90 sec, followed by 2 min on ice. To the tube, 450 $l of pre-
warmed SOC were added and then incubated at 37ºC for 45-60 min at 250 rpm. 
Finally, the cells were plated and controls made as described in Section II.1.8.1. 
 
II.1.8.3 YEAST TRANSFORMATION 
For each transformation one microtube was prepared with 100 ng of the plasmid DNA 
of interest plus 100 $g of Herring Testis Carrier DNA. To this mixture, 100 $l of freshly 
prepared yeast competent cells (of the desired mating type) were added, as well as 
600 $l of sterile PEG/LiAc. After a brief vortex, the tube was incubated at 30ºC for 30 
min at 200 rpm. Afterwards, 70 $l of DMSO were added to the transformation tube 
and gently mixed. Subsequently, it was exposed to a heat-shock of 15 min at 42ºC in 
a water bath. Then, the tube was cooled down on ice and centrifuged at 14,000 rpm 
for 5 sec. Here, the supernatant was carefully removed and the pellet was 
ressuspended in 500 $l of 1x TE Buffer. At this point, the cell suspension was plated 
on the appropriate selection medium plate and then incubated at 30ºC for at least 2 
days, until colonies appeared. The plates were stored at 4ºC for a maximum of 3-4 
weeks.  
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II.1.9 EXTRACTION OF PLASMID DNA 
Plasmid DNA may be isolated using different protocols and at different scales, 
depending on the amount of DNA wanted to purify. For small scale extraction, known 
as mini-prep, two methods were used: the Alkaline Lysis and the QIAprep® Miniprep 
(QIAGEN). For large-scale extraction the HiSpeed Plasmid Maxi Kit (QIAGEN) was 
used.  
 
II.1.9.1 ALKALINE LYSIS 
One colony from the desired bacterial culture was grown in 3 ml of LB (containing the 
appropriate antibiotic and concentration, i.e. ampicillin, chloramphenicol, etc.) at 
37ºC, overnight at 250 rpm. To pellet the cells, 1.5 ml of the culture were transferred 
into a sterile microtube and centrifuged at 14,000 rpm for 1 min at 4ºC. The 
supernatant was discarded and the pellet resuspended in 100 $l of ice cold Solution I 
by vortexing. To each tube 2.5 $l of RNase stock solution 10 mg/ml were added. 
Afterwards, 200 $l of freshly prepared Solution II were added to the tube and mixed 
by inversion for several times. Keeping the sample always on ice, 150 $l of Solution 
III were added to the tube. The mixing by inversion was repeated and the sample was 
left on ice for 5 min. At this point, it was centrifuged at 14,000 rpm for 5 min at 4ºC. 
The supernatant was then transferred into a new tube and 2 volumes of 100% ethanol 
at RT were added to the tube, vortexed and left for 2 min at RT. Afterwards, the tube 
was centrifuged at 14,000 rpm for 5 min at 4ºC, the supernatant was carefully 
removed, without disturbing the DNA, and the pellet washed with 1 ml of 70% ethanol 
at RT. After one last centrifugation, as above, the supernatant was removed and the 
pellet was left to air-dry for about 10 min. Finally, the DNA was ressuspended in 30 $l 
of sterile water (DNase-free) and stored at -20ºC. All solutions are described in 
Section VIII.10.3 under alkaline lysis.  
 
II.1.9.2 QIAPREP MINIPREP 
This method is based on the later but uses the QIAprep spin columns in order to speed 
the process. To obtain the bacterial culture pellet, the same was performed as 
described in Section II.1.9.1. The pellet was completely ressuspended by adding 250 
$l of Buffer P1 to the tube and vortexing it. Then, another 250 $l of Buffer P2 were 
added to the tube, gently mixed by invertion and left to stand for 5 min. At this point, 
350 $l of Buffer N3 were also added and mixed by invertion. Afterwards, the mixture 
was centrifuged for 10 min at 14,000 rpm and the supernatant transferred to a 
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QIAprep spin column. Here, the supernatant was spun down by centrifugation for 1 
min at 14,000 rpm and washed with 750 $l of Buffer PE. To remove the washing 
buffer the column was centrifuged twice for 30-60 sec at 14,000 rpm. Then, 30-50 $l 
of sterile water were added to centre of the column left to stand for 1 min and finally 
centrifuged at 14,000 rpm for 1 min to collect the DNA. With this process the obtained 
DNA is cleaner than the previous method. So, the QIAGEN method was broadly used 
to get DNA for sequencing and the Alkaline Lysis miniprep method for enzymatic 
digestions as follow up.  
 
II.1.9.3 QIAGEN HISPEED PLASMID MAXI KIT 
A pre-culture was prepared by transferring one colony into 2 ml of LB medium 
containing the appropriate selective antibiotic and incubated for 8h at 37ºC with 
vigorous shaking. At this point, the culture was diluted from 1:500 to 1:1000 in 500 
ml of LB medium, also with the appropriate selective antibiotic, and then incubated 
overnight under the same conditions as above. To pellet, the bacterial culture was 
centrifuged at 3000g for 15 min at 4ºC (for high copy plasmids 150 ml of culture were 
used, for the low copy ones 250 ml were used). After discarding the supernatant, the 
pellet was ressuspended in 10 ml of Buffer P1 and then a further 10 ml of Buffer P2 
were also added. Here, the mixture was inverted gently 4-6 times and incubated at RT 
for 5 min. Meanwhile, a QIAfilter maxi cartridge was prepared by screwing the cap and 
inserting it in a convenient rack. To the tube, 10 ml of ice cold Buffer P3 were added 
and immediately but gently mixed by inversion. The lysate was poured into the 
QIAfilter cartridge and incubated at RT for 10 min. During this time, a HiSpeed maxi 
tip was equilibrated applying 10 ml of Buffer QBT and allowed to become empty by 
gravity flow. Then, the cap from the QIAfilter outlet nozzle was removed and the 
plunger was inserted gently. The cell lysate was filtered into the previously 
equilibrated HiSpeed tip and the cleared lysate allowed to enter the resin by gravity 
flow. The HiSpeed maxi tip was then washed with 60 ml of Buffer QC. To elute the 
DNA into a new collection tube, 15 ml of Buffer QF were added to the tip. Here, the 
DNA was precipitated by addition of 10,5 ml (0.7 volumes) of isopropanol at RT and 
mixed. During an incubation of 5 min at RT, the plunger of a 30 ml syringe was 
removed from it and the QIAprecipitator maxi module attached to the syringe outlet 
nozzle. The QIAprecipitator was placed over a waste container and the DNA solution 
transferred into the 30 ml syringe. The DNA was collected in the QIAprecipitator maxi 
module by inserting the plunger in the syringe and filtering the DNA solution at 
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constant pressure. To dry the QIAprecipitator membrane, the module was removed 
from the syringe, the plunger pulled out and the QIAprecipitator attached again as 
well as the plunger. After pressing down the plunger at constant pressure, this 
procedure was repeated one more time to assure that the membrane got dry. Then, 
the outlet nozzle of the QIAprecipitator was cleaned with absorbent paper. Meanwhile, 
the plunger of a 5 ml syringe was removed and the QIAprecipitator attached to the 
syringe outlet nozzle. To elute the DNA, the QIAprecipitator was placed over a 1.5 ml 
tube, 1 ml of sterile water was added into the syringe, the plunger was inserted in the 
tube and pressed at constant pressure. To increase the amount of DNA recovery, the 
QIAprecipitator and plunger were detached from the 5 ml syringe and the collected 
DNA solution in the 1.5 ml tube was applied through the QIAprecipitator and syringe 
once again.  
 
II.1.10 DNA SEQUENCING 
To sequence DNA samples, in a 200 $l microtube, different components were mixed as 
is next described: 500 ng of dsDNA, 3.2 pmol of primer, 4 $l of Ready Reaction Mix 
(from the Applied Biosystems mix, which is composed by: dye terminators; 
deoxynucleoside triphosphates; AmpliTaq DNA polymerase, FS; rTth 
pyrophosphatase; magnesium chloride; and buffer) and sterile water until a final 
volume of 20 $l. After mixing by vortexing briefly and spinning down the tube, a PCR 
was performed under the following conditions: 
 
  
 
After the PCR reaction, the synthesized DNA was purified by ethanol precipitation as 
described in the Section II.1.5.2 but with some small differences. Thus, to each 
reaction 2.0 $l of 3M Sodium acetate (pH 5.2) and 50.0 $l of 100% ethanol were 
added, vortexed briefly and transferred into a 1.5 ml tube. This tube was then 
Table II.3 | PCR parameters to prepare samples for DNA sequencing !
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incubated for at least 15 min at RT to precipitate the DNA and centrifuged at 14,000 
rpm for 20 min at RT. After the supernatant was discarded, the tube was washed with 
250 $l of 70% ethanol, vortexed and centrifuged at 14,000 rpm for 5 min at RT. 
Finally, the supernatant was carefully discarded and the pellet left to air-dry. At this 
point, the sample was ready for sequencing. 
 
II.2 PROTEIN TECHNIQUES 
II.2.1 PREPARATION OF PROTEIN EXTRACTS 
To generate protein extracts, several methods are available depending on the 
objective of the experiment and the type of cells in use. In this case, a couple of 
methods were used to lyse the cells and generate protein cell extracts depending 
whether they were yeast or human cells, as it follows. 
 
II.2.1.1 PREPARATION OF YEAST PROTEIN EXTRACT USING THE UREA METHOD 
Preparation of the culture 
A fresh yeast colony (no more than 4 days old) was grown overnight in 5 ml of the 
appropriate selective medium, at 30ºC and 220 rpm. After vortexing the overnight 
culture for 30-60 sec, it was added to 50 ml of YPD and incubated at 30ºC and 220 
rpm until OD600 was between 0.4 and 0.6 (which could take from 4h to 8h). At this 
point, the culture was quickly cooled down, by pouring it into a centrifuge tube half 
filled with ice. Then, the culture was centrifuged at 1000 g for 5 min at 4ºC, the 
supernatant was discarded and the pellet ressuspended in sterile water at 4ºC. The 
suspension was again centrifuged as above and the supernatant discarded. The pellet 
was immediately frozen in dry ice or liquid nitrogen and store at -80ºC until the 
experiment could proceed.  
 
Yeast protein extraction by the urea method 
After the yeast cultures have been pelleted, as above, complete cracking buffer 
(Section VIII.10.4) was prepared and warmed to 60ºC (since PMSF degrades quickly 
in aqueous solution it was only added to the cracking buffer after being prepared, and 
also at every 7 minutes during subsequent incubation times; this reagent was added 
at 1 $l of stock solution per each 100 $l of Cracking Buffer used). The Total OD600 was 
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calculated multiplying the volume of culture harvested by the OD600 measured at the 
time of harvesting. For each 7.5 units of total OD600, 100 $l of pre-warmed cracking 
buffer were added to the frozen cell pellet. In order to help the pellet to melt the 
samples were place in a 60ºC water bath, for a maximum of 2 min. Then, the mixture 
was transferred to a microtube containing 80 $l of glass beads per each 7.5 units of 
the Total OD600. Afterwards, the samples were heated for 10 min at 70ºC to release 
the proteins associated to the membrane and vortexed for 1 min. Subsequently, the 
sample was centrifuged at 14,000 rpm for 5 min at 4ºC and the supernatant 
transferred into a new microtube stored on ice. The pellet was boiled for 5 min, 
vortexed for 1 min and centrifuged as above. The supernatant was pooled together 
with the previous one and boiled briefly. Finally, it was stored at -80ºC or loaded 
directly on a SDS-PAGE gel.  
 
II.2.1.2 PREPARATION OF PROTEIN CELL EXTRACTS FROM HUMAN CELL LINES 
The 1x lysis buffer (Section VIII.10.5) was freshly prepared before taking the cells out 
from the incubator.  Subsequently, a microtube for each sample (with a pierced lid, 
made with a needle), a tray with ice and a liquid nitrogen container were prepared. At 
this point and always on ice, the medium from the cell culture dish was aspirated and 
then washed with cold PBS, which was completely removed by aspiration afterwards. 
Cells were lysed by the addition of 300 $l of 1x lysis buffer (this volume was used for 
cells at a confluency of about 70-80%, hence this volume may change in order to 
maintain the protein concentration at relatively high levels) and removed from the 
dish with a cell scrapper. The lysate was collected into a microtube and snap frozen. 
The sample was stored at -80ºC until the protein concentration was measured, just 
before being analysed in SDS-PAGE.  
 
II.2.2 IMMUNOPRECIPITATION (IP) 
Several methods for IPs may be found, from cross-linking the antibodies to the beads 
(to avoid heavy and light chain contamination after elution), to include pre-clearing 
steps, etc. Each method is usually adapted for a particular kind of pull-down. Here, 
after a given treatment or the overexpression of certain proteins, cells were lysed as 
described in Section II.2.1.2 and protein in the lysate was quantified using the 
Bradford method (Bradford 1976). Meanwhile, Protein G beads were washed in a 15 
ml tube four times with MQ water and twice with Lysis Buffer, centrifuging for 2 min at 
Protein Phosphatases acting on the Replication Checkpoint                                       Chapter II 
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!
Centro de Biologia Celular 
Universidade de Aveiro | Portugal 69 
Centre for Developmental and 
Biomedical Genetics 
University of Sheffield | UK !
1000 rpm, discarding the supernatant in between washes. Then, 30 $l of packed 
beads were transferred into a microtube. To the beads, 400 $g of the desired cell 
lysate were added and incubated for 1h with agitation (1000 rpm) at 4ºC. 
Subsequently, the tube was centrifuged at 10,000g for 5 min at 4ºC and the 
supernatant transferred into either a new microtube or a ProbeQuantTM column (GE 
Healthcare). To each tube, 1 $g of the desired antibody per 100 $g of cell lysate used 
were added. This mixture was incubated at 1000 rpm, overnight at 4ºC. Afterwards, 
30 $l of packed Protein G beads (after being washed from ethanol as above) were 
added to each condition and incubated at 1000 rpm, for 2.5h at 4ºC. Each tube was 
next washed 4 times as it follows: centrifuging at 10,000g for 5 min at 4ºC, carefully 
discarding the supernatant, ressuspending the beads in 500 $l of washing buffer (50 
mM Tris-HCl and 120 mM NaCl) and incubating it at 1000 rpm for 15 min at 4ºC. After 
the final wash, the beads were ressuspended in 60 $l of 1x SLB and boiled for 10 min. 
In the end, the tubes were briefly centrifuged and either loaded immediately on a 
SDS-PAGE (as it will be described next) or stored at -80ºC until the gel was run. For 
each experiment, negative controls were performed in parallel by the use of non-
specific IgG from the same species of the specific antibody used. 
 
II.2.3 PROTEIN ANALYSIS BY SDS-PAGE 
Protein samples may be separated by SDS polyacrylamide gel electrophoresis (SDS-
PAGE). The technique is based on the fact that proteins after being denatured by SDS 
(an anionic detergent that wraps around the polypeptide backbone conferring a net 
negative charge) and reduced by, for example, "-Mercaptoethanol, become linear with 
a negative charge proportional to its length. Thus, it is possible to separate different 
sized proteins running the samples on an SDS-PAGE, where the percentage will be 
adapted depending on the size of the protein to be analyzed. The following table 
(Table II.4) describes the different components for several percentages of the gel 
matrix (Harlow 1988).  
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The gel apparatus was assembled after cleaning carefully each piece with 70% 
ethanol. Then, the running gel was prepared, adding all the components by the order 
as is shown on the table II.4 above. At this point, the mixture was carefully pipetted 
into the gel sandwich to about 2/3 of the height of the gel. On top of the mixture, 
enough water to cover completely the gel was gently added. After polymerization, 
which takes about 45 min, the water was removed from the top of the running gel and 
the stacking gel, meanwhile prepared, was also pipetted into the gel sandwich. In the 
end, a comb of the right size and desired number of wells was inserted in the gel and 
the latter was left to polymerize for about 30 min. In the meantime, the protein 
samples were prepared by adding to a certain $g of protein, 1/5 of the sample final 
volume of 5x Sample Loading Buffer (SLB) and then, boiled for 5 min. The comb was 
removed from the gel apparatus and running buffer was added to the gel tank in order 
to fill the wells and the chambers. After the samples have been briefly spinned, they 
were carefully loaded in the wells from the stacking gel, along with protein markers 
(Bio-Rad) in separate wells, in order to determine the protein size. Finally, the gel was 
run at 100V until the desired separation was achieved.   
II.2.4 COMASSIE BLUE GEL STAINING 
This method was used to stain proteins in a polyacrylamide gel. The comassie blue 
compound is a non-specific protein binder and in a gel stains every protein with no 
discrimination. The protocol was executed in 3 simple steps: stain in gel proteins after 
SDS-PAGE run, destain the gel to remove background staining and dry the gel. The 
staining step was performed at RT for 30 min with gentle shaking, transferring the gel 
TABLE II.4 | COMPONENTS FOR THE RUNNING AND STACKING GELS FOR SDS-PAGE (VOLUMES IN ML 
ENOUGH FOR MINI GELS)!
Protein Phosphatases acting on the Replication Checkpoint                                       Chapter II 
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!
Centro de Biologia Celular 
Universidade de Aveiro | Portugal 71 
Centre for Developmental and 
Biomedical Genetics 
University of Sheffield | UK !
into a container with enough comassie blue solution (Section VIII.10.1) to cover the 
gel completely. Afterwards, the destaining step was exectued in a similar way but the 
destain solution (Section VIII.10.1) was changed twice and with the help of a sponge 
to speed up the process. Then, the gel was dried in a vacuum gel drier for 1h at 65ºC, 
placing the gel previously over a piece of filter paper and covering it with cling-film. In 
the end, the bands, which came up blue on a white background, were analyzed.  
 
II.2.5 WESTERN BLOT 
In gel, proteins after separation by SDS-PAGE, can be transferred into a nitrocellulose 
membrane always maintaining their relative positions, which then allows the use of 
specific antibodies in order to detect different proteins. The method was performed 
using a tank transfer apparatus. A transfer cassette was prepared assembling the 
“sandwich” with: blotter paper, sponge, nitrocellulose membrane and the gel, all 
fitting the cassette and gel sizes. The stacking gel was excluded for this purpose after 
the gel removal from the electrophoresis apparatus. All transfer cassette components 
were pre-wetted in transfer buffer before its assembly in order to minimize the 
presence of air bubbles in any of the layers. After the assembly, the cassette was 
inserted in the transfer tank in the correct orientation, in order for the proteins to 
migrate towards the membrane. To improve the efficiency of the transfer an ice 
compartment was also placed inside the transfer tank. Then, the tank was filled with 
transfer buffer and allowed to run for 75 min at 100V (these conditions are applicable 
to mini gels). By the end of the transfer, the membrane was either air-dried or used 
for immunodetection.  
 
II.2.6 PONCEAU S 
To check the efficiency of the protein transfer, Ponceau S (Section VIII.10.1) staining 
method was used. Ponceau S has the same principle of Comassie Blue, it binds non-
specifically and reversibly to every protein on a nitrocellulose membrane. In order to 
detect the proteins, the membrane was covered with Ponceau S solution (enough to 
cover it) and shaked for about 30 sec. To clean the background staining the 
membrane was washed several times with distilled water until the bands could be 
clearly recognized. 
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II.2.7 IMMUNODETECTION 
As mentioned earlier, specific antigens may be recognized by the use of antibodies. 
Once the proteins are immobilized in the membrane, these antibodies, either directly 
or indirectly conjugated with horseradish peroxidase (HRP), help to identify the 
antigens by the use of a non-radioactive reagent broadly known as ECL (Enhanced 
ChemiLuminescence). Different ECL reagents are commercially available, and vary on 
the sensitivity of the emmited signal. Here, 3 different reagents were used depending 
on the experiment or antibodies: ECL (Pierce Bio), ECL plus and ECL advance (GE 
Healthcare).  
The membrane, after being transferred, was tested with Ponceau S as described in 
Section II.2.6 and then non-specific binding sites were blocke by covering the 
membrane with 5% low fat milk in TBS-T and incubating it for 1h at RT with gentle 
shaking. Afterwards, this milk solution was discarded and the membrane was 
incubated with a solution of the desired primary antibody, which is usually composed 
by the same as the milk blocking solution plus the antibody at the specific dilution 
according to the manufacturers directions. This incubation, depending on the 
antibody, varied from 1h to overnight periods. At this point, the membrane was 
washed with TBS-T solution 3 times for 10 min each at RT with shaking. Then, 
depending on the species the primary antibody was raised in, the secondary antibody 
HRP-conjugated was diluted to the specific concentration also in the 5% low fat milk 
solution. Again, after an incubation period of 1 to 2 hours, the membrane was washed 
with TBS-T for further 3 times for 10 min with shaking. After this step, the membrane 
was incubated with the desired ECL reagent according to the manufacturer’s 
instructions. To capture the signal from the membrane, the excess of ECL reagent was 
drained with the help of some absorbent paper and the membrane was carefully 
covered with cling-film. Here, the membrane was either exposed to autoradiography 
film in a film cassette (procedure executed in a dark room) or inserted in a dark 
chamber coupled with a digital camera (UVIpro equipment – UVItec). In the first case, 
the film was developed using the IGP OPTIMAX developer. The optimum amount of 
time of exposure varied in between experiments, hence, in each experiment several 
exposure periods were performed.  
In order to re-use and incubate it with different antibodies, a membrane has to be 
stripped with stripping solution for 30 min at 50ºC with gentle shaking. Finally, the 
membrane is washed 3 times for 10 min shaking with TBS and re-tested with the ECL 
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reagent previously used, to check the efficiency of the stripping. All general solutions 
can be found described in Section VIII.10.1. 
 
II.3 CELL CULTURE TECHNIQUES 
II.3.1 MAINTENANCE OF CELL LINES 
The main human cell line used in the experiments performed was HeLa. This line was 
maintained and grown in Dulbecco’s modified Eagle’s medium (DMEM from 
Biowhittaker) supplemented with 10% of Fetal Bovine Serum (FBS from Invitrogen), 
1% of Glutamine stock and 1% of a Penicillin/Streptomycin solution. Usually, cells 
were maintained either on 10 cm dishes or T75 cm2 flasks, in a 5% CO2 humidified 
incubator at 37ºC. They were always subcultured as soon as they got to about 80% 
confluence, which normally took 3-4 days. The subcultures were performed by 
washing the cells with pre-warmed sterile PBS, removed from the dish/flask with 
Trypsin/EDTA solution and finally ressupended and seeded again. 
 
II.3.2 USING THE HEMOCYTOMETER 
To determine cell density in a given culture, in order to seed a specific number of 
cells, a hemocytometer was used. Cells were trypsinized from the dish or flask and 
diluted with growth medium. Using a sterile micropipette and tip, 10 $l of the cell 
suspension were transferred into one of the sides of the hemocytometer. Under the 
microscope, the cells present in each of the four corners were counted and then the 
average calculated. The number of cells/ml was equal to the average number times 
104. Genericaly, all standard procedures to handle hemocytometers, and count cells 
accurately were followed. 
 
II.3.3 THAWING AND FREEZING CELLS 
As normal practice, cell stocks were stored in a liquid nitrogen container. In order to 
thaw the cell stock vial, it was quickly transferred to a 37ºC water bath until it was 
completely thawed (this process needs to be performed under safety measures 
because the vial may explode due to quick vaporization of liquid nitrogen inside the 
tube, thus the screw cap should be loosen slightly to reduce the pressure). At this 
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point, and after rinsing the outside of the vial with 70% ethanol, the cells were quickly 
resuspended in pre-warmed complete DMEM medium and plated in a 10 cm dish or a 
T75cm2 flask. Then, the cells were incubated as described in II.3.1 until they were 
completely adherent to the plastic surface (usually about 2-4h was enough). At this 
point, the cells were washed twice with pre-warmed PBS and again pre-warmed DMEM 
medium was added, before placing the dish/flask back into the incubator.  
To generate cell stocks, a flask was left to grow to about 70% confluency, at which 
point the cells were trypsinized. Afterwards, the trypsin was quenched by the addition 
of pre-warmed complete DMEM medium and the cells transferred into a 15 ml tube. 
The tube was then centrifuged at 1000 rpm for 5 min and the supernatant discarded. 
A second wash was performed by ressupending the cell pellet in DMEM and 
centrifuged for further 5 min at 1000 rpm. Finally, the supernatant was discarded and 
the cell pellet was ressuspended in 1 ml of freezing medium (composed by 50% 
DMEM, 40% FBS and 10% DMSO). The suspension was transferred into a criovial and 
stored overnight at -80ºC in a polyester box padded with absorbent paper. In the 
following day, the vial was inserted into the liquid nitrogen cell freezer. 
 
II.3.4 TRANSFECTION 
The overexpression of exogenous proteins was conducted by two different transfection 
methods: the calcium phosphate and the Superfect transfection reagent (QIAGEN) 
methods. The first was used to overexpress proteins when high transfection 
efficiencies were not necessary and the latter in the opposite situation. When the case 
was the transfection of small interfering RNA (siRNA) duplexes the Oligofectamine 
reagent was used. These methods were performed as are described next. 
 
II.3.4.1 CALCIUM PHOSPHATE 
At about 1 to 2 h before transfection, HeLa cells were split into 3x105 cells per 10 cm 
dish in 10 ml of medium (in order to get a 10-20% confluence) and placed in the 
incubator at 37ºC with 5% CO2. Meanwhile, enough 2x HBS (Hepes Buffer Saline) 
were thawed at RT. Just before transfection, 61 $l of CaCl2, 10 $g of DNA and enough 
sterile MQ Water to bring the total volume to 0.5 ml were transferred into a 
microtube. Here, the mixture was slowly and drop wise added to another tube 
containing 0.5 ml of 2x HBS with constant shaking. Then, the precipitate was added 
directly to the cells by dropping slowly and evenly distributed into the medium, trying 
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to cover the maximum area possible. Afterwards, the plates were incubated for 16-
24h before the medium was removed and the dish washed with pre-warmed PBS. 
Finally, new pre-warmed complete DMEM medium was added to the dish and 
incubated for the desired amount of time prior to perform any assay.  
 
II.3.4.2 SUPERFECT 
On the previous day of transfection enough cells were seeded in order to get a 
confluency of 40-80% (which corresponds for 6 cm dishes 3x105 cells/dish, and for 10 
cm dishes 8x105 cells/dish). The transfection was performed following the 
manufacturer’s instructions for each size of dish and corresponding volumes used. 
Briefly, the DNA solution was mixed with Opti-MEM to the corresponding volume and 
superfect was added to the mix and pipetted up and down 5 times. The mixture was 
then, incubated for 5-10 min at RT. In the meantime, the cell containing dishes were 
washed with pre-warmed PBS and as the incubation time finished, medium was added 
to the DNA/Superfect mixture and pipette up and down twice. This final mixture was 
immediately transferred into the dish and incubated for 2-3h at 37ºC and 5% CO2. 
Here, the cells were washed with pre-warmed PBS and new medium was added to the 
dish. The cells were incubated for the desired amount of time before assaying them.  
 
II.3.4.3 OLIGOFECTAMINE 
In the case of siRNA transfection, cells were seeded in the previous day in a 6-well 
plate in order to get a confluence of 30-50% on the day of transfection (this 
corresponds to 6x104 cells/well). The protocol from the manufacturer’s instructions 
was followed. On the day of transfection, the desired amount of siRNA was gently 
mixed with Opti-MEM I to a final volume of 185 $l/well. In a separate tube 4 $l of 
Oligofectamine were also mixed with Opti-MEM I to a final volume of 15 $l/well and 
incubated for 10 min. At this point, the two different mixtures were combined, gently 
mixed and incubated at RT for 20 min to allow the complexes to form. Meanwhile, 
each well containing cells was washed once with Opti-MEM I and then, 800 $l of this 
same growth medium were added to each well. Afterwards, 200 $l of the complexes 
were added to each well drop wise and evenly distributed. Then, the cells were 
incubated for 4h at 37ºC and 5% CO2. After this incubation period, 500 $l of 
DMEM/30% FBS/1% Glutamine were added to each well and incubated again for the 
optimum time for each specific target siRNA before assaying the cells. 
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II.3.5 REPLICATION PULSE-CHASE ASSAY 
This protocol was based on the method first described by O’Keefe et al. (O'Keefe, 
Henderson et al. 1992; Dimitrova and Gilbert 2000; Feijoo, Hall-Jackson et al. 2001) 
and is used to follow the progression through S phase. Because it uses two different 
halogenated derivative nucleotides (cloro-deoxyuridine and iodo-deoxyuridine), which 
can be recognized by distinct antibodies, this methodology is a potent tool to find 
answers on the regulation of the replication timely controlled program. The method is 
essentially composed by a couple of major steps: the pulse labeling and the 
immunofluorescence. These steps were performed as follows. 
 
II.3.5.1 NUCLEOTIDE PULSE LABELING 
Depending on the starting point of the experiment, either treated with a chemical or 
transfected with different proteins or siRNAs, the number of cells seeded varied as 
well as the size of the dish, and hence, the number of coverslips used per dish. The 
protocol will be described as general for an experiment performed in a 10 cm dish and 
for a chemical treatment, like Okadaic Acid. In the case of transfections, cells were 
treated as described above, except the fact that they were seeded over the coverslips. 
Thus, on the previous day of the experiment, round 22 mm coverslips were microwave 
sterilized for a total of 5 min (3+2 min in the presence of a beaker containing water). 
Then, in the Tissue Culture (TC) hood they were transferred into 10 cm dishes (4 or 5 
per dish) just before HeLa cells were seeded, in order to get a confluency of 50-60% 
on the following day (which corresponds to 6x105 cells/dish), and incubated overnight 
(16h) at 37ºC and 5% CO2 until the pulse labelling was performed. After pre-warming 
all solutions, the medium was removed and replaced by new medium containing 30 
$M CldU and incubated for 20 min at 37ºC and 5% CO2. Afterwards, cells were briefly 
washed 4 times with PBS and then incubated for 6h or 12h with different sorts of 
treatments (for example Aphidicolin alone, Aphidicolin+Okadaic Acid, etc.). Later, the 
cells were once again briefly washed for 3 times to remove the drugs and incubated 
for a further 20 min with medium containing 30 $M IdU. Subsequently, cells were 
washed with PBS 3 more times. Finally, each coverslip was transferred into a well, 
from a 6-well plate, and the cells were fixed with 70% ethanol (cooled at -20ºC) for 
15 min on ice. Before storing the cells at 4ºC (until probing), they were washed with 
PBS 3 times, 10 min each, on ice. 
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II.3.5.2 IMMUNOFLUORESCENCE 
This process aims to stain the incorporated halogenated derivative nucleotides, using 
specific fluorescent antibodies. The 6-well plate containing the coverslips was removed 
from the fridge and allowed to warm up at RT. Meanwhile, fresh 1.5 N HCl was 
prepared in order to fix the cells in the coverslips by incubating them for 30 min in the 
HCl solution. Afterwards, the coverslips were washed 3 times for 10 min with PBS and 
the pH was controlled with indicator strips. Then each coverslip, manipulated with the 
help of two appropriate forceps, was blocked for 1h using a PBS/1% Newborn Calf 
Serum (NCS) solution. All of the incubations performed, blocking included, were 
executed under an humidified chamber and the coverslips were placed over a 
stretched piece of parafilm, in a way that the side containing the cells was facing a 35 
$l drop of the solution in use. After blocking, the coverslips were washed in PBS for 5 
min. Then, it followed incubation with primary antibodies (for CldU and IdU, rat anti-
BrdU and mouse anti-BrdU, respectively, both at a final concentration of 8 $g/ml) 
diluted in PBS/1% NCS solution for 1h at RT, under the humidified chamber. 
Subsequently, the coverslips were once again washed 3 times, for 10 min, in PBS. The 
secondary antibodies (donkey anti-rat FITC diluted at 1:110 and goat anti-mouse 
TRITC diluted at 1:100) also diluted in PBS/1% NCS solution, were incubated with the 
coverslips as described for the primary antibodies. From this moment on, coverslips 
need to be protected from light as too much exposure may cause fluorophores 
bleaching. Following the secondary antibodies incubation, the coverslips were washed 
3 times, for 10 min in PBS and then incubated for 5 min in a 10 $M DRAQ5 solution 
(also in PBS/1% NCS). Afterwards, the coverslips were washed a couple of times, for 
10 min, in PBS and then mounted on slides previously cleaned with 70% ethanol, and 
containing a drop of ProLong Gold antifade reagent (Invitrogen). The slides were then 
stored in a folder, protected from the light, and after staying overnight at RT to fix the 
coverslips to the slide, they were sealed using clear nail varnish. After the varnish was 
dry, the slides were stored at -20ºC until the analysis by Confocal Microscopy was 
performed. This analysis was performed with a Leica TCS SP1 Confocal microscope 
using either a 100x/1.40 oil PH3 HCX PL APO or a 40.0X/1.25 OIL UV HCX PL APO 
objective. This microscope has 2 lasers: the Ar (for 458, 476, 488 and 514 nm) and 
the Kr (for 568 nm). In order to acquire the data, the Leica Confocal Software (1997-
2004, v2.61 Build 15.37) was used. 
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II.3.6 ANALYSIS OF CELLS BY FLUORESCENCE-ACTIVATED CELL SORTING 
(FACS) 
II.3.6.1 FIXATION OF MAMMALIAN CELLS 
In order to evaluate all the cells, both the population that was in suspension in the 
medium and the one that was adherent to the dish was collected into a 50 ml tube by 
transferring both the medium from the dish, as well as the 1 ml Trypsin/EDTA wash 
performed after medium removal. Subsequently, the cells still adherent in the dish 
were detached from it by the addition of 2 ml of Trypsin/EDTA and hitting the side of 
the dish to help the process. This process was monitored by the use of a microscope. 
When the cells were completely detached, trypsin was quenched by the addition of 8 
ml of complete DMEM medium and pooled with the previous cell washes. Afterwards, 
the dish was washed one last time with 10 ml of ice-cold PBS/1 mM EDTA/1% BSA, 
volume that was also pooled with the other washes. Then, the cell suspension was 
centrifuged at 1000 rpm for 5 min, the supernatant was discarded by aspiration and 
the pellet gently resuspended in 100 $l of ice-cold PBS/1 mM EDTA. Finally, the cells 
were fixed by the addition, dropwise, of 900 $l of ice-cold 70% ethanol, while 
vortexing the tube. The cells were then immediately stored at -20ºC until they were 
labeled for Flow Cytometry analysis. In the case of the analysis of GFP expression 
signal in a given cell population, the protocol was the same until the centrifugation 
step. After this, the pellet was ressuspended in 1 ml of ice-cold PBS/1 mM EDTA/1% 
BSA and stored on ice until it was analysed by Flow Cytometry (which occurred within 
the following hour). The volumes here described are relative to the use of 10 cm 
dishes. In the event of using 6 cm dishes, the volumes used were half of the ones 
mentioned above. 
 
II.3.6.2 LABELING OF FIXED MAMMALIAN CELLS BY PROPIDIUM IODIDE (PI) STAINING 
After the cells have been fixed as in II.3.6.1, 10 ml of ice-cold PBS/1mM EDTA/1% 
BSA were added to the tube containing these cells and then gently mixed followed by 
centrifugation at 1500 rpm for 5 min. Afterwards, the supernatant was aspirated and 
the cell pellet was resuspended in 100 $l of RNase A solution (100 $g/ml in PBS) by 
flicking the tube. After 10 min incubation at RT, 400 $l of PI solution (50 $g/ml in 
PBS) were added to the cells and incubated for a further 5 min at RT, protected from 
light. In the end, the cells were kept on ice and protected from the light until they 
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were analyzed by flow Cytometry, which occured on average 2h after the labelling. All 
the solutions were always freshly prepared. 
 
II.3.6.3 ANALYSIS OF CELLS BY FLOW CYTOMETRY  
The equipment used in Flow Cytometry was the CyAnTM ADP, Cytometry Analyser – 
Advanced Digital Processing, from Dako. After preparing the samples, as above, cells 
were evaluated for their DNA content, i.e. PI labelling, making use of the Summit v4.3 
software (Dako). In order to gate the cell population for the analysis, two different 
plots with two gating regions were created. In one of the plots, FS Lin x SS Lin, 
individual cells were selected by their size and shape. In the other plot, PE-Texas Red 
Lin x PE-Texas Red Area, cells were selected by the DNA content excluding the ones 
not in a normal distribution (poliploidy). Then, these two gating regions were 
combined in order to select the cells whose values of DNA content would be plotted in 
an histogram of PE-Texas Red Lin x Counts. By the analysis of this histogram, which 
translates how many cells have a given amount of DNA, by being directly proportional 
to the PI staining level, the cell cycle distribution was evaluated. For each experiment, 
data from 10,000 gated events were acquired. These events, were run at a maximum 
rate of 200 events/second. After acquisition, data was analysed also using Summit 
software. To generate the 3D overlays, WinMDI software was used following the same 
gating rules as above.  
 
II.4 CHK1 ANALYSIS TECHNIQUES 
In this Section, the methods describe several techniques whose main object is Chk1, 
going from its production and purification to assaying its phosphorylation state. 
 
II.4.1 BACULOVIRUS SYSTEM 
This system is used to express recombinant proteins in an insect cell context. The 
technique uses virus that contain in its genome the coding for an exogenous protein of 
interest which will be highly expressed and amplified while infecting insect cells with it. 
 
II.4.1.1 CELL MAINTENANCE 
Sf21 cell cultures were maintained in spinner flasks at 27ºC following standard 
procedures for this type of cultures. Briefly, the culture volume used in the spinner 
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flask varied with its size but always following the guideline that it could not exceed 
more than 2/3 of the spinner flask. This is important to maintain an optimum aeration 
in order for the cells to grow normally. To allow a better aeration, the spinner flask 
caps were left slightly loosen and the stirrer at a maximum of 90-100 rpm. The cells 
were diluted with pre-warmed IPL-41 growth medium (supplemented with 10% Heat-
inactivated FBS/1% fungizone/1% Pluronic-F68/2% Yeastolate/0.05% Gentamicin) to 
a concentration of about 3x105 cells/ml every time they got to 2-3x106 cells/ml, which 
happened twice a week.  
 
II.4.1.2 VIRUS AMPLIFICATION 
For best results in amplifying a viral stock is important to know the titer of it. Thus, to 
amplify a given virus stock, 106 cells/ml were seeded in 600 ml of pre-warmed 
medium and then infected at an MOI of 0.1, being the MOI expressed in pfu/cell and 
determined by the following equation: [inoculum used (ml) x titer of viral stock 
(pfu/ml)]/[number of cells]. Then, the cells were incubated under normal conditions 
for 2-3 days, depending on the state of infection, which was being monitored under 
the light microscope. At the point of harvesting the virus, the culture was centrifuged 
for 5 min at 2500 rpm and the supernatant was transferred into a sterile flask. The 
viral stock was tested for its titer and stored at 4ºC, wrapped in foil at least for 1 year. 
In the case of the production of a higher titer viral stock the steps of amplification 
were repeated taking the previous stock produced as a starting point.   
  
II.4.1.3 TITRATION OF THE VIRAL STOCK 
Infection 
The viral stocks were titrated using the BD BacPAKTM Baculovirus Rapid Titer kit. This 
method is more reproducible and quick, as compared with other tittering assays. In 
this case, the method is based on an immunoassay for a viral envelope glycoprotein 
that is produced in infected cells in about only two days and can be assayed well 
before plaques can be detected in a standard plaque assay. The manufacturer’s 
directions were followed during the whole process. Hence, per viral stock to titrate, 
one row of a 96-well plate (12 wells) was seeded with log phase Sf21 cells (6.5x104 
cells/well) and the wells were labeled as the following figure shows. 
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The plate was next incubated for 1 h at 27ºC, inside a sealed plastic bag containing a 
moisted paper towel. Meanwhile, a serial dilution, according to the figure above, was 
performed by adding 100 $l of the viral stock to 900 $l of IPL-41/10% FBS in order to 
obtain the final dilutions of 10-2, 10-3, 10-4 and 10-5. After the incubation period, the 
medium was carefully aspirated from each well and 25 $l of the viral dilutions were 
added to respective wells. To the negative control well it was added 25 $l of medium 
used to dilute the viral stocks. Then, the plate was gently agitated in order to evenly 
distribute the virus and incubated for a further 1 h at RT inside the sealed plastic bag 
containing the moisted paper towel. Then, the virus-containing medium was carefully 
aspirated from each well, taking care not to scrape the cells from the bottom of the 
wells. Finally, 50 $l of the Methyl Cellulose Overlay were added to each well and the 
96-well plate was wrapped in a moisted paper towel. The plate was then incubated 
inside a sealed plastic bag at 27ºC for 43-47h.  
 
Virus detection 
To each well, 150 $l of freshly prepared ice-cold formyl buffered acetone (30% of 
PBS/25% of a 37% formaldehyde solution/45% of acetone) were carefully added and 
incubated for 10 min at RT. Then, the reagents were removed from the plate in the 
sink and cleaned by gently tapping on a paper towel. Afterwards, each well was 
washed 3 times with 200 $l of PBS/0.05% Tween 20, for 5 min. Subsequently, 50 $l 
of diluted normal goat serum was added to each well and incubated for 5 min on a 
FIGURE II.1 | SCHEMATIC REPRESENTATION OF A 96-WELL PLATE SHOWING THE DISTRIBUTION OF 
THE DIFFERENT DILUTIONS TO USE IN THE TITERING OF A BACULOVIRUS STOCK. !
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shaker at RT. These reagents were next removed from the plate, as above, so that 25 
$l of the diluted mouse gp64 antibody could be added to each well and incubated for 
25 min at 37ºC. The antibody was then discarded and the wells were washed twice 
with 200 $l of PBS/0.05% Tween 20 for 5 min with shaking. After the washes, 25 $l of 
the secondary antidody, goat anti-mouse/HRP conjugate, were added to each well and 
incubated again for 25 min at 37ºC. Finally, the antibody was removed as above, and 
washed 3 more times with 200 $l of PBS/0.05% Tween 20 for 5 min, in a shaker. To 
develop the staining, 50 $l of blue peroxidase substrate were added to each well and 
incubated at RT for 3h. After this incubation, the wells were observed under a light 
microscope and the clusters of stained cells (foci) counted to determine the virus titer. 
The virus titer (pfu/ml) was determined applying the following formula: average no. of 
foci per well x dilution factor x 40 x 2.  
 
II.4.1.4 GST-CHK1 PURIFICATION (KD AND WT) 
In order to express the GST-Chk1 in large scale, the Baculovirus system was used in 
Sf21 cells. On the previous day of infection, cells were seeded in 500 ml of the 
appropriate medium at a density of 5x105 cells/ml, so that on the following day they 
were at 106 cells/ml and could be infected with the appropriate baculovirus stock at an 
MOI of 7. The cells were checked for infection along time and as soon they looked 
infected (cells not round as usual), they were left for another 24h to express the 
desired protein before lysing them. Usually, the cells are left for a total time of 72h 
post-infection. At this point, the cells were pelleted by centrifugation in 50 ml tubes 
for 5 min at 2,000 rpm and the supernatant was discarded. The pellet was then 
ressuspended in 0.5 volumes (of the original culture volume) of chilled MBS (Section 
VIII.10.6) and pelleted again by centrifugation for 5 min at 2000 rpm. After discarding 
the supernatant, the pellet was ressuspended in 10 ml per 100 ml of culture with lysis 
buffer (Section VIII.10.6) on ice. Subsequently, the lysate was clarified by 
centrifugation at 12,000 rpm for 10 min at 4ºC and the pellet was discarded. The 
supernatant was then kept on ice and its volume was estimated. Meanwhile, the pre-
swollen glutathione agarose beads were equilibrated with equilibration buffer (Section 
VIII.10.6), by transferring them into a 50 ml tube, topping it up with buffer and 
mixing. The beads were spun down at 2,000 rpm for 5 min. These equilibration steps 
were repeated 4 times, to completely remove the salt from the beads. For the volume 
of culture used, 8 ml of beads were needed for the protein purification. After the last 
wash, the buffer was removed from the tube containing the beads and the clarified 
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lysate was mixed. After sealing the tube with parafilm, it was incubated at 4ºC for 45 
min in a end-over-end roller. Then, the beads were centrifuged at 2,000 rpm for 2 min 
and the supernatant was retained at 4ºC until a successful pull-down was confirmed. 
The beads were subsequently washed for a couple of times with 10 volumes of pre-
chilled washing buffer and centrifuging for 3 min at 2,000 rpm. The supernatant from 
the washes were stored at 4ºC, while measuring the absorbance at 595nm (by the 
Bradford assay) to check the washes efficiency. In the case where the absorbance did 
not go down to zero, some more washes were performed. To elute the protein from 
the beads, which was carried out in the cold room, these were carefully transferred to 
a disposable column after being ressuspended in washing buffer. The tube containing 
the beads was then washed with buffer to collect the remaining beads from it, which 
they were afterwards transferred into the column. The beads were allowed to pack 
down and once that was finished, the excess buffer on top of the beads was removed 
with a pipette and the buffer left to drip through the column, without leaving it to run 
dry. At this point, the protein was eluted from the beads with 2 column volumes of 
elution buffer (Section VIII.10.6) and collected in fractions of about 500 $l. The 
elution was repeated with 2 more volumes of elution buffer. When the elution finished, 
the fractions were kept on ice and the protein concentration was measured by the 
Bradford assay. Here, the fractions with the highest protein concentrations were 
pooled and dialyzed in dialysis buffer (100 ml of buffer per ml of protein solution) for 
6-16h at 4ºC. During dialysis, the buffer was changed a couple of times. In the end, 
the material was snap frozen in 50 $l aliquots and stored at -80ºC.  
 
II.4.2 CHK1 ANTIBODY AFFINITY PURIFICATION 
II.4.2.1 PROTEIN-AFFINITY PURIFICATION COLUMN PREPRARATION 
Before preparing the resin for the column, the target protein (Chk1) was dialyzed in 
pre-cooled coupling buffer (0.1 M NaHCO3/0.5 M NaCl, pH 8.0) at 4ºC. For this 
purpose, 2.7 mg of wtChk1 were transferred into a piece of dialysis tubing and 
incubated overnight at 4ºC with a magnetic stirrer in 1 L of coupling buffer (this buffer 
was changed 3h after the dialysis started). Afterwards, 1 g of CH-activated sepharose 
resin was swollen in 150 ml of 1 mM HCl for 15 min and then centrifuged at 3,000 rpm 
for 2 min. After discarding the supernatant, the resin was washed in coupling buffer 
(the pH was checked to be at 8.0) and centrifuged as above. The protein dialyzed 
overnight was next pooled with the resin and coupled for 4 h at 4ºC, rolling end-over-
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end. The amount of protein coupled to the resin was monitored by Bradford assay 
every 2 h. At this point, after removing the protein solution from the resin by 
centrifugation as before, the unbound sites on the resin were blocked with 20 ml of 
0.1 M Tris-HCl (pH 8.0) for 1h at RT, rolling end-over-end. Subsequently, the column 
was alternatively washed, for a couple of times, either with 30 ml of 50 mM Tris-HCl 
(pH 8.0)/0.5 M NaCl or Sodium Acetate (pH 4.0)/0.5 M NaCl. The column was finally 
washed with 30 ml of 1x TBS/0.1% Tween 20/0.02% Sodium Azide and then stored at 
4ºC in a slurry with new washing solution.  
 
II.4.2.2 PURIFICATION OF ANTI-CHK1 ANTIBODY 
Once the column was prepared, it was washed with 2 column volumes of 1x TBS/0.1% 
Tween 20, but because the column was reused, before this wash the column was also 
washed with 10x TBS/1% Tween 20. At this point, 3 ml of sheep anti-serum were 
diluted 1:3 in 50 mM Tri-HCl (pH 7.5)/2% triton X-100 and filtered through a 0.2 $m 
filter. Subsequently, the serum was incubated in the column overnight at 4ºC, rolling 
end-over-end. After this incubation the column was washed 4 times with 6 column 
volumes of 20 mM Tris-HCl (pH 7.5)/0.4 M NaCl, while monitoring the OD595 until it 
was smaller than 0.003. To elute the antibodies, 20 ml of 50 mM Glycine pH 2.5 were 
allowed to run through the column and collected into 1.5 ml microtubes containing 
200 $l of 1.0 M Tris-HCl (pH 8.0). The final fraction volumes were approximately of 1 
ml. Subsequently, the protein concentration from each fraction was measured by the 
Bradford assay. The highest concentration fractions were pooled and stored overnight 
at 4ºC in order to allow the antibodies to refold. Meanwhile, the column was washed 
with 2 column volumes of 10x TBS/1% Tween 20 and then stored in 1x TBS/0.1% 
Tween 20/0.02% Sodium azide at 4ºC. On the following day, the protein concentration 
from the purified antibody was measured once again, aliquoted in 100 $l fractions and 
stored at -20ºC.  
 
II.4.3 CHK1 DEPHOSPHORYLATION ASSAYS 
The following methods were developed and performed to determine the identity of 
protein phosphatase groups involved in the regulation of Chk1 phosphorylation state 
in response to an intra S phase stress. A first approach was performed in vitro using 
HeLa cells lysates and a second monitoring the response in vivo as is next described.  
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II.4.3.1 IN VITRO ASSAY 
To generate the lysates used in this assay, HeLa cells were seeded at 3.5x105 cells per 
10 cm dish and incubated overnight at 37ºC and 5% CO2. After this incubation period 
cells were about 50-60% confluent. At this point, the cultures were treated with 2 mM 
Hydroxyurea (HU) for 24h also, by incubating them at 37ºC with 5% CO2. Then, all 
the cells were lysed as described in Section II.2.1.2 using a lysis buffer without any 
protein phosphatase inhibitors, followed by protein concentration determination using 
the Bradford assay. The dephosphorylation reaction was performed with 100 $g of 
protein per tube, in a total volume of 80 $l. The volume was set with the same lysis 
buffer used to generate the lysate. In separate tubes, different dephosphorylation 
conditions were generated by the addition of specific protein phosphatase inhibitors 
asis described on the following table. 
 
All tubes were prepared on ice and a pre-incubation of 30 min was also carried out on 
ice. Afterwards, the tubes were incubated at 30ºC for 1 h at 200 rpm. To stop the 
reaction, 20 $l of 5x SLB were added to each tube and then boiled for 5 min. Finally, 
the reaction samples were either immediately loaded on an SDS-PAGE for immunoblot 
analysis for specifc phospho-signals or frozen at -80ºC until the analysis was carried 
on as mentioned. 
 
II.4.3.2 IN VIVO ASSAY 
This specific experiment had different starting points depending on the type of 
treatment preformed before the HU treatment. Hence, cells were either transfected 
with specific siRNA for PP4 or PP6, over-expression constructs of I-2, PME-1 or PP1! 
(using Superfect transfection reagent) or even treated with Okadaic Acid (OA). In the 
case of transfections, already described in the II.3.4 Section, after allowing sufficient 
TABLE II.5 | DESCRIPTION OF THE DEPHOSPHORYLATION REACTION CONDITIONS. (+) indicates the 
presence of the respective reagent and (-) indicates its absence. The title of each set of 
conditions indicates which protein phosphatase group is active. 
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time to express the protein or for the knockdown to occur, cells were treated with 2 
mM HU for 24h. After this period, the HU was washed way and the cells were left to 
recover from the arrest. During the period of recovery, cells were harvested at 
different timepoints (0h, 0.5h, 2h, 8h and 24h after HU has been washed away), for 
SDS-PAGE (by lysis) and FACS analysis, as described above. For the OA treatment, 
cells were first seeded at 3x105 cells per 10 cm dish and incubated overnight in the 
tissue culture incubator (37ºC, 5% CO2) and just then, the dishes were incubated with 
2 mM HU for 24h. After this treatment, the dishes were washed and allowed to 
recover from arrest either in the presence or absence of 100 nM OA. At the same 
timepoints as for the transfections, the cells were also harvested for SDS-PAGE and 
FACS analysis as described above. The lysis buffer used in this Section contained 
Protein Phosphatase inhibitors, in order to prevent further dephosphorylation to occur 
during the sample processing. The appropriate controls were performed during each of 
these assays. 
 
II.5 YEAST TWO-HYBRID SYSTEM 
II.5.1 CONSTRUCTS AND SUBCLONING 
The screen was performed using human Chk1 as bait. In order to use Chk1 in this 
system, its cDNA was removed from a pOTB7 vector (VIII.7.5) by digestion with PstI 
and inserted in the pAS2-1 vector (VIII.7.1), using the techniques of restriction 
digestion, gel extraction (by "-Agarase I method) and ligation as described in Section 
II.2. The pAS2-1 vector was used for the bait protein because it expresses the GAL4 
DNA-binding domain fused to Chk1 protein and allows selection by specific nutritional 
conditions (allows growth in the absence of Tryptophan) and antibiotic resistance 
(ampicilin and cyclohexamide). A positive control prey was also generated by the 
subcloning of CDC25C from the pOTB7 vector into the pACT2 vector from the YTH 
system. CDC25C cDNA was copied from the pOTB7 vector by PCR, as described in 
Section II.1, and the restriction enzymes used for the multiple cloning site of the 
pACT2 vector were BamHI and XhoI. This vector contains the GAL4 Activation domain 
that, after subcloning, is fused to the prey protein and, besides the antibiotic selection 
markers, also allows cell growth in medium lacking Leucine. In both Chk1 and CDC25C 
subcloning procedures, the sequences were verified as described in Section II.1.10.  
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II.5.2 CDNA LIBRARY SCREENING 
To perform the screen, a culture expressing the bait protein (human Chk1) was 
previously generated and tested for its expression, nutritional selection and reporter 
gene self activation. This culture was generated in AH109 strain (mat a) in order to be 
able to mate with Y187 (mat !) that was pretransformed with a human testis cDNA 
library in the pACT2 vector (the cDNAs are fused with the GAL4 Activation domain). 
This method was performed following the manufacturer instructions.  
A colony from the strain containing the bait, was inoculated in 50 ml of the 
appropriate selective medium (SD/-Trp) and incubated overnight at 30ºC and 250 
rpm. In the end of the incubation, the OD600 should be higher than 0.8. Afterwards, 
the culture was centrifuged at 1000g for 5 min at RT and the supernatant carefully 
discarded, leaving some residual medium (~5 ml) to ressuspend the yeast pellet. After 
ressuspending the cells, its concentration should be 1x109 cells/ml. The cDNA library 
(1 ml) was thawed in a water bath at RT just before usage. At this point, 10 $l of the 
library were kept in a separate tube to titrate it (as described below, in Section 
II.5.3). In a 2L conical flask the bait culture and the cDNA library aliquot were mixed 
together and 45 ml of 2x YPDA/Kan were added. The cDNA library tube was washed 
twice with 1 ml of 2x YPDA/Kan and the washes were also added to the 2L conical 
flask. The final mixture, which had a volume of about 50 ml, was gently swirled and 
incubated at 30ºC for 20-24h at 40 rpm. The culture was monitored for the presence 
of zygotes 20h after the incubation started by looking to the culture under the phase-
contrast microscope. If that was the case, the culture was incubated for a further 4h 
as before. Subsequently, the culture was centrifuged at 1,000g for 10 min at RT. 
Meanwhile, the 2L conical flask was washed twice with 50 ml of 2x YPDA/Kan. This 
medium was then, used to ressuspend the cell pellet after carefully discarding the 
supernatant. The cell suspension was centrifuged again in order to remove the 
medium, and after discarding it, the cells were ressuspended in 10 ml of 0.5x 
YPDA/Kan. The final cell suspension volume was measured and in order to determine 
the mating efficiency 100 $l of sequential dilutions (1:10; 1:100; 1:1,000 and 
1:10,000) were plated in 10 cm plates with different selective medium: SD/-Trp, SD/-
Leu and SD/-Trp/-Leu. The mating culture was plated in 50 plates (200 $l per 15 cm 
plate), 25 of which contained TDO medium and the other 25 QDO medium. Then, the 
plates were incubated at 30ºC until colonies appeared, which usually happens within 3 
to 8 days after plating on TDO plates and 8-21 days on QDO plates. After the colonies 
grow in the control plates, their number was determined and the mating efficiency, as 
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well as the number of clones screened, was calculated. During the incubation of the 
plates, the positive clones had been replated twice on QDO medium/X-!-Gal 
containing plates and incubated at 30ºC for 3-8 days. The true positives were selected 
by the blue color they had in the presence of X-!-Gal. At this point, glycerol stocks of 
each positive clone were prepared and stored at -80ºC, as well as the master plates 
sealed with parafilm and stored at 4ºC. 
II.5.3 LIBRARY TITERING 
The 10 $l from the cDNA library, collect before the screen were diluted in 1 ml of 
YPDA/Kan (corresponding to the dilution A, whose dilution factor is 10-2) and gently 
mixed. Then, 10 $l of this dilution were transferred into a new microtube with another 
1 ml of YPDA/Kan and gently mixed (corresponding to the dilution B, whose dilution 
factor is 10-4). From the dilution A, 10 $l of it were added to 50 $l of YPDA/Kan in a 
new microtube and after gently mixing it was plated in a SD/-Leu plate. Volumes of 50 
$l and 100 $l were also plated in SD/-Leu plates. The same was performed with 
dilution B. Subsequently all plates were incubated at 30ºC for 3-5 days. Finally, the 
number of colonies was determined on the plates with 30-300 range and the titer 
calculated based on the expression: cfu/ml = #colonies / [plated volume (ml) x 
dilution factor]. 
  
II.5.4 ANALYSIS OF POSITIVE CLONES 
After the screen was performed different assays were carried out in order to 
determine the identity of the positive clones and validate the interaction. To determine 
the identity of the positive clones, each individual cDNA was sequenced. The validation 
of the interaction was performed with only 3 of the positive clones identified in the 
screen, through the "-Galactosidase assay and a co-immunoprecipitation from HeLa 
cells lysate.   
 
II.5.4.1 DNA EXTRACTION FROM YEAST CELLS 
To extract the DNA from yeast cells, the protocol followed was the same as the one 
described in the II.1.9.2 Section. To this protocol a couple of changes were introduced 
in order to improve the efficiency of the DNA extraction. First, instead of pelleting 1.5 
ml of culture, 3 ml of culture were used. And also, when resuspending the yeast 
pellet, 250 $l of glass beads were added to it as well as the Buffer P1 and then 
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vortexed for 3-5 min. The DNA extracted from yeast was used to transform bacteria 
as described previously. Single colonies originated from this last step were grown and 
its DNA extracted to be analysed by restriction digestion and sequencing. 
 
II.5.4.2 RESTRICTION DIGESTIONS 
The plasmid DNA was digested with HindIII enzyme, followed by an agarose gel 
electrophoresis in order to analyze the fragments originated in the digestion reaction. 
Both digestion restriction and agarose gel electrophoresis were carried out as 
described in Section II.1. 
 
II.5.4.3 IDENTIFICATION OF THE CDNA INSERTS BY SEQUENCING AND DATABASE SEARCH 
Each positive clone was sequenced to determine the identity of its cDNA. The 
sequencing was performed as described in Section II.1.10. Subsequently, the cDNA 
sequence was used in BLAST algorithm to search for similarities on a database of 
known sequences.  
 
II.5.4.4 MATINGS 
Before performing the "-Galactosidase assay, all the YTH plasmids in use were 
retransformed into the relevant mating types and strains of yeast to retest the 
interaction through mating and plating in the appropriate selective medium containing 
X-!-Gal.  
Before retransforming yeast with the positive clones cDNA, some sequence 
modification was performed in the region between the linker and starting ATG. This 
modification was conducted in order to remove stop codons that were identified by 
sequencing in that region. The sequence modification was executed by PCR followed 
by DNA ligation (using the EcoRI and the XhoI restriction sites), as described in 
Section II.1. The yeast transformation was performed as described in Section II.1.8.3. 
In order to mate two different mating types of yeast expressing the relevant proteins, 
one colony of each (less than 2 months old) was transferred into a microtube with 500 
$l of YPD medium and then vortexed to disperse the cell clumps. Afterwards, the tube 
was incubated at 30ºC for 20-24h at 200 rpm. At this point, different dilutions of the 
overnight culture were prepared (e.g. 1:100; 1:1,000) and 100 $l of them were plated 
in the appropriate selective medium. The plates were then incubated at 30ºC for 3-5 
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days until the colonies appeared. Finally, theses colonies were used to test for the 
interaction as is next described. 
 
II.5.4.5 "-GALACTOSIDASE ASSAY 
To quantify the intensity of interactions in this system, a useful reporter assay is the 
one that measures the "-galactosidase enzyme activity. This enzyme correlates with 
the intensity of the interaction, because its expression is dependent on the interaction 
itself. Hence, after growing the desired interaction in yeast, the lysate is exposed to a 
substrate (ONPG) that changes colour when is degraded by "-galactosidase. This 
colour change is then quantified and the determined value reports the intensity of the 
interaction.  
To perform the assay, a pre-culture of 5 ml in the appropriate SD selection medium 
was grown overnight at 30ºC and 250 rpm. Next, the overnight culture was vortexed 
for 0.5-1 min to disaggregate cell clumps possibly formed and immediately transferred 
into 30 ml of fresh medium. Then, the culture was incubated at 30ºC and 250 rpm 
until the cells got to mid-log phase (OD600=0.5-0.8). At this point, the OD600 was 
registered and the cells were harvested by centrifugation at 3,000 rpm for 5 min. After 
discarding the supernatant the cell pellet was washed with sterile water and 
centrifuged once again as before. Subsequently, the cell pellet was ressuspended in 
1/10 of the original volume with Z Buffer and vortexed to ressuspend the cells. 
Afterwards, the cells were subjected to 3 freeze/thaw cycles by incubating at them     
-80ºC and 40ºC, respectively. Before performing the reaction, the lysates were 
centrifuged at 1,000 rpm for 5 min at 4ºC. The protein concentration of the 
supernatant was measured by the Bradford assay. Next, the reaction was set up in a 
96-well plate where one sample was assayed per column, including a column with a 
negative control. This was performed by transferring 100 $l of the respective 
supernatant into each well and then, to start the reaction, 50 $l of the ONPG (5 
mg/ml) solution were added to each sample. Each reaction was allowed to occur for 
24h at RT and finally stopped with 50 $l of a 1M Na2CO3 solution. The OD420 from each 
well was measured and the activity values were normalized for the level of protein in 
each reaction. The "-galactosidase units were calculated by multiplying the normalized 
value by  (t=elapsed reaction time in minutes; V=0.1 ml x concentration 
factor, which is 10 in this case), (Miller 1972; Miller 1992). 
 ! 
1000
t "V
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II.5.4.6 CO-IMMUNOPRECIPITATION 
To validate the interaction in a human cell line (HeLa), the positive clones cDNAs were 
subcloned from the YTH vector into a mammalian expressing vector pCMV-HA 
(VIII.7.7) using restriction digestion (with EcoRI and XhoI), gel purification and DNA 
ligation techniques as described in Section II.1. Then, the clones were transfected into 
HeLa cells by the Calcium Phosphate method as described in Section II.3.4.1. The co-
immunoprecipitation was performed as described in Section II.2.2, using for each set 
of different lysates anti-Chk1 and anti-HA antibodies, as well as the respective IgG 
controls. 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
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CHAPTER III 
P R O T E I N  P H O S P H A T A S E S  
R E S P O N S I B L E  F O R  T H E  R E G U L A T I O N  
O F  C H K 1  A C T I V I T Y  
Protein Phosphatases acting on the Replication Checkpoint                                       Chapter III 
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!
Centro de Biologia Celular 
Universidade de Aveiro | Portugal 94 
Centre for Developmental and 
Biomedical Genetics 
University of Sheffield | UK !
Chapter III | Protein Phosphatases responsible for the 
regulation of Chk1 activity 
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III.1 INTRODUCTION 
III.1.1 CHECKPOINTS AND THE DNA-DAMAGE RESPONSE PATHWAY  
The DNA-damage response (DDR) pathway integrates distinct mechanisms that 
regulate vital cell functions (Cimprich and Cortez 2008). In this context, checkpoints 
ensure that those vital mechanisms, such as DNA replication or DNA repair, occur in a 
controlled and efficient way by preventing late cell cycle events from being initiated 
before earlier ones are finished (Hartwell and Weinert 1989). Hence, checkpoints may 
be triggered at different points through the cell cycle, always with the main goal of 
preventing the propagation of mutations and maintaining the genomic integrity at its 
maximum level. Typically, as the end target of the mechanism, a checkpoint uses one 
of the main group of cell cycle regulatory proteins, the CDKs. In signal transduction 
pathways, as previously mentioned, proteins can be classified into various categories 
according to their specific roles: sensors, transducers/mediators or effectors. In Table 
III.1 a list of proteins, showing such a classification for the specific context of the DDR 
pathway is presented. The main sensor/transducer proteins in these pathways belong 
to the Phosphoinositide 3-kinase-like kinase (PIKK) family of proteins. This family 
comprises kinases such as ATM (Ataxia Telangiectasia Mutated), ATR (AT and Rad 3 
related) and DNA-PK (DNA-dependent Protein Kinase). In particular, ATM and ATR are 
involved in the response to DNA double (DSBs) and single strand breaks (SSBs), 
respectively. Both kinases are large proteins with high homology in their sequence and 
a strong preference to phosphorylate Ser or Thr residues that are followed by Gln. 
While ATR has been demonstrated in various studies to be an essential gene, ATM has 
not. In fact, individuals with an impaired ATM function may live for a large number of 
years, although suffering from a condition called Ataxia Telangiectasia, where the 
patient has predisposition for a neurodegenerative and cancer disorder due to high 
sensitivity to ionizing radiation (IR) (Brown and Baltimore 2000; de Klein, Muijtjens et 
al. 2000; Cortez, Guntuku et al. 2001). ATM expression levels tend to be roughly 
constant throughout the whole cell cycle with its activity being low under normal 
conditions. It exists in an inactive dimmer that when recruited to DNA DSBs, 
originated by genotoxic stress such as IR, immediately dissociates and 
autophosphorylates on multiple residues, activating itself (Bakkenist and Kastan 
2003). This recruitment occurs through the interaction of ATM with NBS1 (Nijmegen 
Breakage Syndrome protein-1), between the C-terminal of the latter and the HEAT 
repeats of ATM (Falck, Coates et al. 2005; You, Chahwan et al. 2005).  
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NBS1 has been shown, in real time studies using live human cells, to readily assemble 
at the DSB sites (Lukas, Melander et al. 2004). This protein belongs to the complex 
that is first recruited to the DNA DSB site, the MRN complex (Petrini and Stracker 
2003). Besides NSB1, the MRN complex is constituted by: Meiotic Recombination 11 
(MRE11) and RAD50 proteins. Once ATM is activated, the DDR signal amplification 
starts by phosphorylation of the H2AX histone variant, which leads to the formation of 
the Ionizing Radiation-Induced Foci (IRIF). Although different members of the PIKK 
family can phosphorylate the H2AX histone, ATM seems to be the main kinase to 
contribute for this event in response to DSBs (Burma, Chen et al. 2001). The 
phosphorylated popultation of H2AX histone is commonly referred to as "H2AX and is 
TABLE III.1 | PROTEINS INVOLVED IN THE RESPONSE PATHWAYS TO DNA DAMAGE. For each 
protein, its role in signalling cascade and type (similarity in function/activity) is specified. 
The orthologs among species are positioned in the same line. The different species analysed 
are: Saccharomyces cereviseae (Sc), Schizosaccaromyces pombe (Sp), Drosophilla (Dm) 
and Vertebrates (Su 2006).!
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formed by the phosphorylation of a conserved serine, Ser129 in budding yeast and 
Ser139 in mammals, quickly after of the generation of DSBs. Subsequently, Mediator 
of DNA-damage checkpoint 1 (MDC1) is recruited to the damage site, binding directly 
to both "H2AX and NBS1 (Stucki, Clapperton et al. 2005), and thus generating an 
anchoring site for the MRN complex. These interactions amplify the signal in the 
flanking region of the damage, by recruiting more ATM and MRN complex, which 
ultimately will also recruit more MDC1 and originate further "H2AX (Figure III.1) 
(Stucki and Jackson 2006).  
 
 
FIGURE III.1 | MODEL FOR THE DNA DAMAGE RESPONSE IN MAMMALS. The different pathways 
that may be followed after DNA damage are depicted, as described in the text. In watermark 
are the pathways not approached in the text. The red Xs represent replication blocks and the 
red arrows indicate the direction of movement for the replication helicases and polymerases. 
Open circles containing ‘‘P’’ represent phosphate, while green filled circles represent ubiquitin 
(Harper and Elledge 2007).!
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Following activation of ATM, downstream targets are also phosphorylated by this 
kinase, triggering a process of repair and checkpoint activation driven by Chk2. 
Overall this is the typical start of a response to DSBs. However, when a cell faces 
SSBs, such as sometimes occurs during the course of DNA replication, another DDR 
route is triggered by activation of ATR. Under certain circumstances DSBs may also 
trigger that route, when these go through end reSection, in a CDK-dependent manner 
(Bartek and Lukas 2007).  
In opposition to ATM, which is expressed throughout the cell cycle, ATR is only 
expressed after the restriction point in G1, limiting its action to both S and G2 phases 
(Jazayeri, Falck et al. 2006). This limited expression is a consequence of the 
regulation carried out by the transcription factor E2F, which in its turn is activated by 
pRb. Under stress conditions, ATR activity is controlled either by its subcellular 
location or by the regulation of ATR-Interacting protein (ATRIP). As mentioned, ATR 
senses SSBs, but more precisely 5’ primed structures. This is a consequence of RPA, a 
ssDNA binding protein, being recruited to stabilize those structures, which ultimately 
activates ATR signalling (Lee, Moore et al. 1998; Umezu, Sugawara et al. 1998; 
Costanzo, Shechter et al. 2003; Zou and Elledge 2003; Fanning, Klimovich et al. 
2006). A detailed example is presented, for a replication fork that stalls or collapses. 
In this case, ssDNA becomes unprotected, and therefore inducing RPA recruitment. 
Afterwards, two different complexes are also recruited to the damaged area: the 
RAD9-RAD1-HUS1 complex and the complex constituted by RAD17 and RFC2 to 5. 
While the first, also known as the 9-1-1 complex, generates a heteromeric ring-
shaped PCNA-like sliding clamp structure, the second generates a clamp loader-like 
structure. When these structures are in place at the site of damage, the ATR and 
ATRIP complex is also recruited. However, in order to activate ATR signalling, TOPBP1 
needs also to be recruited (Figure III.1). TopBP1 (represented as TopBP in Figure 
III.1), a protein involved in replication, is recruited through a 9-1-1-mediated 
mechanism, where the TopBP1 BRCT domains I and II recognize the phosphorylated 
Ser387 from the C-terminal tail of RAD9 (St Onge, Besley et al. 2003). This 
interaction brings TopBP1 near ATR by TopBP1 binding to ATRIP (Kumagai, Lee et al. 
2006; Delacroix, Wagner et al. 2007; Lee, Kumagai et al. 2007). This induces ATR 
interaction with TopBP1, via TopBP1 ATR activation domain located between TopBP1 
BRCT domains VI and VII (Kumagai, Lee et al. 2006), which results in ATR activation. 
Following ATR activation, its targets are phosphorylated helping to amplify the signal 
as it occurs in the ATM pathway. Among its targets are found proteins from the actual 
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damage foci, such as RAD17, RAD9 and TopBP1. In addition, the main target of ATR is 
the Checkpoint kinase 1 (Chk1), which will be described in the following Sections.   
 
III.1.1.1 THE DNA DAMAGE RESPONSE AT G1 PHASE 
During G1 phase, the key DNA damage pathway operates through p53 regulation, a 
function that is carried out by the activity of both ATM and Chk2. Hence, in response 
to DSBs, p53 is phosphorylated by ATM at the Ser15 residue, and by Chk2 at both 
Thr18 and Ser20, all residues in its N-terminal transactivating domain. In addition, 
these kinases also phosphorylate MDM2. Phosphorylation of both these targets take 
place in order to stabilize p53. This occurs either by its phosphorylation at the N-
terminal transactivating domain or by the abrogation of the p53 MDM2-dependent 
degradation, through the inhibition of the MDM2 ubiquitin ligase function. This 
stabilization allows the transcriptional activation of the p21 CDK-inhibitor that 
ultimately prevents the E-CDK2 complex from being activated, therefore inhibiting the 
transition from G1 to S phase (Kastan and Lim 2000; Wahl and Carr 2001). Moreover, 
preventing E-CDK2 complex activation, allows pRb to maintain its gatekeeping role 
active, as described above in Section I.2.2. Once the cell cycle goes through the 
restriction point and ATR and Chk1 protein expression levels start to increase, these 
may also help in this signalling pathway. In fact, these kinases can induce arrest even 
during late G1 through phosphorylation of the CDC25 family members. In comparison 
with the p53 signalling cascade, which also operates in late G1, CDC25 
phosphorylation seems to work faster since it does not require the transcription and 
accumulation of newly synthesized proteins, but only the rapid protein degradation 
cascade. Hence, it is usually described that CDC25A route delays the cell cycle and 
p53 signalling sustains it (Kastan and Bartek 2004).  
 
III.1.1.2 THE DNA DAMAGE RESPONSE AT S PHASE 
The replication checkpoint operates in order to ensure the genomic integrity during S 
phase, by stabilizing ongoing replication forks and preventing new origins from firing. 
SSBs are one of the main DNA damage structures that may be generated during S 
phase, due to the colapse or stall of replication forks. These, as mentioned, ultimately 
activate the ATR cascade. Once the latter is active it begins phosphorylating its targets 
at the fork, including: the replication factor C (RFC) complex, RPA1 and RPA2, the 
minichromosome maintenance (MCM)2–7 complex, MCM10, several DNA polymerases 
and the checkpoint mediator Claspin (that occurs via RAD17 binding) (Liu, Bekker-
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Jensen et al. 2006). After being phosphorylated, Claspin regulates Chk1 activity by 
recruiting it to the site of DNA damage, where it allows Chk1 to be phosphorylated 
and activated by ATR (Kumagai and Dunphy 2000; Kumagai and Dunphy 2003). Chk1 
activation by the phosphorylation at the Ser345 residue (Lopez-Girona, Tanaka et al. 
2001; Capasso, Palermo et al. 2002) is a key event to trigger replication arrest, 
through its phosphorylation activity on proteins such as CDC25 or Wee1 (O'Connell, 
Raleigh et al. 1997; Sanchez, Wong et al. 1997; Boddy, Furnari et al. 1998; Furnari, 
Blasina et al. 1999). Hence, while Chk1-dependent phosphorylation results in CDC25 
activity inhibition, on Wee1 the phosphorylation activates it. Hence, the outcome of 
Chk1 activity towards cell cycle arrest is the balance between the regulation of both 
CDC25 and Wee1 functions. Briefly, when active, CDC25 phosphatases 
dephosphorylate the inhibitory site (Y15) of the cyclin/CDK complex, activating it. 
Wee1 phosphorylates at that same site, inhibiting its activity and preventing cell cycle 
progression. CDC25 Protein Tyrosine Phosphatases can be inhibited through different 
mechanisms, depending on which specific group they belong to (Figure III.1). For 
example, when phosphorylated, CDC25C is sequestered by a 14-3-3 protein that 
prevents it from being active. In opposition, CDC25A, an enzyme that works earlier 
than CDC25C in the cell cycle and is thought to be important for maximal CDK activity 
during progression through S phase, is subjected to ubiquitin-mediated proteolysis. 
This ubiquitination is performed by SCF!-TRCP ubiquitin ligase right after CDC25A 
phosphorylation (Guardavaccaro and Pagano 2006).  
As mentioned, with the cell cycle arrest during S phase, new replication origins are 
prevented from firing while the stress is being resolved. This is carried out by the 
inhibition of CDK2, which prevents CDC45 recruitment onto assembled pre-replication 
complexes, an event necessary for the loading of DNA Polymerase ! (Bartek and 
Lukas 2003; Bartek, Lukas et al. 2004). In addition, under replication stress, Cdt1, 
which is important for the initiation of the replication process, is targeted for ubiquitin-
mediated destruction by an SCF-like ubiquitin ligase, in this way preventing new 
origins from firing (Arias and Walter 2007).  
When the DNA damage is resolved, in order to recover from this ATR/Chk1 
dependent-arrest, Polo-like kinase 1 (Plk1) phosphorylates both Claspin and Wee1. 
Once targeted, these proteins are signalled for degradation by ubiquitin-mediated 
proteolysis, where SCF!-TRCP is also the ubiquitin ligase responsible for that signalling 
event (Figure III.1).  
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III.1.1.3 THE DNA DAMAGE RESPONSE AT G2 PHASE 
Checkpoints triggered during the G2 phase of the cell cycle may result from 
unresolved G1/S DNA damage, or even from an ineffective replication checkpoint that 
leads to the generation of structures of inappropriately or not fully replicated DNA 
(Kastan and Bartek 2004). While in G1 and S phases, checkpoints operate through 
inhibition of CDK2 containing complexes, during G2 the endpoint target complex is the 
cyclin B-CDK1. In this case, as before, the inhibition of this complex results from the 
subcellular sequestration, degradation and/or inhibition of the CDC25 family of 
phosphatases, again triggered by ATR-Chk1 signalling pathway. In addition, during 
this phase, the p38-kinase pathway may also work in parallel to the ATR-Chk1 
pathway to inhibit the cyclin B-CDK1 complex (Bulavin, Higashimoto et al. 2001).  
 
III.1.1.4 REPLICATION CHECKPOINT INDUCERS 
There are several drugs that allow for the study of the cell cycle, by inducing its arrest 
through checkpoint function. For example, Nocodazole is used to block the mitotic 
function by promoting tubulin depolymerisation, an event that triggers the spindle 
checkpoint, hence arresting cells in mitosis (Fleischman, Pilaro et al. 1993). 
Specifically for S phase studies, drugs such as Mimosine, Hydroxyurea (HU) or 
Aphidicolin are available. Mimosine, a naturally-occurring amino acid derivative from 
Leucaena, was first described as a cell-growth inhibitor that arrested cells at a specific 
point during late G1 phase (Lalande 1990; Lalande and Hanauske-Abel 1990). 
However, when looking closer to its mode of action, it was reported that Mimosine is 
in fact a very efficient DNA replication inhibitor as it prevents the formation of 
replication forks (Lin, Falchetto et al. 1996). Aphidicolin, an antibiotic isolated from 
Nigrospora sphaerica with potent antiviral and antimitotic capacities (Ikegami, Taguchi 
et al. 1978), specifically inhibits the DNA polymerase ! and # in eukaryotic cells and in 
some virus (Ohashi, Taguchi et al. 1978; Huberman 1981). Due to its cell-permeable 
properties, Aphidicolin is widely used in cell culture experimental setups to trigger the 
replication checkpoint. Finally, HU, usually described as an anti-neoplastic agent, 
inhibits DNA replication progression. This is carried out through the inactivation of the 
ribonucleoside reductase, by forming a free nitroxide radical that binds a free tyrosyl 
radical in the active site of the enzyme. As a result, the synthesis of deoxynucleotides 
is blocked, which leads to the depletion of the cellular nucleotide pool, hence inhibiting 
DNA synthesis and inducing the activation of the replication checkpoint (Lassmann, 
Thelander et al. 1992; Yarbro 1992; Hendricks and Mathews 1998). 
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III.1.2 THE CHECKPOINT KINASE 1 (CHK1) 
Checkpoint Kinase 1 (Chk1) was first described to induce sensitivity to DNA damage or 
incomplete replicated DNA when it was knocked-out from a yeast background 
(Walworth, Davey et al. 1993). Playing a central role on the DDR pathway, Chk1 is a 
kinase belonging to the family of the CaMK Ser/Thr protein kinases and to the NIM1 
subfamily. As mentioned, its expression levels increase from S to M phases (Kaneko, 
Watanabe et al. 1999) as well as when cells are exposed to genotoxic stress 
(Gottifredi, Shieh et al. 2001). Chk1 is composed of 476 aminoacids, resultant from 
the transcription of a gene constituted by 13 exons, located in chromosome 11 at the 
position 11q24-q24. The catalytic domain, the most conserved region of the protein 
throughout species (Figure III.2.B), is located in the N-terminus (positions 1-265). 
The C-terminus is less conserved and is implicated in the regulation of the kinase 
activity. This fact was supported by the determination of the kinase domain region 
crystal structure (positions 1-289 - Figure III.2.A), where it was found that when the 
C-terminal region was present, the kinase activity was reduced by about 20 fold 
(Chen, Luo et al. 2000). The catalytic domain has preference to phosphorylate RxxS 
consensus sites (O'Neill, Giarratani et al. 2002). 
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FIGURE III.2 | CRYSTAL STRUCTURE AND AMINO ACID SEQUENCE OF THE HUMAN CHK1 KINASE 
DOMAIN (N-TERMINAL, POSITIONS 1-289). A. A ribbon diagram of Chk1 kinase domain coupled 
with AMP-PNP at the active site. The # helices are shown in blue, " strands in cyan, the 
catalytic loop in yellow and the activation loop in red. AMP-PNP and the sulphate ion are 
shown as ball and stick models. B. Sequence alignment of Chk1 kinase domain throughout 
species, using ClustalW, where the secondary structural elements of human Chk1, coloured 
as in A., are shown above the alignment. On the left side, the species are stated as: hs 
(human), mm (mouse), xl (Xenopus), dm (Drosophila), ce (C.elegans), sc (S.cerevisiae) and 
sp (S.pombe). On the right the numbers of the amino acids are presented. Residues not 
modelled in current structures are indicated as a dotted line. In red are the residues that are 
invariant throughout species and in cyan the human Chk1 residues that are conserved in 
other species (adapted from (Chen, Luo et al. 2000).!
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Typically, during DNA replication checkpoint or with certain genotoxic stress events, 
Chk1 is highly activated through phosphorylation on both Ser317 and Ser345 
residues, either by Ataxia Telangiectasia-Mutated and Rad-3 related (ATR) or, with 
much lower predominance, by ATM (Liu, Guntuku et al. 2000; Zhao and Piwnica-
Worms 2001; Capasso, Palermo et al. 2002). These phosphorylations are dependent 
on the activity of the adaptor protein Claspin that recruits Chk1 to the vicinity of the 
damage site, where both ATR-ATRIP and RFC-Rad17/9-1-1 complexes are already 
located. These complexes are necessary to be assembled at the damage site for the 
ATR-dependent Chk1 phosphorylation to occur (Kumagai and Dunphy 2000; Kumagai, 
Kim et al. 2004). Once active, Chk1 itself can phosphorylate its downstream targets, 
such as CDC25C and Wee1, that ultimately prevent cell cycle progression (O'Connell, 
Raleigh et al. 1997; Sanchez, Wong et al. 1997; Boddy, Furnari et al. 1998; Furnari, 
Blasina et al. 1999). Moreover, Chk1 phosphorylation-induced conformational change 
promotes its interaction with proteins such as 14-3-3, maintaining Chk1 in the nucleus 
(Jiang, Pereira et al. 2003), where it can fulfil specific tasks. These include: prevention 
of premature mitosis by stabilizing stalled replication forks and preventing the firing of 
late origins (Abraham 2001; Feijoo, Hall-Jackson et al. 2001; Lundin, Erixon et al. 
2002; Zachos, Rainey et al. 2005); activation of Homologous Recombination 
(Sorensen, Hansen et al. 2005); regulation of DNA damage-induced transcriptional 
repression by the phosphorylation of H3 (Shimada, Niida et al. 2008). In addition to 
these functions during replication and DNA damage stresses, Chk1 has been shown to 
have basal kinase activity while it is associated with chromatin in cycling cells under 
normal growth conditions (Jiang, Pereira et al. 2003). Outside the nucleus, Chk1 was 
described to be present at the centrosome level during interphase, preventing the 
activation of B1-CDK1 and consequently avoiding premature mitosis entry (Kramer, 
Mailand et al. 2004; Lukas, Melander et al. 2004). To allow this migratory property, 
Chk1 presents both NLS and NES types of nuclear localization and export signals in its 
sequence (Jiang, Pereira et al. 2003).  
Using in vivo studies, the Chk1 gene was shown to be essential for development since 
Chk1 knocked-out mice exhibited embryonic lethality (E6.5) due to the generation of a 
peri-implantation defect (Liu, Guntuku et al. 2000; Takai, Tominaga et al. 2000). 
Additionally, work performed by Lam and colleagues using conditional Chk1 mice, 
revealed that in the event of heterozygosity there were several haploinsufficient 
phenotypes that could be distinguished, such as: inappropriate S phase entry, 
accumulation of DNA damage during replication and failure to restrain mitotic entry 
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(Lam, Liu et al. 2004). In humans, some degree of correlation was demonstrated to 
occur between Chk1 gene instability, as well as frameshit mutations, with either MSI-
positve colorectal cancers or tumourigenesis in a subset of colorectal cancers (Kim, 
Lee et al. 2007). 
As described, Chk1 has interesting key regulatory roles with high relevance in cancer 
research. Therefore, Chk1 has been targeted for the development of new therapies 
that already resulted in the characterization of several specific Chk1 inhibitors in the 
past few years. Examples of these small molecule inhibitors can be: UCN-01, Gö6976 
and DBH (Figure III.3).  
 
 
 
 
 
 
 
 
 
UCN-01, also known as 7-Hydroxystaurosporine, first found to be a PKC inhibitor 
(Akinaga, Gomi et al. 1991; Seynaeve, Kazanietz et al. 1994; Shao, Cao et al. 2004), 
is probably the most used Chk1 inhibitor in experimental approaches. As a 
consequence of Chk1 inhibition (Busby, Leistritz et al. 2000; Graves, Yu et al. 2000; 
Yu, La Rose et al. 2002), UCN-01 was used in many experiments due to its G2 
checkpoint abrogation, allowing CDK1 activation and subsequent cell cycle 
progression. This property coupled with the activity of DNA-damaging agents, such as 
cisplatin, camptothecin and ionizing radiation, potentiated the citotoxicity of the latter 
(Bunch and Eastman 1996; Wang, Fan et al. 1996; Shao, Cao et al. 1997). Therefore, 
UCN-01 was thought to be a potential drug to use in cancer therapies. However, after 
going into clinical trials and completing Phase I, it was determined that UCN-01 bound 
avidly to the human plasma protein !1-acid glycoprotein which decreased its 
bioavailability and greatly increased its half-life (Fuse, Tanii et al. 1998; Sausville, 
Arbuck et al. 2001). In accordance, Kohn and colleagues have shown that when using 
5% human serum instead of bovine serum in cell culture, the concentration of UCN-01 
FIGURE III.3 | STRUCTURE OF UCN-01, GÖ6976 AND DBH.!
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needed to abrogate the DNA damage-induced arrest during S and G2, would need to 
be nearly 100-fold higher (Kohn, Ruth et al. 2002). 
 
III.1.3 GOALS 
The main goal of this chapter was to understand the role of Ser/Thr protein 
phosphatases in the regulation of Chk1 activity. For that, several approaches were 
used, including the use of specific small molecule inhibitors or siRNAs, coupled to 
drugs that allow for the study of both the activation and the recovery from the 
replication checkpoint in mammalian cell lines. In the regulation of Chk1, protein 
phosphatases can have two potential roles. The regulation of Chk1 activation rate by 
affecting upstream proteins and the regulation of its activity status by inducing, 
stabilizing or inhibiting it. Therefore, the work described in this chapter was aimed at 
testing these hypotheses, taking the level of Chk1 phosphorylation as a read out for 
the role of PPs in the recovery from the replication checkpoint.  
 
III.2 CHK1 DEPHOSPHORYLATION TIME COURSE 
The identification of protein phosphatases responsible for the regulation of protein 
kinase activity in vitro has proven to be valuable to rule out their role in cellular in 
vivo processes. Confirming this, Félix and colleagues (1990) have shown that it was 
possible to add several different protein phosphatase inhibitors to Xenopus egg 
extracts to clarify which protein phosphatases were having a role on the regulation of 
the CDC2 kinase activity during the transition to M phase. The same type of approach 
was therefore used, whereby utilizing different types of protein phosphatase inhibitors 
we could determine which protein phosphatase groups had a role on the regulation of 
Chk1.  
The problem was approached using two different systems, in vitro and in vivo. Thus, 
for the in vivo time course of Chk1 dephosphorylation, HeLa cells were pre-treated 
with 2mM of HU for 24h and lysed at different timepoints following HU removal - 0h, 
0.5h, 2h, 8h and 24h - (Figure III.4.A). As a control for the basal level of Chk1 
phosphorylation, an additional set of HeLa cells with no HU pre-treatment was lysed 
after 24h incubation (Figure III.4.A, 0h -HU). For the in vitro time course, lysates used 
to perform the assay were prepared as above by pre-treating HeLa cells with 2 mM HU 
for 24h and lysing them right after HU washout (0h +HU). In order to perform the 
assay, these lysates were incubated at 30ºC for different lengths of time (Figure 
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III.4.B – after which the reaction was stopped by adding Sample Loading Buffer and 
boiling the mixture for 5 min). The immunoblot analysis from each experiment was 
performed by using phospho-specific antibodies against both pSer317 and pSer345 
residues from Chk1. 
 
 
The first timepoint (0h -HU) corresponds to cells with no HU pre-treatment that were 
lysed simultaneously with cells at the second timepoint, which were previously 
submitted to 24h incubation with 2 mM HU (0h +HU). From both data sets, in vivo 
FIGURE III.4 | ANALYSIS OF CHK1 DEPHOSPHORYLATION TIME COURSE. Samples from in vivo (A) 
and in vitro (B) approaches were submitted to SDS-PAGE followed by Western Blotting. The 
membranes were probed with Chk1-pSer317, Chk1-pSer345 and actin antibodies (A.1 and 
B.1). The blots were quantified using the UVIband software and the normalized values (to 
actin average) were plotted for each timepoint (A.2 and B.2). The timepoints included were: 
for the in vivo (A) 0h, 0.5h, 2h, 8h and 24h after HU removal (+HU), and 0h with no HU 
treatment (–HU); for the in vitro (B) 0h, 0.5h, 1h, 1.5h and 2h after HU removal (+HU), and 
0h with no HU treatment (-HU). !
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and in vitro, it is clear that HU treatment induces high levels of phosphorylation on 
both Ser317 and Ser345 Chk1 residues. These phosphorylation levels decline once HU 
is removed from the medium, in a bi-phasic manner. In the first half-hour (first 
phase) both phosphorylation sites, Ser 317 and Ser345, lose 60-80% of their specific 
phosphorylation, and the remaining dephosphorylation reaction (second phase) occurs 
at a much lower rate in both types of assays. However, as the timepoints used on 
both assays were different, the data suggests that the second phase in vivo is slower 
than the one in vitro, as it took about 24h for the former to achieve the same level of 
dephosphorylation that the latter had after 2h of HU removal. In either assay, in the 
last timepoint, Chk1 phosphorylation levels still did not reach the basal levels of cells 
not pre-treated with HU (-HU, 0h timepoint, both in vivo and in vitro). 
This result shows that overall both systems present the same Chk1 dephosphorylation 
dynamics, being both valuable to analyse Chk1 dephosphorylation, either together or 
separately.  
III.3 CHK1 IN VITRO DEPHOSPHORYLATION APPROACH 
Upon determining the dynamics of Chk1 dephosphorylation in both systems, the 
optimal timepoint for the in vitro approach was further addressed. Since only small 
changes were observed in the phosphorylation state of Chk1 between 0.5 and 1h (as 
seen in Figure III.4.B), the latter point was used for subsequent in vitro analyzes on 
the role of different phosphatase classes in the dephosphorylation of Chk1. 
In order to determine the specific contribution of different protein phosphatase groups 
(1, 2A and 2C) to the dephosphorylation of Chk1 in vitro, extracts derived from HU 
pre-treated cells, and therefore containing phosphorylated Chk1, were incubated for 
1h at 30ºC in a variety of conditions in which each class of phosphatases was 
selectively inhibited (as previously presented in Table II.5 and also below in Figure 
III.5.B.2). After incubation, 25 $g of each sample were analysed by immunoblotting 
using anti-pSer317 and anti-pSer345 antibodies to determine Chk1 phosphorylation 
state (Figure III.5.A). This experiment was performed in quadruplicates and the 
immunoblot data was quantitatively analysed by the UVIband software, further 
processed and plotted (Figure III.5.B.1.). 
 
 
 
 
Protein Phosphatases acting on the Replication Checkpoint                                       Chapter III 
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!
Centro de Biologia Celular 
Universidade de Aveiro | Portugal 109 
Centre for Developmental and 
Biomedical Genetics 
University of Sheffield | UK !
 
When all phosphatase groups are inhibited, no Chk1 dephosphorylation at both Ser317 
and Ser345 could be observed, as expected. When PP1 and PP2A classes are both 
active (Figure III.5.A - lane 4) the level of Chk1 remaining phosphorylation is close to 
the one when all protein phosphatase groups are active (Figure III.5.A - lane 2). This 
indicates that either one or both groups have a role on Chk1 regulation. When only 
PP2C group is active (Figure III.5.A - lane 7), a decrease in Chk1 phosphorylation 
could only be observed for Ser345 dephosphorylation, while Ser317 phosphorylation 
level almost remained unaltered as compared with t=0h (Figure III.5.A - lane 1). 
Regarding the condition where PP2A is the only protein phosphatase group active 
(Figure III.5.A - lane 6) the level of phosphorylation on both residues drops almost to 
the levels observed when all protein phosphatases are active (Figure III.5.A - lane 2), 
suggesting that this is the main group involved in regulating Chk1 dephosphorylation. 
In fact, when PP1 is the only group active (Figure III.5.A - lane 5), smaller decreases 
on the phosphorylation levels of both residues are observed, which supports the 
indication that the PP2A family is the major phosphatase group regulating Chk1 
Ser317 and Ser345 phospho-residues. These observations are supported by the 
FIGURE III.5 | ANALYSIS OF 
SELECTIVE CHK1 IN VITRO 
DEPHOSPHORYLATION. 
Samples from each reaction 
were submitted to SDS-PAGE 
followed by Western blotting. 
The membrane was probed 
with Chk1-pSer317, Chk1-
pSer345 and actin antibodies 
(A). The phospho-signals 
from 4 parallel experiments 
were quantified using 
UVIband software and the 
average of Chk1 
phosphorylation levels in 
each phospho-residue was 
calculated and plotted (B.1). 
The table presents the 
protein phosphatase groups 
inhibited in each set of 
conditions – corresponding 
to the plot above (B.2). !!
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quantitative analysis (Figure III.5.B.1), where a role for PP2A on the regulation of 
Chk1 phosphorylation becomes evident. 
With this approach we were able to narrow down the Ser/Thr protein phosphatase 
spectrum potentially involved on Chk1 dephosphorylation. Since these results should 
ultimately be consistent with in vivo studies, we proceeded with different approaches 
to affect specific protein phosphatase activities at the cellular level. These involved the 
use of either: overexpression of protein phosphatase inhibitors (I-2 and PME-1) or of 
protein phosphatase itself (PP1!); siRNA transfection methodologies (PP4 and PP6 
siRNA); the use of cell-membrane permeable small molecule inhibitors (okadaic acid). 
 
III.4 CONTRIBUTION OF THE PROTEIN PHOSPHATASE 1 FAMILY TO CHK1 
DEPHOSPHORYLATION 
According to our previous in vitro results, PP1 family members seem not to have an 
important role on Chk1 dephosphorylation. Nonetheless, den Elzen and O’Connel 
(2004) have found evidences that PP1 could indeed dephosphorylate Chk1. On their 
fission yeast system (S. pombe), den Elzen and O’Connell have shown that a yeast 
homolog of PP1, Dis2, could abrogate Chk1 phosphorylation as well as its activation in 
vivo, and dephosphorylate a phospho-Ser345 Chk1 peptide in vitro. Hence, in order to 
clarify this issue, we performed a series of assays to increase or decrease PP1 activity 
by over expressing PP1! or I-2, respectively. Results by Den Elzen and O’Connel 
results suggested that by overexpressing either the PP1! or I-2 proteins in vivo, we 
could have an effect on Chk1 dephosphorylation. Regarding I-2, a potent inhibitor of 
PP1 proteins, Bennett and colleagues (2003) showed that it is possible to achieve a 
functional inhibitory effect on PP1 activity by ectopically overexpressing I-2 in vivo. In 
order to persue this approach, we first subcloned the I-2 cDNA encoding sequence into 
a suitable mammalian expression vector. This allowed us to overexpress I-2 in 
mammalian cells, as further described. 
 
III.4.1 I-2 SUBCLONING AND EXPRESSION IN HELA CELLS 
A cDNA encoding I-2 was obtained from ImaGenes (clone IRALp962O165Q, supplied 
in a pOTB7 vector), and its DNA sequence confirmed using both M13 forward (-21) 
and M13 reverse primers (Table VIII.2 - Appendix). The I-2 sequence was then 
subcloned by PCR into pcDNA5/TO mammalian expression vector, using the primers I-
Protein Phosphatases acting on the Replication Checkpoint                                       Chapter III 
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!
Centro de Biologia Celular 
Universidade de Aveiro | Portugal 111 
Centre for Developmental and 
Biomedical Genetics 
University of Sheffield | UK !
5’ and I-3’ (Table VIII.2 - Appendix) and restriction by BamHI and XhoI.  The resulting 
construct (pcDNA5/TO[I-2]) was sequenced in order to verify the I-2 sequence, as 
shown in Figure III.6. 
 
ggatccgcccggcaatggcggcctcgacggcctcgcaccggcccatcaaggggatcttgaag 
               M  A  A  S  T  A  S  H  R  P  I  K  G  I  L  K  
aacaagacctctacgacttcctctatggtggcgtcggccgaacagccccgcgggaatgtc 
 N  K  T  S  T  T  S  S  M  V  A  S  A  E  Q  P  R  G  N  V  
gacgaggagctgagcaaaaaatcccagaagtgggatgaaatgaacatcttggcgacgtat 
 D  E  E  L  S  K  K  S  Q  K  W  D  E  M  N  I  L  A  T  Y  
catccagcagacaaagactatggtttaatgaaaatagatgaaccaagcactccttaccat 
 H  P  A  D  K  D  Y  G  L  M  K  I  D  E  P  S  T  P  Y  H  
agtatgatgggggatgatgaagatgcctgtagtgacaccgaggccactgaagccatggcg 
 S  M  M  G  D  D  E  D  A  C  S  D  T  E  A  T  E  A  M  A  
ccagacatcttagccaggaaattagctgcagctgaaggcttggagccaaagtatcggatt 
 P  D  I  L  A  R  K  L  A  A  A  E  G  L  E  P  K  Y  R  I  
caggaacaagaaagcagtggagaggaggatagtgacctctcacctgaagaacgagaaaaa 
 Q  E  Q  E  S  S  G  E  E  D  S  D  L  S  P  E  E  R  E  K  
aagcgacaatttgaaatgaaaaggaagcttcactacaatgaaggactcaatatcaaacta 
 K  R  Q  F  E  M  K  R  K  L  H  Y  N  E  G  L  N  I  K  L  
gccagacaattaatttcaaaagacctacatgatgatgatgaagatgaagaaatgttagag 
 A  R  Q  L  I  S  K  D  L  H  D  D  D  E  D  E  E  M  L  E  
actgcagatggagaaagcatgaatacggaagaatcaaatcaaggatctactccaagtgac 
 T  A  D  G  E  S  M  N  T  E  E  S  N  Q  G  S  T  P  S  D  
caacagcaaaacaaattacgaagttcatagacgagatttctcgag 
 Q  Q  Q  N  K  L  R  S  S  -                 
 
In order to establish that pcDNA5/TO[I-2] transfection resulted in overexpression of I-
2, HeLa cells were transfected with either pcDNA5/TO[I-2] or empty vector, using the 
Calcium Phosphate method, as previously described in Section II.3.4.1. Cells were 
lysed 24h post-transfection and lysates were analysed by Immunoblotting using a 
commercially available anti-Protein Phosphatase 1 inhibitor subunit 2 (phospho T72) 
antibody (Abcam), as shown in Figure III.7.  
FIGURE III.6 | SEQUENCE OF THE PCDNA5/TO[I-2] CONSTRUCT. I-2 sequence is shown in 
orange (•), the stop codon in grey (•) and both restriction sites that link the cDNA to the 
vector, in blue (•).!
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Figure III.7 blots show that transfection of HeLa cells with pcDNA5/TO[I-2] 
significantly increased the level of I-2 expression by about 21.5 fold over the control 
transfection (fold increase calculated by quantitative western blot analysis using the 
UVIband software).  
 
III.4.2 EFFECT OF PP1!  AND I-2 OVEREXPRESSION 
To evaluate the effect of PP1! and I-2 overexpression on Chk1 dephosphorylation, the 
method described in II.4.3.2 Section was followed. The dephosphorylation reaction 
was performed using the same timepoints as in Figure III.4.A.  
In order to overexpress I-2, the construct generated earlier (Section III.4.1) was 
used. To overexpress PP1!, a pCMV vector containing PP1! cDNA was obtained (da 
Cruz e Silva). In all cases the pcDNA5/TO empty vector was used as control. As 
mentioned, the experiment was performed as described in Section II.4.3.2: the cells 
expressing the transfected vectors for 24h before HU treatment, were lysed at specific 
timepoints after HU treatment and analysed by SDS-PAGE followed with Western 
Blotting. The membranes were probed to evaluate Chk1 phosphorylation state, 
followed by quantitative analysis of the phospho-bands as shown in Figures III.8 and 
III.9 for PP1! and I-2 overexpression, respectively. 
FIGURE III.7 | IMMUNOBLOT ANALYSIS OF PCDNA5/TO 
[I-2] EXPRESSION IN HELA CELLS. Lysates from empty 
pcDNA5/TO vector and pcDNA5/TO[I-2]  construct 
transfections were generated 24h post transfection. 
These were further analysed by SDS-PAGE followed by 
Western Blotting. The membrane was subsequently 
probed with I-2 and actin antibodies.!
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When PP1! is overexpressed, the rate at which Chk1 is dephosphorylated during the 
first phase increases when compared to the control as is observed in Figure III.8. The 
slope between timepoint 0h and 0.5h is consistently higher for both phosphorylation 
sites, Ser317 and Ser345, and in both experiments A and B. However, during the 
second phase (0.5h to 24h - Figure III.8.B) there is the indication that the 
dephosphorylation rate itself is not affected by the overexpression of this protein 
phosphatase, being this similar to the control condition. Hence, these results indicate 
that PP1! dephosphorylates Chk1 residues during the first phase of the 
dephosphorylation pattern. Moreover, from the analysis presented in Figure III.8.B.2 
FIGURE III.8 | ANALYSIS OF THE EFFECT OF PP1!  OVEREXPRESSION TO CHK1 DEPHOSPHORYLATION. 
Lysates from two independent PP1# overexpression experiments (A and B), prepared as 
described in the text, were submitted to SDS-PAGE followed by Western Blotting. The time 
course in experiment A did not include the 8h and 24h timepoints. Chk1 phosphorylation 
levels were analysed by using pSer317 and pSer345 antibodies to probe the blots. These 
were also probed with PP1# as well as actin (A1 and B1). The phospho-signals were 
quantified by using UVIband software and subsequently plotted (pSer317 levels - A2 and B2, 
pSer345 levels - A3 and B3). For each experiment, pcDNA5/TO empty vector was also 
transfected as control. Its transfections and respective analysis was performed at the same 
time and in the same way as for PP1#.  
 !
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there is the suggestion that the overexpression of PP1! when combined with HU 
treatment may result in the hyper-phosphorylation of Chk1 Ser317 residue, as 
compared with its control condition. The fact that this observation is only made in one 
of the two independent experiments presented in Figure III.8, could be due to 
differences in the PP1! transfection efficiency.  
 
In the case of I-2 overexpression, which in principle should be inhibiting the activity of 
endogenous PP1 type of phosphatases, no significant change in the rate of Chk1 
dephosphorylation was observed for either the first or second phases. Nonetheless, 
accordingly with the previous results (Figure III.8), a significant reduction of the initial 
Chk1 Ser345 phospho-signal after HU treatment was observed, as compared to the 
control condition (Figure III.9.C - 0h +HU timepoint). 
All these data indicate that PP1 family members, may increase the rate of Chk1 
dephosphorylation during its first phase (from 0h to 0.5h after HU removal), as seen 
with the PP1! overexpression data, and have a positive regulatory effect on Chk1 
activation in response to HU treatment. In addition, I-2 results support the idea that 
there is selectivity for the protein phosphatases that may have a role regulating 
specific Chk1 residues, either at its activation or inactivation. 
 
FIGURE III.9 | ANALYSIS OF THE EFFECT OF 
I-2 OVEREXPRESSION TO CHK1 
DEPHOSPHORYLATION. Lysates from the 
overexpression of I-2, prepared as 
described in the text, were submitted to 
SDS-PAGE followed by Western Blotting. 
Chk1 phosphorylation levels were 
analysed by using pSer317 and pSer345 
antibodies to probe the blots. These 
were also probed with I-2 as well as 
actin (A). The phospho-signals were 
quantified by using UVIband softwares 
and subsequently plotted (pSer317 
levels - B, pSer345 levels - C). As 
control, pcDNA5/TO empty vector was 
also transfected. Its transfection and 
respective analysis was performed in 
parallel as for I-2. 
 !
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III.5 CONTRIBUTION OF THE PROTEIN PHOSPHATASE 2A FAMILY TO CHK1 
DEPHOSPHORYLATION 
Since inhibition of PP2A family members resulted in significant inhibition of Chk1 
dephosphorylation in vitro (Figure III.5), we set out to determine whether inhibiting 
PP2A in vivo had similar effects on Chk1 dephosphorylation following release from HU 
arrest.  
Okadaic acid, a cell-membrane permeant small molecule, is a potent inhibitor of PP2A 
family members and has been a useful tool for the elucidation of PP2A family functions 
in vivo (Yamashita, Yasuda et al. 1990; Yan and Mumby 1999). Hence, in our 
experimental setup we used okadaic acid as an in vivo PP2A family inhibitor. !
III.5.1 EFFECT OF OKADAIC ACID TREATMENT 
In the following experiments (previously described in detail in Section II.4.3.2), HeLa 
cells were treated with 2 mM HU for 24h and afterwards washed into new medium in 
the presence or absence of various concentrations of okadaic acid. Of note, 
concentrations of okadaic acid in excess of 100 nM resulted in almost total loss of cell 
adherence, thus this being the concentration used. The effect of 100 nM OA treatment 
in the dephosphorylation of Chk1 after HU removal is shown in Figure III.10. Cells 
were lysed at the same timepoints as in previous assays and analysed by immunoblot.  
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Data from both experiments suggested that OA treatment, at a concentration of 100 
nM had an effect on the regulation of Ser345 dephosphorylation (Figure III.10.A.3 and 
III.10.B.3). However, due to the variability observed in between experiments, this has 
to be further tested. In addition, no significant effect was observed for the 
dephosphorylation of the Ser317 residue (Figure III.10.A.2 and III.10.B.2).  
Interestingly, we have observed that the levels of phospho-Chk1 at 24h timepoint 
after recovery from HU removal were consistently reduced in an OA treatment-
FIGURE III.10 | ANALYSIS OF THE EFFECT 
OF OKADAIC ACID TREATMENT TO CHK1 
DEPHOSPHORYLATION. Lysates from two 
independent experiments (A and B) of 
100 nM Okadaic acid treatment after 
24h of 2 mM HU incubation, were 
submitted to SDS-PAGE followed by 
Western Blotting. Dephosphorylation 
was analysed probing the blots with 
Chk1-pSer317 and Chk1-pSer345 as 
well as with actin and total Chk1 (this 
latter one only in B). The phospho-
signals were quantified using UVIband 
software, normalized to the actin 
average levels and subsequently 
plotted (pSer317 shown in A2 and B2, 
pSer345 shown in A3 and B3). Control 
conditions, where o OA was added at 
any point, were processed and 
analysed at the same time as 
conditions where OA included. !
Western Blotting. Dephosphorylation was analysed by probing the blots with Chk1-
pSer317 and Chk1-pSer345 antibodies, as well as with anti-actin and anti-total Chk1 (only 
in B). The phospho-signals were quantified using UVIband software and subsequently 
plotted (pSer317 shown in A2 and B2, pSer345 shown in A3 and B3). Control conditions, 
where no OA was added at any timepoint were processed and analysed at the same time 
as conditions where OA was included. !
Protein Phosphatases acting on the Replication Checkpoint                                       Chapter III 
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!
Centro de Biologia Celular 
Universidade de Aveiro | Portugal 117 
Centre for Developmental and 
Biomedical Genetics 
University of Sheffield | UK !
dependent manner. To investigate this further, we also determined the level of total 
Chk1 using an antibody recognizing Chk1 polypeptide (purified as in Section V.2.2). 
This analysis has shown that the total Chk1 level decreased in the presence of 100 nM 
OA (Figure III.10.B.4).  
Because the data obtained with OA treatments did not permit establishing a role for 
PP2A in the regulation of Chk1 activity in vivo, we investigated the possibility of 
developing other molecular tools to inactivate PP2A family members in vivo in a more 
specific manner.   
 
III.5.2 EFFECT OF PME-1 OVEREXPRESSION 
The Protein Phosphatase Methylesterase-1 (PME-1) is a PP2A specific methylesterase 
responsible for the demethylation of PP2A. For many years it was not clear whether 
this molecular event was responsible or not for PP2A inactivation, since it was only 
known that its methylation was needed for the interation with its B regulatory subunit 
(Ogris, Gibson et al. 1997; Lee, Chang et al. 2000; Tolstykh, Lee et al. 2000; Yu, Du 
et al. 2001; Ortega-Gutierrez, Leung et al. 2008). In addition, other observations have 
found PME-1 to be located in the cell nucleus, in complex with the inactive 
demethylated form of PP2A (Longin, Zwaenepoel et al. 2008). Just recently, it was 
shown that this interaction of PME-1 with PP2A removed the manganese ions from the 
phosphatase. Since these ions are needed for PP2A activity, it was therefore 
demonstrated that PME-1 inhibits PP2A activity (Xing, Li et al. 2008). Hence, the same 
approach as described before for I-2 (PP1 specific inhibitor), in Section III.4, was 
followed, in order to inhibit PP2A in a more specific manner.  Meanwhile, supporting 
our hypothesis, some groups have already reported that in vivo overexpression of 
PME-1 in mammalian cells leads to an increase in the demethylated form of PP2A that 
as mentioned before, results into its inhibition (Sontag, Nunbhakdi-Craig et al. 2007; 
Longin, Zwaenepoel et al. 2008). To proceed with this approach, PME-1 had first to be 
subcloned into a suitable mammalian expression vector. 
 !
III.5.2.1 PME-1 SUBCLONING AND EXPRESSION IN HELA CELLS 
In order to express the PP2A inhibitor PME-1 in mammalian cells, a cDNA encoding 
PME-1 was obtained from ImaGenes (clone IRATp970C1178D, supplied in a pCMV-
SPORT6 vector) and its DNA sequence analysed using SP6 and T7 primers (Table 
VIII.2 – Appendix) in order to confirm its identity. Afterwards, the PME-1 sequence 
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was subcloned into pcDNA5/TO mammalian expression vector through PCR techniques 
using the primers PME-5’ and PME-3’ (Table VIII.2 – Appendix), followed by BamHI 
and XhoI restriction digestion. The final construct was then sequenced in order to 
validate PME-1 sequence, as is shown in Figure III.11. 
 
 
ggatccgcctccccgcgatgtcggccctcgaaaagagcatgcacctcggccgccttccctct 
                  M  S  A  L  E  K  S  M  H  L  G  R  L  P  S  
cgcccacctctacccggcagcgggggcagtcagagcggagccaagatgcgaatgggccct 
 R  P  P  L  P  G  S  G  G  S  Q  S  G  A  K  M  R  M  G  P  
ggaagaaagcgggacttttcccctgttccttggagtcagtattttgagtccatggaagat 
 G  R  K  R  D  F  S  P  V  P  W  S  Q  Y  F  E  S  M  E  D  
gtagaagtagagaatgaaactggcaaggatacttttcgagtctacaagagtggttcagag 
 V  E  V  E  N  E  T  G  K  D  T  F  R  V  Y  K  S  G  S  E  
ggtccagtcctgctccttctgcatggaggaggtcattctgccctttcttgggctgtgttc 
 G  P  V  L  L  L  L  H  G  G  G  H  S  A  L  S  W  A  V  F  
acggcagcgattattagtagagttcagtgtaggattgtagctttggatctgcgaagtcat 
 T  A  A  I  I  S  R  V  Q  C  R  I  V  A  L  D  L  R  S  H  
ggtgaaacaaaggtcaagaatcctgaagatctgtctgcagaaacaatggcaaaagacgtt 
 G  E  T  K  V  K  N  P  E  D  L  S  A  E  T  M  A  K  D  V  
ggcaatgtggttgaagccatgtatggggaccttcctcctccaattatgctgattggacat 
 G  N  V  V  E  A  M  Y  G  D  L  P  P  P  I  M  L  I  G  H  
agcatgggtggtgctattgcagtccacacagcatcatccaacctggtaccaagcctcttg 
 S  M  G  G  A  I  A  V  H  T  A  S  S  N  L  V  P  S  L  L  
ggtctgtgcatgattgatgttgtagaaggtacagctatggatgcacttaatagcatgcag 
 G  L  C  M  I  D  V  V  E  G  T  A  M  D  A  L  N  S  M  Q  
aatttcttacggggtcgtcctaaaaccttcaagtctctggagaatgctattgaatggagt 
 N  F  L  R  G  R  P  K  T  F  K  S  L  E  N  A  I  E  W  S  
gtgaagagtggccagattcgaaatctggagtctgcccgtgtctcaatggttggccaagtc 
 V  K  S  G  Q  I  R  N  L  E  S  A  R  V  S  M  V  G  Q  V  
aaacagtgtgaaggaattacaagtccagaaggctcaaaatctatagtggaaggaatcata 
 K  Q  C  E  G  I  T  S  P  E  G  S  K  S  I  V  E  G  I  I  
gaggaagaagaagaagatgaggaaggaagtgagtctataagcaagaggaaaaaggaagat 
 E  E  E  E  E  D  E  E  G  S  E  S  I  S  K  R  K  K  E  D  
gacatggagaccaagaaagaccatccatacacctggagaattgaactggcaaaaacagaa 
 D  M  E  T  K  K  D  H  P  Y  T  W  R  I  E  L  A  K  T  E  
aaatactgggacggctggttccgaggcttatccaatctctttcttagttgtcccattcct 
 K  Y  W  D  G  W  F  R  G  L  S  N  L  F  L  S  C  P  I  P  
aaattgctgctcttggctggtgttgatagattggataaagatctgaccattggccagatg 
 K  L  L  L  L  A  G  V  D  R  L  D  K  D  L  T  I  G  Q  M  
caagggaagttccagatgcaggtcctaccccagtgtggccatgcagtccatgaggatgcc 
 Q  G  K  F  Q  M  Q  V  L  P  Q  C  G  H  A  V  H  E  D  A  
cctgacaaggtagctgaagctgttgccactttcctgatccggcacaggtttgcagaaccc 
 P  D  K  V  A  E  A  V  A  T  F  L  I  R  H  R  F  A  E  P  
atcggtggattccagtgtgtgtttcctggctgttagtgacctgctcgag 
 I  G  G  F  Q  C  V  F  P  G  C  -   
FIGURE III.11 | SEQUENCE OF THE PCDNA5/TO[PME-1] CONSTRUCT. PME-1 sequence is shown 
in orange (•), the stop codon in grey (•) and both restriction sites that link the cDNA to the 
vector, in blue (•).!
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In order to test if pcDNA5/TO[PME-1] transfection into HeLa cells resulted in PME-1 
overexpression, the plasmid was transfected by the calcium phosphate method, as 
described in Section II.3.4.1, and cells left to express the transfected construct for 
24h before being lised and collected. As negative control, empty pcDNA5/TO was 
tranfected and processed in parallel as carried out for the PME-1 construct. Lysates 
were analysed by immunoblot using a commercially available anti-Protein Phosphatase 
Methylesterase-1 antibody (Upstate Biotechnology) (Figure III.12).  
 
 
 
PME-1 expression was significantly increased, by about 20.5 fold (quantitative western 
blot analysis performed using UVIband software) when cells were transfected with the 
pcDNA5/TO[PME-1] construct, as compared with endogenous levels in control-
transfected cells. This result indicated that the construct was functional and could be 
used in further experiments as shown in Section III.5.2.2 and chapter IV. 
 
III.5.2.2 IN VIVO CHK1 DEPHOSPHORYLATION ASSAY IN A BACKGROUND OF PME-1 
OVEREXPRESSION 
PME-1 was expressed in HeLa cells as previously described in Section II.3.4.2, in order 
to assess the effect of inhibiting PP2A on Chk1 dephosphorylation, following HU 
removal. The experiment was performed as described in Section II.4.3.2. Briefly, cells 
were transfected either with pcDNA5/TO[PME-1]  or pcDNA5/TO empty vector 
(negative control), allowed to recover for 24h, treated with HU for another 24h before 
removal into fresh medium. Samples were harvested at various timepoints, as in 
previous Sections (0h, 0.5h, 2h, 8h and 24h after HU removal), and lysates further 
analysed by immunoblotting using specific Chk1 phospho-antibodies (anti-pSer317 
and anti-pSer345), as well as antibodies recognizing actin and PME-1 (Figure 
FIGURE III.12 | IMMUNOBLOT ANALYSIS OF 
PCDNA5/TO[PME-1] EXPRESSION IN HELA CELLS. 
Lysates from empty pcDNA5/TO vector and 
pcDNA5/TO[PME-1] construct transfections were 
generated 24h post transfection. These were further 
analysed by SDS-PAGE followed by Western Blotting. 
The membrane was subsequently probed with PME-1 
and actin antibodies.!
Protein Phosphatases acting on the Replication Checkpoint                                       Chapter III 
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!
Centro de Biologia Celular 
Universidade de Aveiro | Portugal 120 
Centre for Developmental and 
Biomedical Genetics 
University of Sheffield | UK !
III.13.A). Chk1 phospho-signals were quantified by using UVIband software and 
subsequently plotted (Figure III.13.B and C). 
 
!  
Interestingly, when PME-1 overexpressing cells were incubated with 2 mM HU for 24h, 
Chk1 phosphorylation levels at both Ser317 and Ser345 residues after HU removal 
were dramatically reduced, in comparison to control transfected cells under the same 
treatment. In addition, Chk1 dephosphorylation rates in both phases are not altered 
under PME-1 overexpressing conditions, when compared to control conditions. Hence, 
in the context of PME-1 overexpression, these results indicate a function for PP2A 
family members on the activation of Chk1 in response to prolonged HU treatment, but 
not in its dephosphorylation after HU removal.  
 
III.5.3 EFFECT OF PP4 AND PP6 KNOCKDOWN BY SIRNA 
III.5.3.1 OPTIMIZATION OF PP4 AND PP6 KNOCKDOWN CONDITIONS 
Given the known pleotropic cellular functions of PP1 and PP2A, it seemed likely that 
their siRNA-induced knockdown would have a severe cytotoxic effect in cells. 
However, in the case of the less studied PP4 and PP6, members of the PP2A family, it 
FIGURE III.13 | ANALYSIS OF THE EFFECT OF 
PME-1 OVEREXPRESSION TO CHK1 
DEPHOSPHORYLATION. Lysates from the 
PME-1 overexpression experiment, 
prepared as described in the text, were 
submitted to SDS-PAGE followed by 
Western Blotting. Chk1 phosphorylation 
levels were analysed by using pSer317 
and pSer345 antibodies to probe the 
blots. These were also probed for PME-1 
as well as actin, using specific antibodies 
(A). The phospho-signals were quantified 
by using UVIband software and 
subsequently plotted (pSer317 levels - B, 
pSer345 levels - C). As negative control, 
pcDNA5/TO empty vector was also 
transfected. Transfection and respective 
analysis was performed in parallel as for 
PME-1.  !
Protein Phosphatases acting on the Replication Checkpoint                                       Chapter III 
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!
Centro de Biologia Celular 
Universidade de Aveiro | Portugal 121 
Centre for Developmental and 
Biomedical Genetics 
University of Sheffield | UK !
was conceivable that cells might remain viable in the absence of either of these gene 
products. Therefore, the conditions under which the expression of PP4 and PP6 might 
be eliminated or reduced by using siRNA, were established and optimized. 
Briefly, the procedure consisted in seeding 6x104 cells/well in 6-well plates followed by 
overnight incubation before transfection with two different quantities of siRNA (30 and 
120 pmol per well), as described in Section II.3.4.3. Cells were further lysed at 
different timepoints to allow evaluation of the levels of knockdown for either PP4 or 
PP6, accordingly. This was performed by SDS-PAGE followed by Western blotting using 
the commercially available anti-Protein Phosphatase 4 catalytic subunit (Abcam) and 
anti-serine/threonine Protein Phosphatase 6/C (V/C) (Sigma) antibodies, as is shown 
in Figure III.14. 
 
Concentrations of specific siRNA molecules as low as 30 pmol/well (from 6-well plate) 
were very effective at inducing knockdown of both PP4 and PP6 with significant 
(>80%) reduction in protein level expression within 24h of siRNA application. In 
addition, protein expression continued to decline with virtually no protein detectable at 
72h post-transfection. Thus, it was established that in both cases a concentration of 
30 pmol siRNA/well would be used for transfections in future experiments. On the 
FIGURE III.14 | ANALYSIS OF PP4 AND PP6 KNOCKDOWN BY SIRNA TRANSFECTION. Lysates 
from different conditions of PP4, PP6, as well as, Control siRNA transfections were analysed 
by immunobloting using specific anti-PP4 and anti-PP6 antibodies. For each siRNA, 30 and 
120 pmol/well of siRNA were transfected and cells incubated for 24h, 48h and 72h post-
transfection. Specific protein phosphatase levels were determined using UVIband software 
and subsequently plotted (A.1 and A.2, blot and plot, respectively, of the PP4 knockdown 
analysis; B.1 and B.2 the same for the PP6 knockdown analysis).   
 
 !
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other hand, concerning incubation times, since PP6 siRNA was slower than the PP4 
siRNA to induce the same knockdown effect, in following experiments the latter was 
incubated for 48h post-transfection, while the former for 72h, before application of 
either HU or Aph treatments.  
 
III.5.3.2 IN VIVO CHK1 DEPHOSPHORYLATION ASSAY WITH SIRNA KNOCKDOWN OF PP4 
AND PP6 
The Chk1 dephosphorylation assay was carried out as detailed before (Section 
II.4.3.2). However, specifically in these experiments HU was added to the cell media 
usign the timing of siRNA treatments as described above. The remaining protocol was 
performed as described previously. The cells were lysed at the indicated timepoints 
and the lysates analysed by SDS-PAGE followed by Western Blotting, as shown below 
(Figures III.15.A.1 and B.1 for the event of PP4 knockdown, and Figures III.16.A.1 
and B.1 in the case of PP6 knockdown). 
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With respect to PP4 knockdown, the results showed that overall the rate of Chk1 
dephosphorylation on both Ser317 and Ser345 is slower in the absence of PP4, when 
comparing to control conditions. This overall delay in Chk1 dephosphorylation may be 
related to an increase in the initial Chk1 phosphorylation levels as observed in Figure 
III.15 (0h+PP4 siRNA). Generically, Chk1 phosphorylation levels on both Ser317 and 
Ser345 at the 24h timepoint after HU removal are higher than when compared to 
control conditions.  
 
 
 
 
 
FIGURE III.15 | ANALYSIS OF THE EFFECT OF PP4 KNOCKDOWN TO CHK1 DEPHOSPHORYLATION. 
Lysates from two independent PP4 knockdown experiments, prepared as described in the 
text, were submitted to immunoblot analysis. Chk1 phosphorylation levels were analysed 
by using pSer317 and pSer345 antibodies to probe the blots. These were also probed for 
PP4 as well as actin, using specific antibodies (A.1 and B.1). The phospho-signals were 
quantified using UVIband software and subsequently plotted (pSer317 levels – A.2 and B.2, 
pSer345 levels – A.3 and B.3). As negative control, Control siRNA was also transfected and 
samples processed as for PP4 siRNA.  !
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Interestingly, when knocking down PP4 or PP6, Chk1 initial phosphorylation levels are 
affected, although in opposite directions (Figure III.15 and III.16). While in the case 
of PP4 reduced expression the level of Chk1 activation after 24h of 2 mM HU 
treatment is overall increased, in the event of PP6 knockdown, the level of Chk1 
phosphorylation is reduced after the same HU treatment (Figure III.16 – 0h+PP6 
siRNA). This last result partially reproduces the outcome of when PME-1 is 
overexpressed, indicating that PME-1 has either a specific effect on PP6 activity, or on 
another PP2A family member, which may present partially overlapping functions. 
Moreover, also in the event of PP6 knockdown, the results indicate that this specific 
phosphatase is needed for Chk1 Ser317 dephosphorylation during both phases. In 
fact, when compared with control conditions, the rate of Ser317 dephosphorylation, 
but not Ser345, is significantly slower in the case where PP6 level is reduced (Figure 
III.16). 
FIGURE III.16 | ANALYSIS OF THE EFFECT OF PP6 KNOCKDOWN TO CHK1 DEPHOSPHORYLATION. 
Lysates from two independent PP6 knockdown experiments, prepared as described in the 
text, were submitted to immunoblot analysis. Chk1 phosphorylation levels were analysed 
by using pSer317 and pSer345 antibodies to probe the blots. These were also probed for 
PP6 as well as actin, using specific antibodies (A.1 and B.1). The phospho-signals were 
quantified using UVIband software and subsequently plotted (pSer317 levels – A.2 and B.2, 
pSer345 levels – A.3 and B.3). As negative control, Control siRNA was also transfected and 
samples processed as for PP6 siRNA.  !!
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CHAPTER IV 
C O N S E Q U E N C E S  O F  D E R E G U L A T I O N  O F  
T H E  P R O T E I N  P H O S P H A T A S E  
F U N C T I O N  O N  T H E  R E P L I C A T I O N  
C H E C K P O I N T  A R R E S T  A N D  R E C O V E R Y   
Protein Phosphatases acting on the Replication Checkpoint                                       Chapter IV 
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!
Centro de Biologia Celular 
Universidade de Aveiro | Portugal 128 
Centre for Developmental and 
Biomedical Genetics 
University of Sheffield | UK !
Chapter IV | Consequences of deregulation of the 
Protein Phosphatase function on the replication 
checkpoint arrest and recovery 
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IV.1 INTRODUCTION 
IV.1.1 REPLICATION ORIGIN-FIRING CONTROL 
IV.1.1.1 DEFINITION OF A REPLICATION ORIGIN 
It is crucial for the living cell to maintain its genomic integrity. In order to ensure this, 
DNA replication must occur once, and only once, per cell cycle. Whilst in bacteria DNA 
replication occurs from one single origin, in eukaryotes replication starts from many 
different origins that are scattered throughout the chromosomes. Hence, while in 
prokaryotes the time required to complete replication is directly proportional to the 
size of the genome, in eukaryotes is largely dependent on the number of origins that 
fire and the distance between those origins (Cairns 1966; Huberman and Riggs 1966; 
Huberman and Riggs 1968). In fact, in the same organism, for instance Drosophila 
melanogaster, replication may take 3-4 min during embryogenesis and about 10 h in 
some cells from adult animal (Blumenthal, Kriegstein et al. 1974). This process is 
generically referred as the replication origin-firing program. Supporting this notion 
that replication origins fire in a time and spatial organized way, chromosome Giemsa 
stain experiments were performed. These experiments showed that the different 
staining bands would be placed in different areas of the nucleus and replicated at 
specific times during S phase (Stubblefield 1975; Gilbert 1986; Hatton, Dhar et al. 
1988; Drouin, Lemieux et al. 1990; Manuelidis 1990). 
Just in the past decade it became clear that in eukaryotes what defines the replication 
origin is the presence of origin recognition complex (ORC). Indeed, this has been topic 
for many discussions since it was very hard to determine a conserved origin from 
simple eukaryotes, such as yeast, to more complex metazoa, such as human cells. 
Since in prokaryotes, the replication origin (ORI) is defined by a specific DNA 
sequence, different groups decided to pursue the identification of these sequences in 
eukaryotes. In budding yeast, these sequences, the autonomous replicating sequences 
(ARS), were identified and lead to the determination of the 11-bp ARS consensus 
sequence (ACS). However, it as been shown that many, but not all ARSs, act as 
replication origins even in their normal chromosomal location (Diffley 1995). In 
addition, an ACS per se is not sufficient for its replication origin function. This is only 
accomplished when it is accompanied by specific flanking sequences (Diffley 1996). 
Despite all efforts, the identification of these sequences in multicellular organisms had 
revealed a very complex task. A big drawback occurred when Xenopus laevi egg 
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extracts were used as cell-free replication system and showed that apparently 
replication initiation was occurring at some random sites (Hyrien and Mechali 1992; 
Mahbubani, Paull et al. 1992).  Hence, in order to determine what defines replication 
origins in metazoan cells, some genes were used as proof of concept. One of those 
was the dihidrofolate reductase (DHFR) gene from Chinese hamster ovary (CHO) cells, 
the CHO C400. This cell line has the particularity of having the DHFR locus amplified to 
about 1000 copies (Looney and Hamlin 1987), which helped throughout different 
stochastic profiling assays, by allowing the amplification of specific signals, to 
determine the identity of the replication origins. Nonetheless, and despite of being 
able to determine the replication origins present in this locus, all the experiments 
performed did not detect any real consensus DNA sequence. Only based on the 
principles from the Replicon model, which described the basis of how DNA replication 
was regulated in E. coli, and with the finding that ORC proteins were present in all 
replication origins throughout the cell cycle (Diffley, Cocker et al. 1994), the different 
observations made in different organisms started to converge into a more generalized 
DNA replication model.  
 
IV.1.1.2 REGULATION OF REPLICATION ORIGIN-FIRING 
The assembly and firing of replication forks are very tightly regulated processes. This 
is due to the fact that the cell cannot afford its DNA to be replicated more than once 
per cell cycle. Hence, these two steps that lead to DNA replication, are temporally 
separated in order to prevent both the formation of new pre-replicative complexes 
(pre-RC) at origins that have already fired, and the firing of pre-RCs before the pre-
initiation complexes (pre-IC) are formed. In order to accomplish this task, while the 
licensing of replication origins (process of pre-RC assembly (Rowles and Blow 1997) 
can only occur during G1 phase, the competency of pre-RCs (process of pre-IC 
formation) only occurs during the S phase. The licensing step, as can be observed in 
Figure IV.1 and as it was briefly described in Section I.1.2, first needs the pre-loading 
of CDC6 (Hogan and Koshland 1992; Liang, Weinreich et al. 1995) and Cdt1 proteins 
onto the ORC, which then allows for the recruitment of the helicase complex MCM2-7.  
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Afterwards, in order for the licensed origin to become a competent origin, and is able 
to start replication, there is a need for the activity of two kinases, both the E-CDK2 
and the CDC7/Dbf4. In addition to the activity of these two kinases, in order to 
assemble the pre-IC and for the origin to fire, other proteins such as Mcm10, CDC45, 
Sld2, Sld3, GINS and Dpb11 (ortholog of human TopBP1) need to be transiently 
recruited to the origin. Just at this point the origin fires and starts DNA replication. As 
FIGURE IV.1 | SCHEMATIC DIAGRAM FOR THE MODULATION OF THE REPLICATION ORIGIN-FIRING 
LICENSING IN BUDDING YEAST. Replication forks are shown from assembly in G1 to firing in S 
phase. Distinction from early (left) to late (right) origins is made by the differential 
assembly of initiator proteins. CDC6 and Cdt1 are not required for initiation after G1 since 
they are only needed for MCM complex recruitment. For simplification, the ORC is only 
shown bound to DNA during G1 phase. However, this complex is bound to it throughout the 
whole cell cycle (adapted from (Zegerman and Diffley 2009). #!
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observed from Figure IV.1, late origins are no different from early ones, except the 
fact that they are activated at a later point in S phase (Zegerman and Diffley 2009). 
This spatial and time defined origin-firing program, that makes origins to fire at 
different times throughout S phase, is established in early G1 phase, at a time that 
has been called the origin decision point (ODP) and occurs before the restriction point 
(R point) (Wu and Gilbert 1996; Wu and Gilbert 1997; Dimitrova and Gilbert 1999). 
This observation was made by Wu and Gilbert (1996) when testing the origin-firing 
from the DHFR locus of CHO nuclei in Xenopus egg extracts. Depending whether these 
nuclei were at early or late G1 phase, DNA replication would occur at random or 
specific origins, respectively. The reasoning for this difference from early to late G1 
phase in the origin licensing/competency, is due to the low activity of CDKs (Coverley, 
Wilkinson et al. 1996; Noton and Diffley 2000) and Geminin (Cdt1 inhibitor - (McGarry 
and Kirschner 1998; Wohlschlegel, Dwyer et al. 2000; Tada, Li et al. 2001) observed 
in early G1 phase, as consequence of the activity of APC/C. As soon as the APC/C 
levels drop, CDK4/6 starts to operate as well as Geminin levels rise, thus preventing 
new pre-RCs to assemble. Along with these, other events, such as CDC6 degradation 
and nucleus exportation, operate in order to prevent new pre-RC formation (for review 
(Diffley 2004). 
To keep the tight time dependent origin-firing, late origins are regulated in a 
replication checkpoint-like manner, being, in budding yeast, dependent on 
Mec1/Rad53 kinases. In fact, in the presence of DNA damage, these are also needed 
for the prevention of late origin-firing (Santocanale and Diffley 1998; Shirahige, Hori 
et al. 1998). In human cells, a similar task seems to be performed by Chk1 both 
during normal S phase, as well as in the presence of DNA-damage (Fisher and Mechali 
2004; Kastan and Bartek 2004; Petermann, Maya-Mendoza et al. 2006; Maya-
Mendoza, Petermann et al. 2007). It has been shown that under normal conditions, 
Chk1 regulates the physiological turnover of CDC25A, which in turn regulates the 
activation of replication origins through the action on E/A-CDK2 and CDC45 (Zhao, 
Watkins et al. 2002; Sorensen, Syljuasen et al. 2003). This pathway provides a 
mechanism for regulating origin activation throughout S phase (Fisher and Mechali 
2004; Shechter and Gautier 2005). Recently, it was added that when Chk1 function is 
compromised, there is a 2- to 3-fold increase in origin-firing density, indicating that 
Chk1 function in normal S phase is to suppress adjacent dormant (inactive) origins 
from a given replicon cluster to fire, thus regulating the density of active origins 
(Maya-Mendoza, Petermann et al. 2007).  
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IV.1.1.3 SPATIO-TEMPORAL ORIGIN-FIRING OBSERVATION TECHNIQUES 
For a long time it has been intriguing which are the factors that determine the spatio-
temporal origin-firing program in metazoan cells. Many experiments have associated 
this program with the transcriptional activity of the replicated genes, where early 
replication origins would be placed in more actively transcribed genes, and late in less 
important genes. In fact, if an early replicating gene would be transferred into the 
context of a telomere it would confer late initiation (Ferguson and Fangman 1992). 
Hence, it seems clear that both translocations and deletions can influence the 
replication timing of large chromosomal domains (Calza, Eckhardt et al. 1984; 
Forrester, Epner et al. 1990).  
Under normal conditions replication starts at defined origin clusters, where just some 
origins are active while, others are dormant (inactive). These, with the passage of 
active replication forks are prevented from firing later in S phase, mechanism that also 
helps the cell to prevent re-replication within the same cell cycle (Harland and Laskey 
1980). In addition, if dormant origins are inhibited when they are passively replicated, 
that is not the case when both passive replication through them is prevented and the 
Mec1/Rad53 checkpoint that blocks late-origin-firing is inactivated. Under these 
conditions, dormant origins fire very late relative to other active origins (Santocanale, 
Sharma et al. 1999). 
In order to evaluate how replication origins are regulated, different methods, such as 
microscopy techniques and DNA fibre analysis may be used. Some of these techniques 
allow the visualization of origins fire in a discrete and reproducible fashion in a given 
organism.  
DNA fiber analysis was a technique first performed using 3H-thymidine that allowed 
the study of many features of the eukaryotic DNA replication, such as the bidirectional 
replication. In this specific study in vivo labeled DNA molecules were stretched out on 
filters or microscope slides and then autoradiographed (by being exposed to a 
photographic emulsion sensitive to the #-particles given off by 3H). In the regions 
where the 3H-thymidine was incorporated, it produced a track of silver grains. Then, in 
order to evaluate the direction of the DNA replication fork movement, the specific 
activity of the 3H-thymidine was altered intentionally during an experiment. This 
alteration translated into change in grain density in the autoradiogram, allowing 
inferring to the direction of the fork movement (Huberman and Tsai 1973). With the 
development of halogenated nucleotide derivatives such as CldU (Cloro-deoxyuridine), 
IdU (Iodo-deoxyuridine) or BrdU (Bromo-deoxyuridine) and with the increasing 
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diversity on the available fluorophores, along with imaging techniques, DNA fiber 
analysis became a faster and more potent assay. This allowed for more complex 
studies, such as pulse chase experiments, where two different nucleotide derivatives 
are pulsed at different times, being then detected with different colours (Jackson and 
Pombo 1998). 
Similarly, experimental systems to observe full nuclei under the proper microscope, 
following the same principles as the DNA fiber analysis, by using halogenated 
nucleotide derivatives, were developed. This specific microscopy approach allowed to 
visualize that replication takes place at discrete sites in the nucleus (Nakamura, Morita 
et al. 1986), and also with this technique, distinct groups started to characterize the 
replication foci of different cell lines throughout S phase (Nakayasu and Berezney 
1989). In fact, O’Keefe and colleagues have identified five different patterns for DNA 
replication that translate the replication origin-firing program. In broad terms, those 
patterns can be condensed into three: early, mid and late. The early foci are 
characterized by nucleotide incorporation throughout the nucleoplasm, except the 
nucleolus. Then the mid foci present nucleotide incorporation in the perinuclear and 
perinucleolar regions. Finally, the late replication foci pattern is characterized by a few 
large regions of nucleotide incorporation scattered in the nucleus. 
After the isolation of two antibodies that were specific for either CldU or IdU it became 
easier to perform pulse chase experiments in whole cells and then track back where 
did the different molecules were incorporated (Aten, Bakker et al. 1992). This new 
setup allowed replication inhibitors, such as aphidicolin, to be introduced in the system 
and observe their effect on the regulation of the spatio-temporal defined origin-firing 
program (Dimitrova, Todorov et al. 1999).  
 
IV.1.2 REPLICATION FORK ARREST AND RESTART, THE DNA REPAIR PATHWAY 
When a replication fork arrests by facing a problem in the DNA structure, or when 
specific components of the replication machinery are inhibited, such as for example 
the DNA polymerase by the use of aphidicolin, aberrant DNA structures may be 
formed which then trigger the replication checkpoint. For instance, the continuing DNA 
unwinding by the helicase, in the event of DNA polymerase inhibition, generates tracts 
of ssDNA that can activate the replication checkpoint (Walter and Newport 2000; 
Byun, Pacek et al. 2005). In order for the cell cycle to progress and the DNA 
replication to resume, the cell needs to deal with the aberrant DNA structures and 
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repair them, which will then allow shutting down all triggered DNA-damage pathways 
and carrying on the cell cycle. Of course, cells can bypass DNA damage in order to 
tolerate it and not to trigger the DNA repair pathway. This can be the case when a 
fork faces a DSB. Here, this fork is resolved locally and replication at the site of 
damage is rescued by the firing of dormant origins or adjacent replicons, while its the 
sister fork is not prevented from continuing replication (Doksani, Bermejo et al. 2009). 
However, this is not the general case. Due to the fact that when replication forks 
arrest there is the risk of collapse, which may induce different types of DNA lesion, in 
those event cells generally trigger DNA repair pathways. Hence, to repair its DNA, the 
cell takes into account 2 factors: the type of lesion and the cell-cycle phase where it 
occurs. Since, the typical aberrant DNA structures formed in this situation are either 
SSBs or DSBs, the most common DNA repair mechanisms used are the homologous 
recombination (HR) and the non-homologous end joining (NHEJ). While the latter is 
error-prone and more probable to occur in G1 phase, because it does not require a 
homologous sequence for the repair, HR, which is an error-free mechanism, is the 
preferred mechanism during S-G2 phases and needs homologous sequence for the 
repair (Kanaar, Wyman et al. 2008). When the cell is engaged for HR, NHEJ is 
prevented (Frank-Vaillant and Marcand 2002; Daley and Wilson 2005). The choice 
between NHEJ and HR is regulated by CDKs and thus influenced by the cell cycle stage 
(Ira, Pellicioli et al. 2004). 
 
IV.1.2.1 HOMOLOGOUS RECOMBINATION (HR) 
HR comes downstream from the ATM pathway (Section III.1.1), which is activated 
with the presence of the MRN complex, more specifically the NBS1 protein. As the ATM 
pathway is important for the cell-cycle arrest signal, the MRN is also important for the 
repair of the DNA-damage. In fact, in yeast, the MRN homolog complex, the MRX, in 
addition with ExoI and other exonucleases (Krogh and Symington 2004; Sung and 
Klein 2006), regulates the extensive 5’ to 3’ end-processing at broken ends. From this 
processing, a 3’ ssDNA overhang is generated, which is stabilized initially by RPA, and 
then replaced by RAD51 and two of its paralogs. This replacement is helped both by 
BRCA2, which binds and transports RAD51, and also by RAD52 that facilitates the 
binding to the 3’ ends. In addition, the efficient recruitment and binding of RAD51 to 
the chromatin is dependent on Thr 309 phosphorylation by Chk1 (Sorensen, Hansen et 
al. 2005). Ultimately, this recruitment will generate a RAD51 nucleoprotein filament 
that has the ability of searching and invading the homolog sequence at the sister 
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chromatid, creating a structure known as the D-loop, process that is assisted by 
RAD54.  The D-loop allows normal base-pairing between the invading and the 
complementary donor strands, being the latter used as template sequence for repair 
by the DNA polymerase (Shrivastav, De Haro et al. 2008). The DNA strand structure 
generated after DNA synthesis within this invasion of homolog DNA strands is known 
as Holliday Junction, and is described as a cruciform intermediate generated late in HR 
whose resolution may result in crossover products (San Filippo, Sung et al. 2008). 
Once the sequences are copied from both strands, resolvases restore the junctions 
formed during the repair process, generating two intact DNA molecule copies. Other 
proteins, such as cohesins help in this process. Indeed, they are recruited to sites of 
damage and facilitate repair, presumably by helping to promote interchromosomal 
interactions needed for this homology repair (Su 2006). While this repair process is 
ongoing, the ATR pathway is also activated through the recruitment of RPA to the 
generated ssDNA after the DSB reSection, and thus arresting the cell-cycle, 
reinforcing as well the cell-cycle delay produced via ATM pathway (Zou and Elledge 
2003). 
 
IV.1.2.2 NON-HOMOLOGOUS END JOINING (NHEJ) 
Being an error-prone repair process, the NHEJ, results in the loss of the original 
sequence or even in the addition of some new nucleotides to the sequence. In some 
cases there may be the alignment of a few homolog nucleotides (tipically from 1 to 4 
nt in lenght) whose structure presented is called terminal microhomology.  
The protein complex involved at the NHEJ repair process, downstream of the ATM 
pathway, is composed by the Ku subunits (Ku70 and Ku80), DNA-PKc, XRCC4, DNA 
ligase IV (LigIV), Artemis and the recently identified Cernunnos-XLF (Hakem 2008). 
Both Ku subunits together with DNA-PKc, form the actual DNA-PK enzyme, where the 
heterodimer Ku70/Ku80 is important for DNA end binding, as well as for the 
recruitment of the DNA-PKc to the site of DSB, with subsequent activation. DNA-PK 
besides auto-phosphorylating itself, phosphorylates other NHEJ related proteins, such 
as Artemis or XRCC4 (Collis, DeWeese et al. 2005). In broad terms, NHEJ starts with 
the recruitment of Ku proteins to the DSB, which once bound allow a more efficient 
recruitment of the specific nuclease, polymerase and ligase for the repair. In this 
process Artemis:DNA-PK functions as nuclease, where DNA-PK may at least help 
altering DNA end configuration (Goodarzi, Yu et al. 2006; Niewolik, Pannicke et al. 
2006). Afterwards, the action of the polymerases take place, where both Polymerases 
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$ and % fill in the overhangs with newly synthesized strand (Povirk 2006). Finally, both 
strands are ligated by the complex Cernunnos-XLF:XRCC4:Lig IV, restoring the 
integrity of the damaged DNA (Ahnesorg, Smith et al. 2006; Buck, Malivert et al. 
2006). The way all these enzymes accomplish their task towards the end repair varies 
depending on the damage that incurs in the DSB, making this a very flexible process.  
 
IV.1.3 CHAPTER GOALS 
Results from the previous chapter revealed that Chk1 phosphorylation/ 
dephosphorylation processes are complex, due to the fact that several protein 
phosphatases seem to affect both processes in different directions. This complexity 
increases more with the suggestion that Chk1 dephosphorylation (inactivation) may 
occur in a biphasic manner, where the first phase is faster and more pronounced than 
the second. Chk1 has been involved in regulation of both normal replication (Maya-
Mendoza, Petermann et al. 2007), and the replication checkpoint in response to 
genotoxic stress, where it plays a role in the stabilization of replication forks and the 
prevention of late-origin-firing (Feijoo, Hall-Jackson et al. 2001). For this reason we 
tested whether the effects observed in the previous chapter, by deregulating normal 
protein phosphatase activity levels, would affect the levels of replication fork stability 
and the cellular control of late origin-firing. Hence, CldU and IdU pulse-chase indirect 
imunnofluorescence microscopy was used to visualize these parameters under the 
presence or absence of genotoxic stress, induced by aphidicolin.   
In addition, because Chk1 activation induces cell-cycle arrest and, as seen in the 
previous chapter, interference on normal PP activity alters the rate of Chk1 
dephosphorylation, these treatments might also affect the ability of a cell to recover 
from replication arrest. Hence, we decided to evaluate the cell cycle effect that the 
interference on normal PP activity had in the recovery from HU-induced arrest, using 
for that purpose FACS analysis. 
IV.2 REPLICATION CHECKPOINT, THE REPLICATION PULSE-CHASE ASSAY 
IV.2.1 PATTERNS AND TIMING OF REPLICATION 
To demonstrate the temporal relationship between the various replication patterns, 
asynchronous HeLa cells were pulsed initially with CldU. Cells showing each of the 
defined replication patterns (early, mid and late), were incubated for measuring 
replication progress, being afterwards pulsed with IdU and processed for 
Protein Phosphatases acting on the Replication Checkpoint                                       Chapter IV 
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!
Centro de Biologia Celular 
Universidade de Aveiro | Portugal 138 
Centre for Developmental and 
Biomedical Genetics 
University of Sheffield | UK !
immunofluorescence, as described in Section II.3.5. The possible combinations of 
patterns that can be found in a pulse-chase experiment are shown (Figure IV.2 – 
detailed legend in page 140).  
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Typical replication patterns observed during S phase are presented in a chronological 
order in Figure IV.2.A, in proportion with their specific time span for early, mid and 
late patterns. Early patterns correspond to nucleotide incorporation throughout the 
euchromatin in the interior of the nucleus. In mid patterns the nucleotide 
incorporation occurs in the periphery of the nucleus as well as in the nucleolus. Finally, 
in late patterns nucleotide incorporation presents few, but big, foci scattered in the 
periphery and interior of the nucleus, being the latter more common. Figure IV.2.B 
shows typical examples of such double-labelled cells in which, the ones initially in 
early S phase, show progression with the second label revealing early, mid and late 
patterns (uppermost 3 panels). Cells labelled towards the end of the early period can 
show no labelling with the subsequent pulse, in case they have exited S phase (lower 
panels). 
Similarly, cells initially labelled in mid S phase with CldU show progression to mid or 
late S phase with the IdU pulse (Figure IV.2.C), while late pattern cells can only 
exhibited further late pattern labelling (Figure IV.2.D, upper panel) or no further 
labelling (Figure IV.2.D, lower panel). 
In order to demonstrate the relationship between the various replication patterns, the 
fate of cells labelled with CldU showing an early S phase pattern was followed over 
12h, with these cells being labelled with IdU, 6h and 12h after the initial CldU pulse. 
The data relative to the time course of 100 individual nuclei, are plotted in Figure IV.3 
(left plot - Control) as the percentage of cells that presented an early pattern in the 
first pulse and progressed to the other patterns as a function of time.  
FIGURE IV.2 | ANALYSIS OF THE DNA REPLICATION PATTERNING. Asynchronous HeLa cells were 
double pulse labelled with halogenated nucleotide derivatives (first with CldU in green, and 
afterwards with IdU in red), with variable times in between pulses in order to follow 
replication progress. Cells were fixed and prepared for confocal analysis. Panel (A) presents 
the timing relative to the cell cycle phases and the duration of the three main replications 
patterns: early, mid and late. Panels (B), (C) and (D) show the possible combinations of 
patterns that can be found being the CldU labelled patterns: early, mid and late, 
respectively for each panel. Each set of pictures presented in these 3 panels were collected 
from specific experiments as follows: early-early from 6h incubation with aphidicolin; early-
mid, early-late, early-... and mid-mid from control transfection with 6h incubation in 
between pulses; mid-late, mid-… from 6h incubation with OA; late-late from siRNA control 
transfection with 6h incubation in between pulses; and late-… from I-2 transfection with 6h 
incubation in between pulses. For all sets of pictures, except for the ones in panel (D), the 
HCX PL APO 40.0X 1.25 OIL UV objective was used. The pictures presented in panel (D) 
were captured using the PL APO 100.0X 1.40 OIL PH3 UV objective.  
  
 
 !
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Cells, which were in early S phase at the time of first labelling, have for the most part 
progressed into mid S phase by 6h and have exited S phase after 12h. 
Treating cells with the replication inhibitor aphidicolin (50 µg/ml) following the first 
CldU pulse, for either 6h or 12h, resulted in almost all cells retaining an early S phase 
pattern on resumption of replication following washout of the inhibitor Figure IV.3 
(right plot – Control+Aph). This confirms that for HeLa cells, replication arrest results 
in checkpoint-mediated suppression of late-origin-firing (Santocanale and Diffley 
1998; Feijoo, Hall-Jackson et al. 2001; Muller, Blackburn et al. 2007).  
 
IV.2.2 EFFECT OF PP1 FAMILY 
IV.2.2.1 EFFECT OF PP1# AND I-2 OVER-EXPRESSION 
In this Section, the effects of altering PP1 family expression/activity in the replication 
checkpoint control, and more specifically on the regulation of origin-firing, was 
investigated. Cells were transfected, as in the experiments presented in the previous 
chapter, with either pcDNA5/TO (control - empty vector), or PP1! or I-2 expression 
vectors (as described in Section II.3.4.2). 24h post-transfection, cells were submitted 
to the replication pulse-chase assay (Section II.3.5), in order to test if these proteins 
had any effect either on the normal replication timing program, or on the replication 
FIGURE IV.3 | DNA REPLICATION TIMING AND PATTERNING IN ASYNCHRONOUS HELA CELL 
POPULATION. Asynchronous HeLa cell population was double pulse-labelled, either in the 
presence or absence of aphidicolin in between pulses, and the patterns observed by 
confocal microscopy analysis were scored for each timepoint. Patterning and timing of 
replication progression was determined analysing 100 foci that presented early patterns in 
the first pulse. Progression was plotted as a function of time (6h and 12h) and percentage 
of analysed foci progressing throughout each pattern. The total number of analysed nuclei 
was 100.  
 
  
 
 !
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checkpoint mediated control of late origin-firing. Replication patterns were scored 
according to those described in Figure IV.2.A and that data was plotted as a 
percentage of the total number of assayed cells presenting an early pattern during the 
first pulse (Figure IV.4). The data was acquired following 100 nuclei for each timepoint 
and condition. 
 
 
FIGURE IV.4 | DNA REPLICATION TIMING AND PATTERNING IN THE PRESENCE OF OVEREXPRESSED 
PP1!  AND I-2. Control, PP1# or I-2 transfected HeLa cell populations were double pulse-
labelled, either in the presence or absence of aphidicolin in between pulses, and the 
patterns observed by confocal microscopy analysis were scored for each timepoint. 
Patterning and timing of replication progression was determined analysing 100 foci that 
presented an early pattern in the first pulse. Progression was plotted as a function of time 
(6h and 12h) and percentage of analysed foci progressing to each pattern. 
 !!
FIGURE IV.X | DNA REPLICATION TIMING  
AND PATTERNING IN THE PRESENCE OF OVEREXPRESSED PP1#  AND I-2. Mock, PP1# or I-2 
tran fect  HeLa cell populations were double pulse-labelled, either in the presence or 
absence of aphidicolin in between pulses, and the patterns acquired by confocal microscopy 
analysis were scored for each timepoint. Patterning and timing of replication progression 
was determined analysing only the foci that presented early patterns in the first pulse. 
Progression was plotted as a function of time (6h and 12h) and percentage of analysed foci 
progressing to each pattern.  
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The data presented for both control and PP1! transfections, are similar to the analysis 
presented with the control conditions in the previous Section (Figure IV.3). However, 
in both conditions, in the absence of aphidicolin, cells progressed at a slightly slower 
rate than that experiment. Thus, at the 6h timepoint, it is possible to observe a 10-
15% increase in cells presenting a mid pattern and approximately 5% decrease in the 
cells still with an early pattern. No foci presenting a late pattern was detected in these 
experiments, as the graphs show. At the 12h timepoint most cells have already 
abandoned S phase. Moreover, in the case of treatment with aphidicolin, there is no 
significant replication progression in either control or PP1! overexpression. Therefore, 
these data show that overexpression of PP1! has no significant effect on either the 
replication checkpoint control of origin-firing or the normal timing of replication 
progression. 
In the case of cells overexpressing I-2, the rate of progression from early to mid 
patterns is much reduced when compared to control cells, with significant 50% more 
cells retaining an early S phase pattern up to 12h after the initial CldU pulse. As a 
consequence, a reduction of about 15% on the total number of cells presenting a mid 
replication pattern at 6h timepoint, is observed. These data suggest that I-2 may be 
affecting the normal spatio-temporal dynamics of origin-firing under normal 
conditions. Also, these data indicate that despite the slowdown effect observed on 
replication progression under no genotoxic stress, overexpression of I-2 does not 
seem to affect the replication checkpoint function of preventing late replication origin-
firing under the presence a DNA synthesis inhibitor such as aphidicolin (Figure IV.4 
bottom-right graph). This is due to the fact that no significant progression is observed 
during the incubation with aphidicolin, although a reduction of approximately 15% of 
the cells presenting an early pattern, at the 6h timepoint, is detected. This suggests 
that I-2 overexpression either induces the collapse of arrested replication forks, or it 
slows the process of replication resumption once its inhibitor, aphidicolin, has been 
removed. 
  
IV.2.3 EFFECT OF PP2A FAMILY 
IV.2.3.1 EFFECT OF OKADAIC ACID TREATMENT 
As a first approach to alter PP2A family members activity, an asynchronous cell 
population was submitted to the replication pulse-chase assay, as described in Section 
II.3.5, either in the presence or absence of 100 nM okadaic acid in between pulses. 
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After incubation periods of 6h or 12h in between pulses, cells were processed for 
immunofluorescence and further analysed using confocal microscopy. Cells presenting 
an early pattern in the first pulse were scored for progression of the replication 
patterns, under the different conditions: Control, Control+Aph, +OA and +OA+Aph. 
Data relative to the fate of 100 cells was plotted as a function of the percentage of the 
total foci analysed presenting an early pattern in the first pulse, and their progression 
along the time course (Figure IV.5) 
 
  
 
When okadaic acid is incubated alone in between pulses, the normal timing of origin 
replication is compromised. Hence, at the 6h timepoint, okadaic acid treatment 
reduces the percentage of early patterns in about 10% and increases the percentage 
of mid replication pattern in about 15%, indicating an acceleration of the progression 
through S phase, when compared with the control condition. However, at the 12h 
timepoint, mid patterns show slow down in their progression rate, being about 40% 
FIGURE IV.5 | DNA REPLICATION TIMING AND PATTERNING IN ASYNCHRONOUS HELA CELL 
POPULATION TREATED WITH OKADAIC ACID. Asynchronous HeLa population was double pulse-
labelled, either in the presence or absence of aphidicolin and/or okadaic acid in between 
pulses. The patterns observed by confocal microscopy analysis were scored for each 
timepoint. Patterning and timing of replication progression was determined analysing 100 
foci that presented an early pattern in the first pulse. Progression was plotted as a function 
of time (6h and 12h) and percentage of analysed foci progressing to each pattern. 
 
  
 
 !
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from the total foci analysed, and also an increase of about 40% of nuclei presenting 
an early replication pattern is observed. Moreover, when trying to understand these 
data, it is very important to take into account the fact that when incubating cells with 
OA for a long period of time, they start to round up and detach from the dish.  
If OA treatment shows an effect on the regulation of the normal replication, that is not 
the case for the regulation of the replication checkpoint. Our data shows that, 
aphidicolin-induced triggering of replication checkpoint is not abrogated by 
simultaneous incubation with okadaic acid in between pulses. In this condition, almost 
all foci with an early pattern, at the time of the first pulse, maintain it, across the 
experimental time course, either at 6h or 12h. A small variation at the 6h timepoint is 
observed, as it was also the case for I-2 overexpression.  
 
IV.2.3.2 EFFECT OF PME-1 OVER-EXPRESSION 
In order to evaluate the effect of reduced PP2A activity both on the replication 
checkpoint control of origin-firing and on the normal timing of replication progression, 
either pcDNA5/TO empty vector (as negative control) or pcDNA5/TO[PME-1] construct 
(prepared as in Section III.5.2.1) were transfected into HeLa cells, as described in 
Section II.3.4.2. After transfection, cells where incubated for 24h, point at which the 
replication process was assayed as described in Section II.3.5. Nuclei were further 
analysed by confocal microscopy and once the replication patterns corresponding to 
100 cells were scored according to the parameters described in Figure IV.2.A, the data 
was plotted as described in previous Sections (Figure IV.6). 
Concerning the regulation of origin-firing in response to the activation of the 
replication checkpoint by treating cells with aphidicolin, these data indicates that it is 
independent of PP2A activity. This is because when cells are overexpressing PME-1 
and simultaneously in the presence of aphidicolin, the replication checkpoint is not 
affected and the early replication pattern is maintained across the whole time course, 
as it is the case for the control condition in the presence of aphidicolin alone. 
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However, the normal timing of replication progression presents a small delay when 
PME-1 is overexpressed under no genotoxic stress conditions. This is observed by both 
the retention of approximately 20% more cells presenting an early pattern and a 
reduction of around 10% of mid patterns at the 6h timepoint.  At the 12h timepoint, 
these differences are not observed because in both control and PME-1 transfected 
cells, for the most part, cells have exited replication and thus could not incorporate 
Idu at the time of the second pulse. 
 
IV.2.3.3 EFFECT OF PP4 AND PP6 KNOCKDOWN BY SIRNA 
To assess the impact of the loss of either PP4 or PP6 expression/activity on the 
replication checkpoint control of origin-firing and on the normal timing of replication 
progression, cells were treated as described in Section III.5.3.2, reducing the level of 
expression/activity of these protein phosphatases, independently. After specific 
FIGURE IV.6 | DNA REPLICATION TIMING AND PATTERNING IN THE PRESENCE OF OVEREXPRESSED 
PME-1. Control and PME-1 transfected HeLa cell populations were double pulse-labelled, 
either in the presence or absence of aphidicolin in between pulses, and the patterns 
observed by confocal microscopy analysis were scored for each timepoint. Patterning and 
timing of replication progression was determined analysing 100 foci that presented an early 
patterns in the first pulse. Progression was plotted as a function of time (6h and 12h) and 
percentage of analysed foci progressing to each pattern. 
 !!
FIGURE IV.X | DNA REPLICATION TIMING  
AND PATTERNING IN THE PRESENCE OF OVEREXPRESSED PP1#  AND I-2. Mock, PP1# or I-2 
transfected HeLa cell populations were double pulse-labelled, either in the presence or 
absence of aphidicolin in between pulses, and the patterns acquired by confocal microscopy 
analysis were scored for each timepoint. Patterning and timing of replication progression 
was determined analysing only the foci that presented early patterns in the first pulse. 
Progression was plotted as a function of time (6h and 12h) percentage of analysed f ci 
progressing to each pattern.  !!
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periods of incubation post-transfection, 48h for PP4 siRNA and 72h for PP6 siRNA, cells 
were assayed for replication pulse-chase assay, as described in Section II.3.5. In 
parallel, as control, cells were treated with control siRNA, incubated for the same 
length of time as the PP4 siRNA (48h) and also processed as in Section II.3.5. 
Subsequentely, the cells were further analysed by confocal microscopy and the 
replication patterns were evaluated and scored according to the information presented 
in Figure IV.2.A. The progression of early patterns through the time course, were then 
plotted as a percentage of the total nuclei (n=100) analysed for control, PP4 and PP6 
siRNAs in the absence and presence of aphidicolin (Figure IV.7). 
 
FIGURE IV.7 | DNA replication timing and patterning in the event of PP4 or PP6 are 
knockdown. Control siRNA, PP4 siRNA or PP6 siRNA transfected HeLa populations were 
double-pulse labelled, either in the presence or absence of aphidicolin in between pulses, 
and the patterns observed by confocal microscopy analysis were scored for each timepoint. 
Patterning and timing of replication progression was determined analysing 100 foci that 
presented an early patterns in the first pulse. Progression was plotted as a function of time 
(6h and 12h) and percentage of analysed foci progressing to each pattern. 
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When no aphidicolin is used in the incubations in between CldU and IdU pulses, 
neither the knockdown of PP4 or PP6 significantly affects the normal timing of 
replication progression when compared with control conditions (Figure IV.7 – top-left 
graph). Small variations occur at the 12h timepoint for all three different siRNAs, PP4, 
PP6 and control but without a significant impact on the normal timing of replication 
progression.    
In the event of DNA polymerase inhibition, by the addition of aphidicolin in between 
both pulses, there is also no significant effect on the replication checkpoint control of 
origin-firing, since no abrogation of the checkpoint was observed with firing of later 
replication origins. However, some variability is observed when comparing PP4 or PP6 
expression/activity knockdown with control conditions. These data show a 15% 
decrease in the foci presenting early patterns at 6h and 12h, for PP4 siRNA and PP6 
siRNA transfected cells when compared to control siRNA, respectively. The variability 
observed might indicate that some cells have difficulty in resuming replication after 
long exposure to aphidicolin, fact that is explained by the absence of IdU incorporation 
at the time of the second pulse. 
 
IV.3 FACS ANALYSIS OF CELL CYCLE RECOVERY FROM HU-INDUCED 
REPLICATION ARREST 
As observed in previous Sections, the alteration of specific protein phosphatase groups 
activity can result, for instance, in alteration of Chk1 dephosphorylation dynamics, as 
well as it can compromise the normal replication progression timing. Hence, due to 
these facts, we raised the hypothesis to whether the alteration of specific protein 
phosphatase activity/expression could alter the normal profile of recovery from HU-
induced replication arrest. To examine this process, after performing the same 
treatments as in previous Sections, we utilized a FACS technique, where cells were 
evaluated for their DNA content making use of propidium idodide staining method, as 
described in Section II.3.6. !!!!!!!
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IV.3.1 TIME COURSE ON CONTROL CONDITION 
To determine the normal recovery pattern after HU-induced replication arrest, cells 
were first treated with 2 mM HU for 24h and then allowed to recover after HU removal 
(0h timepoint). Cells were harvested at 0h, 0.5h, 1h, 1.5h, 2h, 4h, 6h, 8h, and 24h 
and cell populations were evaluated for their DNA content, using propidium iodide 
(PI). For a better visualization of the cell cycle recovery from the HU-induced 
replication arrest, histograms from the DNA content of the cell population relative to 
each timepoint were overlaid utilizing WinMDI v2.9 software (Figure IV.8).  
 
When no HU is added to the cells and the population is asynchronous, the DNA 
content histogram is characterized to present two peaks, where the first corresponds 
to cells in G1, the second to cells in G2/M and in between cells going through S phase. 
As deduced from the figure, peaks are directly proportional to the time needed for 
each cell cycle phase. In the event of a 2 mM HU treatment for 24h, the G2 peak is 
diminished and most of the cells appear to be in the G1 to S transition phase, 
although some were already in S phase when treated with HU, as observed by the 
right hand-side tail. This is observed in Figure IV.8 at the 0h timepoint after HU 
removal. When HU treatment is removed, cells (re)start DNA synthesis, being possible 
to observe that event at the 4h timepoint, where a significant amount of cells 
synthesized enough DNA to allow this observation by FACS analysis. At 24h after HU 
removal, a G1 peak starts to emerge indicating that those cells recovered from HU-
induced arrest and underwent cell division, cytokinesis. As can be observed, for 
example at the 0h timepoint, prolonged HU treatment generates a pseudo-
FIGURE IV.8 | FACS ANALYSIS OF 
CELL CYCLE RECOVERY FROM HU-
INDUCED REPLICATION ARREST. After a 
treatment of 2 mM of HU for 24h, 
cells were washed from HU and 
fixed at the referred timepoints. 
Cells from each timepoint were 
analysed for DNA content (PI stain) 
by the CyAnTM ADP system using 
Summit v4.3 software. Data was 
analysed and profiles were overlaid 
utilizing WinMDI 2.9 FACS analysis 
software.  
Protein Phosphatases acting on the Replication Checkpoint                                       Chapter IV 
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!
Centro de Biologia Celular 
Universidade de Aveiro | Portugal 150 
Centre for Developmental and 
Biomedical Genetics 
University of Sheffield | UK !
synchronous cell population, fact that should be taken into account when interpreting 
the data. 
In order to determine the effect of the deregulation of cellular protein phosphatase 
function on the recovery from HU-induced replication arrest, and considering the 
result obtained above, it was decided to conserve the same timepoints as those used 
in previous experiments (Sections III.4 and III.5): -HU (before HU treatment), 0h, 
0.5h, 2h, 8h and 24h after HU removal.  
 
IV.3.2 EFFECT OF PP1 FAMILY 
IV.3.2.1 EFFECT OF PP1# AND I-2 OVEREXPRESSION  
The effect of deregulating PP1 family activity was evaluated by transfecting PP1! and 
I-2 (described in Section III.4.1), where the former increased PP1! expression and the 
latter predicted to reduce cellular PP1 activity by I-2 overexpression. Cells were 
transfected as described earlier (in Section II.3.4.2) and allowed to express the 
transfected vectors for 24h. A set of cells was also transfected with a pcDNA5/TO 
empty vector as transfection control. 24h post-transfection, cells were treated with 2 
mM HU for further 24h and then allowed to recover after HU removal. Cells were 
collected and fixed (as described in Section II.3.6.1) at the indicated timepoints, for 
later analysis by FACS. Before performing this analysis, cells were stained with PI 
(Section II.3.6.2). The DNA content profiles acquired using Summit v4.3 software 
were then overlaid onto data from the control transfection (pcDNA5/TO) for each of 
the specific timepoints and treatments (Figure IV.9). 
These overlays are representative of the replicate experiments carried out. The data 
show that neither overexpression of PP1!, nor reduction of global PP1 activity has a 
negative effect either on the HU-induced arrest response or on the recovery from the 
replication checkpoint. However, overexpression of I-2 did result in a small delay in 
the emergence of an asynchronous cycling population of cells. This is observed by the 
smaller G2/M peak shown by the I-2 overexpression treatment at the 24h recovery 
condition, when compared with control. For the control condition in both experiments 
(Figure IV.9), as well as the PP1! overexpression, the DNA content profiles in the 
absence of HU (-HU) and throughout the recovery from HU-induced arrest are similar 
to that shown in Figure IV.8. 
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A 
B 
FIGURE IV.9 | FACS ANALYSIS OF CELL CYCLE RECOVERY FROM HU-INDUCED REPLICATION ARREST 
IN THE PRESENCE OF PP1!  OR I-2 OVEREXPRESSION. Control, PP1# and I-2 transfected cells 
after a 2 mM HU treatment for 24h were washed and fixed at the defined timepoints. Cells 
from each timepoint were analysed for DNA content (PI stain) by the CyAnTM ADP system 
using Summit v4.3 software. Profiles from both PP1#  (A) and I-2 (B) overexpressing 
experiments, were overlaid with the respective control condition for each timepoint utilizing 
the same software. 
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Briefly, in the absence of HU the cell population shows a DNA content profile 
characterized by two more pronounced peaks, corresponding to cells in G1 and G2. 
When recovering from a 24h HU treatment, the DNA content profile shows that the 
population of cells progress from the G1/S transition phase, presented at the 0h of 
recovery, to a more asynchronous cell population which starts to present again the 
two more pronounced peaks, at the 24h timepoint after HU removal. Specifically in the 
experiment shown in Figure IV.9.A, the two peaks corresponding to cells in G1 and 
G2, when not treated with HU, have demonstrated to be difficult to distinguish. This 
might be due to a pseudo-synchronization of the cell population as a consequence of 
the transfection procedure.  
 
IV.3.3 EFFECT OF PP2A FAMILY 
IV.3.3.1 EFFECT OF OKADAIC ACID TREATMENT 
The availability of okadaic acid, which may be used to selectively inhibit PP2A family 
members in vivo, made this a potentially useful approach to investigate a role for 
PP2A family members in the recovery from replication arrest. To assay the recovery, 
cells were treated as presented schematically (Figure IV.10). 
FIGURE IV.10 | SCHEMATIC DIAGRAM FOR THE OKADAIC ACID EXPERIMENTAL SETUP. Three 
different sets of cells were treated with and without either HU (2 mM) or OA (100 nM) for 
the lengths of time and in the combinations of conditions indicated above. At the 
timepoints indicated by the coloured circles, cells were collected for analysis. The first circle 
in each set of cells corresponds to the same sample, a control before any treatment. Each 
colour indicates an experimental combination: HU control in red (•), +HU +OA in green (•) 
and +OA in blue (•). 
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In the first set of conditions, cells were treated with 2 mM HU for 24h and allowed to 
recover for an additional 0h, 0.5h, 2h, 8h and 24h after HU removal, as indicated in 
the figure above. In the second set, the experiment varied at the HU removal point, 
where OA was added to the cells, while recovering from HU-induced arrest. In this 
experiment, cells were collected at the same timepoints as in the first set. The last 
experimental set, is similar to the second with the difference that the first 24h occur in 
the absence of HU treatment.       
Thus, at the indicated timepoints, cells were collected for FACS analysis and stained 
with PI (as in Section II.3.6). After analysis, the DNA content profiles were overlaid 
using Summit v4.3 software as is shown in Figure IV.11. 
Okadaic acid treatment had no significant effect on the recovery from the HU-induced 
replication checkpoint, more specifically at the (re)start of replication. This is observed 
by an almost complete overlap of the DNA content profiles throughout the timepoints 
FIGURE IV.11 | FACS ANALYSIS OF CELL CYCLE RECOVERY FROM HU-INDUCED REPLICATION 
ARREST IN THE PRESENCE OF OKADAIC ACID. After a treatment of 24h at 2 mM of HU, cells 
were washed and left to recover either in presence or absence of 100 nM Okadaic Acid. At 
the same time cells with no previous HU treatment where treated with 100 nM Okadaic 
Acid. At the indicated timepoints cells were fixed and PI stained for DNA content analysis. 
Fixed cells were analysed by the CyAnTM ADP system using Summit v4.3 software. 
Profiles from the three experiments were overlaid for each timepoint utilizing the same 
software. 
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from 0h until 8h after HU removal, in the presence or absence of OA (Figure IV.11 – 
green and red histograms, respectively). However, okadaic acid treatment per se 
resulted in a progressive accumulation of cells in G2/M phase, irrespective of whether 
okadaic acid treated cells had been exposed previously to HU or not (Figure IV.11 – 
green and blue histograms, respectively). The G2/M peak becomes more pronounced 
at the 24h timepoint, after HU removal. This result contrasts with the normal recovery 
observed in the condition with HU treatment only (Figure IV.11 – red histograms), 
where 24h after HU removal the G1 peak could already be observed, as it was the 
case in previous experiments. 
 
IV.3.3.2 EFFECT OF PME-1 OVEREXPRESSION 
In a further attempt to establish a role for PP2A family members in the recovery from 
the replication checkpoint in vivo, the effect of PME-1 overexpression was 
investigated. This was performed following the same method described before for the 
equivalent experiment where Chk1 phosphorylation state was evaluated (Section 
III.5.2.2). Instead of harvesting the cells for lysis at the indicated timepoints, cells 
were collected, fixed and stained for FACS analysis (Section II.3.6). After analysing 
the different samples, profiles from control transfected and PME-1 overexpressing cells 
were overlaid in order to estimate differences between treatments at each timepoint 
(Figure IV.12 - below).  
Interestingly, cells overexpressing PME-1 show a distinct cell cycle DNA content profile 
compared with control transfected cells following 24h exposure to HU. PME-1 
overexpression resulted in a greater proportion of HU treated cells acquiring a mid S 
phase DNA content. Moreover, PME-1 overexpression resulted in a slower rate of 
recovery from HU-induced arrest as compared to controls. This is observed by the loss 
of higher DNA content in the PME-1 overexpressing cells, when compared to the 
control cells, as they recover. Hence, as a consequence, 8h after HU removal, both 
control and PME-1 overexpressing cells show no difference in the DNA content of the 
cell populations and 24h after HU removal, PME-1 overexpressing cells present a 
smaller G2 fraction. 
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IV.3.3.3 EFFECT OF PP4 AND PP6 KNOCKDOWN BY SIRNA 
The conditions established in Section III.5.3.1 to reduce the PP4 and PP6 expression 
using siRNA-mediated knockdown were used to investigate the roles for PP4 and PP6 
in the recovery from the replication checkpoint. The experimental time lines used for 
this assay were the same as those used before in Section III.5.3.2. Briefly, siRNA was 
transfected and cells incubated for 48h or 72h, respectively for PP4 and PP6 
knockdowns, at which point HU was added and cells were incubated for a further 24h 
period. HU was then removed and cells were processed for FACS analysis at the 
indicated timepoints. Additionally, the effect of PP4 and PP6 knockdown on cell cycle 
progression was analysed independently of the effects associated with replication 
arrest. This was performed by treating separate populations of cells with either PP4 or 
PP6 siRNA and incubating for further 48h, in addition to the incubation times 
mentioned above, before being harvested and processed for FACS analysis as 
described in Section II.3.6. For all timepoints and conditions, a control sample was 
produced by transfecting cells with control siRNA and incubating with or without HU 
before being washed, re-incubated for the appropriate time, harvested and fixed for  
FIGURE IV.12 | FACS ANALYSIS OF CELL CYCLE RECOVERY FROM HU-INDUCED REPLICATION 
ARREST IN THE PRESENCE OF PME-1 OVEREXPRESSION. Mock and PME-1 transfected cells after a 
2 mM HU treatment for 24h were washed and fixed at the defined timepoints. Cells from 
each timepoint were analysed for DNA content (PI stain) by the CyAnTM ADP system using 
Summit v4.3 software. Profiles from both transfections were overlaid for each timepoint 
utilizing the same software. 
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B 
A 
FIGURE IV.13 | FACS ANALYSIS OF CELL CYCLE RECOVERY FROM HU-INDUCED REPLICATION 
ARREST IN THE EVENT OF PP4 OR PP6 KNOCKDOWN. Control, PP4 siRNA and PP6 siRNA 
transfected cells after 2 mM HU treatment for 24h, were washed and fixed at the defined 
timepoints. An additional set of samples was not treated with HU and was collected at the 
same time as the last timepoint. Cells from each timepoint were analysed for DNA content 
(PI stain) by the CyAnTM ADP system using Summit v4.3 software. Profiles from both PP4 
(A) and PP6 (B) knockdown experiments were overlaid with the respective siRNA control 
condition for each timepoint using the same software. 
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FACS analysis. Once data was acquired, using Summit v4.3 software, profiles were 
overlaid (Figure IV.13 - above). 
Profiles show that both PP4 and PP6 have little effect in the rate of recovery from the 
HU-induced arrest. Interestingly, cells lacking PP4, when recovering from a 24h 2mM 
HU treatment, become delayed in G2/M (24h timepoint from Figure IV.13.A). This 
delay is dependent on cells being exposed to HU, as the condition with the same 
incubation time but no HU added at any point shows (Figure IV.13.A, 24h | No HU 
timepoint). In contrast, cells that had been exposed to HU lacking PP6, readily 
progress through G2 (Figure IV.13.B 24h timepoint). Additionally, with this PP6 
knockdown treatment, profiles from both before and after HU incubation, show a small 
shift to the left indicating a cell population effect, which translates a subtle decrease in 
the overall DNA content that is present in G1, as compared to control conditions.  
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CHAPTER V 
I D E N T I F I C A T I O N  O F  N O V E L  C H K 1  
I N T E R A C T O R S  T H R O U G H  T H E  Y E A S T  
T W O - H Y B R I D  S Y S T E M  
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Chapter V | Identification of novel Chk1 interactors 
through the Yeast Two-Hybrid system 
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V.1 INTRODUCTION 
V.1.1 YEAST TWO-HYBRID SYSTEM 
The Yeast Two-hybrid (YTH) system is used to screen putative new interactions 
between proteins in a cell context. This system is based on the fact that genes in 
order to be transcribed need to be activated by specific transcription factors. These 
bind to the promoter region of the gene and may be composed by two independent 
domains: the DNA-Binding and the Activation domains (Fields and Song 1989). The 
first domain recognizes the specific DNA sequence from the promoter and the latter 
one recruits the transcription machinery. The concept of the system uses these two 
domains fused with two different and independent proteins to verify a certain 
interaction. Thus, if the two proteins interact, they will bring both domains close to 
each other, allowing the transcription machinery to be recruited and a given reporter 
gene to be transcribed. The reporter genes normally used in this system, regulated by 
higher or lower levels of stringency, are either involved in the galactose degradation 
(like ! or " galactosidase enzymes which are respectively encoded by the MEL1 and 
lacZ reporter genes) or in nutritional selective growth, allowing the cell to grow in the 
absence of specific aminoacids (by the activation of reporters such as ADE2 and HIS3, 
allowing for growth in the absence of adenine and histidine, respectively). To screen 
for new interactions in the YTH, usually two mating yeast types are used, one 
expressing the protein of interest, called bait, and another expressing a cDNA library 
from a given tissue or organism, called preys. The different yeast mating types are 
then incubated together in order to mate, generating a diploid cell. This cell will be 
more tolerant to the expression of toxic proteins and less prone to give false positives 
as its reporter genes are less sensitive to transcription (Kolonin and Finley 1998). This 
interaction screening method often generates an enormous number of positive clones 
representing putative interactions between the protein of interest and those selected 
from the library. In order to validate the interactions found, a number of assays can 
be performed from co-immunoprecipitation to microscopy analysis. Nonetheless, this 
is only possible if the right reagents are available. As a screening method this has 
revealed to be very robust and helped scientists to unveil a huge number of new 
interactions, which otherwise may not have been discovered. In addition, since 
virtually any cDNA library can be used in the screen, if available and cloned in the 
right vector system, the operator may choose a library with the characteristics that fit 
best, both for the bait and for the purpose of the screen, i.e., that allows studying the 
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specific function of the bait protein in different tissues. This property makes the YTH a 
more potent and versatile system. In this case, the cDNA library used was from 
human testis. 
 
V.1.2 CHK1 AND MEIOSIS 
Meiosis is a special type of cell division that occurs in specialized organs, the gonads, 
in order to produce gametes for reproduction. There, the cell division is performed in 
such a way that at the end, instead of two, it generates four new cells, each one 
containing only half of the genetic information that a normal cell contains in G1. These 
cells with half of the chromosomes are called haploid, in opposition to the ones that 
contain the pairs of chromosomes, which are called diploids. The specific pairs of 
chromosomes are also known as homologs. The advantage of meiosis is that it allows 
the mixture of genetic information from two individuals of opposite sex gender (female 
and male gametes), re-establishing in this way the normal number of chromosomes 
from a given species and ultimately, giving rise to a totally new individual after fusion 
of the two gametes. 
Briefly, meiosis results from two subsequent cell divisions with no intermediate DNA 
replication or significant interphase. To reinforce this idea, sometimes chromosomes 
do not even decondense in between divisions. Although the basic processes are similar 
to mitosis, which was described in Section I.1, there are some differences in between 
them (Figure V.1).  
The main differences are present in meiotic division I. While in mitosis there is no 
relation in between homolog chromosomes, in meiosis (meiotic division I) the homolog 
chromosomes behave as sister chromatids, meaning that they are paired until 
Anaphase I. This is revealed by a structure that is assembled and disassembled during 
Prophase I, the synaptonemal complex. This structure is a protein complex that pairs 
the homolog chromosomes, allowing the formation of another structure called the 
chiasma. Chiasmata (plural for chiasma) are important because they help in the 
phenomenon of crossing-over, which is the recombination of equivalent pieces of DNA 
from homolog chromosomes. In addition, while in mitosis, during metaphase, the 
kinetochores are at the metaphasic plate, in meiotic division I chiasmata are in that 
region, due to the fact that the kinetochores of sister chromatids work as one during 
the first division.  
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FIGURE V.1 | MEIOSIS VS MITOSIS. For simple schematic representation, only one 
chromosome is depicted. While in meiosis after DNA replication the cell is submited to two 
rounds of nucleus and cell division, with no additional intermediate DNA replication, giving 
origin to four genetically different cells, in mitosis each individual cell gives rise to two 
diploid daughter cells genetically identical (Alberts, Johnson et al. 2002).!
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As in mitosis, meiosis is divided in the same number of steps, but making reference to 
the first and second meiotic divisions with I and II, respectively. Since Prophase I may 
last for about 90% or more of the total time of meiosis, some authors divided it into 5 
sub-phases: leptotene (replicated chromosomes start to condense), zygotene (the 
synaptonemal complex between homologs starts to assemble), pachytene (synapsis 
between homologs is complete and may last for days), diplotene (generally 
accompanied by chromosome decondensation and gene transcription but this is more 
common in female gametes than in male ones; this is the time where the first 
chiasmata are observed) and diakinesis (transition to metaphase where chromosomes 
recondense and gene transcription stops). During the whole process of Prophase I the 
sister chromatids are tightly glued together. In fact, just in Anaphase I after the 
homologs get separated to each daughter cell, the sister chromatids from each 
duplicated chromosome get suddenly unglued in the arms but clipped together by the 
centromere. This is contrary to what happens in mitosis where in the metaphase the 
sister chromatids are all glued together along their full extension and at anaphase 
they get separated from one end to the other. In meiosis, the sister chromatids will 
only be segregated at Anaphase II, by a similar mechanism to the one carried out in 
mitotic anaphase. By the end of the first meiotic division cells will have a haploid 
number of chromosomes but diploid amount of DNA, which will also turn haploid after 
the second division.  
Along with the crossing-over at the chiasmata (which is on average about 2 or 3 per 
pair of homolog chromosomes), the random process of homolog chromosomes 
distribution in the final haploid gametes, turns this type of cell division very potent in 
introducing genetic variability. In addition, because these cells will potentially 
generate new individuals from a given species, every single phase takes longer when 
compared with mitosis, in order for the accuracy of the process to be assured. 
Specifically looking at S phase, its time length is longer than the one in mitotic 
division.  
Chk1 has been described already as a key protein in the surveillance of DNA integrity 
during the normal replication process (Petermann, Maya-Mendoza et al. 2006), as well 
as for triggering cell cycle arrest when that integrity is in danger (Feijoo, Hall-Jackson 
et al. 2001), during mitosis. Specifically, in meiosis, Chk1 has been suggested to be 
involved in physiological prophase I arrest of Xenopus oocytes via the direct inhibition 
of CDC25C, by phosphorylation at Ser287 (Nakajo, Oe et al. 1999). However, the 
same authors suggested that other Ser287-specific kinases, distinct from the Xenopus 
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Chk1, could be involved in this arrest of immature oocytes (Nakajo, Oe et al. 1999). 
In addition, Chk1 has been shown to accumulate in late zygotene and pachytene 
mouse spermatocytes, being distributed along synapsed meiotic chromosomes 
(Flaggs, Plug et al. 1997). This observation may just be due to the known Chk1 
function as DNA damage checkpoint kinase, since during meiosis the formation of DNA 
DSBs is a natural process for the occurrence of meiotic recombination (Hawley and 
Arbel 1993; Lydall, Nikolsky et al. 1996). In S.cerevisiae, this phenomenon has been 
shown to be the actual initiator of the meiotic recombination and to be an essential 
component of meiosis (Sun, Treco et al. 1989; Cao, Alani et al. 1990; Keeney, Giroux 
et al. 1997; Cervantes, Farah et al. 2000). Several lines of evidence have suggested 
that proteins that were originally identified as being part of either DNA repair or 
mitotic checkpoint machinery, control also these meiotic recombination processes 
(Tonami, Murakami et al. 2005). For instance, in budding yeast Mec1 and RAD24 
single mutants appear to undergo meiotic division I before all recombination events 
are complete (Lydall, Nikolsky et al. 1996) and a mutation in Mec1 confers defect in 
meiotic recombination (Kato and Ogawa 1994). In higher eukaryotes that was also the 
case: mutations in Drosophila ATR homolog, mei-41 translated into reduced meiotic 
recombination frequencies along with aberrant recombination nodules (Carpenter 
1979); and knocking out mouse ATM resulted in the individual being infertile and 
showing significant synaptonemal complex fragmentation (Barlow, Hirotsune et al. 
1996; Elson, Wang et al. 1996; Xu, Ashley et al. 1996). Hence, similarly to what it 
was described for homologous recombination repair in mitosis, where Chk1 
phosphorylates Rad51 at Thr309 allowing its recruitment to the foci (Sorensen, 
Hansen et al. 2005), under the meiotic process Chk1 may integrate ATM and ATR 
signals and monitor the processing of meiotic recombination.  
 
V.1.3 CHAPTER GOALS  
Despite all the functions that have been described for Chk1, both under normal cell 
development and under genotoxic stress, only a small number of proteins are, at 
present, known to interact with Chk1. These include Claspin and CDC25C. The former 
by binding facilitates Chk1 phosphorylation at key residues in order to activate it 
(Kumagai and Dunphy 2000; Kumagai and Dunphy 2003). The latter is 
phosphorylated by Chk1 to prevent progression through the cell cycle, in particular 
from S to G2, in the event of DNA-damage (O'Connell, Raleigh et al. 1997; Sanchez, 
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Wong et al. 1997; Boddy, Furnari et al. 1998; Furnari, Blasina et al. 1999). Because of 
the low number of known Chk1 interactors, it was expected that an YTH screen would 
help in the determination on new putative interactors and reveal new roles for Chk1. 
For this purpose, the screen has been performed, as mentioned, using a human testis 
cDNA library. This specific library was chosen due to the particular properties of the 
tissue used: the intense cell division frequency, as well as both the meiotic 
recombination and the occurrence of meiosis per se, properties that by themselves 
seem to be correlated with a generic Chk1 function in the surveillance of DNA integrity 
and cell cycle regulation. Thus, it was expected that this screen could identify positive 
clones that could actually be relevant Chk1 interactors and therefore reveal new 
interactions. As a follow up of the YTH screen, some additional tests, such as #-
galactosidase reporter gene assay and co-immunoprecipitation, were performed in 
order to support the eventual interaction. 
 
V.2 YEAST TWO-HYBRID SCREEN 
V.2.1 AFFINITY PURIFICATION OF A SHEEP ANTI-CHK1 POLYCLONAL 
ANTIBODY 
In order to have available an antibody for Chk1 detection in immunoblot analysis, an 
antibody affinity purification was performed. This was carried out in two broad steps: 
purification of the recombinant GST-kdChk1 protein and purification of the Chk1 
antibody itself. In order to perform the first step, a baculovirus system was used. This 
purified GST-kdChk1 recombinant protein was needed to generate a column for 
antibody affinity purification.  !
V.2.1.1 BACULOVIRUS STOCK TITRATION 
The efficiency of viral infection is dependent on the infection MOI (Multiplicity Of 
Infection), which can only be determined knowing the titer of the viral stock. Thus, the 
baculovirus stock titer was determined by using the BD BacPAKTM Baculovirus Rapid 
Titer kit, as described in Section II.4.1.3. 
After performing the assay, the number of foci for each stock and dilution were 
determined and the specific titer was calculated as described previously. The results 
show that this method has high level of confidence because the calculated titer for the 
Protein Phosphatases acting on the Replication Checkpoint                                        Chapter V 
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!
Centro de Biologia Celular 
Universidade de Aveiro | Portugal 167 
Centre for Developmental and 
Biomedical Genetics 
University of Sheffield | UK !
control viral stock (9.87x107 pfu/ml) was close to that indicated in the vial. For the 
GST-kdChk1 stock the determined titer was of 2.88x108 pfu/ml. 
 
V.2.1.2 GST-CHK1 PULL DOWN FROM THE BACULOVIRUS SYSTEM 
Having determined the titer of the different baculovirus stock solutions, Sf21 cells 
were infected with different MOIs to produce GST-kdChk1. Cells were lysed as 
described for the Insect cell expression system (Section II.4.1.4) and proteins were 
pulled down and eluted in a Glutathione-agarose column. To analyze the efficiency of 
the pull down, samples from the whole process of protein purification were run in a 
12% SDS-PAGE, followed by Comassie staining (Figure V.2). 
 
 
 
FIGURE V.2 | SDS-PAGE ANALYSIS FROM THE GST-KDCHK1 PROTEIN PURIFICATION PROCESS. 
Samples from GST-kdChk1 purification (MOI of 2, 5, 10 and 15) were submitted to SDS-
PAGE and comassie blue staining. Lanes: 1 – 10 #l purified GST-Chk1, 2 – 20 #l purified 
GST-Chk1, 3 – 30 #g clarified lysate, 4 – 30 #g unbound material, [5..7] – 20 #l subsequent 
washes.!
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From the comassie gel analysis, it is possible to observe that the MOIs 2 and 15 have 
produced lower levels of GST-kdChk1 than MOIs 5 and 10, where the amount of 
protein generated appears the same. In addition, the size observed for the 
recombinant protein produced is about 75 KDa.  
 
V.2.1.3 ANTIBODY ELUTION AND VALIDATION 
To affinity purify sheep Chk1 antibody, a GST-kdChk1 column was generated with the 
previously purified recombinant protein (Section V.2.1.2). The column was then 
incubated with anti-Chk1 serum and the bound antibodies were collected by low pH 
elution, as described in Section II.4.2. Protein concentration from the different 
fractions was measured and the OD595 plotted in order to determine the elution 
efficiency (Figure V.3).  
 
 
 
This assay permited the determination of which fractions contained higher levels of 
antibody, allowing, in its turn, the selection of those to be pooled together, in order to 
produce an antibody stock solution. The figure shows that the elution occurred in two 
peaks (fractions 5 and 21). To check the quality of the eluted antibodies, these 
specific fractions were tested for specificity by immunoblot analysis (Figure V.4). 
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FIGURE V.3 | BRADFORD ASSAY ON FRACTIONS FROM THE ELUTION OF CHK1 ANTIBODY AFFINITY 
PURIFICATION. The protein concentration of each fraction is expressed in OD595 units. !
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Both fractions recognized the different forms of Chk1, either the GST-kdChk1 in the 
first three lanes (75 KDa) or the endogenous wtChk1 (50 KDa) present in the last 3 
lanes. In comparison with the old stock, the two fractions tested displayed higher 
sensitivity to recognize Chk1 in a Western because at the same concentration of 
antibody (1 $l/ml), the signal for the specific Chk1 band is stronger.  
Since the specificity of the affinity purified antibodies was validated, the higher 
concentration fractions (fractions 2 to 10 and 21) were pooled, mixed and stored in 
100 $l aliquots at -20ºC. The remaining fractions were also pooled and stored at         
FIGURE V.4 | ANTI-CHK1 AFFINITY 
PURIFIED ANTIBODY TEST, IN IMMUNO-
BLOT ANALYSIS USING RECOMBINANT 
GST-KDCHK1 AND HELA LYSATE. The 
immunoblots are relative to the 
analysis performed with the eluted 
fractions 5 and 21, as well as an old 
stock of Chk1 antibody. The 
antibodies were used at a final 
concentration of 1 #g/ml.  
Lane 1 | 5 ng (GST-kd Chk1) 
Lane 2 | 50 ng (GST-kd Chk1)  
Lane 3 | 150 ng (GST-kd Chk1) 
Lane 4 | 12.5 #g (HeLa lysate) 
Lane 5 | 25.0 #g (HeLa lysate) 
Lane 6 | 50.0 #g (HeLa lysate)!
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-20ºC. Protein concentration was determined for each pool of antibodies by the 
Bradford assay. 
V.2.2 SUBCLONING OF CHK1 AND CDC25C INTO YTH VECTORS 
In order to perform the YTH screen using Chk1 as bait, its cDNA was subcloned into a 
suitable vector, producing a fusion protein with the GAL4 DNA-binding domain in a 
yeast host. In this case, the vector used was pAS2-1 (Section VIII.7.1). To perform 
the subcloning, the Chk1 cDNA was extracted from the carrying plasmid, the pOTB7 
(Section VIII.7.5), with the PstI restriction enzyme, and inserted into the PstI in the 
restriction site of pAS2-1, as described in Section II.5.1. The resulting construct, 
named pAS2-1/Chk1, was sequenced in order to check if the resulting protein was in 
frame with the GAL4 DNA-BD and to verify the absence of any sequence errors (Figure 
V.5).  
 
atgaagctactgtcttctatcgaacaagcatgcgatatttgccgacttaaaaagctcaag 
 M  K  L  L  S  S  I  E  Q  A  C  D  I  C  R  L  K  K  L  K  
tgctccaaagaaaaaccgaagtgcgccaagtgtctgaagaacaactgggagtgtcgctac 
 C  S  K  E  K  P  K  C  A  K  C  L  K  N  N  W  E  C  R  Y  
tctcccaaaaccaaaaggtctccgctgactagggcacatctgacagaagtggaatcaagg 
 S  P  K  T  K  R  S  P  L  T  R  A  H  L  T  E  V  E  S  R  
ctagaaagactggaacagctatttctactgatttttcctcgagaagaccttgacatgatt 
 L  E  R  L  E  Q  L  F  L  L  I  F  P  R  E  D  L  D  M  I  
ttgaaaatggattctttacaggatataaaagcattgttaacaggattatttgtacaagat 
 L  K  M  D  S  L  Q  D  I  K  A  L  L  T  G  L  F  V  Q  D  
aatgtgaataaagatgccgtcacagatagattggcttcagtggagactgatatgcctcta 
 N  V  N  K  D  A  V  T  D  R  L  A  S  V  E  T  D  M  P  L  
acattgagacagcatagaataagtgcgacatcatcatcggaagagagtagtaacaaaggt 
 T  L  R  Q  H  R  I  S  A  T  S  S  S  E  E  S  S  N  K  G  
caaagacagttgactgtatcgccggtattgcaatacccagctttgactcatatggccatg 
 Q  R  Q  L  T  V  S  P  V  L  Q  Y  P  A  L  T  H  M  A  M  
gaggccgaattcccggggatccgtcgacctgcagtggtgggcaaaggacagtccgccgag 
 E  A  E  F  P  G  I  R  R  P  A  V  V  G  K  G  Q  S  A  E  
gtgctcggtggagtcatggcagtgccctttgtggaagactgggacttggtgcaaaccctg 
 V  L  G  G  V  M  A  V  P  F  V  E  D  W  D  L  V  Q  T  L  
ggagaaggtgcctatggagaagttcaacttgctgtgaatagagtaactgaagaagcagtc 
 G  E  G  A  Y  G  E  V  Q  L  A  V  N  R  V  T  E  E  A  V  
gcagtgaagattgtagatatgaagcgtgccgtagactgtccagaaaatattaagaaagag 
 A  V  K  I  V  D  M  K  R  A  V  D  C  P  E  N  I  K  K  E  
atctgtatcaataaaatgctaaatcatgaaaatgtagtaaaattctatggtcacaggaga 
 I  C  I  N  K  M  L  N  H  E  N  V  V  K  F  Y  G  H  R  R  
gaaggcaatatccaatatttatttctggagtactgtagtggaggagagctttttgacaga 
 E  G  N  I  Q  Y  L  F  L  E  Y  C  S  G  G  E  L  F  D  R  
atagagccagacataggcatgcctgaaccagatgctcagagattcttccatcaactcatg 
 I  E  P  D  I  G  M  P  E  P  D  A  Q  R  F  F  H  Q  L  M  
gcaggggtggtttatctgcatggtattggaataactcacagggatattaaaccagaaaat 
 A  G  V  V  Y  L  H  G  I  G  I  T  H  R  D  I  K  P  E  N  
cttctgttggatgaaagggataacctcaaaatctcagactttggcttggcaacagtattt 
Protein Phosphatases acting on the Replication Checkpoint                                        Chapter V 
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!
Centro de Biologia Celular 
Universidade de Aveiro | Portugal 171 
Centre for Developmental and 
Biomedical Genetics 
University of Sheffield | UK !
 L  L  L  D  E  R  D  N  L  K  I  S  D  F  G  L  A  T  V  F  
cggtataataatcgtgagcgtttgttgaacaagatgtgtggtactttaccatatgttgct 
 R  Y  N  N  R  E  R  L  L  N  K  M  C  G  T  L  P  Y  V  A  
ccagaacttctgaagagaagagaatttcatgcagaaccagttgatgtttggtcctgtgga 
 P  E  L  L  K  R  R  E  F  H  A  E  P  V  D  V  W  S  C  G  
atagtacttactgcaatgctcgctggagaattgccatgggaccaacccagtgacagctgt 
 I  V  L  T  A  M  L  A  G  E  L  P  W  D  Q  P  S  D  S  C  
caggagtattctgactggaaagaaaaaaaaacatacctcaacccttggaaaaaaatcgat 
 Q  E  Y  S  D  W  K  E  K  K  T  Y  L  N  P  W  K  K  I  D  
tctgctcctctagctctgctgcataaaatcttagttgagaatccatcagcaagaattacc 
 S  A  P  L  A  L  L  H  K  I  L  V  E  N  P  S  A  R  I  T  
attccagacatcaaaaaagatagatggtacaacaaacccctcaagaaaggggcaaaaagg 
 I  P  D  I  K  K  D  R  W  Y  N  K  P  L  K  K  G  A  K  R  
ccccgagtcacttcaggtggtgtgtcagagtctcccagtggattttctaagcacattcaa 
 P  R  V  T  S  G  G  V  S  E  S  P  S  G  F  S  K  H  I  Q  
tccaatttggacttctctccagtaaacagtgcttctagtgaagaaaatgtgaagtactcc 
 S  N  L  D  F  S  P  V  N  S  A  S  S  E  E  N  V  K  Y  S  
agttctcagccagaaccccgcacaggtctttccttatgggataccagcccctcatacatt 
 S  S  Q  P  E  P  R  T  G  L  S  L  W  D  T  S  P  S  Y  I  
gataaattggtacaagggatcagcttttcccagcccacatgtcctgatcatatgcttttg 
 D  K  L  V  Q  G  I  S  F  S  Q  P  T  C  P  D  H  M  L  L  
aatagtcagttacttggcaccccaggatcctcacagaacccctggcagcggttggtcaaa 
 N  S  Q  L  L  G  T  P  G  S  S  Q  N  P  W  Q  R  L  V  K  
agaatgacacgattctttaccaaattggatgcagacaaatcttatcaatgcctgaaagag 
 R  M  T  R  F  F  T  K  L  D  A  D  K  S  Y  Q  C  L  K  E  
acttgtgagaagttgggctatcaatggaagaaaagttgtatgaatcaggttactatatca 
 T  C  E  K  L  G  Y  Q  W  K  K  S  C  M  N  Q  V  T  I  S  
acaactgataggagaaacaataaactcattttcaaagtgaatttgttagaaatggatgat 
 T  T  D  R  R  N  N  K  L  I  F  K  V  N  L  L  E  M  D  D  
aaaatattggttgacttccggctttctaagggtgatggattggagttcaagagacacttc 
 K  I  L  V  D  F  R  L  S  K  G  D  G  L  E  F  K  R  H  F  
ctgaagattaaagggaagctgattgatattgtgagcagccagaaggtttggcttcctgcc 
 L  K  I  K  G  K  L  I  D  I  V  S  S  Q  K  V  W  L  P  A  
Acatga 
 T  - 
A positive control was also used to allow the validation of the interactions and increase 
the confidence on the data from the YTH screen. Hence, a CDC25C cDNA obtained 
from ImaGenes (clone IRAUp969H0775D, supplied in a pOTB7 vector) was subcloned 
into a vector that fuses the “prey” protein to the GAL4 AD. This vector was the pACT2 
(Section VIII.7.2). Briefly, CDC25C was subcloned by PCR followed by restriction 
digestion with BamHI and XhoI, and then ligated to pACT2 through its MCS (described 
in Section II.5.1). To confirm the pACT2/CDC25C construct sequence, as well as if 
CDC25C sequence was in frame with the GAL4 AD protein, both pACT2-CDC25C 5’ and 
FIGURE V.5 | PAS2-1/CHK1 CONSTRUCT SEQUENCE. The Chk1 sequence is shown in orange (•), 
the DNA-BD sequence in blue (•), the stop codon in grey (•) and the restriction site used in 
green (•). !
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pACT2-CDC25C 3’ primers (Table VIII.2) were used. The results are shown below 
(Figure V.6): 
 
atggataaagcggaattaattcccgagcctccaaaaaagaagagaaaggtcgaattgggt 
 M  D  K  A  E  L  I  P  E  P  P  K  K  K  R  K  V  E  L  G  
accgccgccaattttaatcaaagtgggaatattgctgatagctcattgtccttcactttc 
 T  A  A  N  F  N  Q  S  G  N  I  A  D  S  S  L  S  F  T  F  
actaacagtagcaacggtccgaacctcataacaactcaaacaaattctcaagcgctttca 
 T  N  S  S  N  G  P  N  L  I  T  T  Q  T  N  S  Q  A  L  S  
caaccaattgcctcctctaacgttcatgataacttcatgaataatgaaatcacggctagt 
 Q  P  I  A  S  S  N  V  H  D  N  F  M  N  N  E  I  T  A  S  
aaaattgatgatggtaataattcaaaaccactgtcacctggttggacggaccaaactgcg 
 K  I  D  D  G  N  N  S  K  P  L  S  P  G  W  T  D  Q  T  A  
tataacgcgtttggaatcactacagggatgtttaataccactacaatggatgatgtatat 
 Y  N  A  F  G  I  T  T  G  M  F  N  T  T  T  M  D  D  V  Y  
aactatctattcgatgatgaagataccccaccaaacccaaaaaaagagatctgtatggct 
 N  Y  L  F  D  D  E  D  T  P  P  N  P  K  K  E  I  C  M  A  
tacccatacgatgttccagattacgctagcttgggtggtcatatggccatggaggccccg 
 Y  P  Y  D  V  P  D  Y  A  S  L  G  G  H  M  A  M  E  A  P  
gggatccacaagaccatgtctacggaactcttctcatccacaagagaggaaggaagctct 
 G  I  H  K  T  M  S  T  E  L  F  S  S  T  R  E  E  G  S  S  
ggctcaggacccagttttaggtctaatcaaaggaaaatgttaaacctgctcctggagaga 
 G  S  G  P  S  F  R  S  N  Q  R  K  M  L  N  L  L  L  E  R  
gacacttcctttaccgtctgtccagatgtccctagaactccagtgggcaaatttcttggt 
 D  T  S  F  T  V  C  P  D  V  P  R  T  P  V  G  K  F  L  G  
gattctgcaaacctaagcattttgtctggaggaaccccaaaatgttgcctcgatctttcg 
 D  S  A  N  L  S  I  L  S  G  G  T  P  K  C  C  L  D  L  S  
aatcttagcagtggggagataactgccactcagcttaccacttctgcagaccttgatgaa 
 N  L  S  S  G  E  I  T  A  T  Q  L  T  T  S  A  D  L  D  E  
actggtcacctggattcttcaggacttcaggaagtgcatttagctgggatgaatcatgac 
 T  G  H  L  D  S  S  G  L  Q  E  V  H  L  A  G  M  N  H  D  
cagcacctaatgaaatgtagcccagcacagcttctttgtagcactccgaatggtttggac 
 Q  H  L  M  K  C  S  P  A  Q  L  L  C  S  T  P  N  G  L  D  
cgtggccatagaaagagagatgcaatgtgtagttcatctgcaaataaagaaaatgacaat 
 R  G  H  R  K  R  D  A  M  C  S  S  S  A  N  K  E  N  D  N  
ggaaacttggtggacagtgaaatgaaatatttgggcagtcccattactactgttccaaaa 
 G  N  L  V  D  S  E  M  K  Y  L  G  S  P  I  T  T  V  P  K  
ttggataaaaatccaaacctaggagaagaccaggcagaagagatttcagatgaattaatg 
 L  D  K  N  P  N  L  G  E  D  Q  A  E  E  I  S  D  E  L  M  
gagttttccctgaaagatcaagaagcaaaggtgagcagaagtggcctatatcgctccccg 
 E  F  S  L  K  D  Q  E  A  K  V  S  R  S  G  L  Y  R  S  P  
tcgatgccagagaacttgaacaggccaagactgaagcaggtggaaaaattcaaggacaac 
 S  M  P  E  N  L  N  R  P  R  L  K  Q  V  E  K  F  K  D  N  
acaataccagataaagttaaaaaaaagtatttttctggccaaggaaagctcaggaagggc 
 T  I  P  D  K  V  K  K  K  Y  F  S  G  Q  G  K  L  R  K  G  
ttatgtttaaagaagacagtctctctgtgtgacattactatcactcagatgctggaggaa 
 L  C  L  K  K  T  V  S  L  C  D  I  T  I  T  Q  M  L  E  E  
gattctaaccaggggcacctgattggtgatttttccaaggtatgtgcgctgccaaccgtg 
 D  S  N  Q  G  H  L  I  G  D  F  S  K  V  C  A  L  P  T  V  
tcagggaaacaccaagatctgaagtatgtcaacccagaaacagtggctgccttactgtcg 
 S  G  K  H  Q  D  L  K  Y  V  N  P  E  T  V  A  A  L  L  S  
gggaagttccagggtctgattgagaagttttatgtcattgattgtcgctatccatatgag 
 G  K  F  Q  G  L  I  E  K  F  Y  V  I  D  C  R  Y  P  Y  E  
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tatctgggaggacacatccagggagccttaaacttatatagtcaggaagaactgtttaac 
 Y  L  G  G  H  I  Q  G  A  L  N  L  Y  S  Q  E  E  L  F  N  
ttctttctgaagaagcccatcgtccctttggacacccagaagagaataatcatcgtgttc 
 F  F  L  K  K  P  I  V  P  L  D  T  Q  K  R  I  I  I  V  F  
cactgtgaattctcctcagagaggggcccccgaatgtgccgctgtctgcgtgaagaggac 
 H  C  E  F  S  S  E  R  G  P  R  M  C  R  C  L  R  E  E  D  
aggtctctgaaccagtatcctgcattgtactacccagagctatatatccttaaaggcggc 
 R  S  L  N  Q  Y  P  A  L  Y  Y  P  E  L  Y  I  L  K  G  G  
tacagagacttctttccagaatatatggaactgtgtgaaccacagagctactgccctatg 
 Y  R  D  F  F  P  E  Y  M  E  L  C  E  P  Q  S  Y  C  P  M  
catcatcaggaccacaagactgagttgctgaggtgtcgaagccagagcaaagtgcaggaa 
 H  H  Q  D  H  K  T  E  L  L  R  C  R  S  Q  S  K  V  Q  E  
ggggagcggcagctgcgggagcagattgcccttctggtgaaggacatgagcccatga 
 G  E  R  Q  L  R  E  Q  I  A  L  L  V  K  D  M  S  P  - 
 
The next step was to check if the proteins were being expressed in the yeast host.  
 
V.2.3 VALIDATION OF PROTEIN EXPRESSION 
In order to produce the lysates to be tested by immunoblotting, the constructs were 
transformed into suitable yeast strains, pAS2-1/Chk1 into AH109 (mat a) and 
pACT2/CDC25C into Y187 (mat !). After selective growth in specific medium, lacking 
either Tryptophan or Leucine, for the AH109[pAS2-1/Chk1] and Leucine  
Y187[pACT2/CDC25C] respectively, cells were lysed by the Urea method (Section 
II.2.1.1). All lysates were analysed by immunoblot, probed either with the affinity 
purified anti-Chk1 antibody or with the commercially available anti-CDC25C (C -20) 
antibody. The relevant negative controls 
were also included in the analysis as 
shown in (Figure V.7). 
FIGURE V.6 | PACT2/CDC25C CONSTRUCT SEQUENCE. The CDC25C sequence is shown in 
orange (•), the DNA-AD sequence in blue (•), the stop codon in grey (•) and the restriction 
site used in green (•). !
FIGURE V.7 | IMMUNOBLOT ANALYSIS OF 
PROTEIN EXTRACTS FROM YEAST TRANSFORMED 
WITH EITHER PAS2-1/CHK1 OR PACT2/ 
CDC25C CONSTRUCTS. Lysates were analysed 
by SDS-PAGE followed by Western Blotting. 
Both membranes were subsequently probed 
with specific Chk1 and CDC25C antibodies, 
respectively. Different negative controls 
were also loaded in each gel as shown.!
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Both blots clearly show that only in the case where the specific constructs were 
transformed into the respective yeast strains, the relevant proteins could be detected. 
In addition, in all included negative controls, either in untransformed yeast strain or in 
yeast transformed with unrelated plasmids, or even transformed with a version of the 
same plasmid as the constructs but with no insert, no band of the expected size was 
detected. 
AH109[pAS2-1/Chk1] was also tested for self-activation of reporter genes specifically 
controlled by the GAL4 DNA-BD. None of the tests performed, for example growth test 
in selective medium (data not shown), revealed that the expressed fusion protein 
could activate those reporter genes. This fact allowed the use of this transformed 
strain in the YTH screen.  
V.2.4 SELECTION OF PUTATIVE CHK1 INTERACTORS 
In order to perform the screen, AH109 (mat a) yeast strain transformed with the bait 
vector (pAS2-1/Chk1), as well as, a compatible and relevant pretransformed cDNA 
library were used. In this specific screen the cDNA library used was from human 
testis. In this library the cDNAs were inserted into the GAL4-AD expressing vector, 
pACT2 (Section VIII.7.2), and subsequently transformed into the Y187 (mat !) yeast 
strain.  
The method used to perform the screen was yeast mating, hence the use of two 
opposite mating types in the bait and the library transformations. Yeast mating, in 
comparison with the traditional cotransformation protocol, produces more unique 
positive clones mainly due to the “jump-start” that the new diploids receive before 
being plated on respective selective medium. In addition, diploids, in comparison to 
haploids, bring some more advantages to the screening system by being more robust 
and resistant to the expression of toxic proteins, as well as less sensitive to 
transcription activation, which reduces the incidence of false positives from 
transactivating baits. 
The screen was performed, as described in Section II.5.2, by mating the 
pretransformed human testis library (in Y187, mat !) with the Chk1 containing yeast 
strain (AH109, mat a). After the mating protocol was started, the culture was 
analysed under a phase-contrast microscope to check the mating progress. This was 
monitored by the presence of zygotes, which present a three-lobed shape, 
corresponding to the emerging diploid daughter cell, as well as the two haploid 
parental cells (Figure V.8). 
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The mating mixture was plated in the relevant selective medium (TDO and QDO) and 
incubated for several days until colonies started to appear. As soon as the colonies 
grew, they were transferred into a QDO selective plate, which tests the nutritional 
reporter genes HIS3 and ADE2. Along with this, in order to eliminate false positives 
they were tested for the activation of the MEL 1 reporter gene, by also transferring the 
colonies into a QDO selective plate containing X-!-Gal (data not shown). The final 
selected positives were then plated 
into a master QDO plate (Figure 
V.9), which allowed the generation 
of positive clone stocks for further 
analysis.  
   
 
 
 
FIGURE V.8 | ZYGOTE FORMATION DURING 
MATING PROCESS. Mating mixture was 
analysed by inverted microscopy (in phase 
contrast mode). The arrow points the typical 
three-lobed shape of the zygote being the 2 
cells nearer the arrow the parental and 
opposite the budding diploid cell.!
FIGURE V.9 | POSITIVE CLONES 
IDENTIFIED IN THE YEAST TWO-HYBRID 
SCREEN USING CHK1 AS BAIT. (A) 
SD/QDO plate of positive clones 
collected from the original SD/TDO 
and SD/QDO plates. (B) Identifica-
tion of the clones in (A). The 
numbering is related to the order 
that the clones were collected.!
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The control plates were scored in order to determine the mating efficiency, the 
number of clones screened, as well as the cell viability and the library titer (Table 
V.1). From the 37 positive clones that remained after the screen and false positive 
elimination: 17 were sequenced, 12 did not grow further to allow its analysis and 8 
were just stored in glycerol stocks. Despite of this low number of positive clones 
detected, the total number of clones screened ensure that all possible combinations 
were covered.  
 
!
V.3 CHARACTERIZATION OF THE POSITIVE CLONES 
V.3.1 PLASMID DIGESTION AND SEQUENCING 
The positive clones were analysed and identified using plasmid purification and 
sequencing techniques. In brief, the first step of this process was to purify, from the 
yeast cells, the plasmid DNA that contains the library cDNA clone. Afterwards, the 
DNA mixture, which was purified from the yeast, was transformed into E.coli XL1-Blue, 
in order to have a single plasmid per colony and to be able to get higher purity DNA 
plasmid. At this point, it was possible to purify the plasmids and analyse them by 
restriction digestion, using the endonuclease HindIII. The digestion fragments were, 
subsequently, submitted to agarose gel electrophoresis (Figure V.10).  
TABLE V.1 | RESULTS FROM THE CHK1 YEAST TWO HYBRID SCREEN. For the different parameters 
the following equations were applied: Library titer - #cfu/ml = #colonies / [plated volume 
(ml) x dilution factor] | #viable cfu/ml = [#cfu x 1000 #l/ml] / [plated volume (#l) x dilution 
factor] | Mating efficiency (% diploids) = [cfu/ml diploids x 100] / (cfu/ml of limiting 
partner) | #Clones screened = #cfu/ml diploids x ressuspension volume!
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After purifying the plasmids from the different positive clones that were analysed, the 
cDNA inserts from the library were sequenced with the GAL4-AD primer (Table VIII.2) 
as described in Section II.1.10. The result from the sequencing reaction, after being 
processed by the specific sequencing equipment, was analysed using the FinchTV 
v1.4.0 software (Figure V.11). 
 
This software allows the analysis of the chromatogram generated by the sequencing 
equipment. When interpreting the data it is possible to infer about the quality of the 
sequence and also to correct some mistakes that the software may have introduce in 
the sequence by misreading the data. To compare the clone sequence to a given data 
base of nucleotide sequences, first it has to be converted into FASTA format (Figure 
V.12.A) and then be submitted to a BLAST analysis (Figure V.12.B) which gives a list 
of similar sequences in a decreased order of similarity score attributed by the software 
(Figure V.12.C) 
FIGURE V.10 | HINDIII DIGESTION AND 
ANALYSIS OF YEAST TWO HYBRID PLASMIDS. 
Agarose gel electrophoresis analysis was 
performed for samples digested with HindIII 
restriction enzyme as follows: 
Lane 1. pAS2-1/Chk1 (4.6+2.8+2.2+0.9) 
Lane 2. pACT2/CDC25C (7.3+2.2) 
Lane 3. pACT2/143 (7.3+1.1+0.3) 
Lane 4. pACT2/152 (7.3+1.5+1.1) 
Lane 5. pACT2/296 (7.3+1.6)!
FIGURE V.11 | CHROMATOGRAM FROM THE POSITIVE CLONE 152. The sequencing resulting file 
was analysed with FinchTV v1.4.0 software (from Geopiza Inc.).!
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This identification method was applied to each of the 17 clones analysed. After BLAST 
analysis, of the partial or full DNA sequence, it was possible to separate the 17 clones 
into 6 categories (Table V.2 - below).  
The categories presented in the table were established based on the properties of the 
identified sequences. Therefore the 6 categories were: clones encoding known 
proteins (in orange), clones whose reading frame did not correspond to the database 
(in blue), clones whose sequences align after the CDS of known proteins (in purple), 
clones whose sequences align only at the genomic level (in yellow), sequences that 
align with Mitochondrial DNA (in light green) and sequences that did not align with any 
of the databases (in dark green).  
 
 
 
 
 
 
FIGURE V.12 | POSITIVE CLONE 152 NUCLEOTIDE SEQUENCE BLAST ANALYSIS. Sequence of the 
positive clone 152 in FASTA format was extracted from the sequencing file using FinchTV (A) 
and subjected to BLAST analysis inserting the sequence in the query box from the BLAST 
webpage (B). BLAST results are presented in a decreasing order of similarity (C).!
Protein Phosphatases acting on the Replication Checkpoint                                        Chapter V 
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!
Centro de Biologia Celular 
Universidade de Aveiro | Portugal 179 
Centre for Developmental and 
Biomedical Genetics 
University of Sheffield | UK !
 
 
All of these sequences were then analysed in the same way. After partial or complete 
sequencing of each clone, the properties of the deduced amino-acid sequences were 
analysed for Chk1 phosphorylation site motif (RxxS, SF, SI), as well as for the 
occurence of other known motifs and domains, by the use of online databases search 
engines. Besides these, the sequences were also searched for the existence of ESTs 
(expressed sequence tags). This process was carried out for the three reading frames 
of each clone.  
From the table it is evident that only the first three correspond to the full length 
sequence expressed in the correct reading frame. In most other cases, when 
translating all three reading frames, the presence of premature stop codons became 
evident. This raised the hypothesis that the expressed peptides had strong affinity 
either to Chk1 or to the GAL4 DNA-BD. Also, and because probably these peptides are 
not physiological relevant in the cell context due to their small size, these specific 
TABLE V.2 | IDENTIFICATION OF THE POSITIVE CLONES FROM THE CHK1 YEAST TWO HYBRID SCREEN. 
Positive clones were subdivided into 6 different groups based on BLAST results as follows: 
clones with full length cDNA in orange (•), clones with the WRF in blue (•), clones with DNA 
after the CDS in purple (•), clones with genomic contig in yellow (•), clones with 
Mitochondrial genome in light green (•) and clones with no homology in dark green (•). 
Legend: WRF, wrong reading frame; CDS, coding sequence; Chr, chromosome. !
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identified clones might represent false positives. This is also the case for the 
mitochondrial gene identified (Cox2). Mitochondria have their specific genetic code 
(Anderson et al., 1981) that results in some some of its codons being translated 
differently from the genomic code. This fact supports the hypothesis that this 
identified interaction does not occur in a normal cell situation, which suggests that it 
may be a false positive.   
Further analysis was only focused on the clones that were being expressed in the 
correct reading frame and with the full length protein, as is shown in the following 
Section.  
 
V.3.2 VALIDATION OF PUTATIVE INTERACTIONS 
V.3.2.1 SUBCLONING OF THE POSITIVE CDNAS INTO A MAMMALIAN EXPRESSION VECTOR 
None of the identified full length proteins were known Chk1 interactors. Hence, several 
tests were performed in order to test the strength and the relevance of those specific 
interactions.  
When analysing the sequence of the selected clones, premature stop codons were 
detected in their reading frames. Most of these stop codons were localized between 
the GAL4 AD sequence and the starting ATG from the CDS of the positive clone. 
However, under these conditions, it was possible to observe the expression of proteins 
with the expected size by Western blot analysis, although the levels of expression 
were low when compared with other proteins with no premature stop codons (data not 
shown). Thus, in order to optimize the expression of the relevant proteins, the 
premature stop codons were removed using PCR, restriction digestion and ligation 
techniques as described in Section II.1. The PCR reactions were carried out with the 5’ 
primers specific to each clone (143 clone, 152 clone and 296 clone) and the HA vector 
3’ primer (Table VIII.2). The resulting sequences after PCR are shown in Table V.3. 
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After the PCR reaction the fragments were purified by agarose gel extraction, followed 
by restriction digestion with EcoRI and XhoI, as well as the pACT2 (Section VIII.7.2) 
and the pCMV-HA (Section VIII.7.7) empty plasmids, where the fragments were re-
inserted. After validation of the subcloning, the resulting constructs were sequenced to 
check if the PCR inserted any errors in the sequence and if the protein was being 
expressed in the correct reading frame. The following three figures show the resulting 
sequences of the expressed fusion proteins of the three positive clones that were 
analysed. These sequences include the region where the proteins are fused to the HA 
tag in the version of the pCMV-HA subcloning. 
 
atgtacccatacgatgttccagattacgctcttatggccatggaggcccgaattcaaatg 
 M  Y  P  Y  D  V  P  D  Y  A  L  M  A  M  E  A  R  I  Q  M  
agttggcgaggaagatcgacctattattggcctagaccaaggcgctatgtacagcctcct 
 S  W  R  G  R  S  T  Y  Y  W  P  R  P  R  R  Y  V  Q  P  P  
gaaatgattgggcctatgcggcccgagcagttcagtgatgaagtggaaccagcaacacct 
 E  M  I  G  P  M  R  P  E  Q  F  S  D  E  V  E  P  A  T  P  
TABLE V.3 | REMOVAL OF STOP CODONS BEFORE INITIAL ATG FROM POSITIVE CLONES. Sequences 
from the positive clones 143, 152 and 296 were modified by PCR in order to remove the 
stop codon present in frame before the initial ATG of the clone. The sequence from the 
regions of interest are shown with the initial ATG is in orange (•), the stop codon underlined 
and in black (•) and the EcoRI restriction site in green (•).!
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gaagaaggggaaccagcaactcaatgtcaggatcctgcagctgctcaggagggagaggat 
 E  E  G  E  P  A  T  Q  C  Q  D  P  A  A  A  Q  E  G  E  D  
gagggagcatctgcaggtcaagggccgaagcctgaagctcatagccaggaacagggtcac 
 E  G  A  S  A  G  Q  G  P  K  P  E  A  H  S  Q  E  Q  G  H  
ccacagactgggtgtgagtgtgaagatggtcctgatgggcaggagatggacccgccaaat 
 P  Q  T  G  C  E  C  E  D  G  P  D  G  Q  E  M  D  P  P  N  
ccagaggaggtgaaaacgcctgaagaaggtgaaaagcaatcacagtgttaa 
 P  E  E  V  K  T  P  E  E  G  E  K  Q  S  Q  C  -   
 
atgtacccatacgatgttccagattacgctcttatggccatggaggcccgaattcgcaaa 
 M  Y  P  Y  D  V  P  D  Y  A  L  M  A  M  E  A  R  I  R  K  
atgggaaaggaaaagactcatatcaacattgtcgtcattggacacgtagattcgggcaag 
 M  G  K  E  K  T  H  I  N  I  V  V  I  G  H  V  D  S  G  K  
tccaccactactggccatctgatctataaatgcggtggcatcgacaaaagaaccattgaa 
 S  T  T  T  G  H  L  I  Y  K  C  G  G  I  D  K  R  T  I  E  
aaatttgagaaggaggctgctgagatgggaaagggctccttcaagtatgcctgggtcttg 
 K  F  E  K  E  A  A  E  M  G  K  G  S  F  K  Y  A  W  V  L  
gataaactgaaagctgagcgtgaacgtggtatcaccattgatatctccttgtggaaattt 
 D  K  L  K  A  E  R  E  R  G  I  T  I  D  I  S  L  W  K  F  
gagaccagcaagtactatgtgactatcattgatgccccaggacacagagactttatcaaa 
 E  T  S  K  Y  Y  V  T  I  I  D  A  P  G  H  R  D  F  I  K  
aacatgattacagggacatctcaggctgactgtgctgtcctgattgttgctgctggtgtt 
 N  M  I  T  G  T  S  Q  A  D  C  A  V  L  I  V  A  A  G  V  
ggtgaatttgaagctggtatctccaagaatgggcagacccgagagcatgcccttctggct 
 G  E  F  E  A  G  I  S  K  N  G  Q  T  R  E  H  A  L  L  A  
tacacactgggtgtgaaacaactaattgtcggtgttaacaaaatggattccactgagcca 
 Y  T  L  G  V  K  Q  L  I  V  G  V  N  K  M  D  S  T  E  P  
ccctacagccagaagagatatgaggaaattgttaaggaagtcagcacttacattaagaaa 
 P  Y  S  Q  K  R  Y  E  E  I  V  K  E  V  S  T  Y  I  K  K  
attggctacaaccccgacacagtagcatttgtgccaatttctggttggaatggtgacaac 
 I  G  Y  N  P  D  T  V  A  F  V  P  I  S  G  W  N  G  D  N  
atgctggagccaagtgctaacatgccttggttcaagggatggaaagtcacccgtaaggat 
 M  L  E  P  S  A  N  M  P  W  F  K  G  W  K  V  T  R  K  D  
ggcaatgccagtggaaccacgctgcttgaggctctggactgcatcctaccaccaactcgt 
 G  N  A  S  G  T  T  L  L  E  A  L  D  C  I  L  P  P  T  R  
ccaactgacaagcccttgcgcctgcctctccaggatgtctacaaaattggtggtattggt 
 P  T  D  K  P  L  R  L  P  L  Q  D  V  Y  K  I  G  G  I  G  
actgttcctgttggccgagtggagactggtgttctcaaacccggtatggtggtcaccttt 
 T  V  P  V  G  R  V  E  T  G  V  L  K  P  G  M  V  V  T  F  
gctccagtcaacgttacaacggaagtaaaatctgtcgaaatgcaccatgaagctttgagt 
 A  P  V  N  V  T  T  E  V  K  S  V  E  M  H  H  E  A  L  S  
gaagctcttcctggggacaatgtgggcttcaatgtcaagaatgtgtctgtcaaggatgtt 
 E  A  L  P  G  D  N  V  G  F  N  V  K  N  V  S  V  K  D  V  
cgtcgtggcaacgttgctggtgacagcaaaaatgacccaccaatggaagcagctggcttc 
 R  R  G  N  V  A  G  D  S  K  N  D  P  P  M  E  A  A  G  F  
actgctcaggtgattatcctgaaccatccaggccaaataagcgccggctatgcccctgta 
 T  A  Q  V  I  I  L  N  H  P  G  Q  I  S  A  G  Y  A  P  V  
ttggattgccacacggctcacattgcatgcaagtttgctgagctgaaggaaaagattgat 
 L  D  C  H  T  A  H  I  A  C  K  F  A  E  L  K  E  K  I  D  
FIGURE V.13 | SEQUENCE OF THE PCMV-HA/143 CONSTRUCT. 143 sequence is shown in orange 
(•), HA sequence in blue (•), the stop codon in grey (•) and the restriction site in green (•).!
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cgccgttctggtaaaaagctggaagatggccctaaattcttgaagtctggtgatgctgcc 
 R  R  S  G  K  K  L  E  D  G  P  K  F  L  K  S  G  D  A  A  
attgttgatatggttcctggcaagcccatgtgtgttgagagcttctcagactatccacct 
 I  V  D  M  V  P  G  K  P  M  C  V  E  S  F  S  D  Y  P  P  
ttgggtcgctttgctgttcgtgatatgagacagacagttgcggtgggtgtcatcaaagca 
 L  G  R  F  A  V  R  D  M  R  Q  T  V  A  V  G  V  I  K  A  
gtggacaagaaggctgctggagctggcaaggtcaccaagtctgcccagaaagctcagaag 
 V  D  K  K  A  A  G  A  G  K  V  T  K  S  A  Q  K  A  Q  K  
gctaaatga 
 A  K  -   
 
atgtacccatacgatgttccagattacgctcttatggccatggaggcccgaattcaaatg 
 M  Y  P  Y  D  V  P  D  Y  A  L  M  A  M  E  A  R  I  Q  M  
accgagtgggagacagcagcaccagcggtggcagagaccccagacatcaagctctttggg 
 T  E  W  E  T  A  A  P  A  V  A  E  T  P  D  I  K  L  F  G  
aagtggagcaccgatgatgtgcagatcaatgacatttccctgcaggattacattgcagtg 
 K  W  S  T  D  D  V  Q  I  N  D  I  S  L  Q  D  Y  I  A  V  
aaggagaagtatgccaagtacctgcctcacagtgcagggcggtatgccgccaaacgcttc 
 K  E  K  Y  A  K  Y  L  P  H  S  A  G  R  Y  A  A  K  R  F  
cgcaaagctcagtgtcccattgtggagcgcctcactaactccatgatgatgcacggccgc 
 R  K  A  Q  C  P  I  V  E  R  L  T  N  S  M  M  M  H  G  R  
aacaacggcaagaagctcatgactgtgcgcatcgtcaagcatgccttcgagatcatacac 
 N  N  G  K  K  L  M  T  V  R  I  V  K  H  A  F  E  I  I  H  
ctgctcacaggcgagaaccctctgcaggtcctggtgaacgccatcatcaacagtggtccc 
 L  L  T  G  E  N  P  L  Q  V  L  V  N  A  I  I  N  S  G  P  
cgggaggactccacacgcattgggcgcgccgggactgtgagacgacaggctgtggatgtg 
 R  E  D  S  T  R  I  G  R  A  G  T  V  R  R  Q  A  V  D  V  
tcccccctgcgccgtgtgaaccaggccatctggctgctgtgcacaggcgctcgtgaggct 
 S  P  L  R  R  V  N  Q  A  I  W  L  L  C  T  G  A  R  E  A  
gccttccggaacattaagaccattgctgagtgcctggcagatgagctcatcaatgctgcc 
 A  F  R  N  I  K  T  I  A  E  C  L  A  D  E  L  I  N  A  A  
aagggctcctcgaactcctatgccattaagaagaaggacgagctggagcgtgtggccaag 
 K  G  S  S  N  S  Y  A  I  K  K  K  D  E  L  E  R  V  A  K  
tccaaccgctga 
 S  N  R  -   
 
 
To test the expression of these recombinant proteins in mammalian cell lines, the 
specific constructs were transfected into HeLa cells by the Calcium Phosphate method, 
as described in Section II.3.4.1. In addition, an empty pCMV-HA plasmid was 
transfected by the same method, and also a mock transfection with no DNA were 
performed as negative control. After an incubation of 24h (post-transfection), the cells 
FIGURE V.14 | SEQUENCE OF THE PCMV-HA/152 CONSTRUCT. 152 sequence is shown in orange 
(•), HA sequence in blue (•), the stop codon in grey (•) and the restriction site in green (•).!
FIGURE V.15 | SEQUENCE OF THE PCMV-HA/296 CONSTRUCT. 296 sequence is shown in orange 
(•), HA sequence in blue (•), the stop codon in grey (•) and the restriction site in green (•).!
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were lysed and analysed by SDS-PAGE followed by Western blotting, using a 
commercially available anti-HA antibody (Covance) (Figure V.16). 
 
 
 
 !!!
 
The different constructs express the specific proteins and were recognized by the HA 
antibody. The expected size of the proteins are: 15 KDa, 52 KDa and 25 KDa, for HA-
143, HA-152 and HA-296, respectively. However, the HA-143 construct produces a 
protein with a much higher apparent molecular weight than the expected. This larger 
size may be due to several different post-translational modifications or even some 
type of dimerization that could not be resolved by the SDS-PAGE. After this validation, 
the constructs were transfected into HeLa cells to test the interaction, as it will be 
approached in Section V.3.2.3. 
 
V.3.2.2 "-GALACTOSIDASE ASSAY 
In order to further investigate the relevance of the Chk1 YTH results, a quantitative 
assay to evaluate the strength of the interactions was performed. The assay is based 
on the activation of the lacZ reporter gene, which produces the "-galactosidase 
enzyme. The expression of this enzyme follows the same principle as the one that 
applies to the selection of the positive clones by growing them in selective medium. 
Hence, the stronger the interaction the more "-galactosidase is produced. In this 
specific assay, ONPG is used as a substrate, which, by the activity of "-galactosidase, 
is decomposed into a product that has a yellow colour, thus being possible to measure 
its concentration by the OD420.  
FIGURE V.16 | IMMUNOBLOT ANALYSIS OF 
PCMV-HA/CLONE CONSTRUCTS. Lysates from 
mock, empty pCMV-HA, pCMV-HA/143, 
pCMV-HA/152 and pCMV-HA/296 
transfections were subjected to SDS-PAGE 
followed by Western Blotting. The membrane 
was probed with anti-HA antibody.!
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Before performing the #-Galactosidase assay, the new versions of the pACT2 
constructs containing the corrected sequence of the cDNA from the positive clones 
(without the premature STOP codons, referred in Section V.3.2.1) were transformed 
into the PJ69-4! yeast strain, as well as the pAS2-1/Chk1 plasmid into the PJ69-4A. 
This was performed in order to get more stable strains expressing the proteins of 
interest. Once they were selected and validated for their specific nutritional markers, 
the strains were mated as described in Section II.5.4.4, so that the assay could be 
performed with diploids containing the putative interactors and the strength of the 
interaction could be tested. Along with the YTH positive clones 143, 152 and 296, 
some controls were also performed. Hence, as positive control for the assay, both the 
pVA3-1 (Section VIII.7.3) and the pTD1-1 (Section VIII.7.4) vectors were used. These 
express the murine p53 fused to the GAL4 DNA-BD and the SV40 large T-antigen 
fused with the GAL4 AD, respectively, whose interaction result in a very strong 
positive signal. In the context of Chk1 interactions, pACT2/CDC25C was also 
transformed into the PJ69-4!, so that by mating with the Chk1 expressing yeast, it 
could be used as a positive control for Chk1 interaction. As a negative control for the 
activation of the lacZ gene, the yeast strain containing the pAS2-1/Chk1 alone was 
used. When all these diploid and haploid yeast strains were available the assay was 
performed as described in Section II.5.4.5. The reactions were carried out in triplicate 
with 3 independent cultures for each condition, except the systems’ positive control. 
While the "-galactosidase reaction was occurring, the protein levels of each sample 
were also determined. By the end of the 24h reaction, the resulting OD420 signals from 
the yellow product, were measured (Figure V.17.A). Once this information was 
determined, the "-gal units were calculated for each condition. This was not the case 
for the systems’ positive control due to its signal saturation at 24h, which would 
produce an under-estimated result. The averages for each condition were determined, 
as well as the standard errors. The resulting data was plotted (Figure V.17.B).  
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As can be observed on Figure V.17.A, there is an obvious low activation of the lacZ 
reporter gene in all cases except for the positive control, where the stregth of the 
yellow product signal is very high. In all the mating conditions tested, the signal 
obtained, when compared with the negative Chk1 control, did not reveal significant 
differences. In fact, in the mating conditions with the 152 and 296 clones, the signal 
was slightly lower. In contrast, mating Chk1 with the 143 clone, yelded a higher signal 
when compared with Chk1 alone. This was also the case of the positive control 
interaction, Chk1xCDC25C. This last case gives confidence to the data resulting from 
the "-galactosidase assay, because the levels of lacZ activation from a known and 
FIGURE V.17 | !-GALACTOSIDASE ACTIVITY ASSAY FOR THE PUTATIVE INTERACTIONS. Cell extracts 
from the respective matings were assayed for "-Galactosidase activity with ONPG as a 
substrate. Levels of product from the different reactions (A) were measured at OD420 and 
the "-Gal units were calculated, averaged and plotted (B). !
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documented interaction (Chk1xCDC25C) were not very different from the levels of 
activation resulting from the identified positive clones.  
 
V.3.2.3 CO-IMMUNOPRECIPITATION 
As mentioned earlier, the putative interactions were also tested in a mammalian 
system, in order to generate a closer environment to the one that occurs in a normal 
human cell. Hence, the generated pCMV-HA constructs were transfected using the 
Calcium Phosphate method (Section II.3.4.1) into HeLa cells and incubated for 24h. 
After this period of incubation, a set of cells for each clone was treated with 2 mM HU 
and then incubated for a further 24h before lysing them. Co-immunoprecipitation was 
performed as described above (Section II.2.2), using anti-Chk1 (sheep) and anti-HA 
(mouse) antibodies, as well as the IgG controls specific for each species where the 
antibodies were raised. The samples from each pull-down, including all the IgG 
control, were analysed by SDS-PAGE followed with a Western blot (Figure V.18).  
 
FIGURE V.18 | IMMUNOBLOT ANALYSIS OF SAMPLES FROM THE IMMUNOPRECIPITATION OF HA 
CLONES OVEREXPRESSING LYSATES. HeLa lysates from HA clone transfected cell populations, 
either treated or non-treated with 2 mM HU for 24h, were subjected to immunoprecipitation 
using antibodies against either Chk1 or HA tag. The same procedure was performed using 
the respective IgG controls. Samples from immunoprecipitation were analysed with SDS-
PAGE followed by Western Blotting. Membranes were probed with anti-HA and anti-Chk1 
antibodies. 
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Concerning the control of all pull-down experiments, blots show that they worked 
since it is possible to observe that where the specific antibodies were used, either 
anti-Chk1 or anti-HA, the target proteins were detected. In this experiment, by 
definition, a reciprocal pull-down, indicates that when Chk1 is being pulled-down, with 
a Chk1 antibody, an HA tagged interacting protein should be co-immunoprecipitated 
and vice-versa. This could not be observed at least in the case of the 143 clone. When 
pulling down with either anti-Chk1 or anti-HA antibody, the signal of the reciprocal 
protein did not increase when comparing with the IgG controls. With the other two 
clones, 152 and 296, the data is not very clear in confirming the interaction. This is 
due to the fact that the interaction between Chk1 and the 152 (EEF1!1) seems to 
occur only when Chk1 was previously phosphorylated in an HU-induced manner. In 
addition, the interaction is only clearly distinguished when pulling down with the HA 
antibody and probing for Chk1 protein. In the reciprocal condition this is not very 
clear. Finally, the interaction between Chk1 and 296 (RPS5) seems that can only be 
detected in the absence of a HU cell stimulation and when Chk1 antibody is used to 
pull the proteins down. In the reciprocal conditions, i.e. when performing the pull-
down with the HA antibody and probing the specific blot with anti-Chk1 antibody, no 
significant differences can be detected.  
Several explanations can be raised to explain these poor and inconclusive interactions, 
as discussed in the following Chapter. Additionally, in order to detail more the putative 
interactions, other assays could be performed, such as in vitro phosphorylation, 
immunofluorescence, as well as using protein-interaction cross-linking, among other 
techniques.  
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CHAPTER VI 
D I S C U S S I O N  A N D  C O N C L U S I O N  
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Chapter VI | Discussion and Conclusion 
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Checkpoint signalling cascades operate throughout the cell cycle in order to prevent 
that an event does not start before an earlier one is finished (Hartwell and Weinert 
1989). Hence, they play roles in the regulation of the cell homeostasis by preventing 
for instance the propagation of DNA mutations that ultimately may lead to diseases 
such as cancer (Papaefthymiou, Giaginis et al. 2008). DNA replication and 
chromosomal segregation are the main points of the cell cycle where DNA integrity 
and stability is put at risk and thus where checkpoints provide fundamental controls. 
Signal transduction pathways in checkpoints are generally regulated by protein post-
translational modifications, such as the reversible reaction of phosphorylation (Zhou 
and Elledge 2000). Abnormal protein phosphorylation has been correlated with several 
diseases.  While kinases have been widely used as therapeutic targets, this application 
for protein phosphatases is just now emerging (Cohen 2002; Cohen 2006; Tonks 
2006; Zhang, Kim et al. 2006). 
Since, the signalling cascades that triggered the replication checkpoint in response to 
genotoxic stress were well characterized in terms of the most important protein 
kinases involved (Zhou and Elledge 2000), we decided to study if protein 
phosphatases had specific roles in the regulation of these mechanisms. Because Chk1 
was shown to have a central role in the establishment of the replication checkpoint 
(Francesconi, Grenon et al. 1997), we decided to take this protein as a first read out 
of the putative role of PPs on the replication checkpoint. This task was carried out by 
investigating the mechanisms of Chk1 modulation, focussing specifically on its 
dephosphorylation.  
The use of a set of in vitro and in vivo assays allowed us to establish the PP2A group 
as a major contributor for Chk1 (de)phosphorylation modulation, in response to 
replication arrest. In addition, we also decided to explore the role of specific Protein 
Phosphatases in the recovery from replication arrest as well as in the control of 
replication origin-firing. These studies revealed an interesting result concerning PP4 (a 
member of the PP2A family of protein phosphatases), which is necessary for the 
effective recovery from the replication arrest. Indeed, following PP4 knockdown, cells 
accumulate in G2/M after release from the exposure to 2 mM HU for 24h. Finally, and 
because throughout the years Chk1 has been implicated in many different 
mechanisms, we found useful the use of Yeast Two-hybrid techniques to detect 
potentially interesting Chk1 binding partners related to the context of meiosis. Hence, 
we performed a screen in a human testis cDNA library, having human Chk1 as bait. 
From the screen, 37 positive clones were recovered, 3 of which (GAGE12E, RPS5 and 
Protein Phosphatases acting on the Replication Checkpoint                                       Chapter VI 
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!
Centro de Biologia Celular 
Universidade de Aveiro | Portugal 194 
Centre for Developmental and 
Biomedical Genetics 
University of Sheffield | UK !
EEF1A1) were analysed in more detailed. All clones that were sequenced did not 
reveal any previously known Chk1 interacting protein, such as for example Claspin or 
CDC25C (Sanchez, Wong et al. 1997; Boddy, Furnari et al. 1998; Furnari, Blasina et 
al. 1999; Kumagai and Dunphy 2000; Kumagai and Dunphy 2003). However, 
confirmation assays subsequently performed have increased the confidence in the 
interacting proteins we obtained and suggest new interesting roles for Chk1. 
Altogether, our data opens new lines of investigation, either through the interesting 
putative new roles and binding partners for Chk1, or the role of Protein Phosphatases 
in the regulation of the replication checkpoint. Furthermore, these results may allow 
the identification of new targets for the treatment of diseases, such as cancer, and the 
consequent development of new drugs. More importantly, this is of high relevance in 
the case of PPs as their regulatory mechanisms are dependent on specific regulatory 
subunits that are usually unique for specific phosphatase roles. Subsequently, PPs 
may allow the development of drugs that could have fewer side effects. This is in fact 
opposite to what normally occurs when targeting a kinase, which can induce several 
and strong undesired side effects.  
 
VI.1 PROTEIN PHOSPHATASES AND THE REPLICATION CHECKPOINT 
VI.1.1 DYNAMICS OF CHK1 DEPHOSPHORYLATION 
Deregulation of the DNA-damage response or ineffective DNA repair mechanisms 
result in the propagation of mutations. In this context, checkpoints, where Chk1 plays 
a key role, provide an important platform to reduce opportunities for the propagation 
of those mutations.  When cells experience replication block, Chk1 becomes activated 
by phosphorylation in key residues that trigger the phosphorylation and subsequent 
inactivation of CDC25C (Sanchez, Wong et al. 1997; Boddy, Furnari et al. 1998; 
Furnari, Blasina et al. 1999; Kumagai and Dunphy 2000; Kumagai and Dunphy 2003). 
This ultimately prevents cells from moving out of S phase while the problem is not 
solved. In addition, Chk1 is also responsible for two other key roles: the stabilization 
of stalled replication forks as well as preventing later replication origins to fire while 
replication is stalled (Feijoo, Hall-Jackson et al. 2001). For these reasons, Chk1 
phosphorylation status seemed a good read out for the activation of the replication 
checkpoint. Since our main goal was to define the roles of protein phosphatases in the 
replication checkpoint, and because at the beginning of the project nothing was known 
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about the protein phosphatases responsible for Chk1 dephosphorylation, this became 
our first goal.  
To better understand the mechanisms that work in a cell, one must think about it as a 
dynamic balance between enzymes with opposite functions that fluctuate with time 
due to various stimuli. This is the case of phosphorylation as well, where a given 
phosphorylation state results from the balance between kinase and phosphatase 
activities. From our first approach to the problem, in order to validate the systems 
where we were going to test the hypothesis, we had to determine the timing and the 
dynamics of the dephosphorylation reaction. Therefore, we carried out in vitro and in 
vivo independent experiments, where the dephosphorylation of endogenous Chk1 was 
either followed in HU-treated HeLa cell lysates or in HeLa cells in culture, which were 
lysed at specific timepoints after HU removal. The outcome was very interesting since, 
although the timepoints in both experiments were different, it revealed that in both in 
vitro (in lysates) and in vivo (in cell culture) the system performed with approximately 
the same dynamics (Figure III.4). Hence, it has shown that Chk1 dephosphorylation 
occurs in a biphasic manner, where in a first and faster phase (occurring in the first 30 
min of reaction) 60-80% of the total phosphorylation is removed, and in a second and 
slower phase (which can take the following 24h, in the case of the in vivo experiment) 
the remaining signal drops, although not reaching basal phosphorylation levels as the 
non-treated conditions.  
This biphasic behaviour of Chk1 dephosphorylation may result from the ability of HU 
to induce phosphorylation of different pools of Chk1, that may be fulfilling different 
functions in the cell, and hence be dephosphorylated at different rates. This result 
would support the idea that Chk1 has multiple functions, some yet unknown and at 
different subcellular locations, which would respond differently to the same stimulus. 
It is also conceivable that HU treatment, by inactivating the ribonucleotide reductase, 
may be too severe for some cells and may lead to irreversible DNA damage and 
replication fork colapse. Supporting this hypothesis, in HL-60 (human promyelocytic) 
cells it was shown that treatment with either HU or Aph induced DSBs (measured by 
the levels of "H2AX) and did not activate ATM at Ser1981 (Kurose, Tanaka et al. 
2006). This result indicates that this "H2AX phosphorylation could be dependent on an 
ATR-Chk1 pathway and not an ATM-Chk2 pathway, as has been shown by Ward and 
Chen (Ward and Chen 2001). Interestingly, Kurose and colleagues (2006) have also 
shown that these HU- and Aph-dependent effects produced higher accumulation of 
DSBs in early S phase than in late S phase cells, as well as increased apoptosis in 
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these cells after 2h of exposure. Hence, it is conceivable that HU induces Chk1 
phosphorylation in order for it to accomplish its functions in: replication fork 
stabilization, prevention of late-origin-firing and DNA repair mechanisms. Then, 
assuming that once HU is removed cells can immediately restart replication as a 
consequence of Chk1 dephosphorylation, on a small number of cells this might not be 
the case. In those cells, where HU may have induced irreversible or extreme DNA 
damage, as appears to occur in cells arrested during early S phase, replication may 
not be restarted due to ongoing DNA repair or ultimately by being in an apoptotic 
process, and thus sustaining the phosphorylation of this pool of Chk1. This hypothesis 
could be tested by correlating, in a one-cell type of experiment, the level of Chk1 
phosphorylation with the levels of both the nucleotide incorporation and "H2AX 
present in the cell. This could be performed using FACS techiques where markers for 
each one of these parameters can be used at the same time to evaluate the time 
course of the recovery from a HU-induced arrest. Alternatively, the biphasic dynamics 
of Chk1 dephosphorylation could also be assayed by synchronizing cells in G0, with a 
serum deprived cell culture medium. This would allow a synchronized cell release into 
S phase, where independent cell populations would be treated with HU at different 
timepoints and assayed by immunobloting analysis in a time course manner, as 
above. In this way, it would be possible to understand if this observation is really due 
to different pools of Chk1 being dephosphorylated at different rates, or due to 
different reactions to the HU-induced arrest depending on how early in S phase the 
cell was arrested.   
 
VI.1.2 PROTEIN PHOSPHATASES AND CHK1 DEPHOSPHORYLATION 
Since the previous results lead us to assume that the in vitro could recapitulate the in 
vivo approach with regards to Chk1 dephosphorylation, we proceeded with a broader 
approach in vitro. Here, by using specific inhibitors to selectively target specific Protein 
Phosphate group activities in HeLa cell lysates, we were able to observe the influence 
of each selected group on Chk1 dephosphorylation. Analysis in lysates showed that at 
least PP1, PP2A and PP2C groups shared the responsibility to dephosphorylate the 
residues previously shown to be involved in Chk1 activation (Ser317 and Ser345). 
According to our data (Figure III.5), both PP1 and PP2C groups, had higher affinity for 
the dephosphorylation of the Ser345 residue. Consistent with our result Lu et al. 
showed that PPM1D, a protein phosphatese from the PP2C group, also known as 
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PP2C#, dephosphorylates Chk1 Ser345 residue (Lu, Nannenga et al. 2005). In 
addition, also supporting our data, the work from den Elzen and O’Connell, indicated 
that the fission yeast PP1 homolog Dis2 was responsible for the dephosphorylation of 
Chk1 Ser345 residue during G2 arrest (den Elzen and O'Connell 2004). To support an 
eventual role of the PP2C group in these pathways, the PP2C S. cerevisiae orthologs 
Ptc2 and Ptc3 have been implicated in the recovery from a double-stranded break 
induced arrest by the inactivation and dephosphorylation of Rad53 (Chk2 ortholog) 
(Leroy, Lee et al. 2003). However, despite the contribution from both PP1 and PP2C 
groups on Chk1’s dephosphorylation, our in vitro data strongly suggests that the 
major protein phosphatase group responsible for the dephosphorylation of both Chk1 
Ser317 and Ser345 after HU-induced activation is a member of the PP2A family. This 
finding is supported by data presented by Leung-Pineda et al. which showed that PP2A 
is a regulator of Chk1 phosphorylation state in the absence of genotoxic stress 
(Leung-Pineda, Ryan et al. 2006).  
A predictable next step in this study would be to perform in vitro Chk1 
dephosphorylation assays using purified protein phosphatases. However, in order to 
get a more reliable result, we thought that an in vivo cell culture approach would be 
better. This is due to the fact that in vitro Protein Phosphatases are usually very 
promiscuous and redundant and tend not to be specific despite its in vivo specificity. 
We thus decided to use an in vivo system to carry on specifically with the analysis of 
the roles from both PP1 and PP2A groups through the use of different approaches. The 
PP1 group was studied by the overexpression of either PP1! or I-2 proteins. For the 
PP2A group, besides the cell treatment with 100 nM OA, another approach was used 
where cells were also subjected to PME-1 overexpression. In addition, since some of 
the work that was published by other groups supported our own data and already 
involved PP2A enzyme on Chk1 dephosphorylation, we decided that it would be more 
profitable to proceed the investigations with PP4 and PP6 protein phosphatases that, 
at the time, were hardly studied in human cells and had interesting results in yeast 
systems. Hence, included in the study of the PP2A group, a knockdown of PP4 and PP6 
was carried out.  
 
VI.1.2.1 PROTEIN PHOSPHATASE 1 FAMILY CONTRIBUTION 
The Protein Phosphatase 1 (PP1) family has been implicated in mechanisms crucial for 
the prevention of cell transformation, as well as observed to be overexpressed in 
various tumours (Sogawa, Yamada et al. 1994; Sogawa, Yamada et al. 1995; Sogawa, 
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Masaki et al. 1997; Liu, Wang et al. 2006). In a DNA replication context there are 
lines of evidence that support a putative role for this group of phosphatases during S 
phase. In 1992 it was found that nuclear PP1 and PP2A activities increased from G1 
until M phase, where it dropped dramatically, while in the cytoplasm this dynamics 
was not observed (Nakamura, Koda et al. 1992). In addition, in a recent study by 
Flores-Delgado et al. (Flores-Delgado, Liu et al. 2007) where they performed a screen 
for PP1 using an array with a 100 specifically selected antibodies, it was found that 
PP1 co-immunoprecipitated with several different proteins including PCNA, an element 
from the DNA replication machinery. Besides PP1, the PP1 Inhibitor-2 (I-2) has also 
been reported to migrate to the nucleus at the entry of S phase after several crucial 
phosphorylations at key residues (Kakinoki, Somers et al. 1997). In the case where 
those residues were mutated to non-phosphorylatable ones, or where the NLS was 
also mutated, I-2 remained in the cytoplasm.  
In our work we tested the hypothesis that overexpressing PP1! or I-2 in vivo would 
affect the dynamics of Chk1 dephosphorylation. In fact, two phenomena occurred 
when PP1! was overexpressed. First, the increased expression of this enzyme also 
increased the rate of Chk1 dephosphorylation during the first phase on both Ser317 
and Ser345, supporting the result previously obtained with our in vitro approach. 
Second, in one of the experiments where PP1! is overexpressed, the initial level of 
Chk1 phosphorylation on Ser317, after 24h treatment of 2 mM HU, was significantly 
increased when compared to control conditions. This second phenomenon was also 
supported by the I-2 overexpression assays, where it was observed that the initial 
Chk1 phosphorylation level after 24h incubation with 2 mM HU was diminished, 
although in this case on Ser345 and not Ser317. These results suggest that besides a 
role for the PP1 group on the specific dephosphorylation of Chk1, this phosphatase 
may also be important for Chk1 activation in response to replication stress, through 
the regulation of upstream players. This role in Chk1 activation seems to act 
differently in both residues, where Ser317 is affected by the overexpression of PP1! 
and Ser345 by the overexpression of I-2. The differential phosphorylation specificity 
may be important for the different Chk1 functions, and may result from the action of 
other PP1 proteins rather than PP1!, such as PP1", which is also inhibited by I-2. 
Supporting our findings on the role for the PP1 group on Chk1 dephosphorylation, are 
the observations from den Elzen and O’Connell (2004) showing that either Dis2 or 
recombinant PP1! could dephosphorylate both recombinant Chk1 and a phospho-345 
peptide. The latter was further supported by the work from Lu et al. (Lu, Nannenga et 
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al. 2005), which by performing the same type of in vitro dephosphorylation assay on 
phospho-345 peptide observed the same response relative to PP1. We have 
additionally observed that inbiting PP1 activity through the overexpression of I-2 
renders no difference in the rate of Chk1 dephosphorylation, for both phases. This 
highlights the concept that, because many different PPs may be involved in the 
regulation of Chk1, some overlap and redundancy can occur in what concerns the 
dephosphorylation of both Ser317 and Ser345. Supporting the fact that 
overexpression of either PP1! or I-2 resulted respectively in the hiper- or hipo-
phosphorylation of Chk1 residues in the event of HU-induced replication arrest, 
several lines of evidence have already shown that PP1 becomes activated in response 
to IR-induced DNA damage (Guo, Brautigan et al. 2002; Guo, Mi et al. 2007; Tang, 
Hui et al. 2008). Hence, since PP1 plays an important role subsequently to the 
activation of the DNA damage response, it may also be the case when cells are 
specifically treated with replication inhibitors. Here, PP1 function may be related to the 
regulation of Chk1 activation, fact that is supported by our results. 
In order to better understand the role of these proteins in this context, it would have 
been desirable to generate a stable cell line. However, previously published data 
reports that in what concerns PP1!, it is impossible to generate stable cell lines since 
it seemed to be damaging to the cells and to generate catastrophic mitoses, probably 
due to PP1! role in regulating M-phase entry (Liu, Wang et al. 2006). Additionally, 
these authors have also reported that there was some compensation on the activity of 
PP1! when it was ectopically expressed, by either processes of phosphorylation 
inhibition (Liu, Wang et al. 2006) or endogenous PP1! down expression (Reeder, 
Sowden et al. 2003).  
 
VI.1.2.2 PROTEIN PHOSPHATASE 2A FAMILY CONTRIBUTION 
Protein phosphatase 2A family members have been implicated in several key cellular 
pathways. In the particular topic of our research, PP2A enzyme has been described to 
interact with CDC6 and implicated in the modulation of DNA replication (Yan, Fedorov 
et al. 2000). Also, it has been described as a regulator of several components of the 
DNA-damage response pathways such as ATM and Chk2, by modulating ATM’s 
autophosphorylation (Goodarzi, Jonnalagadda et al. 2004), and interaction via PP2A B’ 
regulatory subunit (Dozier, Bonyadi et al. 2004), respectively. Moreover, as already 
mentioned above, PP2A has as well been implicated in the regulation of Chk1 
phosphorylation status (Leung-Pineda, Ryan et al. 2006). Regarding this specific 
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function here we gave a contribution, since with our approaches we observed the role 
of PP2A family members in the status of Chk1 phosphorylation during the recovery 
from HU treatment. 
Our approaches contemplated either the effect of broad spectrum treatments, such as 
OA incubations and PME-1 overexpression, or the specific knockdown of PP4 and PP6. 
Both these phosphatases have been implicated either with cell cycle regulation or 
DNA-damage response. For instance, PP6 has been related to cell cycle control, more 
specifically with the G1 to S phase transition. This however, has been controversial, 
since data from yeast and mammalian work points towards opposite directions. While 
in budding yeast the Sit4 gene, PP6 ortholog, has been described to induce 
transcription of G1 cyclins, which promote progression through the cell cycle (Sutton, 
Immanuel et al. 1991; Fernandez-Sarabia, Sutton et al. 1992; Clotet, Gari et al. 
1999), in human cells PP6 overexpression blocks the entry into S phase, inducing an 
increase of 20% of cells in G1. This results from the suppression of the levels of cyclin 
D1 in G1 and reduced pRb phosphorylation at Ser807/811 (Stefansson and Brautigan 
2007). PP4, on the other hand, in yeast models has been implicated in the DNA-
damage response to DSBs. Here, different groups have described an interaction 
between Psy2 (yeast regulator of Pph3, ortholog of human PP4) and Rad53 (yeast 
ortholog for Chk2 protein kinase) (Uetz, Giot et al. 2000; Gingras, Caballero et al. 
2005; O'Neill, Szyjka et al. 2007), as well as a delay of 8-9h in the dephosphorylation 
of Rad53 when Pph3 is deleted (Keogh, Kim et al. 2006).  
According to our in vitro results, both broader approaches, OA treatment and PME-1 
overexpression, would in principle inhibit the activity of all PP2A family members and 
result in the slow down of Chk1 dephosphorylation. However, this has not revealed to 
be very obvious from the analysis of our in vivo results. While with OA treatment, only 
on Chk1 Ser345 a small indication of an effect was observed, with the overexpression 
of PME-1 there was an unexpected result. Here, the main effect observed was the 
reduction of the initial Chk1 phosphorylation levels after HU treatment for both Ser317 
and Ser345, and not the reduction of Chk1 dephosphorylation rate. Regarding the 
result with OA treatment, it becomes difficult to analyse due to the fact that this is a 
drug with pleiotropic effects that in many studies, depending on the concentration and 
the cell line used, different outcomes may be obtained. For example, it has been 
shown that HeLa cells after 24h of 300 nM OA treatment, respond with apoptosis 
translated by the increase of DNA fragmentation up to 20% (Morana, Wolf et al. 1996; 
Tergau, Weichert et al. 1997). Hence, due to these and other side effects, a proper 
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conclusion from the use of this drug may be difficult to make. In addition, from our 
results, there is the indication that a treatment of 100 nM OA is not sufficient to 
observe a clear effect on the Chk1 dephosphorylation. This may be due to the fact 
that different concentrations of OA may be needed to inhibit different protein 
phosphatase functions, depending on the demand of that particular PP, as well as, the 
concentration used may not be sufficient to completely inhibit the protein phosphatase 
activity from cellular PP2A family members. 
Concerning PME-1 overexpression, the result suggests that the overall inhibition of 
PP2A family members have a higher impact on Chk1 activation than on its 
dephosphorylation during the recovery from HU-induced replication arrest. This may 
be a consequence of the overall lower level of Chk1 phosphorylation after the HU 
treatment.  Despite the effect observed with the in vitro approach, where protein 
phosphatases were inhibited after replication arrest was released, in the case where 
PME-1 was overexpressed, the PP2A family members were already inhibited before the 
HU-induced replication arrest, which adds some complexity to this analysis. PME-1 is 
responsible for the removal of the methyl ester group from a PP2A Leucine residue at 
the carboxy-termini (Lee and Stock 1993; Xie and Clarke 1994), resulting in its 
inactivation. This interaction induces the removal of the manganese ions essential for 
the phophatase activity (Xing, Li et al. 2008). Since, as can be seen in Figure VI.1, the 
C-terminal from all PP2A family members have a high degree of homology, we may 
assume that they are all regulated by methylation and hence, inhibited by PME-1 
activity.  
PP2A! (P67775)  | (301) TRRTPD  YFL (309) 
PP2A! (P62714)  | (301) TRRTPD  YFL (309) 
PP4 (P60510)  | (301) PVAD     YFL (307) 
PP6 (O00743)  | (301) TP      YFL (305) 
 
In fact, supporting these evidences, several papers have been published proving the 
methylation of at least PP2A and PP4 (Kloeker, Bryant et al. 1997; Tolstykh, Lee et al. 
2000; Cohen, Philp et al. 2005). Because PP6 also shares a certain degree of 
FIGURE VI.1 | C-TERMINAL TERMINAL FROM THE DIFFERENT PP2A FAMILY MEMBERS. The C-
terminal residues from the different PP2A family members are shown. The methylated 
residues are shown in orange (•). The accession number for each protein is presented after 
the specific name and the residue number as well, before and after the specific residues. !
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homology in the C-terminus, at least in the last 3 crucial residues that also present the 
phosphorylatable Tyrosine that modulates the binding of regulator subunits, it is 
conceivable that this Protein Phosphatase is also modulated by the activity of PME-1. 
Hence, while in vitro the result of PP2A family members activity indicates an important 
role on Chk1 dephosphorylation after release from the checkpoint, data from assays of 
when these PPs are inhibited before the replication checkpoint is induced, indicates a 
stronger role on the regulation of Chk1 activation, through the inhibition Ser317 and 
Ser345 phosphorylation. However, it needs to be taken into account that this strong 
inhibition of Chk1 activation may only occur when all PP2A family members are 
inhibited.  
When silencing the activity of either PP4 or PP6, our data indicates that both of them 
also have specific roles in Chk1 regulation. Of note, this was in fact the first time in 
human cells that these PPs were investigated on the role of Chk1 regulation, as well as 
on the replication checkpoint context. As seen in Figure III.15 and III.16, while PP4 
knockdown increases the initial Chk1 phosphorylation state after HU treatment, and 
overall slows down Chk1 dephosphorylation process as compared with control 
conditions, PP6 knockdown reduces both the level of Chk1 phosphorylation after HU 
treatment, as well as the rate of Chk1 dephosphorylation during the second phase. 
These latter results support the outcome obtained by PME-1 overexpression in what 
concerns Chk1 activation, indicating that at least PP6, and probably PP2A, are needed 
for Chk1 activation. This outcome indirectly indicates for the first time, that PP6 
activity can be regulated by methylation. PP4, however, seems to have a different role 
in Chk1 activation, as our data indicates that it is responsible for maintaining Chk1 in 
a less active state, by reducing its phosphorylation levels. Despite this indication, 
further experimental confirmation will be needed. Nonetheless, in agreement with this 
hypothesis, it was recently shown that PPH-4.1 (PP4 ortholog in C.elegans) besides 
being found in a complex with Chk1, it turns off the ATR-Chk1 signalling cascade 
during embryogenesis, in order to prevent a lethal delay during development (Kim, 
Holway et al. 2007). Thus, it is conceivable that PP4 may be responsible to maintain 
Chk1 in its inactive state during normal cell cycle progression, together with a role in 
dephosphorylating Chk1 during the recovery from replication arrest.  
In order to prove these observations and understand if the regulation of the initial 
Chk1 phosphorylation levels after HU treatment is in fact dependent on phosphatase 
activity, both for PP1 and PP2A family members, stable and inducible cell lines would 
need to be produced. These would need to include both overexpression of I-2 and 
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PME-1, as well as the expression of specific PP siRNAs. In this manner it would be 
possible to test whether the induction of phosphatase inhibition before or after the cell 
had been arrested with 2mM HU for 24h would have different outcomes on the level of 
Chk1 phosphorylation. In case this is proven to be positive, it would also be 
interesting to determine to which level each individual PP would regulate Chk1 
activation. Of course more assays should be carried out in order to prove a direct 
interaction between Chk1 and the PPs studied here, such as PP4 or PP6. These assays 
could go from in vitro dephosphorylation assays with purified phosphatases, to overlay 
assays, among others. Additionally, the role of PP6 on the second phase of this 
dephosphorylation process needs to be further characterized, for instance by 
combining the experiments suggested in Section VI.1.1 with the use of the specific 
stable and inducible PP6 knockdown cell line, suggested to be generated above. Here, 
it would be important to understand which were the pools of Chk1 being 
dephosphorylated, and subsequently which functions were being turned off. This, of 
course, could only be possible if we were able to physically uncouple the different 
pools of Chk1 along with the relevant cellular structures, by the use of, for example, 
immunofluorescence techniques. 
 
VI.1.3 PROTEIN PHOSPHATASES IN THE ASSEMBLY OF AND RECOVERY FROM 
THE REPLICATION CHECKPOINT 
After determining that specific PPs had different roles in the (de)activation of Chk1, we 
studied the role of PPs at the overall replication checkpoint function, both during its 
onset and recovery from the arrest. 
When studying the contribution of PP1 family members, as measured either by the 
replication pulse-chase assay or the FACS analysis of the recovery from replication 
arrest, no significant effect was observed by the overexpression of PP1!, as compared 
to control conditions (Figure IV.4 and IV.9.A). However, when I-2 was overexpressed, 
which in principle translates as a reduction in PP1 family members activity, there is an 
effect in the actual normal progression of the replication patterns (Figure IV.4). The 
effect is translated by the deregulation on the normal replication patterning, where at 
the 12h timepoint in the presence of I-2 overexpression it is still possible to observe a 
significant percentage of early replication patterns. This may be explained by some 
unknown PP1 function in the regulation of origin-firing. Supporting this idea, recently 
it was found that PP1 interacts with Pol$ via its p68 subunit (Gao, Zhou et al. 2008), 
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which suggests that PP1 may indeed regulate the origin-firing program. Nonetheless, 
for the moment we are not sure if this is the molecule that de-regulates the normal 
replication progression when PP1 is inhibited by I-2. Despite this data, Figure IV.9.B 
shows that when I-2 is overexpressed, the overall cell population does not show any 
significant effect on the recovery from HU-induced arrest. Hence, the replication 
process seems to still be occurring with normal timing. In addition, the variability 
observed at the 6h timepoint when cells are treated with aphidicolin, may, to a certain 
extent, be correlated with the result obtained with the dephosphorylation assay 
discussed in the previous Section. Thus, if it is true that I-2 overexpression reduces 
the activation of Chk1 under genotoxic stress such as Aph or HU treatments, it might 
be true that under those conditions some cells will not be able to effectively activate 
the checkpoint and stabilize replication forks, which as a consequence are prone for 
colapse. In effect, cells would not be capable of progressing through replication once 
the stress is removed. This would only occur in a part of the cell population and might 
be dependent on a given I-2 expression threshold.  
As observed with the inhibition of PP1 family members, our data reveals that by 
inhibiting PP2A family members, either through the overexpression of PME-1 or OA 
treatment, the normal replication pattern progression is more significantly affected 
than the onset of the replication checkpoint, as observed by the pulse-chase 
replication assay. In principle these two treatments would result in the same outcome, 
but as our results show, that was not the case. In this assay, our results show that 
12h after the first pulse, in the absence of any DNA replication inhibitor but in the 
presence of OA, cells not only present again early replication patterns as well as retain 
a high level of mid replication patterns, approximately 40% for both these patterns 
(Figure IV.5). This result was not expected, since it is not predicted that cells are able 
to regress the normal replication pattern sequence. Despite this data, when evaluating 
the normal progression of DNA synthesis, having the amount of DNA in the nucleus as 
a read out, our results indicate that in the presence of OA alone, cells that enter S 
phase seem to progress normally, but are then arrested in G2/M boundary (Figure 
IV.11). Hence, these two results suggest that when in the presence of OA, cells may 
have trouble in firing late replicons, forcing the nucleus to undergo some type of 
chromatin restructuring in order to finish replication, by using earlier firing replicons. 
This may indeed be the case, as suggested by some lines of evidence that describe 
PP2A as being involved in the regulation of CDC45 loading (Chou, Petersen et al. 
2002), and the observation that OA treatments in human myeloid cells (HL-60 and 
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U937) induce premature chromosome condensation (PCC) (Ishida, Furukawa et al. 
1992). Therefore, it is conceivable that using OA to inhibit cellular PP2A activity 
prevents the loading of CDC45 and, as a consequence, stops the firing of origins 
whose replication complexes were not fully assembled at the time OA was added to 
the cells. Then, in order to finish replication, cells may eventually reorganize their 
chromatin, which seems to occur via a PCC mechanism, where cells become in a 
mitosis-like state by inducing the defragmentation of the nuclear membrane, and the 
condensation as well as partial separation of the chromosomes (Yamashita, Yasuda et 
al. 1990; Ghosh, Schroeter et al. 1996). This seemed to be the case in our 
experiments since after some time of OA treatment, cells started to round up with a 
mitosis-like appearance, but at the same time incorporating the second pulse of 
nucleotides (Figure IV.5). Nonetheless, this solution for termination of DNA replication 
is an inefficient process since cells that go through S phase, end up arresting in G2/M, 
which indicates that somehow the DNA integrity is at risk. This result is observed both 
when cells are pre-incubated or not with 2 mM HU for 24h, before an incubation with 
100 nM of OA (Figure IV.11). In addition to this observation, taking into account that 
generically a mammalian cell division cycle takes from 16 to 24h, and admitting that 
cells that go through DNA replication in the presence of OA are arrested in G2/M, our 
results suggest that OA induces also an arrest in G1. This arrest may eventually 
trigger an apoptotic response, fact that is supported both by a sub-G1 shoulder typical 
for cells in apoptosis (Figure IV.11 24h 100 nM OA), and the reduction of the total 
Chk1 expression observed in Figure III.10.B (24h after incubation with 100 nM OA). 
Indeed, supporting our data, it was shown that in HL-60 and U937 cells, low 
concentrations of OA (2-8 nM) lead to G2/M arrest and apoptotic response, and at 
high concentrations of OA (500 nM) cells arrest in G1/S, hence remaining diploid, but 
presenting a PCC phenotype (Ishida, Furukawa et al. 1992). In our case, the cellular 
response to incubation with 100 nM OA seems to be mainly dependent on the cell 
cycle phase at which the cells were at the time of the OA addition to the medium. 
Hence, if cells were at G2/M/G1 phases they would arrest in G1, and cells starting or 
going through S phase would arrest in G2/M. Broadly, these results, can be due to the 
known pleiotropic effects of OA and not, for the most part, due to the specific 
inhibition of PP2A family members, as should be the case of PME-1 overexpression. 
Finally, because it was already shown that PP2A is also needed for an efficient DNA 
repair (Chowdhury, Keogh et al. 2005), it is conceivable that these results are in part 
due to prolonged OA induced DNA-damage, hence inducing specific cell cycle arrests 
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and, subsequently, apoptosis. All these hypotheses may be clarified by performing 
both TUNEL and comet assays to observe the amount of OA-induced DNA damage and 
apoptotic response, as well as by observing the incorporation of BrdU by FACS 
analysis to see if the addition of OA, at different cell cycle phases, affects the start and 
progression of DNA replication. 
In contrast to OA treatment effects, PME-1 overexpression does not induce such 
dramatic effects. Nonetheless, it seems to induce a delay both at the normal 
replication pattern progression, with 20% more cells with early replication patterns at 
the 6h timepoint after the first pulse, as compared with control condition (Figure 
IV.6). Further, it induced a delay both at the onset of and the recovery from the HU-
induced replication checkpoint arrest (Figure IV.13). As suggested for the OA 
treatment, but with less impact in this case, the delay observed in replication 
patterning progression, in the absence of a replication inhibitor, may be due to the 
inhibition of PP2A enzyme, necessary for the CDC45 loading on pre-replication 
complexes (Chou, Petersen et al. 2002). This being true, it indicates that under these 
conditions, PME-1 inhibition of this PP2A function is not very efficient, as cells are still 
able to progress in replication. Also, the result obtained in Figure IV.12, may be 
explained by both the fact that in the presence of PME-1 overexpression cells are not 
very efficient in activating Chk1 (Figure III.12), event necessary for the replication 
arrest (Feijoo, Hall-Jackson et al. 2001), and that, as we have seen in Figure III.5 and 
was later published by Leung-Pineda and colleagues (2006), the PP2A group is the 
main responsible for Chk1 dephosphorylation, event necessary for the recovery from 
replication arrest. Despite this data, PME-1 overexpression is not able to de-regulate 
the normal sequence in replication foci patterns as it happens with OA treatment.  
Finally, regarding the knockdown of PP4 and PP6, our results indicate that none of 
these proteins is significantly involved in the regulation of origin-firing, both under 
normal growth and under replication stress conditions, such as incubation with 
aphidicolin (Figure IV.7). Nonetheless, since when combining replication stress with 
the absence of PP4, cells have higher levels of phosphorylated Chk1 and take longer 
to dephosphorylate it, as observed in Figure III.15, it is conceivable that the variation 
observed at the 6h timepoint for the PP4 knockdown in the presence of Aphidicolin 
(Figure IV.7) is due to the slow down of some cells to recover from replication arrest. 
Further, with regards to the cell cycle progression our results indicate a function for 
PP4 in the G2/M checkpoint (Figure IV.13). This observation shows an arrest in G2/M 
in a HU pre-treatment dependent manner, only when PP4 is knocked down. This result 
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indicates that PP4 may be involved in the efficient recovery from the DNA-damage 
induced by the incubation with HU. Hence, if HU incubation induces DSBs, as it was 
mentioned earlier by the increased levels of "H2AX (Chowdhury, Keogh et al. 2005; 
Kurose, Tanaka et al. 2006), and since in the absence of PP4, cells do not arrest in S 
phase but in G2/M instead (Figure IV.13), it is conceivable that PP4 is involved in the 
shut down of DBS signalling, which if active induces cell cycle arrest in G2/M. 
According to this hypothesis, one of the PP4 targets might ultimately be "H2AX, which 
in the event of PP4 knockdown may become hyperphosphorylated in response to DNA-
damage, hence inducing G2/M arrest. In fact, this hypothesis was later supported by 
findings from two different groups, both in yeast and mammalian models. Concerning 
the yeast model, it was shown that Pph3 deletion mutants induce a delay in the 
recovery from the G2/M DNA damage checkpoint, and also that the Pph3, Psy4 and 
Psy2 complex is responsible for "H2AX dephosphorylation in order for an efficient 
recovery from the DNA damage checkpoint to occur (Keogh, Kim et al. 2006). Later, a 
similar observation was performed in mammalian cells where it was shown that a 
complex containing PP4C, PP4R2, and PP4R3b was responsible for specifically 
dephosphorylating ATR-mediated "H2AX generated during DNA replication 
(Chowdhury, Xu et al. 2008), similarly to what seems to occurr in our HU treatment. 
All the results obtained with the overexpression of PME-1 and the knockdown of PP4 
and PP6 suggest two hypotheses: either that PME-1 is not inhibiting all PP2A family 
members, since for instance the result observed in Figure IV.12 is not partially or 
totally recapitulated in Figure IV.13; or PME-1 is inhibiting all PP2A family members, 
but the outcome of that inhibition does not correspond to the sum of the inhibition of 
each individual PP2A family member, but to a compromise from all those responses. 
Nonetheless, in this context important is the fact that (de)methylation is indeed a 
crucial process for the regulation of this PP family activity. For instance, nuclear PP4 is 
mainly carboxymethylated (Kloeker, Bryant et al. 1997), whereas PP2A methylation 
state is dependent on cell cycle phase and on sub-cellular compartment. Hence, while 
PP2A cytoplasmic pool is demethylated during G0/G1 boundary and remethylated as 
cells enter S phase, nuclear PP2A is demethylated at S phase entry (Turowski, 
Fernandez et al. 1995). Therefore, to complement our work, and to understand the 
physiological role of PP2A family members (de)methylation, it would be of great 
interest to investigate the phosphorylation status of known PP2A family member 
targets in the event of PME-1 overexpression, as well as in the event of their specific 
individual inhibition or knockdown. In  this context it would also be interesting to 
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understand the effect of these treatments on DNA integrity,  "H2AX levels and the 
phosphorylation status of DNA-damage pathway proteins.  
The last consideration has to do with a technical concern, as too few late patterns in 
the pulse-chase replication assay were detected. This might be due to: the timing of 
the experiment, where 12h may be too long for the observation of that specific 
pattern in this cell population; and the pattern itself, which because it is formed by 
small and discrete areas of nucleotide incorporation,  may be difficult to  observe 
 
 
VI.2 NOVEL CHK1 INTERACTORS 
Since 1989, when it was first described by Fields and Song (1989), the Yeast Two-
Hybrid System has been widely used in various screens  to identify protein 
interactions, as well as submitted to optimizations in order to increase its efficiency 
and reduce negative results. Its citation rate increased exponentially from 1989, thus 
validating this  approach, its robustness and its many advantages when compared  to 
other protein-protein interaction screening methods. The Yeast Two-Hybrid method 
has the advantage of allowing an in vivo high throughput screen with high sensitivity, 
where ultimately the resulting data may be applied to other systems. In addition, the 
experimental setup is straightforward, making it a very attractive method. Although 
these are very strong arguments in favour of the technique, it is necessary to take 
into account several important points in order to get the best of the information that a 
given screen may generate. Hence, in a Yeast Two-Hybrid screen the results are prone 
to reveal both false positive and false negative interactions. This fact may be due to 
several reasons, such as: the overexpression of the proteins; the non-native and non-
endogenous conditions, either intra-cellular or species wise; the proteins being fused 
to either DNA binding or activation domains; besides the fusion itself, the resulting 
proteins may self activate the reporter genes or even be toxic to the cell; and force 
interactions to occur in the nucleus that may not happen under normal conditions, 
because many proteins are not nuclear. The need for confirmation of the identified 
interaction in other systems and methods may be seen as a limitation, but as a large 
scale screening method for new interactions, the Yeast Two-Hybrid approach is a very 
robust technique that generates data that can be reproduced in other systems or even 
species. 
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Due to the important roles played by Chk1 in different genomic surveillance pathways, 
it is of interest to identify new putative interactors for this kinase and even new roles 
for it. Hence, Chk1 was subcloned into a suitable vector for use as bait in a Yeast Two-
Hybrid screen. In this study, the cDNA library used was from human testis. The two 
main reasons to use this specific library were that, first this is a tissue with a high rate 
of cell division and consequently needing to have a very tight control  on the genomic 
integrity in order to transfer good quality DNA to the upcoming generations, pathway 
where Chk1 has a determinant role. The second reason has to do with the meiotic 
DNA recombination, a mechanism that is highly active during meiosis and occurs 
specifically in this tissue in males, along with the ovaries in females. To support this, 
there was evidence in S.cerevisiae that genes previously identified as belonging to the 
DNA repair machinery had a role in meiotic recombination mechanisms (Tonami, 
Murakami et al. 2005). Specifically, Chk1 was described to be involved in the mitotic 
homologous recombination repair pathway (Sorensen, Hansen et al. 2005). Therefore, 
it seemed reasonable that Chk1 could also have a specific role during meiotic 
recombination.  
The outcome of the YTH screen highlighted a couple of new interesting putative roles 
for Chk1, as detailed below. The number of positive clones obtained was 37 and did 
not include any previously known Chk1 interactors. This reduced number of putative 
new interactors might be explained by several Chk1 biochemical properties. This 
protein is a kinase and as such many of its interactions must be highly specific. 
Furthermore, as a kinase, some of its interactions may be too transient because of the 
underlying nature of the phosphorylation reaction. This type of transient reaction may 
not be strong and long enough to induce the activation of the reporter genes, and 
hence not be detected in this type of screen. Another reason for the small number of 
positive clones found may result from the fact that Chk1 is a cell cycle regulator that 
ultimately may be activating some type of cell cycle response in yeast, inducing a 
delay and/or reducing the rate and the speed of cell division, by regulating for 
example DNA replication and/or protein expression. In this case, cells would have 
difficulties to grow under stringent conditions, such as the ones used in the Yeast Two-
Hybrid system, and hence reduce their detection.  
From the 37 clones recovered from the screen, the three clones that were in frame 
and had the complete CDS were analysed in more detail, either by the "-gal assay or 
co-immunoprecipitation. While the latter approach did not produce conclusive results, 
the former presented intriguing but interesting data. Thus, in the "-galactosidase 
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activity assay after yeast mating, results indicated that the signal obtained in the 
matings was not very strong when compared to the activation of the reporter gene 
with Chk1 alone (Figure V.17). In fact, in some matings it was even lower than in the 
control condition of Chk1 alone, maybe suggesting a slow down in the cell cycle due to 
the interactions, which could be triggering some cell cycle response. Nonetheless, 
since our positive clones generated signals of the same amplitude as the positive 
control used, CDC25C as prey for Chk1, the results suggest that these interactions are 
transient as it happens in the event of CDC25C phosphorylation by Chk1. 
Regarding the data from the co-immunoprecipitation experiments, no significant 
differences were observed when comparing the positive clones to the negative 
controls (Figure V.18). These results may be  explained by the same reasons raised 
above concerning Chk1 kinase nature, which, as supported by the "-galactosidase 
assay results, suggests that most of Chk1 interactions are transient or easily disrupted 
through the purification protocol used. Hence, for this specific kind of interaction test, 
probably an overlay experiment would be more suitable, where the HA tagged clones 
could be pulled down, either from transfection or an in vitro transcription-translation 
(IVTT) expression system, transferred to a membrane and then incubated with 
purified wtChk1, or vice versa.  
Another experiment that could be performed in order to test the hypothesis that these 
interactions occur at the phosphorylation reaction level, is an in vitro phosphorylation 
assay with the HA tagged clones, using wtChk1 as the kinase. By analysing the protein 
sequence of the 3 novel interacting proteins, it is possible to identify several residues 
that are putative sites for phosphorylation by Chk1 kinase (Figure VI.2) when taking 
into account the minimal motif presented by O’Neill and colleagues (2002) with their 
peptide library phosphorylation screen. In this work they showed that the RXXS or 
KXXS motifs (mainly the first), along with other residues may be determinant to 
generate a Chk1 phosphorylation site. Together with these putative Chk1 
phosphorylation sites, others were identified on ELM and ProSite online based protein 
motifs search engines. After analysing the outcome of the search we have represented 
the relevant motifs in a linear protein scheme (Figure VI.2) 
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The previous figure shows that besides the putative Chk1 phosphorylation sites, these 
proteins have other motifs related either with DNA-damage response by the PIKK 
phosphorylation sites, or cell cycle regulation by the interaction with Cyclin-CDK 
complexes. This fact strengthens  a possible role for Chk1 in regulating these proteins 
during genotoxic stress events. Hence, as mentioned, two new roles for Chk1 could be 
proposed: genomic surveillance/recombination (through GAGE12E) and regulation of 
protein synthesis (through EEF1!1 and RPS5). Of course, more experimental evidence 
is required, such as cellular co-localization assays through immunofluorescence 
techniques, in order to better support these putative new roles for Chk1. In fact, we 
have tried to establish such assays, but the reagents available did not allow 
confirmation. Nonetheless, given the putative interest of these new roles, further 
description of the models may be found in the following Sections.  
 
VI.2.1 CHK1 AND GAGE 
The G-antigen (GAGE) family of genes was first described in human melanoma MZ2-
MEL cells as belonging to a larger group of genes that express antigens recognized by 
autologous cytolytic T lymphocytes (CTL) (Traversari, van der Bruggen et al. 1992; 
Van den Eynde, Peeters et al. 1995). In this specific family, the translated protein 
presents the antigen YRPRPRRY at its N-terminal that serves as epitope for the 
immune response. GAGE genes are located in the p11.2-11.4 region of chromosome X 
FIGURE VI.2 | SCHEMATIC REPRESENTATION OF THE POSITIVE CLONES PROTEIN SEQUENCE. A linear 
diagram of the proteins with the relevant predicted motifs found through ELM and ProSite 
are represented. The analysed positive clones are: G-antigen 12E (clone 143), Eukaryotic 
Translation Elongation Factor 1#1 (clone 152) and Ribosomal Protein S5 (clone 296).!
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and are presented in a tandem manner suggesting an evolutionary adaptation. The 
various genes have a high degree of similarity and the difference is sometimes just 
one single nucleotide (De Backer, Arden et al. 1999; Gjerstorff and Ditzel 2008). 
Several studies investigated the expression of these genes in different human cells. 
From those studies it was found that GAGE expression occurred in a variety of 
tumours, and in normal tissues it was restricted to testis and ovaries (De Backer, 
Arden et al. 1999; Scanlan, Gure et al. 2002; Gjerstorff, Johansen et al. 2006). For 
this reason, and if taking into account the fact that the germ cells (testis and ovaries) 
do not induce autoimmunity, because they lack both MHC class I and II expression, 
GAGE genes became a very interesting and appreciated target for immunotherapies 
(Uyttenhove, Godfraind et al. 1997).  
Despite the knowledge of its expression, the specific function of these genes is not yet 
clear. Nonetheless, some results point to the correlation of GAGE overexpression with 
anti-apoptotic responses and resistance to chemo- and radiotherapy (Cilensek, Yehiely 
et al. 2002; Kasuga, Nakahara et al. 2008). Along with this information, De Backer 
and colleagues (De Backer, Arden et al. 1999) have demonstrated that treating either 
normal or tumour cells with a demethylating agent, results in the transcriptional 
activation of GAGE genes, an outcome that may help to clear its function. 
Demethylation is an event that occurs in several cellular processes such as DNA 
repair, DNA recombination and chromosome organization (Vairapandi 2004). Taking 
into account that at least DNA recombination and chromosome organization occur 
mainly in actively dividing cells, especially during meiosis, it makes sense for GAGE 
genes to be expressed in testis or ovaries. These genes may have a key role in 
recombination, which might explain their high expression in tumours, since this could 
provide some survival advantage to the cells. If true, this would reveal a mechanism 
for tumour adaptation, supporting its implication in anti-apoptotic responses, as 
already mentioned. Another possible model is that GAGE could also be important in 
cell surveillance for DNA genotoxic stress during meiosis. This would correlate GAGE 
and the DNA-damage response pathways, through Chk1 and the PIKKs. Hence, under 
normal conditions, in testis and ovaries, GAGE would be constitutively expressed in 
order to protect the organism against defective gametes, as a mechanism for selection 
of the fittest. In the event of irreversible DNA-damage, GAGE would then be 
phosphorylated by both Chk1 and PIKKs at specific sites which would induce a CTL 
response in order to eliminate the damaged cell, by changing the conformation of the 
GAGE protein and exhibition of the epitope. In the case of tumour cells, GAGE 
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expression, due to the generalized genomic demethylation that occurs in this 
situation, could be the result of a primary response to the prevention of its 
development. However, its overexpression may saturate the response to eliminate 
tumours, which ultimately increases the anti-apoptotic outcome, giving advantage to 
the tumour cell and thus promoting cancer development. 
In order to investigate this model, several experiments could be carried out, such as 
performing real-time microscopy following the GAGE protein before and after inducing 
different types of DNA damage, as well as analysing the post-translational 
modifications on GAGE at the same timepoints. Also, it would be important to verify if 
GAGE expression might induce or help in DNA recombination mechanisms.  
This specific interaction of GAGE with Chk1 could have an important impact in possible 
therapies that may be developed for cancer treatment. 
 
VI.2.2 CHK1 ROLE IN PROTEIN SYNTHESIS 
Protein synthesis may be regulated at several levels due to the high number of players 
involved in the process. Its activity is dependent on the physiological status of the cell, 
which regulates protein synthesis according to its needs. For example, during DNA 
replication the cell needs to produce a high number of copies of the DNA machinery 
proteins, as well as the different Histones, thus in this case protein synthesis should 
be highly active. Among all the protein synthesis machinery, it is possible to find 
Eukaryotic Translation Elongation Factor 1!1 (EEF1!1) and Ribosomal Protein S5 
(RPS5). Because they were both found in the Yeast Two-Hybrid screen as putative 
interactors of Chk1, it seems that the latter may be involved in the regulation of 
protein synthesis, as a consequence of checkpoint activation or even during normal 
cell cycling. 
EEF1!1 is an isoform of the eEF1A protein family, whose genes are in two different 
chromosomes and have 78% homology in the coding sequence and a protein identity 
of 98% (Lund, Knudsen et al. 1996). The two isoforms have mutually exclusive 
expression, while EEF1!1 is ubiquitously expressed, with the exception of skeletal 
muscle, heart and brain, EEF1!2 is only expressed in these specific tissues (Lee, 
Francoeur et al. 1992; Lee, Wolfraim et al. 1993; Lund, Knudsen et al. 1996; Kahns, 
Lund et al. 1998). EEF1A proteins are responsible for the delivery of the aminoacyl-
transferase RNA complex to the A site of the ribosome, during peptide elongation, 
once the codon-anticodon match is recognized (Browne and Proud 2002). In addition 
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to this function, EEF1!1 is described to be involved in several other cellular processes 
such as signal transduction, mitosis and cytoskeletal organization, where it was shown 
to form complexes with actin and tubulin (Bektas, Nurten et al. 1994; Condeelis 1995; 
Negrutskii and El'skaya 1998; Thornton, Anand et al. 2003; Abbott and Proud 2004). 
EEF1!1 has also been studied from a disease point of view, for example EEF1!1 was 
detected as an autoantigen in 66% of Felty syndrome patients (Ditzel, Masaki et al. 
2000) and described to determine the susceptibility of a number of independent cell 
lines to chemical-and UV-induced transformation (Tatsuka, Mitsui et al. 1992). This 
protein has other synonyms that have been widely used in the literature, such as PTI-
1 (Prostate Tumour-Inducing gene 1) or CCS-3 (Cervical Cancer Suppressor-3). PTI-1 
is a truncated and mutated form of the protein that is detected in various human 
carcinoma cells (Mansilla, Hansen et al. 2005). CCS-3 when overexpressed along with 
PLZF (Promyelocytic leukemia zinc finger protein) in human cervical cell lines inhibit 
cell growth by inducing apoptosis as well as suppressing the promoter activity of 
human cyclin A2, suggesting an overall tumour suppressing function (Rho, Park et al. 
2006). Interestingly, in S.cerevisiae proliferating cells, EEF1!1 associates with ZRP1 
(Zyxin-related protein 1), also a zinc finger protein.  
As can be seen, despite all the information generated around this protein, it is still 
unclear what role and involvement of EEF1!1 may be in response to stress conditions, 
since opposing outcomes are reported from anti- (Thornton, Anand et al. 2003) to 
pro-apoptotic functions (Rho, Park et al. 2006),! depending on the tissue and 
conditions analysed (Grassi, Scaggiante et al. 2007). Nonetheless, it is consistent that 
the protein is over-expressed in many tumours.  
RPS5, less studied than EEF1!1, is one of the proteins that constitute the 40S subunit 
of the ribosome. For this reason, this protein may be considered essential for the 
mechanism of protein synthesis and, as such, is a cytoplasmic protein. The 
translational activity of ribosomal proteins, in a broad sense, is altered by 
posttranslational modifications like phosphorylation, methylation, ubiquitination and 
acetylation (Louie, Resing et al. 1996; Lee, Berger et al. 2002; Mazumder, Sampath et 
al. 2003; Bachand, Lackner et al. 2006). In terms of expression, RPS5 was reported to 
be variable in colorectal cancers, compared with adjacent normal tissue. Nonetheless, 
no correlation was found between the severity of the disease and the level of 
expression (Frigerio, Dagorn et al. 1995). Also, in a couple of studies from murine 
erythroleukemia (MEL) cells, it was described that RPS5 expression is suppressed 
under differentiation conditions and not altered in cells undergoing serum-deprived 
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apoptosis (Vizirianakis, Pappas et al. 1999).  Additonally, derregulated expression, 
delays both the onset of erythroid maturation and entrance in cell cycle arrest at 
G1(G0) phase (Matragkou, Papachristou et al. 2008).  
Despite the normal function of these two proteins in the translation machinery, it 
seems that there is more than that, since they may be implicated in the onset of 
several diseases. Indeed, in a study from Zhang and colleagues (Zhang, Zhou et al. 
1997) on colorectal cancer,  they described that approximately half of the nearly 100 
genes that are specifically upregulated, are ribosomal components and protein 
synthesis factors. Thus, this supports the evidence that protein synthesis affects the 
cell cycle itself.  
In the specific case of the interaction of these proteins with Chk1, it is conceivable 
that Chk1 could be responsible for regulating protein synthesis machinery activity by 
phosphorylation of at least both EEF1!1 and RPS5, as there are putative 
phosphorylation sites in both of them. This would fit in a model that in response to a 
given stress the cell needs to trigger checkpoints in order to solve the problem that 
arose. This checkpoint would then include the slow down in protein synthesis related 
to DNA replication and activate the protein production relative to DNA repair 
machinery. In fact, it has been shown that in human cells, the G1–S transcription 
factor E2F-1 is targeted by checkpoint kinases (Lin, Lin et al. 2001; Stevens, Smith et 
al. 2003) and is required for the upregulation of DNA repair and replication factors 
(Polager, Kalma et al. 2002; Ren, Cam et al. 2002; Stevens and La Thangue 2004). 
This evidence supports the hypothesis that protein synthesis is regulated in response 
to checkpoint activation. In addition, if for the activation of the checkpoint, protein 
synthesis is upregulated, it was shown that the recovery from HU-induced arrest in 
budding yeast could occur in a protein synthesis independent-manner (Tercero, 
Longhese et al. 2003). 
Relative to this putative Chk1 new function, others have shown that in the event of 
cell starvation, eEF1A redistributes from the cytoplasm to the nucleus (Gangwani, 
Mikrut et al. 1998), which could be a consequence of protein posttranslational 
modification, such as phosphorylation, that ultimately reduces protein synthesis. Along 
with putative Chk1 phosphorylation sites, EEF1!1 also has putative PIKK 
phosphorylation sites making the argument of regulation by these kinases in the event 
of genotoxic stress even stronger. Relatively to RPS5, it has an additional regulatory 
site with the interaction to a CDK/cyclin complex. Hence, there is a probability that 
Chk1 phosphorylation interferes with RPS5 normal activity by preventing the 
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interaction with the CDK/cyclin complex, which may result in the prevention of protein 
synthesis, outcome that helps in cell cycle arrest.  
In order to test these hypotheses, it would be of interest to follow posttranslational 
modifications in the three proteins of interest: Chk1, EEF1!1 and RPS5 by either 
immunoblotting or 2-D/MS analysis, in the event of both genotoxic stress, as well as 
in the presence of translation inhibitors. In addition, immunofluorescence techniques 
would also be useful to test for co-localization of Chk1 with the translation machinery. 
This would allow inferring about the physiological relevance of the putative 
interactions and this probable function of Chk1 in the regulation of protein synthesis. 
 
VI.3 CONCLUSION 
In the early days, when protein phosphorylation was discovered, no one could predict 
the impact that such protein post-translation modification could have in the regulation 
and function of living organisms. In fact, even a number of years after the discovery 
of phosphorylase kinase, the first kinase ever to be described (Burnett and Kennedy 
1954; Fischer and Krebs 1955; Krebs and Fischer 1956), scientists thought that 
phosphorylation was a rather specialized regulatory mechanism strictly occurring in 
the glycogen metabolism pathway. History has proven the opposite with the number 
of Nobel prizes already attributed to scientists that made groundbreaking findings 
having this protein post-translation modification as background. Today, it is widely 
accepted that phosphorylation is a well-conserved mechanism of protein function 
regulation. In addition, it is known that deregulation in the function of either kinases 
or phosphatases, which respectively add or remove a phosphate group to/from other 
proteins, can trigger different pathologies such as diabetes, Alzheimer or even cancer. 
The present work contributes to the knowledge necessary to prevent and develop 
treatments for the latter pathology mentioned, and more specifically in what concerns 
both the roles of protein phosphatases in the regulation of the replication checkpoint, 
and the definition of putative new roles for Chk1.  
Tipically, mechanisms of protein phosphorylation are much more described in 
literature than the ones of protein dephosphorylation. This was also the case for Chk1, 
which when our project started, little was known in terms of its deactivation by 
dephosphorylation. Hence, we decided to take Chk1 phosphorylation regulation status 
as a read out to the role of specific protein phosphatases on the replication 
checkpoint. Specifically, we aimed to determine which specific protein phosphatase 
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dephosphorylated Chk1 on both Ser317 and Ser345 residues. The knowledge of this 
arm of the pathway is very important in the sense that it can reveal new targets for 
the development of new cancer therapeutics. For instance, if interfering with the 
dephosphorylation of Chk1, by regulating the activity of specific phosphatases, we 
could prevent its deactivation and subsequent maintenance of the checkpoint this 
could be used as a good candidate for a cytostatic treatment. Also, by understanding 
the roles of PPs in the regulation of normal replication, it may open new avenues for 
drug discovery in cancer treatment, as replication is a key mechanism for cell division. 
Regarding these topics, our work revealed interesting results as it was described in 
Section VI.1 and is summarized here in Figure VI.3 (for description see Section VI.1).  
 
One important feature from our work was that besides being able to desiccate which 
protein phosphatases would be involved in Chk1 dephosphorylation, and its 
subsequent deactivation, we were able to have some insights on the PPs that were 
involved in its activation in response to HU treatment. Both these mechanisms 
(phosphorylation/dephosphorylation) seem to be regulated by several different protein 
phosphatases, with somewhat redundant functions, as observed in Figure VI.3 and 
data presented in Chapter III. In this chapter, it was clear that when specific protein 
phosphatase activity was inhibited, Chk1 would always get dephosphorylated to a 
FIGURE VI.3 | PROTEIN PHOSPHATASE FUNCTIONS ON THE REPLICATION CHECKPOINT. Protein 
Phosphatase functions are splited into the regulation of Chk1 (de)phosphorylation and the 
regulation of replication forks. For detail read Section VI.1.2 and VI.1.3. PP2A* (supported 
by Leung-Pineda, Ryan et al. 2006), PPM1D* (supported by Lu, Nannenga et al. 2005), 
CDC45* (supported by Chou, Petersen et al. 2002) and p68* (supported by (Gao, Zhou et 
al. 2008).  !
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certain extent. This observation is in fact something recurrent in this research field, as 
for instance with regards to Rad53 dephosphorylation studies it was noticed that 
different PPs were dephosphorylating this molecule in the context of different functions 
(Travesa, Duch et al. 2008). In principle, this should be the case here, as Chk1 is 
involved in several different functions as shown below in Figure VI.4. Another evident 
note from our work is that the regulation of both Chk1 Ser317 and Ser345 is 
differentiated, as according to the treatment performed, not always both serine 
residues would be (de)phosphorylated in the same direction. In fact, to support this 
observation it was shown that while a mutation at Ser317 is tolerated by the cells but 
among other effects abrogates G2/M checkpoint activation, a mutation at Ser345 did 
not support viability, indicating an essential role for this residue during the 
unperturbed cell cycle (Wilsker, Petermann et al. 2008). Also, protein phosphatases 
have shown to be more important in the regulation of the normal replication 
progression than at the onset of the aphidicolin-induced replication checkpoint.  
Despite what has been described on Chk1 being turned off by ubiquitination-
dependent degradation under genotoxic stress (Zhang, Otterness et al. 2005), we 
think that in our experiments that is not the case as Figure III.10.B shows. There, it is 
evident that although we see a decrease in the phospho-signal in non OA-treated 
cells, the levels of total Chk1 are maintained constant. However that is not the case 
when cells are treated with 100 nM OA, since 24h after OA treatment it is possible to 
observe a decrease in the level of total Chk1, which should due to an apoptotic 
response, as discussed above.  
With respect to cancer treatment, our results also retrieved an interesting finding 
concerning PP4, as already discussed in Section VI.1.3., and which could ultimately be 
translated into cytostatic cancer therapeutics. This is because in the combinatory 
event of PP4 knockdown and HU treatment and further release, cells arrest in G2/M. 
Thus, having a drug with the same effects, i.e. which would inhibit PP4 and induce 
replication stress in cancer cells, it would ultimately prevent tumour growth. 
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Finally, Chk1 seems to be a multi-task protein and a central player in many important 
cellular events as described in the previous Sections and is summarized below (Figure 
VI.4 - for description see Section VI.2).  
 
The fact that Chk1 is a multi-task protein is first supported by our observation that its 
dephosphorylation occurs in a biphasic manner, characterized by two different rates 
during the recovery from replication arrest. Here, Chk1 has a loss of about 60-80% of 
its phosphorylation in the first 30 min after the removal of the genotoxic stress 
inducing agent (in our case, HU) and the remaining dephosphorylation takes at least 
the next 24h. Hence, there is the suggestion that Chk1 should be activated for 
FIGURE VI.4 | MULTIPLE FUNCTIONS OF CHECKPOINT KINASE 1 (CHK1). Chk1 kinase is involved 
in many different functions in response to genotoxic stress. Under genotoxic stress 
conditions, during S and G2 phases, Chk1 is responsible for: triggering cell cycle arrest by 
phosphorylation of CDC25C; stabilization of the stalled replication forks; prevention of late 
replication origin-firing; association with centrosomes. All these eventually trigger also a 
DNA-damage response. We propose that besides these functions, Chk1 is also responsible 
for the regulation of protein synthesis through both RPS5 and EEF1A1, as well as either the 
surveillance of DNA integrity by triggering CTL responses through GAGE12E or the 
involvement in DNA recombination. !
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different functions that will be down-regulated at different rates, depending on the 
need of Chk1’s activity to accomplish those specific functions. In addition to these 
observations, which attribute to Chk1 a key role in the maintenance of cellular 
homeostasis under genotoxic stress, there are several evidences that Chk1 is also 
involved in cellular functions, in cells under normal development. For example Lam 
and colleagues (2004) have shown that Chk1 is important for normal DNA replication, 
because when its expression is partially reduced, such as in the case of an 
heterozygotic mouse, spontaneous S phase damage in developing mammary 
epithelium in vivo is generated and also as mentioned earlier, Chk1 has been 
demonstrated to be an essential gene (Liu, Guntuku et al. 2000; Takai, Tominaga et 
al. 2000). 
In conclusion, our data comes to highlight the concept that despite the fact current 
research lines try to define fix pathways to respond to a given cellular signal, some 
flexibility should be left open on those pathways, as cells cannot afford to have only 
one mechanism to respond to stress conditions. Although broadly, main pathways that 
cover the cellular responses may be defined, several proteins may have redundant 
functions on several steps of the cascade. In addition, because these pathways are 
complex, the signalling cascades need to be analysed in ways that allow the 
integration of all reactions that are occurring in a cell, and whose response should 
correspond not to the sum of all individual reactions, but to the equilibrium of all of 
them. This principle predicts that many times, cells have a gradient of responses to a 
given stimuli and not a clear and defined outcome, which may become even more 
complex when taking into account the diversity of cellular genetic backgrounds. 
Hence, in the future, as the knowledge on the cell biology increases, more powerful 
computer-based models should be generated in order to predict which is the best 
target to prevent or develop treatment for a given malignancy.  
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VIII.1 EQUIPMENT 
Beckman Coulter | AllegraTM GR Centrifuge 
   | Avanti J-25 centrifuge 
   | JLA 10.500 rotor (500 ml) 
   | JA 25.50 rotor (30-50 ml) 
   | JLA 16.250 rotor (100 ml) 
Bellco   | Spinner flaks  
Bio-Rad  | Horizontal agarose gel electrophoresis apparatus 
   | Vertical SDS-PAGE apparatus 
Dako   | CyAnTM ADP 
Eppendorf   | Centrifuge (5417R) 
Fisherbrand  | Hydnes 300 pH meter 
Gilson   | Pipettes (P2, P20, P200, P1000) 
Grant    | Baths 
IGP   | OPTIMAX film developer machine 
InCuSafe  | Tissue Culture cell incubators 
Millipore  | MilliQ (Biocel) 
Perkin Elmer  | Win Spectral  &/" 1414 liquid scintillation counter 
Stratagen  | Robocycler gradient 96 
TelSTAR  | TelSTAR Bio-II-A Tissue culture hood 
UVItec   | UVIpro (imager) 
 
VIII.2 PLASTICWARE 
Costar   | Pipettes (1, 5, 10, 25 and 50 ml) 
Corning  | Filters (0.2 $m) 
GE Healthcare | ProbeQuantTM G-50 micro columns (#27-5335-01) 
Greiner Bio-One | T25, T75 Flasks 
   | 10 cm dishes 
Nunc   | Cryovials 
Sarstedt  | Inoculation loops (10 $L)  
   | 1.5 ml microtubes 
Sterilin  | 96-well plates 
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VIII.3 KITS 
BD   | BacPAKTM Baculovire Rapid Titer Kit (#K1599-1) 
           | AcNPV Positive Control Supernatant (#554744) 
Clontech  | Pretransformed Human MATCHMAKER cDNA libraries  
                               (#HY4035AH) 
Qiagen  | Mini-prep kit 
   | PCR cleanup kit 
   | Gel extraction kit 
   | High Speed plasmid maxi kit !
VIII.4 CHEMICALS 
Amersham Pharmacie Biotech AB  | Phastel Blue R 
AnalaR  | Potassium acetate (Mw=98.15) 
   | Potassium chloride (Mw=74.55) 
   | Potassium dihydrogen orthophosphate (Mw=136.09) 
   | Ammonium cloride (Mw=53.49) 
   | Calcium chloride dihydrate (Mw=147.02) 
   | EDTA (Mw=372.24) 
   | Disodium hydrogen orthophosphate dihydrate (Mw=177.99) 
   | Glusose – D+ (Mw=180.16) 
   | Magnesium sulphate heptahydrate (Mw=246.48) 
   | Magnesium acetate tetrahydrate (Mw=214.46) 
   | Paraformaldehyde  
Antec    | Virkon 
BD Biosciences | -Trp DO supplement (#630413) 
   | -Leu DO supplement (#630614) 
   | -Trp -Leu DO supplement (#630417) 
   | -Trp -Leu -His DO supplement (#630419) 
   | -Trp -Leu -His -Ade DO supplement (#630428) 
   | Minimal SD Base (#630411) 
   | YPD (#630409) 
             | X-!-Gal (#630407) 
BDH   | Glycine (Mw=75.07) 
| Sodium fluoride (Mw=41.99) 
 | Sodium azide (Mw=65.01) 
| Sodium dihydrogen orthophosphate monohydrate  
(Mw=137.99) 
 | Sodium "-glycerophosphate (Mw= 216.04) 
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 | Sodium acetate (Mw=82.03) 
 | Sodium hydroxide (Mw=40.00) 
 | Sucrose (Mw=342.3) 
 | Tetra-sodium pyrophosphate (Mw=446.06) 
 | Sodium chloride (Mw=58.44) 
 | Ammonium Sulphate (Mw=132.14) 
 | Tris(Hydroxymethyl)methylamine (Mw=121.14) 
 | Magnesium chloride hexahydrate (Mw=203.3) 
 | Manganese chloride (Mw=197.9) 
 | Poly-ethylene-glycol (Mw=3350.0) 
 | Ponceau S (Mw=760.6) 
 | Neutral red (Mw=288.78) 
                  | Poly-L-lysine 
Bioline   | 1Kb ladder 
Bio-Rad | Precision Plus ProteinTM Standards – KaleidoscopeTM  
                            (#161-0375) 
Biowhittaker  | DMEM (4.5 g/L Glucose w/o Sodium pyruvate) 
   | DPBS 
Calbiochem  | Okadaic Acid, ammonium salt (#459161) 
   | Fostriecin, sodium salt, Streptomyces pulveraceous (#344280) 
Fisher Scientific | Ethanol 
   | Isopropanol 
GE Healthcare | ECL plus 
   | ECL advance 
   | Activated CH Sepharose 4B 
Geneflow  | 30% Acrylamide, 0.8% Bisacrylamide 
Invitrogen  | Parafilm 
   | Agarose 
   | Agar 
   | OligofectamineTM (#12252-011) 
   | Opti-MEM® I (Gibco) 
   | FBS (Gibco) 
   | Glutamine (Gibco) 
   | Penicillin/Streptomycin (Gibco) 
   | IPL-41 (Gibco) 
   | Fungizone (Gibco) 
   | Yeastolate (Gibco) 
   | Pluoronic-F68 (Gibco) 
| Gentamicin (Gibco) 
                           | Progold antifading reagen 
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Marvel   | Dried skimmed milk 
NEB   | Protein Phosphatase Inhibitor 2 (I-2) – (#P0755S) 
Normapur  | Glycerol (Mw=92.09) 
Oxoid   | PBS tablets 
Pierce Bio  | ECL reagent 
QIAGEN  | Superfect® 
Roche   | Complete Protease Inhibitor Cocktail tablets (EDTA free) 
                     (#1-873-580) 
Sigma   | Potassium carbonate (Mw=138.21) 
   | PMSF (Mw=174.10) 
 | SDS (Mw=288.38) 
 | Sodium carbonate (Mw=124.01) 
 | Sodium hydrogencarbonate (Mw=84.01) 
 | TEMED (Mw=116.21) 
 | Triton X-100 
 | Tween-20 
 | BSA 
 | Ampicillin (Mw=371.39) 
 | Glass Beads, acid-washed 
 | ONPG (2-Nitrophenyl "-D-galactopyranoside) 
 | Aphidicolin (from Nigrosphora Sphaeria) 
 | Glutathione-Agarose (#G-4510) 
 | Ammonium persulphate (Mw=228.2) 
 | "-glycerophosphate (Mw=216.0) 
 | Chloramphenicol (Mw=323.13) 
 | DMSO-Hybri Max (Mw=78.13) 
 | Etidium bromide tablets (Mw=394.3) 
 | EGTA (Mw=468.3) 
 | Kanamycin (Mw=582.6) 
 | Lithium acetate dihidrate (Mw=102.2) 
 | "-mercaptoethanol (Mw=78.13) 
 | 5-chloro-2-deoxyuridine (CldU) - (#C6891) 
 | 5-iodo-2-deoxyuridine (IdU) - (#I7125) 
 | DNA, sodium salt, from Salmon testes (#D1626) 
 | Phenol/Chloroform 
 | Protein G beads 
 | Microcystin LR (#M2912) 
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VIII.5 ANTIBODIES 
 
VIII.6 ENZYMES 
Applied Biosystems | Sequencing Ready Reaction Mix 
NEB   | "-Agarase I (#M0392) 
   | T4 DNA Ligase (#M0202) 
  | Protein Phosphatase Inhibitor 2 (I-2) – (#P0755S) 
  | Restriction enzymes 
Roche    | Shrimp Alkaline Phosphatase (#1-758-250) 
Sigma   | RNase A 
Stratagene   | PfuUltraTM high-Fidelity DNA Polymerase (#600380) 
 
TABLE VIII.1 | LIST OF ANTIBODIES. Making reference to company, dilution and species where 
they were raised in.!
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VIII.7 PLASMIDS 
VIII.7.1 PAS2-1 
 
 
FIGURE VIII.1 | PAS2-1 VECTOR MAP AND MCS (CLONTECH). Vector used in the YTH system to 
generate fusion proteins with the GAL4 DNA-Binding domain. The expression of the fusion 
protein occurs at high levels in yeast due to the presence of the full-length ADH1 promoter. 
The presence of nuclear localization sequences in the fusion protein, targets this protein to 
that cell compartment. This vector also expresses the TRP1 gene, which allows the Trp- 
auxotrofic strains to grow on medium lacking this aminoacid.!
Protein Phosphatases acting on the Replication Checkpoint                                         Appendix 
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!
Centro de Biologia Celular 
Universidade de Aveiro | Portugal 255 
Centre for Developmental and 
Biomedical Genetics 
University of Sheffield | UK !
VIII.7.2 PACT2  
 !
FIGURE VIII.2 | PACT2 VECTOR MAP AND MCS (CLONTECH). Vector used in the YTH system to 
generate fusion proteins with the GAL4 Activation domain, an HA epitope and protein 
generated by either a cDNA library or a specific subcloned protein of interest. The expression 
of this fusion protein occurs at medium levels in yeast due to the presence of a truncated 
form of the ADH1 promoter. The presence of the SV40 T-antigen nuclear localization 
sequence, targets the fusion protein to that cell compartment. This vector also expresses the 
LEU gene, which allows the Leu- auxotrofic strains to grow on medium lacking this 
aminoacid.!
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VIII.7.3 PVA3-1 
 
 
 
FIGURE VIII.3 | PVA3-1 VECTOR MAP (CLONTECH). This vector is used in the YTH system as 
positive control. It expresses the Murine p53 fused to the GAL4 DNA-Binding domain. The 
vector used to insert the protein was the pAS1CYH2 which is a precursor of the pAS2-1 
(shown in Section VIII.7.1). !
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VIII.7.4 PTD1-1 
 
 
 
 
FIGURE VIII.4 | PTD1-1 VECTOR MAP (CLONTECH). This vector is used in the YTH system as 
positive control along with the pVA3-1 vector (Section VIII.7.3). The vector expresses the 
SV40 large T-antigen fused to the GAL4 Activation domain. To subclone the referred protein, 
the vector used was the pACT2, which is shown in Section VIII.7.2.!
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VIII.7.5 POTB7 
 
 
 
 
 
 
 
 
 
FIGURE VIII.5 | POTB7 VECTOR MAP. Bacterial vector which carried Chk1, CDC25C and I-2 
cDNAs, for subsequent subcloning into the appropriate expression systems. The vector 
allows the host to grow in chloramphenicol containing medium.!
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VIII.7.6 PCMV-SPORT6 
 
 
 
FIGURE VIII.6 | PCMV-SPORT6 VECTOR MAP (INVITROGEN). This vector carried the PME-1 
cDNA for sucloning it into the desired expression system. The vector may also be used for 
expression in eukaryotic systems and confers the host cell with resistance to ampicillin. !
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VIII.7.7 PCMV-HA 
 
 
 
FIGURE VIII.7 | PCMV-HA VECTOR MAP AND MCS (CLONTECH). Vector used to test putative 
interactions identified witg the YTH screen, in a mammalian system. The vector generates a 
fusion protein of the identified positive clone with an HA epitope. 
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VIII.7.8 PCDNA5/TO 
 
 
 
FIGURE VIII.8 | PCDNA5/TO VECTOR MAP (INVITROGEN). This vector is used to establish 
inducible stable cell lines. The cDNA of interest is subcloned into the MCS and its expression 
is regulated by the pCMV promoter and tetracycline operator (2x TetO2). This operator in the 
presence of the Tet repressor prevents the expression of the subcloned protein. The vector 
also confers resistance to Hygromycin, an antibiotic that allows the generation of stable cell 
lines by the selection of the cells that contain this vector.!
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VIII.8 PRIMERS 
 
 
 
 
VIII.9 CDNAS AND SIRNAS 
Imagenes | Protein Phosphatase 1, regulatory (inhibitor) subunit 2 (Clone: 
IRALp962O165Q) 
  | Protein Phosphatase methylesterase 1, (Clone: IRATp970C1178D) 
  | Cell division cycle 25C, (Clone: IRAUp969H0775D) 
(NB: Imagenes was formerly known as RZPD and is based in Germany) 
Dharmacon | siCONTROL Non-targeting siRNA #2 (#D-0012110-02-20) 
| siGENOME SMARTpool, Human PPP4C, NM_002720 
(#M-008486-01-0010) 
| siGENOME SMARTpool, Human PPP6C, NM_002721  
(#M-009935-01-0010) 
 !!!
Table VIII.2 | List of Primers. Making reference to its sequence, size and Tm (ºC)!
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VIII.10 SOLUTIONS 
VIII.10.1 SOLUTIONS FOR SDS-PAGE AND WESTERN BLOTTING 
1.5 M Tris (pH 8.8) Resolution Gel Buffer | 1 L 
• 181.5 g Tris base 
• 800 ml MQ water 
• Adjust pH to 8.8 (with HCl) 
• Adjust volume to 1 L 
• Autoclave at 121 ºC for 15 min 
• Store at room temperature 
 
1M Tris (pH 6.8) Stacking Gel Buffer | 100ml 
• 12.1 g Tris base  
• 80 mL MQ water 
• Adjust pH to 6.8 (with HCl) 
• Adjust volume to 100mL 
• Autoclave at 121 ºC for 15 min 
• Store at room temperature 
 
Running Buffer 10x | 1 L 
• 30.3 g Tris (25 mM) 
• 144.1 g Glicine (192 mM) 
• Fill with water until 800 ml 
• Set pH to 8.3 
• Fill with water until 1 L 
• 10.0 g SDS (0.1%) 
 
Stock solution 30% Acryl/0.8% Bis | 100 ml 
• 30 g Acrylamide 
• 0.8 g Bisacrylamide  
• Dissolve in water (heat to 37ºC) 
• Fill until 100 ml 
• Filter (with a 0.45 $m filter) 
• Store at 4ºC (3 months in the dark)  
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Stock solution 10% APS (ammonium persulfate) | 5 ml 
• 0.5 g APS 
• Fill until 5 ml (store at 4ºC | 1 week) 
• Stock solution 10% SDS (sodium dodecyl sulphate) | 10 ml 
• 1.0 g SDS 
• Solve in 10 ml of sterile water 
 
5x Laemmli Sample Loading Buffer | 50 ml 
• 5 g SDS (5% w/v) 
• 25 g Glycerol (50% w/v) 
• 15 ml Tris (pH 6.8 – 300mM) |  Stock 1M 
• 12.5 mg Bromophenol Blue (0.025%) 
• Fill with sterile water until 50 ml 
• Before use add "-mercaptoethanol in a way that the final concentration with 
the sample is at 1% 
 
Transfer Buffer 10x | 800 ml 
• 30.3 g Tris (25 mM) 
• 144.1 g Glicine (192 mM) 
• Fill with water until 800 ml 
• To use this solution mix as follows: 
• 80 ml Stock solution 
• Fill with water until 800 ml 
• 200 ml Methanol (20% final) 
 
10x TBS | 1 L 
• 12.11 g Tris 
• Fill with water until 800 ml 
• Set pH to 8.0 
• 87.665 g NaCl 
• Fill with water until 1000 ml 
 
1x TBS-T | 1 L 
• 100 ml 10x TBS stock 
• 900 ml  distilled water 
• 1 ml Tween 20 (0.1%) 
• Stir until all Tween 20 is in solution 
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TBS-T/5% Milk | 1 L 
• 100 ml 10x TBS stock 
• 900 ml dH2O 
• 1 ml Tween 20 (0.1%) 
• Stir until all Tween 20 is in solution 
• Add 5 g of dried skimmed milk 
• Stir until the solution is homogeneous 
 
Stripping solution | 500 ml 
• 3.5 ml "-mercaptoethanol (100 mM) 
• 400 ml dH2O 
• 10 g SDS (2%) 
• 3.76 g Tris (62,5 mM) 
• set pH to 6.7 with HCl 
• Fill with dH2O until 500 ml 
 
Comassie blue staining solution | 400 ml 
• 1 tablet of Phastel Blue R 
• 80 ml dH2O 
• 120 ml Methanol 
• 40 ml Acetic acid 
• Stir until the tablet is in solution 
• 160 ml dH2O 
 
1x Destaining solution | 2 L 
• 100 ml Methanol (5%) 
• 150 ml Acetic Acid (7,5%) 
• Fill with water until 2000 ml 
 
Ponceau S stock solution | 100 ml  
• 0.1 g Ponceau S 
• 5 ml Acetic Acid (5%) 
• Fill with water until 100 ml 
 
VIII.10.2 SOLUTIONS FOR DNA ELECTROPHORESIS 
TAE 50X | 1 L 
• 242 g Tris Base 
• 57.1 mL Glacial Acetic Acid 
• 100.0 mL 0,5 M EDTA (pH 8,0) 
• Fill with water until 1L 
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Loading Buffer 6X (DNA) 
• 0,25% Bromophenol Blue 
• 30,0% Glycerol 
 
10x Ladder 1 Kb | 0.6 ml 
• 60 µl (1 Kb Ladder | 1 µg/µL) 
• 100 µl  LB 
• 440 µl Sterile Water 
 
Ethidium Bromide (10 mg/mL) | stock solution 
• 1 g Ethidium Bromide 
• 100 ml Sterile Water 
• Stir on a magnetic stirrer for several hours (ensure that the dye has dissolved) 
• Wrap the container in aluminium foil or transfer the solution to a dark bottle 
and store at room temperature 
• To use in agarose gel dilute to 0.5 mg/ml and use a 1:10.000 dilution in the gel 
(example: 10 µl of Ethidium Bromide in 100 ml agarose gel) 
 
VIII.10.3 SOLUTIONS FOR BACTERIAL CULTURES 
LB | 1 L 
• 10 g Bacto-tryptone 
• 5 g Bacto-yeast extract 
• 10 g NaCl 
• Dissolve in 950 ml of Sterile Water 
• Adjust the pH to 7.0 with 5 N NaOH 
• Autoclave at 121 ºC for 15 min 
 
LB/Agar | 1 L 
• The same as for the LB but add 16 g of agar before autoclaving 
 
250 mM KCl | 100 ml 
• 1.86 g KCl 
• 100 ml dH2O 
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SOB | 1 L 
• 20 g Bacto-tryptone 
• 5 g Bacto-yeast extract 
• 0.5 g NaCl 
• 950 ml Destilled Water 
• Stir until all is dissolved 
• 10 ml KCl (stock 250 mM) 
• Adjust pH to 7.0 with 5N NaOH (0.2 ml) 
• Fill with dH2O until 1000 ml 
• Autoclave at 121ºC for 15 minutes 
• Add 5 ml of a sterile solution of 2 M MgCl2 just prior to use 
 
SOC | 500 ml 
• 1.0 g Bacto-tryptone 
• 2.5 g Bacto-yeast extract 
• Dissolve in 400 ml of Sterile Water 
• 0.5 ml NaCl (1M) 
• 1.25 ml KCl (1M) 
• Adjust the pH to 7.0 
• Adjust the volume to 480.0 ml 
• Autoclave at 121 ºC for 15 min 
• Add sterile: 
• 5.0 ml MgCl2 (1M) 
• 5.0 ml MgSO4 (1M) 
• 10.0 ml Glucose (1M) 
 
Ampicillin  
• Stock solution | 100 mg/ml in dH2O 
 
1M MgCl2 | 1 L 
• 203.3 g MgCl2.6H2O 
• 800 ml dH2O 
• Dissolve and fill with water until 1 L 
• Autoclave at 121 ºC for 15 min 
 
1M MgSO4 | 1 L 
• 246.5 g MgSO4.7H2O 
• 800 ml dH2O  
• Dissolve and fill with water until 1 L 
• Autoclave at 121 ºC for 15 min 
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Competent cells | Solution I | 1 L 
• 9.9 g MnCl2.4H2O 
• 1.5 g CaCl2.2H2O 
• 150 g Glycerol 
• 30 ml Potassium acetate (1 M) 
• Fill with water until 850 ml and adjust the pH to 5.8 with Acetic Acid, adjust 
volume to 1000 ml 
• Filter with a 0.2 µm (Store at 4ºC) 
 
Competent cells | Solution II | 1 L 
• 20 ml MOPS (pH 6.8) | 0.5 M stock 
• 1.2 g RbCl 
• 11.0 g CaCl2.2H2O 
• 150 g Glycerol 
• Filter with a 0.2 µm (Store at 4 ºC) 
 
RNase solution 
• RNAase stock solution | 10mg/ml 
 
Alkaline lysis | Solution I | 100 ml 
• 25 mM TrisHCl pH 8.0 (2.5 mL stock solution – Tris 1 M) 
• 10 mM EDTA pH 8.0 (2.0 mL stock solution – EDTA 0.5M) 
• 90.5 mL sterile water 
• Autoclave at 121 ºC for 15 min 
• 50 mM Glucose (5 mL stock solution – Glucose 1 M) 
 
Alkaline lysis | Solution II | 250 ml 
• 0.2 N NaOH (2.0 g NaOH) 
• 1 % SDS (2.5 g SDS) 
• 250 ml sterile water 
 
Alkaline lysis | Solution III | 100 ml 
• 60.0 ml Potassium Acetate 5 M 
• 11.5 ml Glacial Acetic Acid 
• 28.5 ml Sterile Water 
 
5 M Potassium Acetate | 300 ml 
• 147.15 g Potassium Acetate 
• Add 200 ml Sterile Water 
• Dissolve and adjust volume to 300 ml with water 
• Filter 
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VIII.10.4 SOLUTIONS FOR YEAST CULTURES 
YPD | 1 L 
• 50 g YPD (in case of plates add 20 g of Agar) 
• 1 L Sterile Water 
• Set pH to 6.5 
• Autoclave at 121ºC for 15 min 
 
Adenine 0.2% | 250 ml 
• 0.5 g Adenine 
• 250 ml Sterile Water 
• Autoclave at 121 ºC for 15 min 
 
2x YPDA/Kan | 300 ml 
• 15 g YPD 
• 291 ml Sterile Water 
• Autoclave at 121 ºC for 15 min 
• 9 ml Adenine 0.2% 
• 125 µl Kanamicin (Stock 30 mg/ml) 
 
0.5x YPDA/Kan | 300 ml 
• 2.5 g YPD 
• 500 mL Sterile Water 
• Autoclave at 121 ºC for 15 min 
• 0.375 ml Adenine 0.2% 
• 21 µl Kanamicin (Stock 30 mg/ml) 
 
SD | 100 ml 
• 0.67 g Yeast Nitrogen Base 
• Add the appropriate Dropout supplement powder 
• (in case of plates add 2 g of Agar) 
• 90 ml Sterile Water 
• Adjust pH to 5.8 
• Set volume to 100 ml 
• Autoclave at 121ºC for 15 min 
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Glucose 40% | 1 L 
• 400 g Glucose 
• 500 ml Sterile Water 
• Mix well by adding little glucose at a time 
• After its all mixed set volume to 1 L 
• Filter in a 0.22 µm 
 
Glycerol 50% | 100 ml 
• 50 ml Glycerol 
• 50 ml Sterile Water 
• Autoclave at 121ºC for 15 min 
 
X – # – Gal  
• Dilute 1:5 (to 20 µl of stock solution – 20 mg/ml - add 80 µl of DMF | Dimetil 
Formamide) 
• Use 100 µl in Ø 100 mm plates 
• Use 170 µl in Ø 150 mm plates 
 
PMSF 100x | 10 ml 
• 0.1742 g PMSF 
• 10 ml Isopropanol 
• Keep in the dark 
 
Protease inhibitor solution | 688 µl 
• 66 µl | 0.1 mg/ml Pepstatin A (stock 1 mg/ml in DMSO) 
• 2 µl | 0.03 mM Leupeptin  (stock 10.5 mM) 
• 500 µl | 145 mM Benzamidine  (stock 200 mM) 
• 120 µl | 0.37 mg/ml Aprotinin  (stock 2.1 mg/ml in DMSO) 
 
Cracking buffer stock solution | 100 ml 
• 48 g Urea (8 M) 
• 5 g SDS (5% W/V) 
• 4 ml Tris-HCl (pH 6.8 40 mM) | Stock solution 1 M 
• 20 µl EDTA (0.1 mM) | Stock solution 0.5 M 
• 40 mg Blue Bromophenol (0.4 mg/ml) 
• Fill with water until 100 ml 
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Cracking buffer - complete (1.13 ml) 
• 1 ml cracking buffer stock solution  
• 10 µl "-mercaptoethanol 
• 70 µl Protein Inhibitor Solution (pre-chilled) 
• 50 µl PMSF (100x) 
 
1x TE/LiAc | 1.5 ml  
• 150 µl TE 10x Buffer 10x 
• 150 µl LiAc (1M) 
• 1200 µl dH2O 
 
PEG/LiAc | 1 ml 
• 800 µl 50% PEG 
• 100 µl 10x TE Buffer 
• 100 µl 1M LiAc 
 
TE buffer (pH 7.5) 
• 10mM Tris-HCl, pH 7.5 
• 1mM EDTA, pH 8.0 
 
VIII.10.5 SOLUTIONS FOR MAMMALIAN CELL CULTURE AND ENZYMATIC 
ASSAYS 
DMEM 
• DMEM 
• Glutamine 1% 
• FBS 10% 
• Penicillin/Streptomycin 1% 
• Sterile filter 
 
PBS (pH7.4) 
• 8mM Sodium Phosphate 
• 2mM Potassium Phosphate 
• 140mM NaCl 
• 10mM KCl 
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2X HBS | 500 ml 
• 8 g NaCl 
• 0.2 g Na2HPO4.7H2O (0.14 g if using dehydrate; phosphate concentration must 
be 0.15mM) 
• 6.5 g HEPES 
• Fill with MQ water till 400 ml 
• Set pH 7.0  
• Set volume to 500 ml 
• Sterile filter 
 
5 mg/ml Aphidicolin | 2 ml 
• 10 mg Aphidicolin 
• 2 ml DMSO 
• Sterile filter 
• Aliquot and store at -20ºC 
 
2M CaCl2 | 500 ml 
• 87.6 g CaCl2.6H2O 
• Fill with MQ water  
 
1.3 mM CldU| 30 ml 
• 10.24 mg CldU 
• 30 ml dH2O 
• Sterile filter 
• Aliquot and store at -20ºC 
 
0.95 mM IdU| 30 ml 
• 10.1 mg IdU 
• 30 ml dH2O 
• Sterile filter 
• Aliquot and store at -20ºC 
• 1.5 N HCl | 50 ml 
• 8.3 ml HCl (d=1.16, 32%) 
• 41.7 ml dH2O 
 
1 M HU | 5 ml 
• 0.38 g HU 
• 5 ml dH2O 
• Sterile filter 
• Aliquot and store at -20ºC 
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100 !M OA | 300 !l 
• 25 $g OA (flask opened in the hood) 
• 300 $l sterile filtered dH2O 
• Aliquot and store at -20ºC 
 
100 !M Fostriecin | 221 !l 
• 10 $g Fostriecin (flask opened in the hood) 
• 221 $l sterile filtered dH2O 
• Aliquot and store at -20ºC 
 
1x Lysis buffer without Protein Phosphatase inhibitors | 1 ml 
• 20 mM Tris/Acetate pH 7.5 
• 0.27 M Sucrose 
• 1% Triton X-100 
• 0.1% "-Mercaptoethanol 
• 0.2 mM PMSF 
• 75 µl of a Proteinase inhibitor cocktail 
• 623 µl dH2O 
 
5x Lysis Buffer with Protein Phosphatase inhibitors | 200 ml (Concentrations 
relative to 1X Lysis Buffer) 
• 2.423g Tris (20 mM pH 7.5) 
• 92.421g Sucrose (0.27 M) 
• 10 g Triton X-100 (1% w/v) 
• 0.372 g EDTA (1 mM) 
• 0.468 g EGTA (1 mM) 
• 2.16 g Sodium "-Glycerophosphate (10 mM) 
• 2.23 g Sodium Pyrophosphate (5 mM) 
• 2.10 g Sodium Fluoride (50 mM) 
• Adjust volume until 200 ml (first set pH to 7.5) 
• Store at 4ºC 
• When preparing 1X solution add  
• 10 µl of a 100 mM Sodium orthovanadate stock per ml of solution  
• 75 µl of a Proteinase inhibitor cocktail per ml of solution 
• 1 µl of "-Mercaptoethanol per ml of solution  
• 1 µl of Microcystin (100 $M) per ml of solution  
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100mM Sodium Orthovanadate | 200 ml 
• 3.678g Sodium Orthovanadate 
• Dissolved to 200 mM in 100 ml of MQ water 
• Adjust to pH 10 
• Heat at 100ºC for 10 min 
• Repeat last two steps until solution goes clear 
• Set volume to 200 ml | 100mM 
 
Complete Proteinase Inhibitor Cocktail | Roche | 2 ml 
• 1 tablet 
• Dissolve in 2 ml of MQ water 
• Dispense in suitable aliquots and store at -20ºC 
 
1M HEPES pH 7.9 | 500 ml 
• 119.15g HEPES 
• Dissolve in 400 ml MQ water 
• Set pH to 7.9 
• Adjust volume to 500 ml 
• Reset pH to 7.9 
 
1M KCl | 500 ml 
• 37.275g KCl 
• Dissolve in 400 ml MQ water 
• Adjust volume to 500 ml 
 
1M MgCl2 | 500 ml 
• 101.65g MgCl2 
• Dissolve in 400 ml MQ water 
• Adjust volume to 500 mL 
• 100 mM MnCl2 | 500 ml 
• 9.895g MnCl2 
• Dissolve in 450 mL MQ water 
• Adjust volume to 500 mL 
 
5M NaCl | 500 ml 
• 146.1g NaCl 
• Dissolve in 400 ml MQ water 
• Adjust volume to 500 ml 
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5x Kinase buffer 
• 250 mM Tris-HCl pH 7.5 
• 0.5 mM EGTA 
• 0.5 % "-Mercaptoethanol 
 
VIII.10.6 SOLUTIONS FOR PROTEIN PURIFICATION FROM BACULOVIRUS 
SYSTEM 
Lysis buffer | 1L 
• 50 mM Tris-HCl (pH 7.5) 
• 150 mM NaCl 
• 270 mM Sucrose 
• 1% Triton 
• 0.2 mM EDTA 
• 0.2 mM EGTA 
• 0.1% "-mercaptoethanol  
• 0.2 mM PMSF 
• 1 mM Benzamidine 
 
 
Equilibration buffer and Wash buffer | 1L 
• 50 mM Tris-HCl (pH 7.5) 
• 0.03% Brij-35 
• 250 mM NaCl 
• 0.1 mM EGTA 
• 0.1% "-mercaptoethanol 
• 0.2 mM PMSF 
• 1 mM Benzamidine 
 
Elution buffer | 1L 
• Same as Equilibration buffer 
• 20 mM Glutathione (pH 7.5) 
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Dialysis buffer | 1L 
• 50 mM Tris-HCl (pH 7.5) 
• 0.03% Brij-35 
• 150 mM NaCl 
• 0.1 mM EGTA 
• 270 mM Sucrose 
• 0.1% "-mercaptoethanol  
• 0.2 mM PMSF 
• 1 mM Benzamidine 
 
1M MES | 100mL 
• 19.25g in 80 ml of H2O (pH 6.3 with 5M KOH) 
• add  H2O to do a total of 100 ml 
• sterilize by filtration | 0.45 µm 
• split in 10 ml aliquots 
• store at -20ºC 
 
MBS | 1L 
• 20 mM MES 
• 40 mM KCl 
• 0.1 mM EGTA (pH 6.3) 
 
VIII.10.7 SOLUTIONS FOR #-GAL ASSAY 
4 mg/ml ONPG in Buffer Z  
• ONPG requires 1–2 hr to dissolve 
• Prepare solution fresh before each use 
• On the day of the experiment, dissolve ONPG at 5 mg/ml in Z buffer with 
shaking for 1–2 hr (5 mg/mL ! 10 mL) 
 
Z buffer 
• Na2HPO4.7H2O 16.1 g/L 
• NaH2PO4.H2O 5.50 g/L 
• KCl 0.75 g/L  
• ggMgSO4.7H2O 0.246 g/L 
• Adjust to pH 7.0 and autoclave. Can be stored at room temperature for up to 1 
year. 
 
Z buffer with "-mercaptoethanol 
• To 100 ml of Z buffer, add 0.27 ml of "-mercaptoethanol. 
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1M Na2CO3 | 100 ml 
• 12.401 g Na2CO3 
• 100 ml dH2O 
• Stir until completely dissolved 
• Store at RT 
 
VIII.11 CELL LINES 
Bacteria 
E.coli DH5! subcloning efficiency (Invitrogen) | F- &80lacZ'M15 '(lacZYA-argF)U169 
recA1 endA1 hsdR17 (rk-, mk-) phoA supE44 thi-1 gyrA96 relA1 %-  
 
E. coli XL1- blue | recA endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac[F’ proAB 
lacZ'M15 Tn10(Tetr)] 
 
Yeast 
S. cerevisiae AH109 | MATa trp1-901 leu2-3,112 ura3-52 his3-200 gal4' gal80' 
LYS2::GAL1UAS-GAL1TATA-HIS3 GAL2UAS-GAL2TATA-ADE2 URA3::MEL1UAS-MEL1TATA-lacZ 
MEL1 
 
S. cerevisiae Y187 | MAT! ura3-52 his3-200 ade2-101 trp1-901 leu2-3, 112 gal4' 
met- gal80' URA3:: GAL1UAS-GAL1TATA-lacZ MEL1 
 
S. cerevisiae PJ69-4A | MATa trp1-901 leu2-3,112 ura3-52 his3-200 gal4' gal80' 
LYS2::GAL1UAS-GAL1TATA-HIS3 GAL2UAS-GAL2TATA-ADE2 met2::GAL7UAS-GAL7TATA-lacZ 
 
S. cerevisiae PJ69-4! | MAT! trp1-901 leu2-3,112 ura3-52 his3-200 gal4' gal80' 
LYS2::GAL1UAS-GAL1TATA-HIS3 GAL2UAS-GAL2TATA-ADE2 met2::GAL7UAS-GAL7TATA-lacZ 
 
Insect cell line 
Spodoptera frugiperda Sf21 | from pupal ovarian tissue of the Fall Armyworm 
 
Human cell line 
Homo sapiens HeLa | epithelial adenocarcinoma cell line from cervix 
 
 !
